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Chapter 1
General introduction
Chapter 1     |     General introduction 
10 
Ageing 
It is well known that the world population is ageing. By the year 2050, 20% of the world population 
will be aged 60 years and above [1]. American and European people aged 65 years between 2000-
2015 had a life expectancy of 20 years [2]. Moreover, as assessed in 2014, chronic diseases start to 
occur at 61.4 years for men and 61.8 years for women in the EU [3]. Thus, not only the population is 
ageing, but also the number of people living with chronic diseases is increasing. 
Cognitive decline during ageing 
As part of the ageing process the brain ages as well, leading to a decline in cognitive functioning 
(figure 1). There is convincing evidence demonstrating that age-related cognitive decline starts from 
the late 20’s and continues throughout the lifespan [4]. A progressive – and usually chronic - decline 
in memory, language, problem-solving and other cognitive skills that affects a person’s ability to 
perform everyday activities leads to mild cognitive impairment (MCI) and may progress to dementia 
[5]. Dementia is caused by a variety of brain illnesses, of which Alzheimer’s Disease (AD), vascular 
dementia, dementia with Lewy bodies, and frontotemporal dementia are the most common. 
Dementia results in personal suffering, demands on the family for caregiving, and eventually leads to 
the need for institutionalized care. In 2015, 9.4 American and 10.5 million European people were 
living with dementia and this number is estimated to increase to 131.5 billion worldwide by 2050 [6]. 
Unfortunately, despite this increase in the number of people living with dementia, studies on novel 
drugs to treat dementia have been negative [7]. Thus, there is an urgent need to find modifiable 
strategies to postpone the onset of cognitive decline and dementia. 
Figure 1. Progression from normal ageing to Alzheimer’s disease or another dementia (adapted from [8]). 
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11 
Risk factors for cognitive decline 
There are many risk factors for cognitive decline comprising non-modifiable risk factors and 
modifiable risk factors. Non-modifiable risk factors include age [9], female sex [9], family history [10, 
11] and genetic susceptibility (e.g., the presence of 1 or 2 copies of the apolipoprotein E (APOE) Ɛ4 
allele) [9, 12]. Modifiable risk factors can be divided into cardiovascular risk factors (diabetes, mid-life 
obesity, mid-life hypertension, and hyperlipidaemia), lifestyle risk factors (current smoking, physical 
activity, diet, alcohol, cognitive training, and social engagement), and other risk factors (education, 
brain injury, depression and sleep) [13]. There is strong evidence for an increased risk of cognitive 
decline for brain injury, mid-life obesity and mid-life hypertension, current smoking and diabetes 
(figure 2). 
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Figure 2. Strength of evidence on risk factors for cognitive decline (adapted from [13])  
 
Nutrition and mechanisms in cognitive functioning  
Many of the risk factors described above can be modified by diet. To date, numerous studies have 
been conducted demonstrating a possible link between the intake of specific nutrients and foods on 
cognitive functioning. Examples include omega-3 fatty acids, vitamin D, vitamin B6, vitamin B12, 
folate, flavonoids, and vitamin E, but also foods, such as fish, nuts and seeds, and fruits and 
vegetables [14]. Omega-3 fatty acids have anti-inflammatory [15] and cardiovascular protective 
effects [16] and may therefore reduce the risk of atherothrombotic complications such as stroke [17] 
and subsequent cognitive decline. Furthermore, omega-3 fatty acids may improve the composition of 
cell membranes and therefore stimulate the development and regeneration of nerve cells [18]. 
Vitamin D plays a role in the prevention of neurological, autoimmune, and psychiatric diseases [19]. 
Folate, vitamin B6, and vitamin B12 are required for proper DNA methylation and to prevent the 
accumulation of homocysteine. Homocysteine is an intermediary amino acid that has been 
associated with cardiovascular disease and stroke, as well as cognitive decline [14]. Flavonoids and 
vitamin E have been proposed to have significant antioxidant and anti-inflammatory effects [14]. 
However, evidence from observational and intervention studies provide mixed results for the role of 
single nutrients on cognitive functioning.  
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Dietary patterns; a more powerful approach to study nutrition 
Because people do not consume single nutrients but rather a combination of nutrients and foods 
within a complete diet, the research field has shifted towards studying dietary patterns. Studying 
dietary patterns allows one to combine the synergistic effects of single nutrients [20-22]. Thus, 
studying dietary patterns could be a more powerful approach and also more relevant to the general 
public to unravel the role of diets for a healthier cognitive ageing.  
For dietary patterns, roughly three main biological mechanisms have been proposed by 
which diet could potentially protect against dementia risk and cognitive decline, relating to: 1) the 
vascular system (e.g., aortic stiffness [23] or microvascular function [24]), 2) oxidative stress (e.g., 
free radicals and brain protection or damage [25], or loss of neuronal homeostasis and 
neurodegenerative diseases development [26]) and 3) attenuation of the inflammatory pathway 
(e.g., microglial priming [27, 28]. 
Dietary patterns have frequently been studied in relation to, for example, cardiovascular 
health, but studying the association between dietary patterns and cognitive functioning is relatively 
new and less frequently done. Especially intervention studies are lacking. As a result, the most 
effective dietary pattern that impacts brain health has not yet been found. Dietary patterns of 
interest include the Mediterranean diet [29], the Healthy Diet Indicator (HDI) [30], the Dietary 
Approaches to Stop Hypertension (DASH) diet [31], the Mediterranean-Dietary Approach to Systolic 
Hypertension diet intervention for neurodegenerative delay (MIND) diet [32], and the NUtrients and 
AGEing (NU-AGE) diet [33]. All these dietary patterns are based on prior knowledge – so called a 
priori or knowledge based dietary patterns – as opposed to a posteriori (data driven) dietary 
patterns. A priori dietary patterns can be based on the observation of a healthy dietary pattern 
within a population, for example the Mediterranean diet. Alternatively, a priori dietary patterns can 
be based on dietary recommendations (NU-AGE diet), or components that have been associated with 
certain health outcomes, such as the HDI, the DASH diet and the MIND diet. Table 1 provides an 
overview of dietary components included in each of the dietary patterns. 
 
Mediterranean Diet 
The Mediterranean diet is an example of a healthful dietary pattern observed within a specific 
population as it is a collection of eating habits traditionally followed by people living in the 
Mediterranean. This diet is characterized by a high intake of olive oil, fruit, vegetables and legumes, a 
moderate intake of fish and red wine during meals [34] (table 1). The Mediterranean diet is one of 
the dietary patterns that is most frequently studied in relation to cognitive functioning.  
At the start of this thesis in 2011, there were very few publications about the Mediterranean 
diet and cognitive decline or dementia. Nicolas Scarmeas was one of the first researchers reporting a 
reduced risk of AD among American older adults with the highest adherence to Mediterranean diet 
in a prospective study [35] and a case-control study [36]. In the same cohort, Scarmeas 
demonstrated a reduced risk of (MCI) with higher adherence to the Mediterranean diet [37]. A 
slower rate of cognitive decline was reported among another population of French older adults with 
the highest adherence to the Mediterranean diet [38] and the risk of incidence MCI or dementia was 
reduced in subjects with a high Mediterranean diet score in an Australian cohort [39].
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studying dietary patterns could be a more powerful approach and also more relevant to the general 
public to unravel the role of diets for a healthier cognitive ageing.  
For dietary patterns, roughly three main biological mechanisms have been proposed by 
which diet could potentially protect against dementia risk and cognitive decline, relating to: 1) the 
vascular system (e.g., aortic stiffness [23] or microvascular function [24]), 2) oxidative stress (e.g., 
free radicals and brain protection or damage [25], or loss of neuronal homeostasis and 
neurodegenerative diseases development [26]) and 3) attenuation of the inflammatory pathway 
(e.g., microglial priming [27, 28]. 
Dietary patterns have frequently been studied in relation to, for example, cardiovascular 
health, but studying the association between dietary patterns and cognitive functioning is relatively 
new and less frequently done. Especially intervention studies are lacking. As a result, the most 
effective dietary pattern that impacts brain health has not yet been found. Dietary patterns of 
interest include the Mediterranean diet [29], the Healthy Diet Indicator (HDI) [30], the Dietary 
Approaches to Stop Hypertension (DASH) diet [31], the Mediterranean-Dietary Approach to Systolic 
Hypertension diet intervention for neurodegenerative delay (MIND) diet [32], and the NUtrients and 
AGEing (NU-AGE) diet [33]. All these dietary patterns are based on prior knowledge – so called a 
priori or knowledge based dietary patterns – as opposed to a posteriori (data driven) dietary 
patterns. A priori dietary patterns can be based on the observation of a healthy dietary pattern 
within a population, for example the Mediterranean diet. Alternatively, a priori dietary patterns can 
be based on dietary recommendations (NU-AGE diet), or components that have been associated with 
certain health outcomes, such as the HDI, the DASH diet and the MIND diet. Table 1 provides an 
overview of dietary components included in each of the dietary patterns. 
 
Mediterranean Diet 
The Mediterranean diet is an example of a healthful dietary pattern observed within a specific 
population as it is a collection of eating habits traditionally followed by people living in the 
Mediterranean. This diet is characterized by a high intake of olive oil, fruit, vegetables and legumes, a 
moderate intake of fish and red wine during meals [34] (table 1). The Mediterranean diet is one of 
the dietary patterns that is most frequently studied in relation to cognitive functioning.  
At the start of this thesis in 2011, there were very few publications about the Mediterranean 
diet and cognitive decline or dementia. Nicolas Scarmeas was one of the first researchers reporting a 
reduced risk of AD among American older adults with the highest adherence to Mediterranean diet 
in a prospective study [35] and a case-control study [36]. In the same cohort, Scarmeas 
demonstrated a reduced risk of (MCI) with higher adherence to the Mediterranean diet [37]. A 
slower rate of cognitive decline was reported among another population of French older adults with 
the highest adherence to the Mediterranean diet [38] and the risk of incidence MCI or dementia was 
reduced in subjects with a high Mediterranean diet score in an Australian cohort [39].
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Since then, the interest on the association between the Mediterranean diet and cognitive functioning 
has increased enormously. Dozens of publications were added, of which the majority of the 
observational studies demonstrated an association between higher adherence to the Mediterranean 
diet and cognitive function [45, 46], cognitive decline [47-49], AD [50], or (mild) cognitive impairment 
[46, 50, 51], and a few reported no association [52-54]. Only one intervention study has been 
conducted to date, reporting less cognitive decline among participants following the Mediterranean 
compared to a control group [55]. Another trial reported no association [56], but it was argued that 
this could be due to an enormous time gap between dietary assessment (1994-1996) and cognitive 
assessment (2007-2009) [57]. A review including studies up to January 2012 concluded that higher 
adherence to the Mediterranean diet was associated with better cognitive function, lower rates of 
cognitive decline and a reduced risk of AD in nine out of 12 studies whereas results for MCI were 
inconsistent [58]. A meta-analysis up to October 2012 including eight studies reported a lower risk of 
cognitive impairment for those with higher adherence to the Mediterranean diet [59] and another 
meta-analysis up to November 2012 including five studies on MCI or AD with a follow-up of at least 
one year reported a reduced risk of developing MCI and AD and a reduced risk for progressing from 
MCI to AD [60]. At last, the most recent review based on 14 different cohorts concluded that the role 
of a Mediterranean diet is not consistent across the many cohorts [61]. Given all this evidence, the 
Mediterranean diet seems a promising diet to postpone cognitive decline, however, results are 
mainly based on observational studies and not consistent yet.  
 
 
Healthy Diet Indicator 
The Healthy Diet Indicator (HDI) [30] has been identified as another interesting dietary pattern to 
impact cognitive functioning. This indicator captures a more general healthy dietary pattern, mainly 
based on nutrients instead of foods, which is more globally applicable (table 1). The HDI is a tool to 
classify a healthy diet according to the guidelines of the World Health Organization published in 1990 
[62], including high intakes of fruits, vegetables and fibre and limited intakes of saturated fatty acids, 
sodium and sugars. These guidelines were developed to reduce chronic diseases, such as 
hypertension. As hypertension has been shown to impact cognitive functioning [63-65], it has been 
hypothesized that the HDI could also reduce cognitive decline. The HDI has been cross-sectionally 
investigated in relation to cognitive functioning in 1998 and 2001 [66, 67], showing a tendency 
towards a lower prevalence of cognitive impairment with greater adherence to the HDI. Since then, 
the HDI has been updated [42] based on the latest scientific knowledge and lessons learned from 
implementing national intervention strategies to reduce the burden of chronic diseases [41]. The 
updated HDI has recently been investigated in relation to cardiovascular mortality demonstrating an 
inverse association with greater HDI adherence [42, 68-70]. However, the updated HDI has not yet 
been related to cognitive functioning. As cardiovascular health could be one strategy to impact 
cognitive functioning, the updated HDI seems to be a potential dietary pattern to contribute to 
healthier cognitive ageing. 
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Dietary Approach to Stop Hypertension diet 
A dietary pattern that has increasingly received attention is the Dietary Approach to Stop 
Hypertension (DASH) diet. The DASH diet specifies high intakes of fruits, vegetables, low-fat dairy 
products, whole grains, poultry, fish, and nuts and low intakes of fats, red meat, sweets and sugar-
containing beverages [31, 71] (table 1), and has been shown to lower blood pressure [31, 72]. It has 
been hypothesized that the DASH diet could impact cognitive functioning, as high blood pressure is 
associated with higher risk of MCI [73], vascular dementia [74], and neurocognitive deficits [63]. 
Studies demonstrating an association between the DASH diet and cognitive functioning are limited. 
Two observational studies reported a slower cognitive decline rate with greater DASH adherence 
after 4.7 years [75] and 11 years of follow-up [76]. To date, there is only one trial on the effect of the 
DASH diet on cognitive functioning, demonstrating that there was an improvement in psychomotor 
speed compared with the usual diet control among sedentary and overweight/obese individuals with 
prehypertension and hypertension [77]. 
 
 
Mediterranean-DASH Intervention for Neurodegenerative Delay diet 
A more recently defined dietary pattern is the Mediterranean-dietary approach to stop hypertension 
(DASH) diet Intervention for Neurodegenerative Delay (MIND) diet that specifically captures dietary 
components shown to be neuroprotective [32]. This diet has been developed based on the most 
recent knowledge and evidence from mostly observational studies targeting brain health in humans 
and animal experiments. The MIND diet uniquely specifies the consumption of green leafy vegetables 
and berries (table 1). To date, two observational studies have been conducted demonstrating less 
cognitive decline [32] and a lower risk of AD [44] for those with the highest MIND diet scores [32, 44].  
 
 
NU-AGE diet  
Given the many observational studies, but very limited number of intervention studies on healthful 
dietary patterns and cognitive functioning, there is a need for well-designed randomized dietary 
intervention studies. The NU-AGE (NUtrients and AGEing) dietary intervention study aimed to 
improve healthy ageing of a European population by means of a diet based on nutritional 
recommendations for the ageing population (table 1). This approach was taken because dietary 
intakes of adults aged 60 years and older are often below what is recommended. The prevalence of 
inadequate dietary intakes in European elderly was above 20% for vitamin D, folic acid, calcium, 
selenium and iodine [78]. With respect to malnutrition as assessed with the Mini Nutritional 
Assessment tool, 3% of people with mild to moderate AD were malnourished [79], up to 50% of 
patients with severe AD [80]. The NU-AGE study aimed at developing a dietary pattern that does not 
only meet the dietary habits and preferences of older adults but also uniquely targets the dietary 
recommendations of the ageing population. 
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Aim and outline of this thesis  
As outlined above, it is important to find dietary strategies for healthier cognitive ageing. There is 
quite some observational evidence demonstrating a link between diet and cognitive functioning. 
However, evidence from randomized controlled trials on the effect of a healthful diet on cognitive 
functioning is lacking. Moreover, it is not clear which dietary pattern is most suitable to impact 
cognitive functioning in an ageing population. The main aim of the thesis was to study the association 
of healthful dietary patterns with cognitive functioning. In addition, nutrient intake inadequacies 
were assessed and the potential to change dietary intake in older adults aged 65 years and older was 
studied. This thesis will add evidence to the link between dietary patterns and cognitive functioning 
by describing results from a wide range of studies, including a literature review, observational studies 
and an intervention study.  
 
Chapter 2 presents a cross-sectional description of current dietary intake in a Dutch population of 
adults aged 65 years and older. Chapter 3 includes a review about the current evidence on the 
association between dietary patterns, including the Mediterranean diet, the Dietary Approaches to 
Stop Hypertension (DASH) diet, and the Healthy Diet Indicator (HDI), with cognitive function and 
decline. In the following three chapters the HDI (chapter 4), the DASH diet (chapter 5) and the 
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet (chapter 6) are 
prospectively studied in relation to cognitive function and decline within a large population including 
over 16,000 American women aged 70 years and older. The last chapters of this thesis cover the NU-
AGE (NUtrients and AGEing) dietary intervention study. Chapter 7 provides an overview and the 
design of the NU-AGE dietary intervention study with the aim to improve dietary intakes of a 
European population aged 65 years and older for healthier ageing. Chapter 8 presents results of 
analyses to study if dietary intake of this European population of older adults shifts more towards 
their dietary recommendations. Additionally this paper describes the development and application of 
the NU-AGE diet index. The effects of the changes in the dietary intakes within the NU-AGE 
intervention on cognitive functioning are described in chapter 9. At last, chapter 10 gives an overall 
reflection on the studies that are presented in this thesis.  
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Aim and outline of this thesis  
As outlined above, it is important to find dietary strategies for healthier cognitive ageing. There is 
quite some observational evidence demonstrating a link between diet and cognitive functioning. 
However, evidence from randomized controlled trials on the effect of a healthful diet on cognitive 
functioning is lacking. Moreover, it is not clear which dietary pattern is most suitable to impact 
cognitive functioning in an ageing population. The main aim of the thesis was to study the association 
of healthful dietary patterns with cognitive functioning. In addition, nutrient intake inadequacies 
were assessed and the potential to change dietary intake in older adults aged 65 years and older was 
studied. This thesis will add evidence to the link between dietary patterns and cognitive functioning 
by describing results from a wide range of studies, including a literature review, observational studies 
and an intervention study.  
 
Chapter 2 presents a cross-sectional description of current dietary intake in a Dutch population of 
adults aged 65 years and older. Chapter 3 includes a review about the current evidence on the 
association between dietary patterns, including the Mediterranean diet, the Dietary Approaches to 
Stop Hypertension (DASH) diet, and the Healthy Diet Indicator (HDI), with cognitive function and 
decline. In the following three chapters the HDI (chapter 4), the DASH diet (chapter 5) and the 
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet (chapter 6) are 
prospectively studied in relation to cognitive function and decline within a large population including 
over 16,000 American women aged 70 years and older. The last chapters of this thesis cover the NU-
AGE (NUtrients and AGEing) dietary intervention study. Chapter 7 provides an overview and the 
design of the NU-AGE dietary intervention study with the aim to improve dietary intakes of a 
European population aged 65 years and older for healthier ageing. Chapter 8 presents results of 
analyses to study if dietary intake of this European population of older adults shifts more towards 
their dietary recommendations. Additionally this paper describes the development and application of 
the NU-AGE diet index. The effects of the changes in the dietary intakes within the NU-AGE 
intervention on cognitive functioning are described in chapter 9. At last, chapter 10 gives an overall 
reflection on the studies that are presented in this thesis.  
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Abstract 
With aging, energy needs decrease, necessitating a more nutrient dense diet in order to meet 
nutritional needs. To bridge this gap, the use of nutrient dense foods, fortified foods and dietary 
supplements can be important. This observational study aims to describe current micronutrient 
intakes of Dutch elderly and to identify the contribution of nutrient dense foods, fortified foods and 
dietary supplements to the intake of micronutrients that are often inadequately consumed in Dutch 
elderly. Data of 245 Dutch volunteers from the NU-AGE study aged 65-80 years were used. Dietary 
intake was assessed by means of 7-day food records and dietary supplement use was recorded with 
an additional questionnaire. Information on fortified foods was obtained from the Dutch Food 
Composition Table 2011. Nutrient density of foods was evaluated using the Nutrient Rich Food 9.3 
score. The percentages of participants not meeting their average requirement was high for vitamin D 
(99%), selenium (41%) and vitamin B6 (54%) based on conventional foods, and also when taking into 
account fortified foods (98%, 41%, 27%, respectively) and vitamin and mineral supplements (87%, 
36%, 20%, respectively). Conventional foods were the main source of vitamin D, vitamin B6 and 
selenium intake (42%, 45%, 82% respectively), followed by vitamin and mineral supplements (41%, 
44% and 18%) and fortified foods (17%, 11% and 1%). Foods with the highest nutrient density 
contributed most to total vitamin B6 intake only. In order to optimize nutrient intakes of elderly, 
combinations of natural food sources, fortified foods and dietary supplements should be considered. 
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Introduction 
Similarly to several other developed regions of the world, the European population is aging rapidly. It 
is expected that approximately 30 percent of the European population will be 65 years or older by 
the year 2050 [1]. With aging, energy needs decrease while micronutrient requirements remain or 
increase, necessitating a more nutrient dense diet in order to meet nutritional needs [2]. Inadequate 
nutrient intake may cause chronic metabolic disruption, including mitochondrial decay, resulting in 
acceleration of various degenerative diseases [3]. The prevalence of malnutrition and under 
nutrition is relatively high in both institutionalized (40-65%), and non-institutionalized elderly (5-
10%) [2]. In Europe, more than 20% of the people aged 65 years and older have inadequate intakes 
of vitamin D, folate, calcium, selenium and iodine [4], and intakes of vitamin D, calcium, selenium, 
magnesium, thiamine, riboflavin are of possible public health concern [5].  
These findings are in line with EURRECA outcomes for priority nutrients. EURRECA was an EU 
6th Framework Programme funded Network of Excellence, aimed to align the micronutrient 
recommendations among Europe. EURRECA identified 10 priority micronutrients for elderly (vitamin 
D, folate, vitamin B12, vitamin C, iron, calcium, zinc, selenium, iodine and copper) based on 
heterogeneity in current recommendations, amount of new evidence and importance for public 
health [4].  
Sources of micronutrients include conventional foods, fortified dietary sources and vitamin 
and mineral supplements. The intake of micronutrients can be limited resulting in nutrient 
inadequacies or deficiencies in the population. Over the last few decades, the consumption of 
nutrient-rich conventional foods (e.g., whole grains, vegetables and low-fat dairy products) has been 
partially shifted towards the consumption of nutrient-poor, but, at the same time, energy-dense 
foods (i.e., food with a high content of added sugar or solid fats)(6). This shift in food consumption 
patterns could be considered as another important factor of the observed insufficient dietary intakes 
of micronutrients.  
Widespread nutrient intake shortfalls and associated deficiencies can be prevented or 
improved by means of nutritional advice on consumption patterns, but also by using fortified foods 
[7]. Fortification is the process of adding nutrients or non-nutrient bioactive components to food [7]. 
Food fortification could be considered a public health strategy to enhance nutrient intakes of a 
population. Additionally, dietary supplements can effectively counteract inadequate nutrient intakes 
and its consequences [3]. Besides estimating inadequate nutrient intakes, it is also important to take 
into account the possibility of excessive nutrient intakes as the availability of food fortification and 
dietary supplement intake increases [8].  
This study aimed to describe current dietary intakes compared to nutritional requirements in 
Dutch elderly who were part of a cohort study and to explore which component - e.g. conventional 
foods, fortified foods or dietary supplements - is the main contributor to total dietary intakes of 
elderly. Because not much is known on how to classify conventional foods consumed by elderly 
based on their nutrient content, this study additionally aimed to explore if a concept of nutrient 
density can be used when studying the contribution of nutrient dense foods to total dietary intakes. 
We hypothesized that by knowing how conventional foods, fortified foods or dietary 
supplements differ in their contribution to total dietary intakes, dietary advices can be targeted 
towards bridging the gap between dietary intakes and nutritional needs in elderly. Therefore, the 
objectives of this present study were: 1) to estimate dietary intakes from conventional foods, 
fortified foods and dietary supplements, 2) to compare these intakes to nutritional requirements of 
the elderly, and 3) to explore the use of a nutrient density score in this respect.  
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Methods 
 
Study design and population 
The present study was commissioned by the Nutrient Intake Optimization Task Force of the 
European Branch of the International Life Sciences Institute (ILSI Europe). Baseline data from Dutch 
NU-AGE participants were used. The NU-AGE study is a dietary intervention study among volunteers 
aged 65 years and older living in the Netherlands, the UK, Italy, Poland and France [9].  that focuses 
on the effect of nutrition on inflammageing, i.e. chronic low-grade inflammation, and its 
consequences on the aging process [10]. The NU-AGE dietary intervention study is a one-year 
randomized, single blind, controlled, parallel trial consisting of a control group and a diet group. The 
dietary intervention is specifically adapted to the nutritional needs of elderly and is described in 
detail elsewhere [9].   
A total of 252 apparently healthy and independently living men and women, aged 65-80 years were 
recruited from the Dutch city of Wageningen and surroundings. Exclusion criteria were overt 
diseases, history of severe heart disease, organ failure, insulin dependent diabetes mellitus, chronic 
use of corticosteroids or recent use of antibiotics, undernourishment (BMI <18.5 kg/m2), and frailty. 
A screening questionnaire was used to verify current health, medical history and medication use. 
The presence of frailty was assessed with a test described by Fried et al.[11] The NU-AGE study has 
been approved by the Medical Ethical Committee from Wageningen University (NL37818.081.11) 
and all participants provided written informed consent. The baseline examinations started in April 
2012 and continued until March 2013. Participants were visited by trained dieticians once to 
complete dietary and supplement intake data. Participants completed a questionnaire to collect 
information on lifestyle, social and economic status, food preferences and a supplement 
questionnaire. In the present study, we excluded participants who had not completed the 
supplement questionnaire (n=7), resulting in a population for analysis of 245 participants.  
 
Dietary intake assessment 
Micronutrient intake from foods 
Usual dietary intake was assessed by means of estimated food records [12] that were kept for seven 
consecutive days. Participants received both verbal and written instructions to keep pre-structured 
food records and were trained in advance on the description of foods, portion sizes and food 
preparation methods in order to obtain complete and accurate food records. The food record 
included eight meal occasions per day: before breakfast, breakfast, morning snacks, lunch, afternoon 
snacks, evening meal, evening snacks, night snacks. Portion sizes were reported in household 
measures, based on pictures or measured in grams or millilitres. The consumed foods were coded 
according to standardized coding procedures at the Department of Nutrition and Health from 
Wageningen University and converted to energy and micronutrient intake (mean per day) by use of 
the Dutch food composition table Nederlands Voedingsstoffenbestand (NEVO) 2011 [13]. This table 
was also used to create food groups and to classify foods as fortified if at least one micronutrient 
was added to the food, for example, fortified spreads, milk drinks and juices. No distinction was 
made between mandatory and voluntary fortified foods. Foods without any fortification were 
classified as conventional foods.   
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Micronutrient intake from dietary supplements 
Participants completed an additional questionnaire at home in which they indicated the use of pre-
defined dietary supplements, i.e. multivitamin multimineral (MVMM), iron, vitamin D, vitamin B-
complex, and folic acid supplements. For each supplement, the frequency was recorded in times per 
day, week or month. Additionally, the amount of tablets or drops, type, brand and name were 
recorded for each supplement. The reported brand and name of the supplements was used to 
further specify the type of supplements (e.g., vitamin B12 supplement vs. vitamin B complex 
supplement). The nutrient content of the supplements was based on the product label information 
obtained from the manufacturer or corresponding website. The average daily nutrient intake from 
supplements was calculated per participant by multiplying the frequency by the average amount of 
tablets per day times the nutrient content per supplement and added to the average daily nutrient 
intake from foods.  
 
Micronutrient intake from nutrient dense foods 
Another way to look at sources of micronutrients is to study foods with a high nutrient density [14]. 
Nutrient density can be defined as the ratio of the nutrient composition of a food to the nutrient 
requirements [15], although at the moment, there is no consensus on how best to define nutrient 
density [16]. One of the possible indices to define nutrient density is the Nutrient Rich Food (NRF) 
9.3 score as proposed by Drewnowski [15]. This score is able to distinguish between foods and diets 
that are lower energy dense and more nutrient-rich [17] and it can provide a clear measure of the 
nutrient density of overall diets [18]. Furthermore, it has been shown to explain the highest 
percentage of variation in the Healthy Eating Index (HEI) [19] and it has been shown to correlate very 
well with the Dutch Healthy Diet Indicator [20], a diet score to rank individuals according to their 
adherence to the Dutch dietary guidelines for a healthy diet. These features make the NRF9.3 a 
suitable tool to study the contribution of naturally nutrient dense foods to adequate nutrient intake 
levels. The NRF9.3 score contains nine nutrients to encourage (NR9; protein, dietary fibre, vitamin A, 
vitamin C, vitamin E, calcium, magnesium, iron and potassium) and three nutrients to limit (LIM3; 
saturated fat, added sugar and sodium). Because only limited data on added sugar were available, 
total sugar was used instead.  
To calculate the nutrient density of foods, firstly for each food item, the nutrient contents were 
calculated per 100 kcal resulting in a nutrient content per food item in 100-kcal edible portion. 
Secondly, for each participant, the nutrient content of all consumed food items were divided by the 
corresponding Recommended Daily Values (RDVs) [21-23] or Maximum Daily Values (MDV) [24] 
(table 1) and multiplied by 100, resulting in a nutrient score for each nutrient included in the 
algorithms below. These nutrient scores were capped at 100% avoiding the possibility of a food item 
with high amounts of a single nutrient to contain more than 100 percent of the RDV. 
1) NR9100kcal ∑I = 1-9(Nutrienti/RDVi)*100 Nutrienti: content of beneficial nutrients protein, 
dietary fibre, vitamin A, vitamin C, vitamin E, 
calcium, magnesium, iron and potassium in 100-
kcal edible portion; RDVi: recommended daily 
values for nutrienti 
2) LIM3 ∑I = 1-9(Nutrienti/MDVi)*100 Nutrienti: content of limiting nutrients saturated 
fat, total sugar and sodium in 100-kcal edible 
portion; MDVi: maximum daily values for nutrienti 
3) NRF9.3100kcal NR9100kcal - LIM3100kcal Difference between sums 
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Table 1. Recommended (RDV) and Maximum (MDV) Daily Values for selected nutrients 
used in the NRF9.3 score. 
Nutrient RDV
a, b
 MDV
a, b
 
Nutrient-rich (NR) components    
Protein (g) 57 [23]  
Dietary fibre (g) 25 [22]  
Vitamin A (mcg) 800 [21]  
Vitamin C (mg) 80 [21]  
Vitamin E (mg) 12 [21]  
Calcium (mg) 800 [21]  
Iron (mg) 14 [21]  
Magnesium (mg) 375 [21]  
Potassium (mg) 2000 [21]  
Nutrients to limit (LIM)   
Saturated fat (g)  20 [24] 
Sugar (g)  90 [24] 
Sodium (mg)  2400 [24] 
a 
Based on an intake of 2000 kcal per day.  
b Recommended daily allowances as set by the European Union [21], the labelling reference 
intakes values as set by the European Food Safety Authority [22] were used. Abbreviations: NR, 
nutrient rich; LIM, limiting nutrient; RDV, recommended Daily Values; MDV, Maximum Daily 
Values. 
 
 
Table 2. Nutrient-rich scores (NR9), Limited nutrient scores (LIM3) and Nutrient Rich Food 
index scores (NRF9.3) per 100 kcal on food group level of consumed foods (n=1,107 foods)a 
Food groupb No. food items NR9c LIM3c NRF9.3c 
Vegetables 130 249.8 17.2 232.6 
Legumes 8 83.0 4.7 78.3 
Fruits 74 88.7 23.4 65.3 
Eggs 7 79.7 15.5 64.2 
Alcoholic and non-alcoholic drinks 69 52.3 6.7 50.8 
Potatoes 19 53.1 3.6 49.5 
Fish 57 60.5 18.6 41.9 
Soups 21 97.3 58.8 38.5 
Milk and milk products 87 59.7 24.8 34.9 
Mixed dishes 36 49.4 16.3 33.1 
Meat, meat products and poultry 157 55.7 23.4 32.3 
Nuts, seeds and snacks 60 37.4 13.1 24.3 
Cereal products and binding agents 38 25.7 2.8 22.9 
Savoury sandwich filling 6 33.8 11.5 22.3 
Cheese 48 55.8 36.1 19.7 
Bread 73 31.2 11.4 19.8 
Fats, oils, savoury sauces 61 29.7 22.8 6.9 
Pastry, cake and biscuits 83 19.0 19.9 -0.9 
Sugar, confectionary, sweets 65 17.8 25.5 -7.7 
Soy and vegetarian products 8 46.7 91.4 -44.7 
a For Dutch elderly participants in NU-AGE study (n=245).  
b Food groups are based on the Dutch food composition table ‘Nederlands Voedingsstoffenbestand’ 
(NEVO) 2011 [13].  
c Values are expressed as means per 100 kcal of a food group of consumed foods (n=1,107 foods). 
Abbreviations: NR(F), nutrient rich (food); LIM, limiting nutrient. 
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Thirdly, the NRF9.3 scores were calculated by subtracting the LIM3 scores from the NRF9 scores. 
Table 2 lists the mean NR9, LIM3 and NRF9.3 scores per food group of 1,107 consumed food items. 
Foods with a higher NRF9.3 score have a higher nutrient density per 100 kcal and were considered 
more nutrient dense than foods with a low NRF9.3 score. To distinguish between conventional foods 
with a low, middle and high nutrient density, food items were ranked upon their NRF9.3 score and 
divided into tertiles of nutrient density; 1) Low (NRF9.3 scores -116.7 (e.g. bouillon, gravy) to 9.3 
(e.g., nougat, gingerbread), 2) Middle (NRF9.3 scores 9.4 (e.g., rusk, refined bread) to 42.5 (e.g., 
medium-fat cheese, soup with vegetables), and 3) High (NRF9.3 scores 42.5 (e.g. low-fat chocolate 
milk, low-fat minced meat) to 574.8 (e.g. canned or fresh spinach, turnip greens).  
 
Contribution of conventional foods, fortified foods and dietary supplements 
The relative contribution of nutrient dense conventional foods, fortified foods and dietary 
supplements to the total nutrient intake was calculated as the proportion of intakes from the 
different components at the group level and were expressed as percentages. For those 
micronutrients for which intake was inadequate in more than 20% of the study population, we also 
calculated the contribution of specific food groups to total intake. This was done by taking the ratio 
of the nutrient content per food group to the total nutrient intake. 
 
Comparison to Dietary Reference Values 
Intakes of nutrients identified to require special attention in elderly according to EURRECA [25] and a 
recent systematic review on inadequate intakes among community-dwelling elderly in Western 
countries [5], i.e. vitamin D, folate, vitamin B6, vitamin B12, selenium, iron, calcium, magnesium, 
zinc, iodine and copper, were compared to their dietary reference values. The Average Requirement 
(AR) from the European Food Safety Authority [26] was used as reference value for the comparison 
of most nutrients, as these were also the basis for calculating the NRF9.3 score. The AR represents 
the average daily nutrient intake level that meets the requirement of half of healthy individuals 
within a group. For vitamin D, we used the AR from the Health Council of the Netherlands [27], as it 
was the most up to date at the moment of the study [28]. To assess adequacy of individual nutrient 
intakes, the mean individual intakes were compared with the AR. The prevalence of inadequate 
intakes was calculated using the AR cut-point method by taking the proportion of participants with a 
mean intake below the AR. For magnesium, for which no European AR was set, a quantitative 
approach was used to estimate the prevalence of inadequacy i.e., a low estimated prevalence if 
mean population intake was well above the Adequate Intake (AI). The prevalence of usual intakes 
above the tolerable Upper intake Level (UL) was based on comparisons of mean population intakes 
with European UL’s [29]. For all comparisons, European gender and age-specific ARs and ULs were 
used.  
 
Statistical analyses   
Total nutrient intakes from foods and dietary supplements were calculated as means and standard 
deviations. Baseline characteristics of participants were compared between men and women using 
ANOVA for continuous variables and the χ2 statistics for categorical variables. All statistical analyses 
were performed using SAS software version 9.2 (SAS institute, Inc, Cary, NC). 
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Table 1. Recommended (RDV) and Maximum (MDV) Daily Values for selected nutrients 
used in the NRF9.3 score. 
Nutrient RDV
a, b
 MDV
a, b
 
Nutrient-rich (NR) components    
Protein (g) 57 [23]  
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Iron (mg) 14 [21]  
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Potassium (mg) 2000 [21]  
Nutrients to limit (LIM)   
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Sugar (g)  90 [24] 
Sodium (mg)  2400 [24] 
a 
Based on an intake of 2000 kcal per day.  
b Recommended daily allowances as set by the European Union [21], the labelling reference 
intakes values as set by the European Food Safety Authority [22] were used. Abbreviations: NR, 
nutrient rich; LIM, limiting nutrient; RDV, recommended Daily Values; MDV, Maximum Daily 
Values. 
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Results 
General characteristics of the study population are presented in table 3. The population’s mean age 
was 70.9 ± 4.0 years. Compared to women, men tended to have a higher BMI, were slightly higher 
educated, were more likely to have ever smoked, had higher absolute energy, protein, fat, 
carbohydrate and micronutrient intakes. Macronutrient intakes expressed as percentage of total 
energy intake were similar between men and women. Of the total population, 43% used dietary 
supplements, of which MVMMs were most frequently used (24%), followed by vitamin D 
supplements (10%). Compared to men, the percentage of supplement users was higher in women 
(57% vs. 26%), particularly for vitamin D supplements (16% vs. 2%).  
 
Table 3. Baseline characteristicsa, b  
Characteristic Total population 
(n=245) 
Men 
(n=111) 
Women 
(n=134) 
Age, years 70.9 ± 4.0 70.9 ± 4.3 71.0 ± 3.9 
BMI, kg/m2* 26.0 ± 3.6 26.7 ± 3.6 25.5 ± 3.6 
Education, years* 12.2 ± 3.8 12.7 ± 3.8 11.7 ± 3.6 
Smoking status, n (% of total)*    
Never 126 (50) 44 (39) 82 (59) 
Former 118 (47) 65 (57) 53 (38) 
Current 8 (3) 4 (4) 4 (3) 
Macronutrient intakes    
Energy, kcal* 1912 ± 418 2100 ± 476 1756 ± 280 
Protein, gram 76.3 ± 16.0 82.5 ± 17.0 71.2 ± 13.1 
Protein, EN% 16.1 ± 2.4 15.9 ± 2.2 16.3 ± 2.5 
Fat, gram* 73.1 ± 19.9 78.7 ± 23.0 68.4 ± 15.5 
Fat, EN%* 34.3 ±5.0 33.5 ± 4.5 35.0 ± 5.3 
Carbohydrates, gram* 202 ± 54.4 222 ± 61.8 185 ± 40.2 
Carbohydrates, EN% 42.1 ± 5.9 42.2 ± 5.8 42.0 ± 6.0 
Micronutrient intakes    
Iron, mg*  10.9 ± 2.48 11.6 ± 2.80 10.31 ± 2.00 
Magnesium, mg* 335 ± 78.1 354 ± 93.5 320 ± 58.7 
Zinc, mg* 9.91 ± 2.32 10.7 ± 2.55 9.29 ± 1.91 
Iodine, mg*  164 ± 58.6 179 ± 49.9 151 ± 62.4 
Calcium, mg 969 ± 310 980 ± 361 960 ± 261 
Copper, mg*  1.18 ± 0.32 1.24 ± 0.38 1.14 ± 0.26 
Selenium, ug* 44.5 ± 12.8 47.29 ± 12.63 42.11 ± 12.47 
Vitamin B6, ug* 1.63 ± 0.52 1.77 ± 0.62 1.51 ± 0.38 
Vitamin B12, mg* 5.00 ± 2.68 5.39 ± 3.06 4.68 ± 2.27 
Folate, ug 256 ± 71.5 259 ± 78.11 253 ± 65.65 
Vitamin D, ug* 3.56 ± 2.09 4.09 ± 2.51 3.12 ± 1.55 
Use of dietary supplements    
Any supplements, n (% of total)* 106 (43) 29 (26) 77 (57) 
Multivitamin multimineral, n (% of total) 59 (24) 22 (20) 37 (28) 
Vitamin D, n (% of total) 24 (10) 2 (2) 22 (16) 
Calcium, n (% of total)* 6 (2) 0 (0) 8 (6) 
Calcium/Vitamin D complex, n (% of total) 13 (5) 3 (3) 10 (8) 
Vitamin B12, n (% of total) 1 (<1) 0 (0) 1 (1) 
Vitamin B-complex, n (% of total) 7 (3) 0 (0) 7 (5) 
Folic acid, n (% of total)  6 (2) 0 (0) 6 (5) 
Iron, n (% of total)* 1 (<1) 1 (1) 0 (0) 
a For Dutch elderly participants in NU-AGE study (n=245).  
b Values are presented as means ± SD per day, number (percentage for EN% per day and amount of people (% of total)).  
* Statistical significant differences between men and women (p < 0.05). Abbreviations: BMI, body mass index; kcal, 
kilocalories; EN%, energy percentage. 
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Based on the intake of conventional foods only, 99% of participants did not meet their average 
requirement of vitamin D. Based on the intake of conventional foods plus fortified foods still 98% did 
not meet their AR. Taking into account foods plus the intake from vitamin and mineral supplements, 
87% did not meet their AR, as shown in table 4. For selenium and vitamin B6, based on the intake 
conventional foods, 41% and 54% did not meet their AR. These percentages of inadequate intakes 
decreased to 36% and 20% when taking into account the intake from fortified foods and vitamin and 
mineral supplements. Other nutrients studied showed no or smaller percentages of inadequate 
intakes when including conventional foods, fortified foods and dietary supplements (folate 17%, 
copper 8%, iodine 7%, calcium 6%, zinc 5%, vitamin B12 2%, and 0% for iron and magnesium. No 
nutrient intakes reached levels above the UL.  
 
Table 4. Usual nutrient intakes from conventional foods, fortified foods and dietary supplements compared to 
Dietary Reference Valuesa, b 
Nutrient 
 
Intakec AR % participants with 
intakes < AR 
UL % participants 
with intakes > UL 
Vitamin D (ug/day)  10 ug [27]  100 ug [29]  
Conventional foods 2.49 ± 1.91  99.2 %   
Fortified foods 1.06 ± 0.95     
All foods 3.56 ± 3.09  98.4 %  0 % 
Supplements  2.47 ± 6.19     
Foods+supplements 6.04 ± 6.59  86.5 %  0 % 
Selenium (ug/day)  40 ug [26]  300 ug [29]  
Conventional foods 44.2 ± 12.8  41.2 %   
Fortified foods 0.22 ± 0.53     
All foods 44.5 ± 12.8  41.2 %  0 % 
Supplements  9.47±31.38     
Foods+supplements 53.9 ± 33.8  35.9 %  0.4 % 
Vitamin B6 (ug/day)  1.3 mg [26]  25 mg [29]  
Conventional foods 1.34 ± 0.32  53.5 %   
Fortified foods 0.29 ± 0.39     
All foods 1.63 ± 0.52  26.5 %  0 % 
Supplements  1.21 ± 5.71     
Foods+supplements 2.83 ± 5.73  20.0 %  0.8 % 
Folate (ug/day)  200 ug [26]  1000 ug [29]  
Conventional foods 252.7 ± 70.7  24.1 %   
Fortified foods 3.29 ± 9.32     
All foods 256.0 ± 71.5  22.9 %  0 % 
Supplements  60.38±155.78     
Foods+supplements 316.7±170.5  16.7 %  1.2 % 
Copper (mg/day)  0.8 mg [26]  5 mg [29]  
Conventional foods 1.17 ± 0.32  8.9 %   
Fortified foods 0.01 ± 0.03     
All foods 1.18 ± 0.32  7.8 %  0 % 
Supplements  0.18 ± 0.65     
Foods+supplements 1.36 ± 0.72  7.8 %  0.8 % 
Iodine (mg/day)  100 ug [26]  600 ug [29]  
Conventional foods 162.7 ± 58.5  8.6 %  0.4 % 
Fortified foods 0.97 ± 3.04     
All foods 163.7 ± 58.6  7.8 %  0 % 
Supplements 15.06 ± 55.96     
Foods+supplements 178.7 ± 81.2  6.5 %  0.8 % 
Calcium (mg/day)  550 mg [26]  2500 mg [29]  
Conventional foods 936.4 ± 304.4  7.8 %   
Fortified foods 32.7 ± 69.9     
All foods 969.2 ± 309.9  6.1 %  0 % 
Supplements  56.54±196.24     
Foods+supplements 1026.3±370.8  5.7 %  0.4 % 
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Results 
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Nutrient 
 
Intakec AR % participants with 
intakes < AR 
UL % participants 
with intakes > UL 
Zinc (mg/day)  7.5mg men, 5.5mg 
women[26] 
 45mg [29]  
Conventional foods 9.84 ± 2.34  5.3 %   
Fortified foods 0.07 ± 0.16     
All foods 9.91 ± 2.32  4.9 %  0 % 
Supplements  1.74 ± 5.96     
Foods+supplements 11.7 ± 6.2  4.5 %  0.4 % 
Vitamin B12 (mg/day)  2.0 ug [26]  N/Ad  
Conventional foods 4.75 ± 2.67  4.1 %   
Fortified foods 0.25 ± 0.32     
All foods 5.00 ± 2.68  3.3 %  0 % 
Supplements  4.53 ± 19.92     
Foods+supplements 9.53 ± 20.1  2.0 %  N/A 
Iron (mg/day)  7ug men, 
6ug women [26] 
 75 mg [40]  
Conventional foods 10.7 ± 2.4  1.2 %   
Fortified foods 0.21 ± 0.89     
All foods 10.9 ± 2.5  1.2 %  0 % 
Supplements  1.50 ± 5.79     
Foods+supplements 12.4 ± 6.1  0 %  0.4 % 
Magnesium (mg/day)  150-500 mg[26]  250 mg [26]e  
Conventional foods 329.8 ± 76.3  0.4 %   
Fortified foods 5.40 ± 14.38     
All foods 335.2 ± 78.1  0 %  0.0 % 
Supplements  39.55 ± 55.96     
Foods+supplements 375.5 ± 251.8  0 %  0.0 % 
a For Dutch elderly participants in NU-AGE study (n=245)   
b Recommended daily allowances as set by European Union [21], the labelling reference intakes values as set by the 
European Food Safety Authority [22-24], average requirements and tolerable upper intake levels as set by the Health 
Council of the Netherlands [27,40] and the European Union were used [26,29,41]. 
c Values are expressed as means ± SD 
d For vitamin B12 no UL of safe intakes was established 
e
  The UL for magnesium does not include magnesium normally present in foods and beverages 
Abbreviations: AR,  average requirement; UL, upper intake level  
 
The contributions of dietary supplements, fortified foods and conventional foods to total nutrient 
intakes are presented in figure 1. Almost half of the total vitamin D, vitamin B6 and more than half 
of total selenium intake came from conventional foods (42%, 45%, 82%, respectively), followed by 
dietary supplements (41% , 44%, 18%, respectively) and fortified foods (17%, 11%, 1%, respectively). 
When comparing the contribution of low, middle and high nutrient dense foods to total 
nutrient intakes, high nutrient dense foods contributed most to the total vitamin B6 intake (23%), 
followed by the middle nutrient dense group (19%) (figure 1). For vitamin D and selenium, the 
middle NRF9.3 group contributed most to total vitamin D and selenium intake (18% and 39%). When 
comparing the contribution of the different nutrient density groups to the nutrient intake from 
conventional foods only, half of this intake came from the highest NRF9.3 group for vitamin B6 (50%) 
while half of the intakes from vitamin D and selenium came from the middle NRF9.3 group (44% and 
47%). For all nutrients, the lowest NRF9.3 group contributed least to both total nutrient intake as 
well as the nutrient intake from conventional foods only.  
 Of the food groups, fish contributed most to vitamin D intake, followed by eggs, meat 
(products) and poultry (figure 2). Fish, meat (products) and poultry, and bread contributed most to 
the intake of selenium. For vitamin B6, meat (products) and poultry, followed by potatoes, and  
(non-) alcoholic drinks contributed most to the intake.  
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Figure 1. Contribution of dietary supplements, fortified foods and conventional  
foods categorized into nutrient density scores to the total nutrient intakea, b 
a For Dutch elderly participants in NU-AGE study (n=245).  
b Values are presented as percentage of total intake per micronutrient 
 
 
 
Figure 2. Food groups sorted by their NRF9.3 score (high NRF9.3 on the left to low NRF9.3 on the right) and 
their relative contribution to nutrient intakes (vitamin D, vitamin B6 and selenium)a, b  
a For Dutch elderly participants in NU-AGE study (n=245)   
b Values are presented as percentage of total intake of each micronutrient 
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Nutrient 
 
Intakec AR % participants with 
intakes < AR 
UL % participants 
with intakes > UL 
Zinc (mg/day)  7.5mg men, 5.5mg 
women[26] 
 45mg [29]  
Conventional foods 9.84 ± 2.34  5.3 %   
Fortified foods 0.07 ± 0.16     
All foods 9.91 ± 2.32  4.9 %  0 % 
Supplements  1.74 ± 5.96     
Foods+supplements 11.7 ± 6.2  4.5 %  0.4 % 
Vitamin B12 (mg/day)  2.0 ug [26]  N/Ad  
Conventional foods 4.75 ± 2.67  4.1 %   
Fortified foods 0.25 ± 0.32     
All foods 5.00 ± 2.68  3.3 %  0 % 
Supplements  4.53 ± 19.92     
Foods+supplements 9.53 ± 20.1  2.0 %  N/A 
Iron (mg/day)  7ug men, 
6ug women [26] 
 75 mg [40]  
Conventional foods 10.7 ± 2.4  1.2 %   
Fortified foods 0.21 ± 0.89     
All foods 10.9 ± 2.5  1.2 %  0 % 
Supplements  1.50 ± 5.79     
Foods+supplements 12.4 ± 6.1  0 %  0.4 % 
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Supplements  39.55 ± 55.96     
Foods+supplements 375.5 ± 251.8  0 %  0.0 % 
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b Recommended daily allowances as set by European Union [21], the labelling reference intakes values as set by the 
European Food Safety Authority [22-24], average requirements and tolerable upper intake levels as set by the Health 
Council of the Netherlands [27,40] and the European Union were used [26,29,41]. 
c Values are expressed as means ± SD 
d For vitamin B12 no UL of safe intakes was established 
e
  The UL for magnesium does not include magnesium normally present in foods and beverages 
Abbreviations: AR,  average requirement; UL, upper intake level  
 
The contributions of dietary supplements, fortified foods and conventional foods to total nutrient 
intakes are presented in figure 1. Almost half of the total vitamin D, vitamin B6 and more than half 
of total selenium intake came from conventional foods (42%, 45%, 82%, respectively), followed by 
dietary supplements (41% , 44%, 18%, respectively) and fortified foods (17%, 11%, 1%, respectively). 
When comparing the contribution of low, middle and high nutrient dense foods to total 
nutrient intakes, high nutrient dense foods contributed most to the total vitamin B6 intake (23%), 
followed by the middle nutrient dense group (19%) (figure 1). For vitamin D and selenium, the 
middle NRF9.3 group contributed most to total vitamin D and selenium intake (18% and 39%). When 
comparing the contribution of the different nutrient density groups to the nutrient intake from 
conventional foods only, half of this intake came from the highest NRF9.3 group for vitamin B6 (50%) 
while half of the intakes from vitamin D and selenium came from the middle NRF9.3 group (44% and 
47%). For all nutrients, the lowest NRF9.3 group contributed least to both total nutrient intake as 
well as the nutrient intake from conventional foods only.  
 Of the food groups, fish contributed most to vitamin D intake, followed by eggs, meat 
(products) and poultry (figure 2). Fish, meat (products) and poultry, and bread contributed most to 
the intake of selenium. For vitamin B6, meat (products) and poultry, followed by potatoes, and  
(non-) alcoholic drinks contributed most to the intake.  
 
31 
 
Figure 1. Contribution of dietary supplements, fortified foods and conventional  
foods categorized into nutrient density scores to the total nutrient intakea, b 
a For Dutch elderly participants in NU-AGE study (n=245).  
b Values are presented as percentage of total intake per micronutrient 
 
 
 
Figure 2. Food groups sorted by their NRF9.3 score (high NRF9.3 on the left to low NRF9.3 on the right) and 
their relative contribution to nutrient intakes (vitamin D, vitamin B6 and selenium)a, b  
a For Dutch elderly participants in NU-AGE study (n=245)   
b Values are presented as percentage of total intake of each micronutrient 
Chapter 2     |     Key sources of nutrient intake in Dutch older adults 
32 
Discussion 
In this cross-sectional analysis of 245 Dutch elderly persons based on the consumption of 
conventional foods, the percentage of inadequate intake was high for vitamin D and moderate for 
vitamin B6 and selenium. Including the consumption of fortified foods and dietary supplements 
substantially lowered the percentage of nutrient inadequacy for vitamin B6, but not for vitamin D 
and selenium without affecting risk of excessive intakes. High nutrient dense foods contributed most 
to total vitamin B6 intake, whereas middle nutrient dense foods contributed most to total vitamin D 
and selenium intake.  
 Our finding of a high percentage of inadequate vitamin D intake is in line with other dietary 
intake surveys among Dutch (the Dutch National Food Consumption Survey 2010-2012, DNFCS 2010-
2012) and Irish elderly, showing percentages of inadequate vitamin D intake ranging from 81% to 
100% [30,31] also when including fortified foods and dietary supplements. For selenium, the mean 
prevalence of inadequate intake in European elderly was above 20%, which mirrored our study 
(36%) [4]. The low prevalence of inadequate intakes observed for zinc, vitamin B12, and iron is in line 
with previous Dutch [31] and European findings [31]; showing a mean prevalence of inadequacy 
below 11% for these nutrients. In contrast, the proportion of elderly with inadequate vitamin B6 
intakes was reported as being below 15% in the Netherlands in a previous study [31], compared to 
20% in the present study. Additionally, a higher prevalence of inadequate intakes in European 
elderly were observed for copper (11-20%), folate, calcium, and iodine (all above 20%) [4]. As in the 
present study, the European survey did not find substantial percentages of excessive intakes of 
vitamin D, selenium and vitamin B6 [32]. The observed natural main sources of vitamin D (e.g., fish, 
eggs, and meat), and fortified foods are in line with other studies in Europe [33], as well as the main 
sources of selenium (e.g., fish, meat and cereals [31,32] and vitamin B6 (e.g., meat, potatoes) [31]. 
The difference in the prevalence of inadequate intakes between the present study and 
previous European studies could be explained by differences in study populations and 
methodological differences. First, the NU-AGE study aimed to recruit independently living, 
apparently healthy elderly, which resulted in a generally healthy (50% never smoked), and highly 
educated (12.2 years of education) study population. This could have resulted in better dietary 
intakes and lower percentages of inadequate intakes compared to other community-dwelling Dutch 
[31] and European populations [4]. Second, supplement intake or food fortification was not taken 
into account in the European study [4], possibly overestimating the true percentages of inadequate 
intakes compared to the present study population. Third, different dietary requirements have been 
used as cut-off values to define nutrient adequacy. For example, for calcium, the European study 
used guidelines from the Institute of Medicine (IOM) for North American populations (EAR 800 mg) 
[28] compared to the EAR from the European Commission (EC) for European populations used in the 
present study (EAR 550 mg) [26]. If we would have used the IOM guidelines, the prevalence of 
inadequacy for calcium would have been higher, namely 64% instead of 8% in the current study. 
 With respect to the relative contribution of fortified foods to total nutrient intakes, our 
findings are comparable to the DNFCS 2010-2012, showing the smallest contribution for selenium 
and a highest contribution for vitamin D and vitamin B6 (between 15-8% in DNFCS 2010-2012 [31] 
and 19% and 12% in the current study, respectively). In contrast, the Irish ingest three times as much 
vitamin D from fortified foods compared to participants in the present study [30]. This difference in 
vitamin D intake from fortified foods in the present study compared to the Irish study might be due 
to the fact that fortification with vitamin D is mandatory in Ireland, but not in the Netherlands [33]. 
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To the best of our knowledge, this is the first study to estimate the contribution of high, 
medium and low nutrient dense foods to total nutrient intakes. With this approach, we aimed to 
identify which kind of foods substantially contribute to total nutrient intakes and which foods should 
be encouraged in elderly people to improve their nutritional intakes to meet nutritional 
requirements. Using the NRF9.3 score as developed by Drewnowski et al. [15], the current study has 
shown that the contribution of nutrient dense foods varied between the nutrients investigated. A 
first explanation could be that we have divided the continuum of NRF9.3 scores in tertiles, based on 
the distribution of consumed foods. As the positioning of foods categories along the spectrum is 
arbitrary, this could have led to a ranking of food categories rather than a continuous scale [34]. A 
second explanation could be related to the fact the NRF 9.3 does not take into account the actual 
frequency and amount consumption of a food. Although legumes do have a high NRF 9.3 score, they 
do not substantially contribute to the total nutrient intake as their actual intake is relatively low. At 
last, the NRF9.3 algorithms include nutrients that are not specifically of interest for the elderly, 
resulting in poorly fitting nutrient algorithms for this study population [34]. In order to increase the 
applicability of the NRF9.3 score to diets of the elderly, it might be worthwhile to adapt the NRF9.3 
score to nutrients of concern for older populations [15], such as by including vitamin D, vitamin B12, 
folate and vitamin B6 and other priority micronutrients as proposed by EURRECA. In addition, more 
detailed nutritional information on current available fortified foods should be collected to optimize 
estimation of micronutrient intakes via fortified foods; also the list of fortified foods should be 
updated regularly as new products may be fortified in the future or products may be reformulated. 
A strength of the present study includes the extensive information of vitamin intakes from 
both foods and vitamin and mineral supplements. The food records that were used are based on 
actual intake. In contrast to food frequency questionnaires (FFQs) and 24-h recalls, the use of food 
records has the advantage in older populations in that it minimizes reliance on memory, as food 
intake was recorded by participants at the time the foods were consumed [35]. After completion of 
the food records, they were extensively reviewed and checked for completeness by trained research 
dieticians. This method, in combination with information from the NEVO 2011 [13], allowed us to 
estimate comprehensively nutrient intakes from conventional foods as well as from fortified foods. 
Because of the detailed information solicited with the extensive supplement questionnaire (e.g., 
name, brand, frequency, number of tablets, and label information), we were able to collect the 
specific nutrient contents of all the predefined dietary supplements used.  
A limitation of the present study is the generalizability of our study population, because the 
participants of the NU-AGE study had to be willing to change their dietary habits for the dietary 
intervention, and as such, it is very likely that particularly health-conscious people were included. 
Additionally, our sample mainly consisted of highly-educated, non-Hispanic Whites, former smokers, 
and normal/underweight, which have all been shown to be related to a higher use of dietary 
supplements [36]. When extrapolating our findings, it should be taken into consideration that results 
of our study population probably underestimate the prevalence of inadequate micronutrient intakes 
in the general population, and overestimate the contribution of supplements to micronutrient 
intake. This further highlights the importance of addressing nutrition inadequacy in the general 
population and of encouraging the consumption of nutrient-dense and/or fortified foods. Another 
limitation of the present study concerns the estimation of nutrient adequacy based on dietary intake 
alone. Taking into account micronutrient bioavailability, bio-accessibility and micronutrient status 
would better reflect the nutrient adequacy, also capturing different changes in nutrient status for 
fortified foods or supplement intakes. Some supplements taken separately from food, for example, 
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may result in a rapid increase in plasma concentrations of the supplemented nutrient, whereas 
consuming a food fortified with the same nutrient may have a more gradual effect on blood 
concentrations because of the presence of the food matrix, as has been shown for zinc [37]. For 
other micronutrients, such as folate, changes in serum values could be higher in food fortification 
than through supplementation [38]. 
Because the aim of food fortification is to beneficially impact population health, both the 
total additional intake and the quality of the nutrient or nutrients supplied must be taken into 
account, not just the intake of the vehicle (fortified food) alone [7]. Future studies investigating the 
contribution of dietary supplements, nutrient dense foods and fortified foods to total nutrient 
intakes should consider the bioavailability and bio-accessibility and include status markers indicating 
adequacy of intakes, as defined using the EURRECA guidelines [39].  
To conclude, the intake of vitamin D was inadequate in the vast majority of this Dutch 
elderly population, and nutrient intakes of vitamin B6 and selenium are of concern. The inadequacy 
of vitamin D could be confirmed via biomarkers of vitamin D status. Conventional foods were the 
main source of vitamin D, B6 and selenium intake, followed by vitamin and mineral supplements and 
fortified foods. Although fortified foods and vitamin and mineral supplements importantly 
contributed to the total intake of vitamin D and B6 intake, the use of these components did not 
necessarily lead to adequate intakes of nutrients that are of concern for older populations. Foods 
with the highest nutrient density contributed the most to total vitamin B6 intake only. In order to 
optimize nutrient intakes of elderly, combinations of conventional foods, fortified foods and dietary 
supplements need to be considered.  
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contribution of dietary supplements, nutrient dense foods and fortified foods to total nutrient 
intakes should consider the bioavailability and bio-accessibility and include status markers indicating 
adequacy of intakes, as defined using the EURRECA guidelines [39].  
To conclude, the intake of vitamin D was inadequate in the vast majority of this Dutch 
elderly population, and nutrient intakes of vitamin B6 and selenium are of concern. The inadequacy 
of vitamin D could be confirmed via biomarkers of vitamin D status. Conventional foods were the 
main source of vitamin D, B6 and selenium intake, followed by vitamin and mineral supplements and 
fortified foods. Although fortified foods and vitamin and mineral supplements importantly 
contributed to the total intake of vitamin D and B6 intake, the use of these components did not 
necessarily lead to adequate intakes of nutrients that are of concern for older populations. Foods 
with the highest nutrient density contributed the most to total vitamin B6 intake only. In order to 
optimize nutrient intakes of elderly, combinations of conventional foods, fortified foods and dietary 
supplements need to be considered.  
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Abstract 
Nutrition is an important modifiable risk factor that plays a role in the strategy to prevent or delay 
onset of dementia. Research on nutritional effects has till now mainly focused on the role of 
individual nutrients and bioactive components. However, the evidence for combined effects, such as 
multi-nutrient approaches or a healthy dietary pattern such as the Mediterranean diet is growing. 
These approaches incorporate the complexity of the diet and possible interaction and synergy 
between nutrients. Over the last few years dietary patterns are increasingly investigated to better 
understand the link between diet, cognitive decline, and dementia. In this systematic review we 
provide an overview of the literature on human studies up to May 2014 that examined the role of 
dietary patterns (both a priori as well as a posteriori derived) in relation to cognitive decline or 
dementia. The results suggest that better adherence to a Mediterranean diet is associated with less 
cognitive decline, dementia or AD, as shown by four out of six cross-sectional studies, six out of 12 
longitudinal studies, one trial and three meta-analyses. Other Healthy dietary patterns, both a priori 
(e.g. HDI, HEI and PNNS-GS) and a posteriori derived (e.g. factor analysis, cluster analysis and RRR), 
have shown to be associated with reduced cognitive decline and/or a reduced risk of dementia as 
shown by all six cross-sectional studies and six out of eight longitudinal studies. To come to more 
targeted and detailed guidelines to prevent or postpone cognitive decline more conclusive evidence 
is needed. 
41 
Introduction 
It has been estimated that worldwide 44 million people lived with dementia in 2013. With the ageing 
of the population and with an estimated 7.7 million new cases per year this number doubles every 20 
years and will reach 135 million dementia patients by 2050 [1]. The impact of dementia worldwide 
and the public health importance has been described by the World Health Organization (WHO) and 
Alzheimer’s Disease International (ADI) [2]. They propose to make dementia a global health priority, 
which underlines the importance to find strategies to prevent dementia. Since there is currently still 
no effective treatment to modify the course of dementia, prevention is an urgent priority, both to 
reduce incidence and to slow down progression. Important risk factors need to be further identified 
and in particular the factors that can be modified, such as lifestyle factors. In this systematic review 
we focus on the risk factor nutrition, for which promising indications exist that it can contribute in 
reducing the risk of developing dementia. Over the last years the attention is shifting from the role of 
single nutrients or foods to the role of dietary patterns, such as the promising association of the 
Mediterranean diet with cognitive decline and dementia. A dietary pattern approach better reflects 
the complexity of the diet and our daily eating behavior [3-6]. Multiple reviews and meta-analyses 
have been written in the last years summarizing the evidence of a substantial number of studies 
investigating the influence of a Mediterranean diet on cognitive decline and dementia [7-13]. Besides 
the Mediterranean diet, there are several other knowledge based (a priori) dietary patterns, such as 
the Healthy Diet Index (HDI), Healthy Eating Index-2005 (HEI-2005) and empirically (a posteriori) 
derived dietary patterns (e.g. using factor analysis or principal component analysis) that could be 
associated to cognitive decline and dementia. So far, there has only been one review summarizing 
the literature on different dietary patterns and cognitive aging until 2011 [14]. Therefore, the reviews 
describing studies on the Mediterranean diet and cognitive decline can be updated with several new 
studies that have been published since that review. 
The aim of the present systematic review is to summarize and evaluate available evidence 
from studies investigating dietary patterns, both a priori and a posteriori, in relation to cognitive 
decline and dementia in older adults and elderly people. Although underlying biological mechanisms 
will be touched upon briefly, this review is not intended to provide an extended description of 
mechanisms underlying the association between dietary patterns and cognitive performance. 
Instead, our specific goals are 1) to summarize papers that have studied the Mediterranean diet 2) to 
summarize papers that have studied other dietary patterns 3) to critically evaluate and summarize all 
evidence emerging from these studies on associations between dietary patterns and cognitive 
performance and/or dementia.  
Methods 
Search strategy 
The role of a healthy diet (Mediterranean diet, dietary patterns) in the development of cognitive 
decline and dementia has been the subject of several recent systematic reviews which were the 
starting point of the current review. Medline databases and the Cochrane database were searched 
up to May 2014 for additional, recently published studies. The search strategies used text words and 
relevant indexing (MeSH terms) to capture studies investigating the association between healthy diet 
(Mediterranean diet, dietary patterns) with cognitive decline and dementia. When no systematic 
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reviews were found, narrative reviews were used and both checked and updated using a 
combination of MeSH and text-based terms.  
(“Diet, Mediterranean”[Mesh] OR “Mediterranean diet” OR (“Mediterranean” AND “Diet”)) OR 
“Dietary pattern” AND ((“memory”[MeSH Terms] OR “memory”[All Fields]) OR (“cognition”[MeSH 
Terms] OR “cognition”[All Fields]) OR cognitive[All Fields] ((“alzheimer disease”[MeSH Terms] OR 
“alzheimer”[All Fields] AND “disease”[All Fields]) OR (“alzheimer disease”[All Fields] OR 
“alzheimer”[All Fields]) OR (“dementia”[MeSH Terms] OR “dementia”[All Fields])) AND 
“humans”[MeSH Terms]) 
We only included studies performed in older adults and elderly people and of which full papers were 
published.  
 
Study selection process 
Our search strategy resulted in 65 hits on studies, reviews and meta-analyses on diet and cognition 
and an additional search via reference lists of reviews and meta-analysis resulted in 33 more studies. 
This resulted in a total of 98 studies, of which 36 studies were selected based on full abstracts and 
papers. In total, we found 26 studies on the Mediterranean diet and cognitive function or dementia 
and 15 on other dietary patterns in relation to cognitive function (figure 1). Five studies performed 
analyses on both the Mediterranean diet and other patterns [15-19]. Study selection, data 
extraction, and quality assessment were performed independently by two reviewers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flowchart of selection process resulting in 36 studies included in the review, of which five studies 
performed analyses on both the Mediterranean diet and other dietary patterns 
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Results 
 
Specification and potential underlying mechanisms 
In table 1 characteristics of frequently reported a priori [20-25] and a posteriori [3, 7, 26-28] dietary 
patterns are shown. The majority of a priori dietary patterns consist of adequacy components - such 
as fruits, vegetables, cereals, fatty fish and dairy - and limitation components - such as total fat, 
saturated fatty acids, cholesterol and sodium. In an a posteriori data driven approach data are 
reduced into dietary patterns either based upon differences in intakes between subjects or upon 
inter-correlations between dietary items [29]. Usually this results in dietary patterns consisting of 
combinations of high or low loadings of similar components as defined by the a priori methods. It has 
been proposed that these components in combination could impact on several biological 
mechanisms that may explain how certain healthy dietary patterns can exert their effects on 
cognitive health and decline. Prevailing mechanisms which are believed to play a role in the 
pathogenesis of age-related diseases, including cognitive impairment and AD, are oxidative stress, 
inflammation and vascular risk factors, mechanisms that are ideal targets for nutritional intervention 
with dietary patterns, such as the Mediterranean diet, that are abundant in antioxidants and 
monounsaturated fatty acids and have a balanced ratio of essential n-6:n-3 fatty acids. Based on the 
multiple plausible biological mechanisms, there is a strong theoretical basis that the intake and 
status of these nutrients may affect the known mechanisms for neurodegeneration.  
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Table 1. Characterization of most investigated a priori and a posteriori defined dietary patterns in relation to 
neurodegeneration 
Dietary patterns Characterization 
A priori (hypothesis driven approach) 
Mediterranean diet 
(MeDi) [25] 
Based on traditional eating habits in Crete, South Italy and other Mediterranean countries 
x High in fruits, vegetables, cereals and legumes 
x Low in saturated fats, olive oil main fat source 
x Moderate in fish 
x Low to moderate in dairy products 
x Low in red meat and meat products 
x Moderate in alcohol (wine) 
Healthy Diet 
Indicator (HDI) [21] 
Based on the World Health Organization recommendations for the prevention of chronic diseases 
x Saturated fatty acids ≤10en% 
x Polyunsaturated fatty acids 3-7en% 
x Protein 10-15en% 
x Complex carbohydrates 50-70en% 
x Dietary fiber 27-40 g/day 
x Fruits and vegetables >400 g/day 
x Pulses, nuts and seeds >30 g/day 
x Oligo-/mono- and disaccharides ≤10en% 
x Cholesterol ≤300 mg/day 
Healthy Eating Index 
(HEI) [23] 
Based on the food patterns found in MyPyramid and is a sum of 10 individual components: 
x Adequacy of total whole fruits, vegetables, dark green and orange vegetables and legumes, 
total grains, whole grains, milk, meat and beans, oil 
x Low intakes of saturated fat, sodium and calories from solid fats, alcoholic beverages and 
added sugars 
Recommended Food 
score (RFS) [22] 
Based on the Dietary Guidelines for Americans and calculated as the sum of 23 items that are 
consumed at least once a week. 
1) Apples or pears, 2) Oranges, 3) Cantaloupe, 4) Orange or grapefruit juice, 5) Grapefruit, 6) Other 
fruit juices, 7) Dried beans, 8) Tomatoes, 9) Broccoli, 10), Spinach, 11), Mustard, turnip, or collard 
greens, 12) Carrots or mixed vegetables with carrots, 13) Green salad, 14) Sweet potatoes, yams, 
15) Other potatoes, 16) Baked or stewed chicken or turkey, 17) Baked or broiled fish, 18) Dark 
breads like whole wheat, rye or pumpernickel, 19) Cornbread, tortillas, and grits, 20) High fibre 
cereals, such as bran, granola, or shredded wheat, 21) Cooked cereals, 22) 2% Milk and beverages 
with 2% milk, 23) 1% or skim milk  
Dietary Approaches 
to Stop Hypertension 
(DASH) Trial [24] 
Based on in intakes of nutrients hypothesized to alter blood pressure levels 
x Rich in fruits and vegetables 
x Rich in low-fat dairy food 
x Reduced amounts of saturated fat, total fat, and cholesterol 
French National 
Nutrition and Health 
Program (Program 
National Nutrition 
Santé) Guideline 
Score (PNNS-GS) [20] 
Based on French National Nutrition and Health Program recommendations to improve the health 
status of the general population 
x Fruits and vegetables at least 5/day 
x Bread, cereals, potatoes, and legumes, at each meal 
x Choose whole-grain food and whole-grain bread more often 
x Milk and dairy products 3/d 
x Meat and poultry, seafood, eggs 1-2/d 
x Seafood at least twice per week 
x Limit consumption of added fats 
x Favor fats of vegetable origin 
x Drink water as desired 
x Limit sweetened beverages 
x Limit salt consumption 
x At least 30 min of brisk walking or equivalent/day of physical activity  
A posteriori (exploratory approach) 
Cluster analysis [3, 7, 
27] 
Classification technique, which aggregates subjects with similar defined variables such as dietary 
pattern and the energy contribution of each food group 
Principal Component 
Analysis (PCA) [7, 15]  
Common approach of factor analysis do define dietary patterns, aggregates highly correlated food 
items to identify underlying dietary patterns 
Reduced Rank 
Regression [7, 26, 28] 
Mix of an exploratory and hypothesis-driven approach, involves the element of a priori approach to 
derive dietary patterns 
Abbreviations: en%, percent of energy intake 
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Mediterranean diet 
The role of the Mediterranean diet on cognitive decline and dementia risk has only recently been 
systematically reviewed by Lourida et al in 2013 [8]. This review included literature published until 
January 2012. In addition, Alzheimer’s Disease International published a report on the available 
evidence on this subject in the beginning of 2014 [30]. However, because this area of research is 
developing rapidly the results of these two reviews can already be updated by adding at least 10 new 
studies on the Mediterranean diet and cognition and dementia. We have found a total of six cross-
sectional studies, 15 prospective studies and one intervention trial. The characteristics of these 
studies are summarized in table 2.  
 
Observational evidence 
Four out of the six cross-sectional studies showed an inverse association of the Mediterranean diet 
with cognitive functioning [16, 19, 31] or Alzheimer’s Disease (AD) [31, 32] in American, Puerto Rican, 
and Australian older adults and elderly people. One cross-sectional study in Greek elderly observed a 
protective association with one unit increase in Mediterranean diet in men (OR 0.88; 95%CI 0.80-
0.98), but contrarily a suggestion for an increased risk of cognitive impairment in women (OR 1.11; 
95%CI 1.00-1.22) [33]. A study in Hong Kong did not find associations in either men or women 
(ORT3vsT1 0.89; 95%CI 0.56-1.41 and 1.02; 95%CI 0.75-1.41) [15]. 
Of the 12 prospective studies on adherence to the Mediterranean diet and better cognitive 
performance, six studies observed a beneficial association after 3 to 7.6 years of follow-up [17, 18, 
34-37]. Of these studies five were performed in the USA [17, 18, 35-37] and one in France [34]. All 
five studies performed in the USA showed marginally, but significant associations. The French study 
showed that a one point increase in the Mediterranean diet was associated with fewer MMSE errors, 
but only marginally significant across categories of the Mediterranean diet (βT3vsT1 -0.02, p-value 
0.06). In the other six studies, of which three were performed in the USA [38-40] and the others in 
France [41], Australia [42] and Greece [43], the association was beneficial, but not significant after 2-
3 years of follow-up [38-43]. 
With respect to dementia and AD four out of six studies showed a reduced risk of AD with better 
adherence to the Mediterranean diet after 3-5.4 years of follow-up in US populations (HR 0.91; 
95%CI 0.83-0.98 [44], HR 0.87; 95%CI 0.78-0.97 [45], HR 0.60; 95%CI 0.42-0.97) [46], and a lower risk 
of developing AD after MCI (HR 0.71; 95%CI 0.53-0.95) [36]. Two studies, performed in a France [34] 
and US population [38], did not find associations. 
 
Trial evidence 
The only trial up until now investigating the effect of a Mediterranean type diet either rich in olive oil 
or rich in nuts has been performed in 522 participants with a high cardiovascular risk profile. After 
6.5 years of intervention, participants in both types of the Mediterranean diet had higher cognitive 
performance compared to the control group (adjusted differences for MSSE +0.62; 95%CI +0.18 to 
+1.05, p-value 0.005 and +0.57 (95%CI +0.11 to +1.03), p-value 0.015) [47]. In a smaller subgroup 
(n=285) of this same trial only the Mediterranean diet with olive oil showed better results for five out 
of 16 specific cognitive tests and mild cognitive impairment (OR 0.34; 95%CI 0.12-0.97) [48]. 
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Table 1. Characterization of most investigated a priori and a posteriori defined dietary patterns in relation to 
neurodegeneration 
Dietary patterns Characterization 
A priori (hypothesis driven approach) 
Mediterranean diet 
(MeDi) [25] 
Based on traditional eating habits in Crete, South Italy and other Mediterranean countries 
x High in fruits, vegetables, cereals and legumes 
x Low in saturated fats, olive oil main fat source 
x Moderate in fish 
x Low to moderate in dairy products 
x Low in red meat and meat products 
x Moderate in alcohol (wine) 
Healthy Diet 
Indicator (HDI) [21] 
Based on the World Health Organization recommendations for the prevention of chronic diseases 
x Saturated fatty acids ≤10en% 
x Polyunsaturated fatty acids 3-7en% 
x Protein 10-15en% 
x Complex carbohydrates 50-70en% 
x Dietary fiber 27-40 g/day 
x Fruits and vegetables >400 g/day 
x Pulses, nuts and seeds >30 g/day 
x Oligo-/mono- and disaccharides ≤10en% 
x Cholesterol ≤300 mg/day 
Healthy Eating Index 
(HEI) [23] 
Based on the food patterns found in MyPyramid and is a sum of 10 individual components: 
x Adequacy of total whole fruits, vegetables, dark green and orange vegetables and legumes, 
total grains, whole grains, milk, meat and beans, oil 
x Low intakes of saturated fat, sodium and calories from solid fats, alcoholic beverages and 
added sugars 
Recommended Food 
score (RFS) [22] 
Based on the Dietary Guidelines for Americans and calculated as the sum of 23 items that are 
consumed at least once a week. 
1) Apples or pears, 2) Oranges, 3) Cantaloupe, 4) Orange or grapefruit juice, 5) Grapefruit, 6) Other 
fruit juices, 7) Dried beans, 8) Tomatoes, 9) Broccoli, 10), Spinach, 11), Mustard, turnip, or collard 
greens, 12) Carrots or mixed vegetables with carrots, 13) Green salad, 14) Sweet potatoes, yams, 
15) Other potatoes, 16) Baked or stewed chicken or turkey, 17) Baked or broiled fish, 18) Dark 
breads like whole wheat, rye or pumpernickel, 19) Cornbread, tortillas, and grits, 20) High fibre 
cereals, such as bran, granola, or shredded wheat, 21) Cooked cereals, 22) 2% Milk and beverages 
with 2% milk, 23) 1% or skim milk  
Dietary Approaches 
to Stop Hypertension 
(DASH) Trial [24] 
Based on in intakes of nutrients hypothesized to alter blood pressure levels 
x Rich in fruits and vegetables 
x Rich in low-fat dairy food 
x Reduced amounts of saturated fat, total fat, and cholesterol 
French National 
Nutrition and Health 
Program (Program 
National Nutrition 
Santé) Guideline 
Score (PNNS-GS) [20] 
Based on French National Nutrition and Health Program recommendations to improve the health 
status of the general population 
x Fruits and vegetables at least 5/day 
x Bread, cereals, potatoes, and legumes, at each meal 
x Choose whole-grain food and whole-grain bread more often 
x Milk and dairy products 3/d 
x Meat and poultry, seafood, eggs 1-2/d 
x Seafood at least twice per week 
x Limit consumption of added fats 
x Favor fats of vegetable origin 
x Drink water as desired 
x Limit sweetened beverages 
x Limit salt consumption 
x At least 30 min of brisk walking or equivalent/day of physical activity  
A posteriori (exploratory approach) 
Cluster analysis [3, 7, 
27] 
Classification technique, which aggregates subjects with similar defined variables such as dietary 
pattern and the energy contribution of each food group 
Principal Component 
Analysis (PCA) [7, 15]  
Common approach of factor analysis do define dietary patterns, aggregates highly correlated food 
items to identify underlying dietary patterns 
Reduced Rank 
Regression [7, 26, 28] 
Mix of an exploratory and hypothesis-driven approach, involves the element of a priori approach to 
derive dietary patterns 
Abbreviations: en%, percent of energy intake 
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Four out of the six cross-sectional studies showed an inverse association of the Mediterranean diet 
with cognitive functioning [16, 19, 31] or Alzheimer’s Disease (AD) [31, 32] in American, Puerto Rican, 
and Australian older adults and elderly people. One cross-sectional study in Greek elderly observed a 
protective association with one unit increase in Mediterranean diet in men (OR 0.88; 95%CI 0.80-
0.98), but contrarily a suggestion for an increased risk of cognitive impairment in women (OR 1.11; 
95%CI 1.00-1.22) [33]. A study in Hong Kong did not find associations in either men or women 
(ORT3vsT1 0.89; 95%CI 0.56-1.41 and 1.02; 95%CI 0.75-1.41) [15]. 
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34-37]. Of these studies five were performed in the USA [17, 18, 35-37] and one in France [34]. All 
five studies performed in the USA showed marginally, but significant associations. The French study 
showed that a one point increase in the Mediterranean diet was associated with fewer MMSE errors, 
but only marginally significant across categories of the Mediterranean diet (βT3vsT1 -0.02, p-value 
0.06). In the other six studies, of which three were performed in the USA [38-40] and the others in 
France [41], Australia [42] and Greece [43], the association was beneficial, but not significant after 2-
3 years of follow-up [38-43]. 
With respect to dementia and AD four out of six studies showed a reduced risk of AD with better 
adherence to the Mediterranean diet after 3-5.4 years of follow-up in US populations (HR 0.91; 
95%CI 0.83-0.98 [44], HR 0.87; 95%CI 0.78-0.97 [45], HR 0.60; 95%CI 0.42-0.97) [46], and a lower risk 
of developing AD after MCI (HR 0.71; 95%CI 0.53-0.95) [36]. Two studies, performed in a France [34] 
and US population [38], did not find associations. 
 
Trial evidence 
The only trial up until now investigating the effect of a Mediterranean type diet either rich in olive oil 
or rich in nuts has been performed in 522 participants with a high cardiovascular risk profile. After 
6.5 years of intervention, participants in both types of the Mediterranean diet had higher cognitive 
performance compared to the control group (adjusted differences for MSSE +0.62; 95%CI +0.18 to 
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Table 2. Characteristics of included studies on Mediterranean diet, cognitive decline and dementia 
Author, year, 
country, 
study name 
Population 
(sample size, 
mean age) 
Follow-
up 
Exposure/ 
Intervention 
measure 
Outcome 
measure 
Effect measure 
Cross-sectional studies 
Samieri et al., 
2013 [16] 
USA, NHS 
n=10,670 
59y 
- FFQ, A-MeDi 
score 
Cognitive 
decline (TICS), 
mental health 
(SF-36)  
No significant association between the 
A-MeDi and mental health or cognitive 
impairment (ORQ5vsQ1 1.12; 95%CI 1.01-
1.20, p-trend <0.001 and OR 0.97; 95%CI 
0.95-1.00, p-trend 0.020, resp.) 
Chan et al., 
2013 [15] 
Hong Kong 
n=3,670 
71.8y 
- FFQ, MeDi 
score 
Cognitive 
function (CSI-D) 
No significant association between the 
MeDi and cognitive function in either 
men or women (ORT3vsT1 0.89; 95%CI 
0.56-1.41, p-trend 0.882 and OR 1.02; 
95%CI 0.75-1.41, p-trend 0.952, resp.).  
Ye et al., 
2013 [19] 
Puerto Rico, 
BPRHS 
n=1,269 
57.3y 
- FFQ, MeDi 
score 
Cognitive 
function and 
cognitive 
impairment 
(MMSE) 
A significant association between a 
higher MeDi score higher MMSE scores 
(p-trend 0.012) and a lower risk of 
cognitive impairment (OR 0.80; 95%CI 
0.80-0.94, p-value <0.001) 
Katsiardanis 
et al., 2013 
[33] 
Greece, 
Velestino 
Study 
n=557 
>65y 
 157-item FFQ, 
MeDi score 
Cognitive 
impairment 
(MMSE) 
Significant lower risk of cognitive 
impairment in men per one unit increase 
in adherence to the MeDi (OR 0.88; 
95%CI 0.80-0.98, p-value 0.02) but a 
higher risk in women (OR 1.11; 95%CI 
1.00-1.22, p-value 0.04)  
Gardener et 
al., 2012 [31] 
Australia, 
AIBL study 
n=970 
>60y 
- 74-item 
CCVFFQ, 
MeDi score 
MCI (MMSE), 
AD (DSM-IV, 
NINCDS-
ADRDA) 
Each unit increase in MeDi score was 
significantly associated with a reduced 
risk of MCI or AD (OR 0.87; 95%CI 0.75-
1.00, p-value <0.05 and OR 0.81; 95%CI 
0.71-0.92, p-value <0.01, respectively).    
Scarmeas et 
al., 2006 [32] 
USA, WHICAP 
n=1,984 
76.3y 
nested 
case 
control 
61-item FFQ, 
MeDi score 
Prevalent 
Alzheimer’s 
disease 
(NINCDS-
ADRDA) 
Better adherence to the MeDi was 
significantly associated with lower risk of 
AD (OR 0.76; 95%CI 0.67-0.87, p-value 
<0.01, ORT3vsT1 0.32; 95%CI 0.17-0.59, p-
trend <0.001) 
Longitudinal studies 
Wengreen et 
al., 2013 [18], 
USA, CCMS 
n=3,831 
74.1y 
11y 142-item FFQ, 
MeDi score 
Cognitive 
impairment 
(3MS) 
Better adherence to MeDiet was 
significantly associated with higher 3MS 
scores (MeDietQ5vsQ1 0.94±0.29, p-trend 
0.0022) 
Tsivgoulis et 
al., 2013 [37], 
USA, 
REGARDS 
study 
n=17,478 
64.6y 
4y FFQ, MeDi 
score 
Incident 
cognitive 
impairment 
(SIS) 
Higher adherence to MeDiet was 
significantly associated with a lower 
likelihood of ICI (OR 0.87; 95%CI 0.76-
1.00), especially in non-diabetic 
participants (OR 0.81; 95%CI 0.70-0.94, 
p-value 0.0066), but not in diabetic 
participants (OR 1.27; 95%CI 0.95-1.71, 
p-value 0.1063) 
Samieri et al., 
2013 [35] 
USA, NHS 
n=16,058 
74.3y 
6y 116-item FFQ,  
A-MeDi score 
Cognitive status 
and cognitive 
decline (TICS), 
verbal memory, 
global cognition 
Highest adherence to MeDi was 
significantly associated with cognitive 
status at older ages (adjusted mean 
differences in z-scores Q5vsQ1 were 
0.06; 95%CI 0.01-0.11, p-trend 0.004 for 
TICS, 0.05; 95%CI 0.01-0.08, p-trend 
0.002 for Global score and 0.06; 95%CI 
0,03-0.10, p-trend <0.001 for Verbal 
memory score), but not with cognitive 
decline (0.004; 95%CI -0.011-0.019, p-
trend 0.31), -0.001; 95%CI -0.010-0.007, 
p-trend 0.84, -0.001; 95%CI -0.011-
0.010, p-trend 0.70) 
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Samieri et al., 
2013 [39] 
USA, 
Women’s 
Health Study 
n=6,174 
72y 
2y 131-item FFQ,  
A-MeDi score 
Cognitive 
decline (TICS), 
global 
cognition, 
verbal memory 
No significant associations between 
higher A-MeDi scores and mean 
differences in averaged measures of 
global cognition and verbal memory 
(Q5vsQ1 0.02; 95%CI -0.03-0.06, p-trend 
0.63 and 0.03; 95%CI -0.02-0.07, p-trend 
0.44, respectively), neither over time (p 
for quintiles medians-x-time interaction 
= 0.26 for global score and 0.40 for score 
and cognitive decline)  
Kesse-Guyot 
et al., 2013 
[41] 
France, 
SU.VI.MAX 
n=3,083 
65.4y 
13y Repeated 24h 
records, MeDi 
score and 
MSDPS 
Cognitive 
function; 
episodic and 
lexical-semantic 
memory, 
mental 
flexibility 
No significant association between 
higher adherence to MeDi and MSDPS 
and cognitive scores, except for a lower 
phonemic fluency (-1.00; 95%CI -1.85,-
0.15, p-value 0.048) with decreasing 
MSDPS and lower backward digit with 
decreasing MDS (-0.64; 95%CI -1.60-
0.32, p-value 0.03) 
Vercambre et 
al., 2012 [40] 
USA, WACS  
n=2,504  
72.3y 
5.4y 116-item FFQ, 
MeDi score 
Cognitive 
decline (TICS), 
verbal memory, 
category 
fluency score 
No significant association between 
higher adherence to MeDi and adjusted 
mean differences in annual rates of 
cognitive decline (T3vsT1 0.00; 95%CI -
0.02-0.01, p-value 0.88 for global 
cognition, -0.03; 95%CI -0.11-0.05, p-
value 0.53 for TICS, 0.00; 95%CI -0.02-
0.02, p-value 0.97 for verbal memory 
and -0.03; 95%CI -0.14-0.08, p-value 0.64 
for category fluency) 
Cherbuin et 
al., 2012 [42] 
Australia, 
PATH 
n=1,528  
62.5y 
4y 215-item FFQ, 
MeDi score 
Mild cognitive 
impairment, 
cognitive 
decline, any 
MCD (ICC, CDR) 
No significant association between the 
MeDiet and transition from normal aging 
to MCI, CDR 0.5 and any-MCD (OR 1.41; 
95%CI (0.95-2.10), OR 1.18; 95%CI 0.88-
1.57 and OR 1.20; 95%CI 0.98-1.47, 
respectively)  
Tangney et 
al., 2011 [17] 
USA, CHAP 
n=3,790 
75.4y 
7.6y 139-item FFQ, 
MeDi score 
Global cognitive 
function 
(MMSE, EBMT, 
SDMT) 
Higher MeDi scores were significantly 
associated with better global cognitive 
scores at baseline (β 0.0070; SEE 0.0022, 
p-value 0.0013) and with slower rates of 
decline over time (β 0.0014; SEE 0.0004, 
p-value 0.0004) 
Roberts et al., 
2010 [38] 
USA, MCSA 
n=1,233 
79.6y 
2.2y 128-item FFQ, 
MeDi score 
Mild cognitive 
impairment 
(CDR) 
 
A high MeDi score was not statistically 
associated with risk of incident MCI or 
dementia (HRT3vsT1 0.75; 95%CI 0.46-
1.21, p-value 0.24) 
Gu et al., 
2010 [45] 
USA, WHICAP 
n=1,219 
76.7y 
3.8y 61-item SFFQ, 
MeDi score 
Alzheimer’s 
disease 
(NINCDS-
ADRDA) 
 
Better adherence to MeDi was 
borderline significantly associated with 
lower risk for AD in fully adjusted model 
(HR 0.87; 95%CI 0.78-0.97, p-value 0.01 
and HRT3vsT1 0.68; 95%CI 0.42-1.08, p-
trend 0.06) 
Scarmeas et 
al., 2009 [36] 
USA, WHICAP 
n=1,393  
76.9y 
4.5y FFQ, MeDi 
score 
Mild cognitive 
impairment 
(DSM-III-R), 
Alzheimer’s 
disease 
(NINCDS-
ADRDA) 
 
Better adherence to MeDi was 
significantly associated with a lower risk 
of MCI (HR 0.85; 95%CI 0.72-1.00, p-
trend 0.05, HRT3vsT1 0.72; 95%CI 0.52-
1.00, p-value 0.05) and a lower risk of 
developing AD after MCI (HR 0.71; 95%CI 
0.53-0.95, p-trend 0.02, HRT3vsT1 0.52; 
95%CI 0.30-0.91, p-value 0.02) 
Scarmeas et 
al., 2009 [46] 
USA, WHICAP 
n=1,880 
77.2y 
5.4y 61-item FFQ, 
MeDi score 
Alzheimer’s 
disease 
(NINCDS-
ADRDA) 
Better MeDi adherence was significantly 
associated with lower AD risk (HRT3vsT1 
0.60; 95%CI 0.42-0.97, p-trend 0.008) 
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Table 2. Characteristics of included studies on Mediterranean diet, cognitive decline and dementia 
Author, year, 
country, 
study name 
Population 
(sample size, 
mean age) 
Follow-
up 
Exposure/ 
Intervention 
measure 
Outcome 
measure 
Effect measure 
Cross-sectional studies 
Samieri et al., 
2013 [16] 
USA, NHS 
n=10,670 
59y 
- FFQ, A-MeDi 
score 
Cognitive 
decline (TICS), 
mental health 
(SF-36)  
No significant association between the 
A-MeDi and mental health or cognitive 
impairment (ORQ5vsQ1 1.12; 95%CI 1.01-
1.20, p-trend <0.001 and OR 0.97; 95%CI 
0.95-1.00, p-trend 0.020, resp.) 
Chan et al., 
2013 [15] 
Hong Kong 
n=3,670 
71.8y 
- FFQ, MeDi 
score 
Cognitive 
function (CSI-D) 
No significant association between the 
MeDi and cognitive function in either 
men or women (ORT3vsT1 0.89; 95%CI 
0.56-1.41, p-trend 0.882 and OR 1.02; 
95%CI 0.75-1.41, p-trend 0.952, resp.).  
Ye et al., 
2013 [19] 
Puerto Rico, 
BPRHS 
n=1,269 
57.3y 
- FFQ, MeDi 
score 
Cognitive 
function and 
cognitive 
impairment 
(MMSE) 
A significant association between a 
higher MeDi score higher MMSE scores 
(p-trend 0.012) and a lower risk of 
cognitive impairment (OR 0.80; 95%CI 
0.80-0.94, p-value <0.001) 
Katsiardanis 
et al., 2013 
[33] 
Greece, 
Velestino 
Study 
n=557 
>65y 
 157-item FFQ, 
MeDi score 
Cognitive 
impairment 
(MMSE) 
Significant lower risk of cognitive 
impairment in men per one unit increase 
in adherence to the MeDi (OR 0.88; 
95%CI 0.80-0.98, p-value 0.02) but a 
higher risk in women (OR 1.11; 95%CI 
1.00-1.22, p-value 0.04)  
Gardener et 
al., 2012 [31] 
Australia, 
AIBL study 
n=970 
>60y 
- 74-item 
CCVFFQ, 
MeDi score 
MCI (MMSE), 
AD (DSM-IV, 
NINCDS-
ADRDA) 
Each unit increase in MeDi score was 
significantly associated with a reduced 
risk of MCI or AD (OR 0.87; 95%CI 0.75-
1.00, p-value <0.05 and OR 0.81; 95%CI 
0.71-0.92, p-value <0.01, respectively).    
Scarmeas et 
al., 2006 [32] 
USA, WHICAP 
n=1,984 
76.3y 
nested 
case 
control 
61-item FFQ, 
MeDi score 
Prevalent 
Alzheimer’s 
disease 
(NINCDS-
ADRDA) 
Better adherence to the MeDi was 
significantly associated with lower risk of 
AD (OR 0.76; 95%CI 0.67-0.87, p-value 
<0.01, ORT3vsT1 0.32; 95%CI 0.17-0.59, p-
trend <0.001) 
Longitudinal studies 
Wengreen et 
al., 2013 [18], 
USA, CCMS 
n=3,831 
74.1y 
11y 142-item FFQ, 
MeDi score 
Cognitive 
impairment 
(3MS) 
Better adherence to MeDiet was 
significantly associated with higher 3MS 
scores (MeDietQ5vsQ1 0.94±0.29, p-trend 
0.0022) 
Tsivgoulis et 
al., 2013 [37], 
USA, 
REGARDS 
study 
n=17,478 
64.6y 
4y FFQ, MeDi 
score 
Incident 
cognitive 
impairment 
(SIS) 
Higher adherence to MeDiet was 
significantly associated with a lower 
likelihood of ICI (OR 0.87; 95%CI 0.76-
1.00), especially in non-diabetic 
participants (OR 0.81; 95%CI 0.70-0.94, 
p-value 0.0066), but not in diabetic 
participants (OR 1.27; 95%CI 0.95-1.71, 
p-value 0.1063) 
Samieri et al., 
2013 [35] 
USA, NHS 
n=16,058 
74.3y 
6y 116-item FFQ,  
A-MeDi score 
Cognitive status 
and cognitive 
decline (TICS), 
verbal memory, 
global cognition 
Highest adherence to MeDi was 
significantly associated with cognitive 
status at older ages (adjusted mean 
differences in z-scores Q5vsQ1 were 
0.06; 95%CI 0.01-0.11, p-trend 0.004 for 
TICS, 0.05; 95%CI 0.01-0.08, p-trend 
0.002 for Global score and 0.06; 95%CI 
0,03-0.10, p-trend <0.001 for Verbal 
memory score), but not with cognitive 
decline (0.004; 95%CI -0.011-0.019, p-
trend 0.31), -0.001; 95%CI -0.010-0.007, 
p-trend 0.84, -0.001; 95%CI -0.011-
0.010, p-trend 0.70) 
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Samieri et al., 
2013 [39] 
USA, 
Women’s 
Health Study 
n=6,174 
72y 
2y 131-item FFQ,  
A-MeDi score 
Cognitive 
decline (TICS), 
global 
cognition, 
verbal memory 
No significant associations between 
higher A-MeDi scores and mean 
differences in averaged measures of 
global cognition and verbal memory 
(Q5vsQ1 0.02; 95%CI -0.03-0.06, p-trend 
0.63 and 0.03; 95%CI -0.02-0.07, p-trend 
0.44, respectively), neither over time (p 
for quintiles medians-x-time interaction 
= 0.26 for global score and 0.40 for score 
and cognitive decline)  
Kesse-Guyot 
et al., 2013 
[41] 
France, 
SU.VI.MAX 
n=3,083 
65.4y 
13y Repeated 24h 
records, MeDi 
score and 
MSDPS 
Cognitive 
function; 
episodic and 
lexical-semantic 
memory, 
mental 
flexibility 
No significant association between 
higher adherence to MeDi and MSDPS 
and cognitive scores, except for a lower 
phonemic fluency (-1.00; 95%CI -1.85,-
0.15, p-value 0.048) with decreasing 
MSDPS and lower backward digit with 
decreasing MDS (-0.64; 95%CI -1.60-
0.32, p-value 0.03) 
Vercambre et 
al., 2012 [40] 
USA, WACS  
n=2,504  
72.3y 
5.4y 116-item FFQ, 
MeDi score 
Cognitive 
decline (TICS), 
verbal memory, 
category 
fluency score 
No significant association between 
higher adherence to MeDi and adjusted 
mean differences in annual rates of 
cognitive decline (T3vsT1 0.00; 95%CI -
0.02-0.01, p-value 0.88 for global 
cognition, -0.03; 95%CI -0.11-0.05, p-
value 0.53 for TICS, 0.00; 95%CI -0.02-
0.02, p-value 0.97 for verbal memory 
and -0.03; 95%CI -0.14-0.08, p-value 0.64 
for category fluency) 
Cherbuin et 
al., 2012 [42] 
Australia, 
PATH 
n=1,528  
62.5y 
4y 215-item FFQ, 
MeDi score 
Mild cognitive 
impairment, 
cognitive 
decline, any 
MCD (ICC, CDR) 
No significant association between the 
MeDiet and transition from normal aging 
to MCI, CDR 0.5 and any-MCD (OR 1.41; 
95%CI (0.95-2.10), OR 1.18; 95%CI 0.88-
1.57 and OR 1.20; 95%CI 0.98-1.47, 
respectively)  
Tangney et 
al., 2011 [17] 
USA, CHAP 
n=3,790 
75.4y 
7.6y 139-item FFQ, 
MeDi score 
Global cognitive 
function 
(MMSE, EBMT, 
SDMT) 
Higher MeDi scores were significantly 
associated with better global cognitive 
scores at baseline (β 0.0070; SEE 0.0022, 
p-value 0.0013) and with slower rates of 
decline over time (β 0.0014; SEE 0.0004, 
p-value 0.0004) 
Roberts et al., 
2010 [38] 
USA, MCSA 
n=1,233 
79.6y 
2.2y 128-item FFQ, 
MeDi score 
Mild cognitive 
impairment 
(CDR) 
 
A high MeDi score was not statistically 
associated with risk of incident MCI or 
dementia (HRT3vsT1 0.75; 95%CI 0.46-
1.21, p-value 0.24) 
Gu et al., 
2010 [45] 
USA, WHICAP 
n=1,219 
76.7y 
3.8y 61-item SFFQ, 
MeDi score 
Alzheimer’s 
disease 
(NINCDS-
ADRDA) 
 
Better adherence to MeDi was 
borderline significantly associated with 
lower risk for AD in fully adjusted model 
(HR 0.87; 95%CI 0.78-0.97, p-value 0.01 
and HRT3vsT1 0.68; 95%CI 0.42-1.08, p-
trend 0.06) 
Scarmeas et 
al., 2009 [36] 
USA, WHICAP 
n=1,393  
76.9y 
4.5y FFQ, MeDi 
score 
Mild cognitive 
impairment 
(DSM-III-R), 
Alzheimer’s 
disease 
(NINCDS-
ADRDA) 
 
Better adherence to MeDi was 
significantly associated with a lower risk 
of MCI (HR 0.85; 95%CI 0.72-1.00, p-
trend 0.05, HRT3vsT1 0.72; 95%CI 0.52-
1.00, p-value 0.05) and a lower risk of 
developing AD after MCI (HR 0.71; 95%CI 
0.53-0.95, p-trend 0.02, HRT3vsT1 0.52; 
95%CI 0.30-0.91, p-value 0.02) 
Scarmeas et 
al., 2009 [46] 
USA, WHICAP 
n=1,880 
77.2y 
5.4y 61-item FFQ, 
MeDi score 
Alzheimer’s 
disease 
(NINCDS-
ADRDA) 
Better MeDi adherence was significantly 
associated with lower AD risk (HRT3vsT1 
0.60; 95%CI 0.42-0.97, p-trend 0.008) 
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Feart et al., 
2009 [34]  
France, 3C 
study 
n=1,410 
75.9y 
5y FFQ and 24-
HR, MeDi 
score 
Cognitive 
performance, 
dementia risk 
and Alzheimer’s 
disease risk 
(MMSE, DSM-
III-R) 
A one point increase in the MeDi was 
significantly associated with fewer 
MMSE errors (β -0.006, p-value 0.04), 
and borderline significant across 
categories of MeDi (βT3vsT1 -0.02, p-value 
0.06). There was no significant 
association with dementia risk and AD 
risk (HR 1.06; 95%CI 0.92-1.21, p-value 
0.43, HRT3vsT1 1.12; 95%CI 0.60-2.10, p-
value 0.72 and HR 1.00; 95%CI 0.85-1.19, 
p-value 0.96, HRT3vsT1 0.86; 95%CI 0.39-
1.88, p-value 0.71, respectively) 
Psaltopoulou 
et al., 2008 
[43]  
Greece, EPIC 
n=732 
>60y 
8y 150-food FFQ, 
MeDi score 
Cognitive 
decline, MMSE  
No significant association per one unit 
increase in MeDi and MSSE (β 0.05; 
95%CI -0.09 – 0.19, p-value 0.485) 
Scarmeas et 
al., 2006 [44] 
USA, WHICAP 
n=2,258 
77.2y 
4y 61-item SFFQ, 
MeDi score 
Alzheimer’s 
disease 
(NINCDS-
ADRDA)  
Better adherence to MeDi was 
associated with lower risk for AD (HR 
0.91; 95%CI 0.83-0.98, p-value 0.015, 
HRT3vsT1 0.60; 95% CI 0.42-0.87, p-trend 
0.007) 
 
Randomized controlled trials 
Martinez et 
al. 2013 
[47], [48] 
Spain, 
PREDIMED-
Navarra 
n=522 [47] 
74.6y 
6.5y 137-item FFQ. 
MedDiet 
intervention 
3 arms: 
- MeDi+olive oil 
- MeDi + nuts 
- Low-fat diet 
Cognitive 
performance 
(MMSE, CDT) 
Participants in the MeDi + olive oil and 
the MeDi + nuts group showed better 
cognitive performance compared to the 
control group for MMSE and CDT 
(adjusted differences: 0.62; 95%CI 0.18-
1.05, p-value 0.005 and 0.57; 95%CI 
0.11-1.03, p-value 0.015 for MMSE, 0.51; 
95%CI 0.20-0.82, p-value 0.001 and 0.33; 
95%CI 0.003-0.67, p-value 0.048 for CDT) 
Martinez et 
al. 2013 
[47], [48] 
Spain, 
PREDIMED-
Navarra 
n=268 [48] 
74.1yr  
 
6.5y 137-item FFQ. 
MedDiet 
intervention 
3 arms: 
- MeDi+olive oil 
- MeDi + nuts 
Low-fat diet 
Cognitive 
performance, 
MCI 
MeDi with olive oil was related to better 
cognitive performance (for 5/16 tests) 
and lower MCI (OR 0.34; 95%CI 0.12-
0.97), compared to control group 
MeDi with nuts was not related to better 
cognitive performance or MCI (OR 0.56; 
95%CI 0.22-1.43) 
Abbreviations: 3C, Three-City; 3MS, Modified Mini-Mental State Examination; 24-HR, 24-hour dietary recall; AD, Alzheimer’s Disease; AIBL, 
Australian Imaging, Biomarkers and Lifestyle Study of Ageing cohort; A-MeDi, alternate MeDi; BPRHS, Boston Puerto Rican Health Study; 
CCMS, Cache County Memory Study; CDR, Clinical Dementia Rating; CDT, Clock Drawing Test; CHAP, Chicago Health and Aging Project; CSI-
D, Community Screening Instrument for Dementia; DSM, Diagnostic and Statistical Manual of Mental Disorders; EBMT, East Boston 
Memory Test; EPIC, European Prospective Investigation into Cancer and Nutrition; FFQ, Food Frequency Questionnaire; ICC, International 
Consensus Criteria; MCD, Mild Cognitive Disorder; MCI, Mild Cognitive Impairment; MCSA, Mayo Clinic Study of Aging: MeDi, 
Mediterranean Diet; MMSE, Mini Mental State Examination; MSDPS, Mediterranean Style Dietary Pattern Score; NHS, Nurses’ Health 
Study; NINCDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer Disease and Related 
Disorders Association; PATH, Personality and Total Health Through Life Project; PREDIMED, PREvencion con DIeta MEDiterranea; REGARDS, 
Reasons for Geographic and Racial Differences in Stroke; SDMT, Symbol Digit Modalities Test; SEE, Standard Error Estimate; SF-36, Medical 
Outcomes Short-Form 36 Health Survey; SIS, Six-item Screener; SU.VI.MAX, Supplementation en VItamines et Mineraux Anti-oXydants; 
TICS, Telephone Interview for Cognitive Status; WACS, Women’s Antioxidant Cardiovascular Study; WHICAP, Washington Heights-Inwood 
Columbia Aging Project 
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Meta-analyses 
An updated systematic review and meta-analysis from 2010 pooled data of prospective cohort 
studies on adherence to the Mediterranean diet and risk of AD, Parkinson’s disease, cognitive 
decline, dementia and mild cognitive impairment and showed an inverse association between a 2-
point increase of adherence to the Mediterranean diet and neurodegenerative diseases (RR 0.87; 
95%CI 0.81-0.94, I2 0%, p-value 0.73 [12]; table 3). 
Another meta-analysis [9] pooled data of 2 case-control studies, 5 longitudinal studies and 5 cross-
sectional studies on moderate and high adherence to the Mediterranean diet and risk of cognitive 
impairment, which resulted in inverse associations (RR 0.79; 95%CI 0.67-0.94, I2 28.3% and RR 0.60; 
95%CI 0.43-0.83, I2 76.4%, p-value0.000).  
A more recent systematic review and meta-analysis by Singh et al. [11] analysed data of prospective 
cohort studies with at least 1 year follow-up on the Mediterranean diet and cognitive outcomes (MCI 
or AD). Based on two longitudinal studies performed in the US, there was an association with high 
adherence to the Mediterranean diet (HRT3vsT1 0.73; 95%CI 0.56-0.96, I2 0%), but there was no 
association with moderate adherence compared to poor adherence (HRT2vsT1 0.82 (95%CI 0.64-1.05, I2 
0%), nor per one unit increase in the Mediterranean diet score (HR 0.95; 95%CI 0.84-1.08, I2 33%). 
Pooled analyses of two other longitudinal studies showed an inverse association between adherence 
to the Mediterranean diet (both continuous and categorical) and risk of AD among cognitively normal 
individuals (HR 0.92 (95%CI 0.85-0.99), I2 0% and HRT3vsT1 0.64 (95%CI 0.46-0.89), I2 0%).  
When combining all data this resulted in an inverse association between a better adherence to the 
Mediterranean diet and cognitive impairment (HR 0.92 (95%CI 0.88-0.97), I2 0%, HRT2vsT1 0.80 (95%CI 
0.67-0.95), I2 0%, HRT3vsT1 0.67 (95%CI 0.55-0.81), I2 0%). 
 
Table 3. Characteristics of included reviews and meta-analyses on Mediterranean diet, cognitive decline and 
dementia 
Reference Studies 
included 
Update 
until  
Exposure Outcomes measure Effect  
Singh et al. 
2014 [11] 
Five 
prospective 
cohort studies 
with at least 
1y follow-up 
Nov. 
2012 
MeDi 
score 
From normal to mild 
cognitive impairment, 
from normal to 
Alzheimer’s disease, 
cognitive impairment 
Better adherence to MeDi was 
associated with a lower risk of MCI 
(HRT3vsT1 0.73; 95%CI 0.56-0.96, I
2 0%, 
HR 0.98; 95%CI 0.84-1.08, I2 33%), AD 
(HR 0.92; 95%CI 0.85-0.99, HRT2vsT1 
0.87; 95%CI 0.66-1.14, HRT3vsT1 0.64; 
95%CI 0.46-0.89) and cognitive 
impairment (HR 0.92; 95%CI 0.88-
0.97, HRT2VsT1 0.80; 95%CI 0.67-0.95, 
HRT3vsT1 0.67; 95%CI 0.55-0.81, I
2 0%)  
Psaltopoulou 
et al. 2013 [9] 
9 studies; 
case-control, 
longitudinal, 
cross-sectional 
Oct 31st 
2012 
MeDi 
score 
Cognitive impairment, 
depression 
Both a moderate and a high 
adherence to MeDi were associated 
with a reduced risk of cognitive 
impairment and depression (RR 0.79; 
95%CI 0.67-0.94, I2 28.3%, p-value 
0.19 vs. RR 0.60; 95%CI 0.43-0.83, I2 
76.4%, p-value 0.00 and RR 0.77; 
95%CI 0.62-0.95, I2 54.4% vs. RR 0.68; 
95%CI 0.54-0.86, I2 53.4%, 
respectively).  
Sofi et al. 
2010 [12] 
Five 
prospective 
cohort studies 
June 
2010 
MeDi 
score 
Neurodegenerative 
diseases (cognitive 
decline, risk of 
dementia, MCI, AD 
Parkinson’s disease) 
Per 2-point increase of adherence to 
the MeDi score the risk of incidence of 
neurodegenerative diseases 
decreased (RR 0.87; 95%CI 0.81-0.94). 
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Feart et al., 
2009 [34]  
France, 3C 
study 
n=1,410 
75.9y 
5y FFQ and 24-
HR, MeDi 
score 
Cognitive 
performance, 
dementia risk 
and Alzheimer’s 
disease risk 
(MMSE, DSM-
III-R) 
A one point increase in the MeDi was 
significantly associated with fewer 
MMSE errors (β -0.006, p-value 0.04), 
and borderline significant across 
categories of MeDi (βT3vsT1 -0.02, p-value 
0.06). There was no significant 
association with dementia risk and AD 
risk (HR 1.06; 95%CI 0.92-1.21, p-value 
0.43, HRT3vsT1 1.12; 95%CI 0.60-2.10, p-
value 0.72 and HR 1.00; 95%CI 0.85-1.19, 
p-value 0.96, HRT3vsT1 0.86; 95%CI 0.39-
1.88, p-value 0.71, respectively) 
Psaltopoulou 
et al., 2008 
[43]  
Greece, EPIC 
n=732 
>60y 
8y 150-food FFQ, 
MeDi score 
Cognitive 
decline, MMSE  
No significant association per one unit 
increase in MeDi and MSSE (β 0.05; 
95%CI -0.09 – 0.19, p-value 0.485) 
Scarmeas et 
al., 2006 [44] 
USA, WHICAP 
n=2,258 
77.2y 
4y 61-item SFFQ, 
MeDi score 
Alzheimer’s 
disease 
(NINCDS-
ADRDA)  
Better adherence to MeDi was 
associated with lower risk for AD (HR 
0.91; 95%CI 0.83-0.98, p-value 0.015, 
HRT3vsT1 0.60; 95% CI 0.42-0.87, p-trend 
0.007) 
 
Randomized controlled trials 
Martinez et 
al. 2013 
[47], [48] 
Spain, 
PREDIMED-
Navarra 
n=522 [47] 
74.6y 
6.5y 137-item FFQ. 
MedDiet 
intervention 
3 arms: 
- MeDi+olive oil 
- MeDi + nuts 
- Low-fat diet 
Cognitive 
performance 
(MMSE, CDT) 
Participants in the MeDi + olive oil and 
the MeDi + nuts group showed better 
cognitive performance compared to the 
control group for MMSE and CDT 
(adjusted differences: 0.62; 95%CI 0.18-
1.05, p-value 0.005 and 0.57; 95%CI 
0.11-1.03, p-value 0.015 for MMSE, 0.51; 
95%CI 0.20-0.82, p-value 0.001 and 0.33; 
95%CI 0.003-0.67, p-value 0.048 for CDT) 
Martinez et 
al. 2013 
[47], [48] 
Spain, 
PREDIMED-
Navarra 
n=268 [48] 
74.1yr  
 
6.5y 137-item FFQ. 
MedDiet 
intervention 
3 arms: 
- MeDi+olive oil 
- MeDi + nuts 
Low-fat diet 
Cognitive 
performance, 
MCI 
MeDi with olive oil was related to better 
cognitive performance (for 5/16 tests) 
and lower MCI (OR 0.34; 95%CI 0.12-
0.97), compared to control group 
MeDi with nuts was not related to better 
cognitive performance or MCI (OR 0.56; 
95%CI 0.22-1.43) 
Abbreviations: 3C, Three-City; 3MS, Modified Mini-Mental State Examination; 24-HR, 24-hour dietary recall; AD, Alzheimer’s Disease; AIBL, 
Australian Imaging, Biomarkers and Lifestyle Study of Ageing cohort; A-MeDi, alternate MeDi; BPRHS, Boston Puerto Rican Health Study; 
CCMS, Cache County Memory Study; CDR, Clinical Dementia Rating; CDT, Clock Drawing Test; CHAP, Chicago Health and Aging Project; CSI-
D, Community Screening Instrument for Dementia; DSM, Diagnostic and Statistical Manual of Mental Disorders; EBMT, East Boston 
Memory Test; EPIC, European Prospective Investigation into Cancer and Nutrition; FFQ, Food Frequency Questionnaire; ICC, International 
Consensus Criteria; MCD, Mild Cognitive Disorder; MCI, Mild Cognitive Impairment; MCSA, Mayo Clinic Study of Aging: MeDi, 
Mediterranean Diet; MMSE, Mini Mental State Examination; MSDPS, Mediterranean Style Dietary Pattern Score; NHS, Nurses’ Health 
Study; NINCDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer Disease and Related 
Disorders Association; PATH, Personality and Total Health Through Life Project; PREDIMED, PREvencion con DIeta MEDiterranea; REGARDS, 
Reasons for Geographic and Racial Differences in Stroke; SDMT, Symbol Digit Modalities Test; SEE, Standard Error Estimate; SF-36, Medical 
Outcomes Short-Form 36 Health Survey; SIS, Six-item Screener; SU.VI.MAX, Supplementation en VItamines et Mineraux Anti-oXydants; 
TICS, Telephone Interview for Cognitive Status; WACS, Women’s Antioxidant Cardiovascular Study; WHICAP, Washington Heights-Inwood 
Columbia Aging Project 
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Meta-analyses 
An updated systematic review and meta-analysis from 2010 pooled data of prospective cohort 
studies on adherence to the Mediterranean diet and risk of AD, Parkinson’s disease, cognitive 
decline, dementia and mild cognitive impairment and showed an inverse association between a 2-
point increase of adherence to the Mediterranean diet and neurodegenerative diseases (RR 0.87; 
95%CI 0.81-0.94, I2 0%, p-value 0.73 [12]; table 3). 
Another meta-analysis [9] pooled data of 2 case-control studies, 5 longitudinal studies and 5 cross-
sectional studies on moderate and high adherence to the Mediterranean diet and risk of cognitive 
impairment, which resulted in inverse associations (RR 0.79; 95%CI 0.67-0.94, I2 28.3% and RR 0.60; 
95%CI 0.43-0.83, I2 76.4%, p-value0.000).  
A more recent systematic review and meta-analysis by Singh et al. [11] analysed data of prospective 
cohort studies with at least 1 year follow-up on the Mediterranean diet and cognitive outcomes (MCI 
or AD). Based on two longitudinal studies performed in the US, there was an association with high 
adherence to the Mediterranean diet (HRT3vsT1 0.73; 95%CI 0.56-0.96, I2 0%), but there was no 
association with moderate adherence compared to poor adherence (HRT2vsT1 0.82 (95%CI 0.64-1.05, I2 
0%), nor per one unit increase in the Mediterranean diet score (HR 0.95; 95%CI 0.84-1.08, I2 33%). 
Pooled analyses of two other longitudinal studies showed an inverse association between adherence 
to the Mediterranean diet (both continuous and categorical) and risk of AD among cognitively normal 
individuals (HR 0.92 (95%CI 0.85-0.99), I2 0% and HRT3vsT1 0.64 (95%CI 0.46-0.89), I2 0%).  
When combining all data this resulted in an inverse association between a better adherence to the 
Mediterranean diet and cognitive impairment (HR 0.92 (95%CI 0.88-0.97), I2 0%, HRT2vsT1 0.80 (95%CI 
0.67-0.95), I2 0%, HRT3vsT1 0.67 (95%CI 0.55-0.81), I2 0%). 
 
Table 3. Characteristics of included reviews and meta-analyses on Mediterranean diet, cognitive decline and 
dementia 
Reference Studies 
included 
Update 
until  
Exposure Outcomes measure Effect  
Singh et al. 
2014 [11] 
Five 
prospective 
cohort studies 
with at least 
1y follow-up 
Nov. 
2012 
MeDi 
score 
From normal to mild 
cognitive impairment, 
from normal to 
Alzheimer’s disease, 
cognitive impairment 
Better adherence to MeDi was 
associated with a lower risk of MCI 
(HRT3vsT1 0.73; 95%CI 0.56-0.96, I
2 0%, 
HR 0.98; 95%CI 0.84-1.08, I2 33%), AD 
(HR 0.92; 95%CI 0.85-0.99, HRT2vsT1 
0.87; 95%CI 0.66-1.14, HRT3vsT1 0.64; 
95%CI 0.46-0.89) and cognitive 
impairment (HR 0.92; 95%CI 0.88-
0.97, HRT2VsT1 0.80; 95%CI 0.67-0.95, 
HRT3vsT1 0.67; 95%CI 0.55-0.81, I
2 0%)  
Psaltopoulou 
et al. 2013 [9] 
9 studies; 
case-control, 
longitudinal, 
cross-sectional 
Oct 31st 
2012 
MeDi 
score 
Cognitive impairment, 
depression 
Both a moderate and a high 
adherence to MeDi were associated 
with a reduced risk of cognitive 
impairment and depression (RR 0.79; 
95%CI 0.67-0.94, I2 28.3%, p-value 
0.19 vs. RR 0.60; 95%CI 0.43-0.83, I2 
76.4%, p-value 0.00 and RR 0.77; 
95%CI 0.62-0.95, I2 54.4% vs. RR 0.68; 
95%CI 0.54-0.86, I2 53.4%, 
respectively).  
Sofi et al. 
2010 [12] 
Five 
prospective 
cohort studies 
June 
2010 
MeDi 
score 
Neurodegenerative 
diseases (cognitive 
decline, risk of 
dementia, MCI, AD 
Parkinson’s disease) 
Per 2-point increase of adherence to 
the MeDi score the risk of incidence of 
neurodegenerative diseases 
decreased (RR 0.87; 95%CI 0.81-0.94). 
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Other dietary patterns 
Fewer studies have been performed on other dietary patterns than the Mediterranean diet. So far, 
there has only been one review summarizing the literature of studies on different dietary patterns 
and cognitive aging until 2011 and this review included a total of 13 studies [14]. We have found a 
total of 16 studies of which eight cross-sectional studies, seven prospective studies and one trial 
investigating a priori derived dietary patterns and a posteriori derived dietary patterns in relation to 
cognitive decline (table 4).  
 
Observational evidence 
Of the six cross-sectional studies, four used a priori knowledge to study dietary patterns. Better 
adherence to the Healthy Diet Indicator was associated with a lower prevalence of cognitive deficit 
(OR 0.85; 95%CI 0.77-0.93[50]) and a reduced risk of cognitive impairment (OR 0.75; 95%CI 0.58-0.97 
in an Italian cohort, but not in a Dutch cohort (OR 0.81; 95%CI 0.63-1.04[51]). Higher adherence to 
the Healthy Eating Index of 2005 (HEI-2005) was associated with a lower risk of cognitive impairment 
in a Puerto Rican population (OR 0.86; 95%CI 0.74-0.99[19]), but this was not found for higher 
adherence to the alternative HEI of 2010 in a US population (ORQ5vsQ1 0.99; 95%CI 0.97-1.01 [16]). 
Two studies used an empirical approach such as Principal Component Analysis [15] or cluster analysis 
[49]. One study observed less errors on the MMSE with better adherence to a healthy dietary pattern 
in both men and women (respectively, β -0.11; 95%CI -0.22 to -0.0004 and β -0.13; 95%CI -0.22 to -
0.04 [49]). The other study found a beneficial association only in Chinese women with a higher 
‘Vegetables-Fruits’ and ‘Snacks-Drinks-Milk products’ pattern score and cognitive function, but not in 
men [15].  
Of the eight prospective studies, five studies used a priori defined dietary scores [17, 18, 52, 55, 56] 
and three studies used data driven approaches [26, 53, 54]. Results from studies using a priori diet 
scores showed mixed results with higher cognitive function scores for the Dietary Approaches to Stop 
Hypertension (DASH) diet (3MS score DASHQ5vsQ1 0.97±0.29) [18] and less cognitive declines for the 
Recommended Food Score (RFS) after 11 years of follow-up (3MS score RFSQ4vsQ1 1.79) [56], while 
there was no association between the HEI-2005 (β 0.00002, p-value 0.214) [17] and the C-HEI (β 
0.00008, p-value 0.852) [55] and cognitive decline after respectively 7.6 and 3 years of follow-up. A 
better adherence to the French guidelines (PNNS-GS) was associated with better cognitive function, 
as measured with a great number of specific cognitive function tests [52]. The other three of the 
seven studies used data driven approaches showing consistent beneficial associations between 
dietary patterns and risk of dementia [53], cognitive function [54] and AD [26, 53]. Two studies used 
Reduced Rank Regression of which one study observed a typical ‘Japanese’ pattern and the other 
study reported a ‘Healthy’ pattern. After 15 years of follow-up the ‘Japanese’ pattern was association 
with a reduced risk of dementia (HR 0.66; 95%CI 0.46-0.95), AD (HR 0.65; 95%CI 0.40-1.06) and 
vascular dementia (HR 0.45; 95%CI 0.22-0.91[53]). The ‘Healthy’ pattern was strongly associated with 
a lower AD risk (HRT3vsT1 0.62; 95%CI 0.43-0.89) after 3.9 years of follow-up [26]. The other study used 
factor analysis and reported higher cognitive function scores in the ‘Healthy’ pattern compared to a 
‘Traditional’ pattern (50.1±0.7 vs 48.9±0.7, p-trend 0.001) after 13 years of follow-up [54]. 
 
Trial evidence 
The single trial that has been performed observed better scores on one out of nine cognitive function 
tests (psychomotor speed; Cohen’s D = 0.440, p-value 0.036) after 4-months intervention with the 
DASH diet compared to the usual diet control group in 124 overweight adults with high blood 
pressure [57]. 
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Table 4. Characteristics of included studies on dietary patterns other than Mediterranean diet, cognitive 
decline and dementia 
Author, year, 
country, 
study name 
Population 
(sample size, 
mean age) 
Follow-
up 
Exposure/ 
Intervention 
measure 
Outcome 
measure 
Effect measure 
Cross-sectional studies 
Ye et al., 
2013 y [19] 
Puerto Rico, 
BPRHS 
n=1,269 
57.3y 
- FFQ, HEI-2005 Cognitive 
function and 
cognitive 
impairment 
(MMSE) 
A higher HEI-2005 score was 
significant associated with a higher 
MMSE score (p-trend 0.011) and 
lower risk of cognitive impairment 
(OR10points 0.86; 95%CI 0.74-0.99, p-
value 0.033) 
Chan et al., 
2013 [15] 
Hong Kong 
n=1,926  
71.8y 
 FFQ, Factor analysis, 
3 patterns; 
‘Vegetables-Fruits’, 
‘Snacks-Drinks-Milk 
products’, ‘Meat-
Fish’ 
Cognitive 
function (CSI-D) 
A higher ‘Vegetables-Fruits’ and 
‘Snacks-Drinks-Milk products’ 
pattern score was significantly 
associated with a reduced risk of 
cognitive impairment in women 
(ORQ4vsQ1 0.73; 95%CI 0.54-1.00, p-
trend 0.018 and ORQ4vsQ1 0.65; 95%CI 
0.47-0.90, p-trend 0.003, 
respectively), but not in men.  
Samieri et 
al., 2013 [16] 
USA, NHS 
n=10,670 
59y 
- FFQ, AHEI-2010 Cognitive 
decline, (TICS), 
mental health 
(SF-36) 
The AHEI-2010 was significantly 
associated with greater likelihood of 
no major limitations in mental health 
(ORQ5vsQ1 1.31; 95%CI 1.05-1.22, p-
trend <0.001) and marginally 
associated with no cognitive 
impairment (ORQ5vsQ1 0.99; 95%CI 
0.97-1.01, p-trend 0.09)  
Samieri et 
al., 2008 [49] 
France, 3C 
 
n=1,724 
76.0y 
- FFQ, Cluster 
analysis, five 
patterns; ‘Small 
eaters’, ‘Biscuits and 
Snacking’, ‘Healthy’, 
‘Charcuterie, Meat 
and Alcohol’, ‘Pasta 
eaters’ 
Cognitive 
function 
(MMSE) 
Better adherence to the ‘Healthy’ 
dietary pattern was significantly 
associated with less errors in MMSE 
(β -0.11; CI -0.22 to -0.004 in men 
and β -0.13; CI -0.22 to -0.04 in 
women)  
Corrēa Leite 
et al., 2001 
[50] 
Pavia, Italy 
n=1,651 
76.6y 
- 180-item FFQ, HDI Cognitive 
deficit (NPT) 
Better adherence to the HDI was 
associated with a lower prevalence 
of cognitive deficit (OR 0.85; 95%CI 
0.77-0.93) 
Huijbregts et 
al., 1998 [51] 
Seven 
Countries 
Study 
n=1,049 
76.1y 
- Cross-check dietary 
history, HDI 
Cognitive 
impairment 
(MMSE) 
Better adherence to the HDI has a 
protective effect on cognitive 
impairment, though not consistent 
over all cohorts (Zutphen OR 0.81; 
95%CI 0.63-1.04, Italian OR 0.75; 
95%CI 0.58-0.97) 
 
Longitudinal studies 
Wengreen et 
al., 2013 [18] 
USA, CCMS 
n=3,831 
74.1y 
11y 142-item FFQ, DASH 
score 
Cognitive 
impairment, 
3MS 
Better adherence to DASH diet was 
significantly associated with higher 
3MS scores (DASHQ5vsQ1 0.97±0.29 
points, p-trend 0.0001)  
Kesse-Guyot 
et al., 2011 
[52] 
France, 
SU.VI.MAX 
n=2,135 
65.5y 
12y Repeated 24-HR, 
PNNS-GS scores 
Verbal 
memory, 
executive 
functioning 
Better adherence to nutritional 
recommendations was significantly 
associated with the verbal memory 
factor (β 0.41; 95%CI 0.17-0.64), 
whereas no association was shown 
with the executive functioning factor 
Ozawa et al., 
2013 [53] 
Japan, 
n=1,006 
68.5y 
15y 70-item FFQ, RRR, 7 
patterns; only 
‘Japanese’ 
Dementia risk, 
Alzheimer’s 
disease, 
Better adherence to the ‘Japanese’ 
pattern was associated with a 
reduced risk of dementia (all cause 
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Other dietary patterns 
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total of 16 studies of which eight cross-sectional studies, seven prospective studies and one trial 
investigating a priori derived dietary patterns and a posteriori derived dietary patterns in relation to 
cognitive decline (table 4).  
 
Observational evidence 
Of the six cross-sectional studies, four used a priori knowledge to study dietary patterns. Better 
adherence to the Healthy Diet Indicator was associated with a lower prevalence of cognitive deficit 
(OR 0.85; 95%CI 0.77-0.93[50]) and a reduced risk of cognitive impairment (OR 0.75; 95%CI 0.58-0.97 
in an Italian cohort, but not in a Dutch cohort (OR 0.81; 95%CI 0.63-1.04[51]). Higher adherence to 
the Healthy Eating Index of 2005 (HEI-2005) was associated with a lower risk of cognitive impairment 
in a Puerto Rican population (OR 0.86; 95%CI 0.74-0.99[19]), but this was not found for higher 
adherence to the alternative HEI of 2010 in a US population (ORQ5vsQ1 0.99; 95%CI 0.97-1.01 [16]). 
Two studies used an empirical approach such as Principal Component Analysis [15] or cluster analysis 
[49]. One study observed less errors on the MMSE with better adherence to a healthy dietary pattern 
in both men and women (respectively, β -0.11; 95%CI -0.22 to -0.0004 and β -0.13; 95%CI -0.22 to -
0.04 [49]). The other study found a beneficial association only in Chinese women with a higher 
‘Vegetables-Fruits’ and ‘Snacks-Drinks-Milk products’ pattern score and cognitive function, but not in 
men [15].  
Of the eight prospective studies, five studies used a priori defined dietary scores [17, 18, 52, 55, 56] 
and three studies used data driven approaches [26, 53, 54]. Results from studies using a priori diet 
scores showed mixed results with higher cognitive function scores for the Dietary Approaches to Stop 
Hypertension (DASH) diet (3MS score DASHQ5vsQ1 0.97±0.29) [18] and less cognitive declines for the 
Recommended Food Score (RFS) after 11 years of follow-up (3MS score RFSQ4vsQ1 1.79) [56], while 
there was no association between the HEI-2005 (β 0.00002, p-value 0.214) [17] and the C-HEI (β 
0.00008, p-value 0.852) [55] and cognitive decline after respectively 7.6 and 3 years of follow-up. A 
better adherence to the French guidelines (PNNS-GS) was associated with better cognitive function, 
as measured with a great number of specific cognitive function tests [52]. The other three of the 
seven studies used data driven approaches showing consistent beneficial associations between 
dietary patterns and risk of dementia [53], cognitive function [54] and AD [26, 53]. Two studies used 
Reduced Rank Regression of which one study observed a typical ‘Japanese’ pattern and the other 
study reported a ‘Healthy’ pattern. After 15 years of follow-up the ‘Japanese’ pattern was association 
with a reduced risk of dementia (HR 0.66; 95%CI 0.46-0.95), AD (HR 0.65; 95%CI 0.40-1.06) and 
vascular dementia (HR 0.45; 95%CI 0.22-0.91[53]). The ‘Healthy’ pattern was strongly associated with 
a lower AD risk (HRT3vsT1 0.62; 95%CI 0.43-0.89) after 3.9 years of follow-up [26]. The other study used 
factor analysis and reported higher cognitive function scores in the ‘Healthy’ pattern compared to a 
‘Traditional’ pattern (50.1±0.7 vs 48.9±0.7, p-trend 0.001) after 13 years of follow-up [54]. 
 
Trial evidence 
The single trial that has been performed observed better scores on one out of nine cognitive function 
tests (psychomotor speed; Cohen’s D = 0.440, p-value 0.036) after 4-months intervention with the 
DASH diet compared to the usual diet control group in 124 overweight adults with high blood 
pressure [57]. 
 
 
51 
Table 4. Characteristics of included studies on dietary patterns other than Mediterranean diet, cognitive 
decline and dementia 
Author, year, 
country, 
study name 
Population 
(sample size, 
mean age) 
Follow-
up 
Exposure/ 
Intervention 
measure 
Outcome 
measure 
Effect measure 
Cross-sectional studies 
Ye et al., 
2013 y [19] 
Puerto Rico, 
BPRHS 
n=1,269 
57.3y 
- FFQ, HEI-2005 Cognitive 
function and 
cognitive 
impairment 
(MMSE) 
A higher HEI-2005 score was 
significant associated with a higher 
MMSE score (p-trend 0.011) and 
lower risk of cognitive impairment 
(OR10points 0.86; 95%CI 0.74-0.99, p-
value 0.033) 
Chan et al., 
2013 [15] 
Hong Kong 
n=1,926  
71.8y 
 FFQ, Factor analysis, 
3 patterns; 
‘Vegetables-Fruits’, 
‘Snacks-Drinks-Milk 
products’, ‘Meat-
Fish’ 
Cognitive 
function (CSI-D) 
A higher ‘Vegetables-Fruits’ and 
‘Snacks-Drinks-Milk products’ 
pattern score was significantly 
associated with a reduced risk of 
cognitive impairment in women 
(ORQ4vsQ1 0.73; 95%CI 0.54-1.00, p-
trend 0.018 and ORQ4vsQ1 0.65; 95%CI 
0.47-0.90, p-trend 0.003, 
respectively), but not in men.  
Samieri et 
al., 2013 [16] 
USA, NHS 
n=10,670 
59y 
- FFQ, AHEI-2010 Cognitive 
decline, (TICS), 
mental health 
(SF-36) 
The AHEI-2010 was significantly 
associated with greater likelihood of 
no major limitations in mental health 
(ORQ5vsQ1 1.31; 95%CI 1.05-1.22, p-
trend <0.001) and marginally 
associated with no cognitive 
impairment (ORQ5vsQ1 0.99; 95%CI 
0.97-1.01, p-trend 0.09)  
Samieri et 
al., 2008 [49] 
France, 3C 
 
n=1,724 
76.0y 
- FFQ, Cluster 
analysis, five 
patterns; ‘Small 
eaters’, ‘Biscuits and 
Snacking’, ‘Healthy’, 
‘Charcuterie, Meat 
and Alcohol’, ‘Pasta 
eaters’ 
Cognitive 
function 
(MMSE) 
Better adherence to the ‘Healthy’ 
dietary pattern was significantly 
associated with less errors in MMSE 
(β -0.11; CI -0.22 to -0.004 in men 
and β -0.13; CI -0.22 to -0.04 in 
women)  
Corrēa Leite 
et al., 2001 
[50] 
Pavia, Italy 
n=1,651 
76.6y 
- 180-item FFQ, HDI Cognitive 
deficit (NPT) 
Better adherence to the HDI was 
associated with a lower prevalence 
of cognitive deficit (OR 0.85; 95%CI 
0.77-0.93) 
Huijbregts et 
al., 1998 [51] 
Seven 
Countries 
Study 
n=1,049 
76.1y 
- Cross-check dietary 
history, HDI 
Cognitive 
impairment 
(MMSE) 
Better adherence to the HDI has a 
protective effect on cognitive 
impairment, though not consistent 
over all cohorts (Zutphen OR 0.81; 
95%CI 0.63-1.04, Italian OR 0.75; 
95%CI 0.58-0.97) 
 
Longitudinal studies 
Wengreen et 
al., 2013 [18] 
USA, CCMS 
n=3,831 
74.1y 
11y 142-item FFQ, DASH 
score 
Cognitive 
impairment, 
3MS 
Better adherence to DASH diet was 
significantly associated with higher 
3MS scores (DASHQ5vsQ1 0.97±0.29 
points, p-trend 0.0001)  
Kesse-Guyot 
et al., 2011 
[52] 
France, 
SU.VI.MAX 
n=2,135 
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Verbal 
memory, 
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Better adherence to nutritional 
recommendations was significantly 
associated with the verbal memory 
factor (β 0.41; 95%CI 0.17-0.64), 
whereas no association was shown 
with the executive functioning factor 
Ozawa et al., 
2013 [53] 
Japan, 
n=1,006 
68.5y 
15y 70-item FFQ, RRR, 7 
patterns; only 
‘Japanese’ 
Dementia risk, 
Alzheimer’s 
disease, 
Better adherence to the ‘Japanese’ 
pattern was associated with a 
reduced risk of dementia (all cause 
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Hisayama 
Study 
presented Vascular 
dementia (HDS, 
HDSR, MMSE) 
dementia HR 0.66; 95%CI 0.46-0.95, 
AD HR 0.65; 95%CI 0.40-1.06 and 
VaD HR 0.45; 95%CI 0.22-0.91) 
Kesse-Guyot 
et al., 2012, 
[54] 
France, 
SU.VI.MAX 
n=3,054 
65.4y 
13y Repeated 24h 
dietary records, 
Factor analysis, 2 
patterns; ‘Healthy’, 
‘Traditional’ 
Global 
cognitive 
function, verbal 
memory, 
executive 
functioning 
Significant higher cognitive function 
scores were found with better 
adherence to the ‘Healthy’ pattern 
vs. ‘Traditional’ pattern (adjusted 
means ±SD 50.1±0.7 vs 48.9±0.7, p-
trend 0.001 for global cognitive 
function, 49.7±0.4 vs. 48.7±0.4, p-
trend 0.01 for verbal memory) 
Shatenstein 
et al., 2012 
[55] 
Canada, 
NuAge 
n=1,488 
74.2y 
3y 78-item FFQ, C-HEI Cognitive 
decline (3MS) 
There was no significant association 
between global diet quality (total C-
HEI/100) and cognitive decline after 
3-years follow-up (β0.00008, p-value 
0.852) 
Tangney et 
al., 2011 [17] 
USA, CHAP 
n=3,790 
75.4y 
7.6y 139-item FFQ, HEI-
2005 
Cognitive 
function 
(MMSE) 
HEI-2005 was neither associated 
with better global cognitive score at 
baseline, nor with changes in global 
cognitive score at follow-up (β-
0.0011±0.001, p-value 0.236 and β 
0.00002±0.0002, p-value 0.214, 
respectively) 
Gu et al., 
2010 [26] 
USA, 
WHICAP 
n=2,148 
77.2y 
3.9y FFQ, RRR, 7 
patterns; DP1-DP7 
Alzheimer’s 
disease (DSM) 
Better adherence to the ‘Healthy’ 
pattern was significantly associated 
with a lower AD risk (HRT3vsT1 0.62; 
95%CI 0.43-0.89) 
Wengreen et 
al., 2009 [56] 
USA, Cache 
County 
n=3,634 
74.7y 
11y 142-item FFQ, RFS 
versus non-RFS 
Cognitive 
decline, 3MS 
Better adherence to RFS at baseline 
was associated with less decline in 
3MS scores after 11 years of follow-
up (RFST3vsT1 1.79 point, p-value 
0.0013)  
 
Randomized controlled trials 
Smith et al., 
2010 [57] 
USA, 
ENCORE 
n=124  
52.3y 
4m DASH diet  
3-arms:  
- DASH Alone 
- DASH Weight 
Management 
- Usual Care 
Cognitive 
functioning 
DASH diet alone resulted in better 
psychomotor speed (Cohen’s 
D=0.440; p-value 0.036) compared to 
control group in subjects with high 
blood pressure.  
Abbreviations: 3C, Three-City; 3MS, Modified Mini-Mental State Examination; 24-HR, 24-hour dietary recall; AD, Alzheimer’s Disease; AHEI-
2010, Alternative Healthy Eating Index-2010; BPRHS, Boston Puerto Rican Health Study; CCMS, Cache County Memory Study; CHAP, 
Chicago Health and Aging Project; CHEI, Canadian Healthy Eating Index; CSI-D, Community Screening Instrument for Dementia; DASH, 
Dietary Approaches to Stop Hypertension; DSM, Diagnostic and Statistical Manual of Mental Disorders; ENCORE, Exercise and Nutrition 
Interventions for Cardiovascular Health Study; FFQ, Food Frequency Questionnaire; HDI, Healthy Diet Indicator; HDS, Hasegawa Dementia 
Scale; HDSR, Hasegawa Dementia Scale-Revised; HEI, Healthy Eating Index, MMSE, Mini-Mental State Examination; NHS, Nurses’ Health 
Study; NPT, neuropsychological test; NuAge, Longitudinal Study on Nutrition and Successful Aging; PNNS-GS, Program National Nutrition 
Santé Guideline Score; RFS, Recommended Food Score; RRR, Reduced Rank Regression; SF-36, Medical Outcomes Short-Form 36 Health 
Survey; SU.VI.MAX, Supplementation en VItamines et Mineraux Anti-oXydants; TICS, Telephone Interview for Cognitive Status; VaD, 
vascular dementia; WHICAP, Washington Heights-Inwood Columbia Aging Project 
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Discussion 
We reviewed the current evidence from observational studies and intervention trials investigating 
healthy dietary patterns in relation to cognitive decline and dementia. Overall, the results of all types 
of dietary pattern approaches suggest that better adherence to a healthy dietary pattern is 
associated with less cognitive decline and/or a lower risk of dementia. However, most studies are 
observational and evidence from intervention trials is limited to two trials, of which one investigated 
the effect of the Mediterranean diet [47, 48] and one the effect of the DASH diet [57]. There are 
several different methodological factors between the studies. This heterogeneity hinders comparison 
between studies; therefore the most important points are discussed below.  
 Both a priori and a posteriori approaches to define dietary patterns [3, 7, 58] have been used 
in studies included in this review and each method has its strengths and limitations. A limitation of a 
priori indexes is that they are based on current scientific knowledge on what a healthy diet 
comprises. Evolutions in knowledge should be considered each time the index is applied, which also 
changes the index over time [59]. Also few cues about how to weight food groups or guidelines have 
been proposed. A limitation of both a priori and a posteriori approaches is that complex correlations 
of food matrixes are not taken into account, neither are all components specifically related to 
cognitive outcomes. Indexes described in this review are mainly based on improving overall health 
status [20-23, 25] or blood pressure [60], rather than improving cognitive health specifically. A 
limitation of a posteriori methods is the limited comparability and reproducibility in other study 
samples because dietary patterns are based on food behavior in specific study samples [61]. Another 
limitation of a posteriori methods is that good skills in multidimensional statistical methods are 
required to select the best components of which the choice is subjective [62]. 
 Another subjective choice, which could be confusing, is the naming of the dietary patterns. 
Therefore, for studies performed in different populations, the food consumption characterizing the 
pattern should be described clearly. Populations studied were almost all Western populations, 
mostly from the US and the Mediterranean countries in Europe and a few studies have been 
performed in Australia, China or Japan. According to Solfrizzi et al the components of the 
Mediterranean diet in Western countries could be different from the traditional Mediterranean diet, 
in particular for the high intakes of olive oil and regular consumption of wine with meals [63]. In 
general, a healthy dietary pattern comprises a diet high in fruits, vegetables, other plant-derived 
products, and fish and lower intakes of meat, saturated fats, and added refined sugar. We found no 
clear differences in associations between healthy dietary patterns and cognitive decline and 
dementia across countries. Also Singh and colleagues did not find any heterogeneity in their analysis, 
however, this could be due to the fact that they included three US studies and one French study [11].  
 Dietary intake can be assessed with different methods such as food records, 24 hour recalls 
or food frequency questionnaires (FFQ), of which the latter has been mostly used in the studies 
included in the current review. Different intake methods not only limit comparisons between studies, 
but also impacts on the number of variables to be used for dietary pattern analyses. This could affect 
both the number of derived dietary patterns as well as the dietary patterns itself [62]. It has been 
shown in studies using principle component analyses that this could lead to attenuated disease odds 
[62, 64]. 
 The outcome measures that were included in our review ranged from cognitive performance 
in cross-sectional studies to cognitive decline and risk of AD or dementia in longitudinal studies. 
There are many differences in the way cognitive outcomes have been measured and reported. This 
makes comparison between studies more difficult and limits comparison of studies in a meta-
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mostly from the US and the Mediterranean countries in Europe and a few studies have been 
performed in Australia, China or Japan. According to Solfrizzi et al the components of the 
Mediterranean diet in Western countries could be different from the traditional Mediterranean diet, 
in particular for the high intakes of olive oil and regular consumption of wine with meals [63]. In 
general, a healthy dietary pattern comprises a diet high in fruits, vegetables, other plant-derived 
products, and fish and lower intakes of meat, saturated fats, and added refined sugar. We found no 
clear differences in associations between healthy dietary patterns and cognitive decline and 
dementia across countries. Also Singh and colleagues did not find any heterogeneity in their analysis, 
however, this could be due to the fact that they included three US studies and one French study [11].  
 Dietary intake can be assessed with different methods such as food records, 24 hour recalls 
or food frequency questionnaires (FFQ), of which the latter has been mostly used in the studies 
included in the current review. Different intake methods not only limit comparisons between studies, 
but also impacts on the number of variables to be used for dietary pattern analyses. This could affect 
both the number of derived dietary patterns as well as the dietary patterns itself [62]. It has been 
shown in studies using principle component analyses that this could lead to attenuated disease odds 
[62, 64]. 
 The outcome measures that were included in our review ranged from cognitive performance 
in cross-sectional studies to cognitive decline and risk of AD or dementia in longitudinal studies. 
There are many differences in the way cognitive outcomes have been measured and reported. This 
makes comparison between studies more difficult and limits comparison of studies in a meta-
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analysis, which would provide a more quantitative understanding of the relation between dietary 
patters and cognitive impairment. Length of follow-up time of longitudinal studies ranged from 2 
years to 15 years. To capture changes in cognitive functioning several years of follow-up are needed, 
but how long exactly is sufficient and what the best period to start follow-up would be is not clear. It 
is nowadays suggested to already start at middle-age. 
 Some of the inconsistency in findings may be explained by the general considerations that 
should be taken into account when interpreting results of observational studies, such as residual 
confounding, possible over-adjustment and the fact that different covariates were included across 
the studies. Another important issue with observational studies is that they do not allow causal 
inference. This can be overcome with well-designed intervention studies. However, the only trial on 
the effect of the Mediterranean diet and cognitive decline did not measure cognition at baseline but 
only at follow-up, which limits the possibility to really study cause-effect relations. 
Another point to take into account when interpreting results could be effect modification by 
sex as suggested by findings from Chan and colleagues who found that higher intakes of ‘vegetables-
fruit’ and ‘snacks-drinks-milk’ patterns were associated with reduced risk of cognitive impairment in 
women, but no association was observed in men [15]. In contrast, a Greek study reported an 
increased risk of cognitive impairment with better adherence to the Mediterranean diet in women, 
but a reduced risk in men [33]. As eating behavior may differ between men and women it should be 
taken into account that dietary patterns could have been derived for men and women separately. 
Unfortunately, none of the included studies have examined dietary patterns by gender. These 
possible sex-specific differences merit further investigation and clarification. 
The results suggest that better adherence to a Mediterranean diet is associated with less 
cognitive decline, dementia or AD, as shown by four out of six cross-sectional studies, six out of 12 
longitudinal studies, one trial and three meta-analyses. Other Healthy dietary patterns, both a priori 
(e.g. HDI, HEI and PNNS-GS) and a posteriori derived (e.g. factor analysis, cluster analysis and RRR), 
have shown to be associated with reduced cognitive decline and/or a reduced risk of dementia as 
shown by all seven cross-sectional studies and five out of seven longitudinal studies.  
Investigating whole diet approaches instead of individual nutrients is an attractive strategy, 
because combined effects may yield larger results since effects of individual nutrients may be small. 
Furthermore, a whole diet approach is more comparable to dietary intake in daily life. A dietary index 
specifically aimed at improving cognitive performance would be desirable. To further advance this 
field of research, more intervention trials of sufficient sample size investigating what type of dietary 
pattern is favorable with respect to prevention of cognitive decline are recommended. In this respect 
findings of the ongoing NU-AGE dietary intervention study, in which the effect of a 1-year healthful 
diet on cognitive performance is investigated, are to be awaited [65]. Furthermore, more 
observational studies starting at middle-aged adults and with a sufficient duration of at least >10-15 
years of follow-up are warranted. Those studies should, if possible, take into account the 
methodological issues as pointed out above and should aim for more homogeneity in for example 
cognitive outcomes and composition of dietary patterns to facilitate comparison between studies. 
Also, the suggestion for differences in associations between men and women needs further 
investigation. If effects of certain dietary approaches will be proven, it will be a challenging task to 
change people’s dietary habits, but it is important to take up the challenge now in order to provide 
(pre-) dementia patients some perspective of treatment or delay of the disease process and to come 
to clear recommendations in the future for a cost-effective, safe, and sustainable solution. This is of 
special importance, since there are currently no curative treatments for this disease. 
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analysis, which would provide a more quantitative understanding of the relation between dietary 
patters and cognitive impairment. Length of follow-up time of longitudinal studies ranged from 2 
years to 15 years. To capture changes in cognitive functioning several years of follow-up are needed, 
but how long exactly is sufficient and what the best period to start follow-up would be is not clear. It 
is nowadays suggested to already start at middle-age. 
 Some of the inconsistency in findings may be explained by the general considerations that 
should be taken into account when interpreting results of observational studies, such as residual 
confounding, possible over-adjustment and the fact that different covariates were included across 
the studies. Another important issue with observational studies is that they do not allow causal 
inference. This can be overcome with well-designed intervention studies. However, the only trial on 
the effect of the Mediterranean diet and cognitive decline did not measure cognition at baseline but 
only at follow-up, which limits the possibility to really study cause-effect relations. 
Another point to take into account when interpreting results could be effect modification by 
sex as suggested by findings from Chan and colleagues who found that higher intakes of ‘vegetables-
fruit’ and ‘snacks-drinks-milk’ patterns were associated with reduced risk of cognitive impairment in 
women, but no association was observed in men [15]. In contrast, a Greek study reported an 
increased risk of cognitive impairment with better adherence to the Mediterranean diet in women, 
but a reduced risk in men [33]. As eating behavior may differ between men and women it should be 
taken into account that dietary patterns could have been derived for men and women separately. 
Unfortunately, none of the included studies have examined dietary patterns by gender. These 
possible sex-specific differences merit further investigation and clarification. 
The results suggest that better adherence to a Mediterranean diet is associated with less 
cognitive decline, dementia or AD, as shown by four out of six cross-sectional studies, six out of 12 
longitudinal studies, one trial and three meta-analyses. Other Healthy dietary patterns, both a priori 
(e.g. HDI, HEI and PNNS-GS) and a posteriori derived (e.g. factor analysis, cluster analysis and RRR), 
have shown to be associated with reduced cognitive decline and/or a reduced risk of dementia as 
shown by all seven cross-sectional studies and five out of seven longitudinal studies.  
Investigating whole diet approaches instead of individual nutrients is an attractive strategy, 
because combined effects may yield larger results since effects of individual nutrients may be small. 
Furthermore, a whole diet approach is more comparable to dietary intake in daily life. A dietary index 
specifically aimed at improving cognitive performance would be desirable. To further advance this 
field of research, more intervention trials of sufficient sample size investigating what type of dietary 
pattern is favorable with respect to prevention of cognitive decline are recommended. In this respect 
findings of the ongoing NU-AGE dietary intervention study, in which the effect of a 1-year healthful 
diet on cognitive performance is investigated, are to be awaited [65]. Furthermore, more 
observational studies starting at middle-aged adults and with a sufficient duration of at least >10-15 
years of follow-up are warranted. Those studies should, if possible, take into account the 
methodological issues as pointed out above and should aim for more homogeneity in for example 
cognitive outcomes and composition of dietary patterns to facilitate comparison between studies. 
Also, the suggestion for differences in associations between men and women needs further 
investigation. If effects of certain dietary approaches will be proven, it will be a challenging task to 
change people’s dietary habits, but it is important to take up the challenge now in order to provide 
(pre-) dementia patients some perspective of treatment or delay of the disease process and to come 
to clear recommendations in the future for a cost-effective, safe, and sustainable solution. This is of 
special importance, since there are currently no curative treatments for this disease. 
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Abstract  
Aim: To examine the association between a healthy diet, assessed by the Healthy Diet Indicator 
(HDI), and cognitive decline in older adults.  
Methods: Data from 21,837 participants aged ≥55 years from 3 cohorts (Survey in Europe on 
Nutrition and the Elderly, a Concerted Action [SENECA], Rotterdam Study [RS], Nurses’ Health Study 
[NHS]) were analyzed. HDI scores were based on intakes of saturated fatty acids, polyunsaturated 
fatty acids, mono- and disaccharides, protein, cholesterol, fruits and vegetables, and fiber. The 
Telephone Interview for Cognitive Status in NHS and Mini-Mental State Examination in RS and 
SENECA were used to assess cognitive function from multiple repeated measures. Using 
multivariable-adjusted, mixed linear regression, mean differences in annual rates of cognitive decline 
by HDI quintiles were estimated.  
Results: Multivariable-adjusted differences in rates in the highest versus the lowest HDI quintile were 
0.01 (95% CI –0.01, 0.02) in NHS, 0.00 (95% CI –0.02, 0.01) in RS, and 0.00 (95% CI –0.05, 0.05) in 
SENECA with a pooled estimate of 0.00 (95% CI –0.01, 0.01), I2 = 0%.  
Conclusions: A higher HDI score was not related to reduced rates of cognitive decline in European 
and American older adults. 
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Introduction 
The world’s population aged over 60 years is predicted to double from 11% to 22% between 2000 
and 2050 [1]. This demographic shift is likely to further increase the prevalence of age-related 
diseases and disabilities in the near future. In 2013, there were 44.4 million people with dementia 
worldwide and this number will increase to an estimated 135.5 million in 2050 [2]. Identifying 
modifiable risk factors for cognitive decline as a precursor of dementia is likely to be an important 
strategy for delaying the onset, and reducing the number of people with dementia [3]; a healthy diet 
is hypothesized to reduce risk [4].  
A common approach to explore the impact of nutrition is studying dietary patterns 
comprising combinations of nutrients and foods. A frequently studied dietary pattern is the 
Mediterranean Diet, which is rich in fruits and vegetables and unsaturated fatty acids. Greater 
adherence to the Mediterranean Diet has been associated with a lower rate of cognitive decline in a 
number of observational and intervention studies [5]. However, there is a need to jointly study 
information from multiple studies to establish clear associations between a healthful dietary pattern, 
cognitive function and cognitive decline.  
Recommending dietary patterns at an international level requires the operationalization of 
globally applicable dietary guidelines. Therefore, the 1990 World Health Organization (WHO) 
guidelines for a healthy diet [6] were translated into the Healthy Diet Indicator (HDI) [7, 8]. These 
guidelines were developed to reduce chronic diseases, such as hypertension. As hypertension has 
been shown to impact cognitive function [9-11], it has been hypothesized that the HDI could reduce 
cognitive function decline.  
The HDI based on initial WHO recommendations has been associated with a lower 
prevalence of cognitive impairment [12, 13], however, the association between updated WHO 
guidelines and cognitive decline has not been quantified. We therefore prospectively examined the 
association between baseline HDI and cognitive decline at older age among 21,837 men and women 
from Europe and the United States (US) by conducting a meta-analysis of individual participant data 
from three population-based cohorts involved in the Consortium on Health and Ageing: Network of 
Cohorts in Europe and the United States (CHANCES) [14]. We hypothesized that a higher HDI score 
would be related to less cognitive decline. 
 
 
Materials and methods  
 
Data assessment and harmonization  
The aim of CHANCES is to combine prospective cohort studies to produce, improve, and clarify the 
evidence on the distribution and risk factors of chronic diseases in the elderly and on their 
socioeconomic impact (www.chancesfp7.eu). Data standardization and harmonization procedures 
were largely based upon the experience from the MORGAM project and previous experiences of 
project partners [15]. Data assessment procedures included examination of availability and 
comparability of cohort data, questionnaires and measurement procedures used in the individual 
cohorts, and methods for collection of data on health outcomes [14, 16]. For the present study, 
CHANCES cohorts were selected with harmonized variables on dietary intake, cognitive function and 
covariates according to predefined rules.  
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Study design and population 
We included participants aged ≥55 years from three cohorts, namely the cognitive sub-study of the 
Nurses’ Health Study (NHS) from the United States (US) [17]; the Rotterdam Study (RS) from the 
Netherlands [18]; and the Survey in Europe on Nutrition and the Elderly, a Concerted Action 
(SENECA) Study from Europe (Belgium, Denmark, France, Italy, The Netherlands, Portugal, Spain, 
Switzerland, and Poland) [19].  
NHS began in 1976, with 121,700 female registered nurses aged 30-55 years [17]. During 
1995–2001, women aged ≥70 years were invited to participate in a telephone-based study of 
cognitive function. For the first interview, 93% of eligible women participated (n=19,415). Follow-up 
assessments were performed up to 3 times at 2-year intervals. RS began baseline measures between 
1990 and 1993 in 7,983 men and women aged ≥55 years [20]. The first follow-up examination took 
place between 1993 and 1994 in 6,315 participants (follow-up 88%) and continued in 1997, 1999 and 
2001. The total SENECA population consisted of 2,585 European men and women aged 70-75 years 
at inclusion in 1988, and 124 participants were additionally added in a second wave in 1993. Follow-
up measures were performed in 1993 and 1998 [19]. In all cohorts, the collaborative research 
procedures were in accordance with the ethical standards of the responsible institutional or regional 
committees on human experimentation and informed consent was obtained from all participants. 
 
Dietary assessment 
Information on dietary intake was obtained with a validated 116-item semi quantitative Food 
Frequency Questionnaire (FFQ) in NHS in 1994 and 1998 [17] and a validated 170-item FFQ in RS at 
baseline (1990-1993) [20]. In SENECA, dietary intake was assessed in 1988 (n=2,585) and 1993 
(n=1,301) by means of a dietary history method including a three-day food record and a frequency 
checklist of foods [19]. Participants were interviewed by a dietician about their usual food 
consumption per day during the past month. Food intake estimations were converted into nutrient 
intakes by multiplying the consumption of each food by its nutrient content, using the US 
Department of Agriculture database in NHS and the Dutch food composition table (NEVO) [21] in RS 
and SENECA. The FFQs and dietary history method provided information allowing to estimate usual 
dietary intake per day during a specified period of time.  
 
Healthy Diet Indicator 
We used dietary intake immediately preceding the first cognitive assessment (ranging from zero to 
three years across the three cohorts) to estimate daily energy intake and to assess adherence to the 
updated WHO dietary guidelines in 2003 [8]. From 15 dietary items listed in the guidelines, seven 
items from which information was available across all cohorts were included in the HDI. This resulted 
in a HDI including saturated fatty acids, polyunsaturated fatty acids (PUFAs), mono- and 
disaccharides, protein, cholesterol, fruits and vegetables, and dietary fiber. Not included in the score 
were the intake of n-3 PUFAs, n-6 PUFAs, trans fatty acids, and sodium due to unavailability of data 
across cohorts. Furthermore, as suggested before [7], we excluded total fat and total carbohydrates 
from the HDI score calculation to avoid duplicating weights for these 2 components by the 
component factors and excluded non-starch polysaccharide as it also overlapped with the 
recommendation for total dietary fibre. We also excluded MUFAs, because the WHO guideline does 
not clearly specify the recommended intake of MUFAs in contrast to other fats. We applied a 
recently developed continuous HDI scoring system [22] with scores ranging from 0-10 per dietary 
component to provide greater variation between individuals and to overcome the use of definite cut-
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offs [22]. Intakes below the lower cut-off were assigned 0 points and intakes above the upper cut-off 
were assigned 10 points. Within a given range of intakes for each component, the range was divided 
into 10 and points were given in proportion to the distance from the 0 point cut-off. The scoring 
criteria, as well as the median component scores by cohort are shown in table 1. Total HDI scores 
were divided into sex- and cohort-specific quintiles based on study population intake distributions. 
 
Assessment of cognitive function 
In NHS, the Telephone Interview of Cognitive Status (TICS) [23], a telephone adaptation of the Mini-
Mental State Examination (MMSE) was administered first at baseline (1995-2001), then at 
approximately two-year intervals, with up to three repeated measures. The TICS contains measures 
of orientation, immediate verbal recall, registration, opposites, current events, serial subtraction, 
counting and other elements and assesses global cognitive performance, with scores ranging from 0 
to 41.  
The MMSE [24] assessed global cognitive function in RS in 1990, 1993, 1997, 1999 and 2001 
and in SENECA in 1993 and 1999. The MMSE includes questions on orientation to time and place, 
registration, attention and calculation, recall, language and visual construction, resulting in a score 
from 0 to 30. A correlation of 0.94 between TICS and MMSE and a high test–retest reliability for TICS 
(r = 0.97) was reported [23]. Higher TICS or MMSE scores indicate better cognitive performance. 
We calculated z-scores at each time point using cohort-specific distributions of scores at first 
cognitive assessment allowing comparability of findings across cohorts. 
 
Other variables 
Demographic, health and lifestyle information were obtained from self-administered questionnaires. 
Height and weight were measured at baseline in RS and SENECA and self-reported in NHS [25]. 
Physical activity was assessed by validated questionnaires for elderly by estimating mean energy 
expended per week in NHS (in metabolic equivalent-hours, METs) and as being vigorously physically 
active in SENECA and RS. In RS, physical activity was assessed six years after baseline as no baseline 
measure was available. Prevalence of diabetes mellitus, myocardial infarction, high blood pressure, 
depression, and hypercholesterolemia was obtained by questionnaires. In SENECA, 
hypercholesterolemia was estimated on use of dyslipidemia medications. 
 
Population for analysis 
We excluded participants with incomplete dietary intake data (n=2,144 NHS, n=2 RS, n=16 SENECA), 
without at least one cognitive assessment (n=1,771 RS, n=1,676 SENECA), and missing data for 
physical activity (n=111 NHS, n=1,769 RS), resulting in a total population of 21,837 participants 
(17,160 NHS, 3,660 RS, and 1,017 SENECA). 
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expended per week in NHS (in metabolic equivalent-hours, METs) and as being vigorously physically 
active in SENECA and RS. In RS, physical activity was assessed six years after baseline as no baseline 
measure was available. Prevalence of diabetes mellitus, myocardial infarction, high blood pressure, 
depression, and hypercholesterolemia was obtained by questionnaires. In SENECA, 
hypercholesterolemia was estimated on use of dyslipidemia medications. 
 
Population for analysis 
We excluded participants with incomplete dietary intake data (n=2,144 NHS, n=2 RS, n=16 SENECA), 
without at least one cognitive assessment (n=1,771 RS, n=1,676 SENECA), and missing data for 
physical activity (n=111 NHS, n=1,769 RS), resulting in a total population of 21,837 participants 
(17,160 NHS, 3,660 RS, and 1,017 SENECA). 
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Statistical analyses 
Means and standard deviations were calculated for normally distributed continuous variables and 
numbers and percentages were calculated for categorical variables. 
In the primary approach, we modelled trajectories of repeated cognitive measures using linear 
mixed models [26], with follow-up time from baseline as the time metameter. The linear model 
included an intercept representing the baseline level of cognitive score and a slope representing 
annual cognitive change as well as a random intercept and random slope accounting for inter-
individual variability. Linear trends across quintiles of HDI score were examined using a continuous 
variable in which participants in a given HDI quintile were assigned the median value. 
In a secondary approach, all repeated measures of cognitive function were averaged to create an 
outcome representing long-term cognitive status. Averaging repeated measures of cognition 
attenuates variability in each single cognitive assessment, which may be helpful when cognition is 
measured over a relatively short follow-up period with a modest decline over time in healthy, 
educated participants in NHS, RS and SENECA [17, 27]. Mean differences in cognitive status across 
quintiles of HDI score were modelled using linear regression.  
Adjustments were made for confounding factors that have been related to both dietary intake and 
cognitive function: age, sex, education (low, middle, high) (model 1), and employment history 
(employed, housekeeper, unemployed/retired), BMI (<22, 22-25, ≥25-30, ≥30 kg/m2), smoking status 
(never, former, current), energy intake (cohort specific quintiles), alcohol intake (<1, 1-14.9, ≥15 
g/day), physical activity (yes/no vigorous exercise in RS and SENECA, quintiles of METS in NHS) and 
depression (yes/no) (model 2). Vascular conditions (history of diabetes (yes/no), myocardial 
infarction (yes/no), high blood pressure (yes/no), and hypercholesterolemia (yes/no)) were tested as 
mediators by adding them to the full model (model 3). In the linear regression model studying long-
term cognitive status, a study center variable was added for SENECA to adjust for differences in 
baseline MMSE score between study centers. For BMI, 4.4% was missing in NHS; for employment, 
data were missing for 3.7% in RS; in SENECA data were missing for education (5.9%) and depression 
(15%), thus a specific missing category was created for these 4 variables. For all other covariates, 
participants with missing information were <1% of the sample and were assigned to the reference 
group. In subgroup analyses, we repeated our primary analyses while stratifying by sex (not 
applicable in NHS), baseline cognitive function (worst 10% versus best 90%), age (median split), BMI 
(<25 versus ≥25 kg/m2) and having any major cardiovascular risk factor (high blood pressure, 
hypercholesterolemia, myocardial infarction). As a sensitivity analysis, we determined the potential 
impact on our estimates of a learning effect when participants are administered the same cognitive 
tests multiple times by averaging the first two cognitive assessment within NHS and RS to derive a 
more robust baseline measure variable as first cognitive assessment and then repeating our analysis.  
Subsequently, we summarized the multivariable-adjusted mean differences in slopes of the fifth 
quintile versus first quintile per cohort by random-effects pooling by using DerSimonian and Laird 
random-effects models [28], accounting for differences in sample size and the possibility of 
statistical heterogeneity among the studies. Between-study heterogeneity was assessed via the I2 
statistic [29], expressing the percentage of variation attributable to between-study heterogeneity. 
All statistical analyses were carried out using SAS, version 9.3, software (SAS Institute Inc., Cary, 
North Carolina, USA). For random-effects meta-analyses, we used the metaphor package in R, 
version 3.2.0 (R Foundation for Statistical Computing, Vienna, Austria). P-values < 0.05 were 
considered significant.  
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Statistical analyses 
Means and standard deviations were calculated for normally distributed continuous variables and 
numbers and percentages were calculated for categorical variables. 
In the primary approach, we modelled trajectories of repeated cognitive measures using linear 
mixed models [26], with follow-up time from baseline as the time metameter. The linear model 
included an intercept representing the baseline level of cognitive score and a slope representing 
annual cognitive change as well as a random intercept and random slope accounting for inter-
individual variability. Linear trends across quintiles of HDI score were examined using a continuous 
variable in which participants in a given HDI quintile were assigned the median value. 
In a secondary approach, all repeated measures of cognitive function were averaged to create an 
outcome representing long-term cognitive status. Averaging repeated measures of cognition 
attenuates variability in each single cognitive assessment, which may be helpful when cognition is 
measured over a relatively short follow-up period with a modest decline over time in healthy, 
educated participants in NHS, RS and SENECA [17, 27]. Mean differences in cognitive status across 
quintiles of HDI score were modelled using linear regression.  
Adjustments were made for confounding factors that have been related to both dietary intake and 
cognitive function: age, sex, education (low, middle, high) (model 1), and employment history 
(employed, housekeeper, unemployed/retired), BMI (<22, 22-25, ≥25-30, ≥30 kg/m2), smoking status 
(never, former, current), energy intake (cohort specific quintiles), alcohol intake (<1, 1-14.9, ≥15 
g/day), physical activity (yes/no vigorous exercise in RS and SENECA, quintiles of METS in NHS) and 
depression (yes/no) (model 2). Vascular conditions (history of diabetes (yes/no), myocardial 
infarction (yes/no), high blood pressure (yes/no), and hypercholesterolemia (yes/no)) were tested as 
mediators by adding them to the full model (model 3). In the linear regression model studying long-
term cognitive status, a study center variable was added for SENECA to adjust for differences in 
baseline MMSE score between study centers. For BMI, 4.4% was missing in NHS; for employment, 
data were missing for 3.7% in RS; in SENECA data were missing for education (5.9%) and depression 
(15%), thus a specific missing category was created for these 4 variables. For all other covariates, 
participants with missing information were <1% of the sample and were assigned to the reference 
group. In subgroup analyses, we repeated our primary analyses while stratifying by sex (not 
applicable in NHS), baseline cognitive function (worst 10% versus best 90%), age (median split), BMI 
(<25 versus ≥25 kg/m2) and having any major cardiovascular risk factor (high blood pressure, 
hypercholesterolemia, myocardial infarction). As a sensitivity analysis, we determined the potential 
impact on our estimates of a learning effect when participants are administered the same cognitive 
tests multiple times by averaging the first two cognitive assessment within NHS and RS to derive a 
more robust baseline measure variable as first cognitive assessment and then repeating our analysis.  
Subsequently, we summarized the multivariable-adjusted mean differences in slopes of the fifth 
quintile versus first quintile per cohort by random-effects pooling by using DerSimonian and Laird 
random-effects models [28], accounting for differences in sample size and the possibility of 
statistical heterogeneity among the studies. Between-study heterogeneity was assessed via the I2 
statistic [29], expressing the percentage of variation attributable to between-study heterogeneity. 
All statistical analyses were carried out using SAS, version 9.3, software (SAS Institute Inc., Cary, 
North Carolina, USA). For random-effects meta-analyses, we used the metaphor package in R, 
version 3.2.0 (R Foundation for Statistical Computing, Vienna, Austria). P-values < 0.05 were 
considered significant.  
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Results 
 
General characteristics 
Median HDI scores were 44.6 (range 13.3-62.5) in NHS, 45.5 (range 14.4-62.9) in RS, and 47.9 (range 
20.6-69.9) in SENECA. At the first cognitive assessment, mean age of participants was 74.2 (2.3) 
years in NHS, 65.7 (7.3) in RS, and 78.0 (2.8) in SENECA. Across all cohorts, participants with a higher 
HDI score were more likely to be physically active, higher educated, never smokers, normal weight, 
to have higher energy intakes, and a history of myocardial infarction and to be less likely to have a 
history of diabetes (table 2).  
 
Relation between HDI score and cognitive decline 
A higher HDI score was not associated with cognitive decline in the basic adjusted model (adjusted 
mean differences in rates between extreme quintiles = 0.005 (95%CI -0.005,0.016), P-trend=0.17 in 
NHS, 0.001 (95%CI -0.014,0.015), P-trend=0.69 in RS and 0.008 (95%CI -0.041,0.052), P-trend=0.49 in 
SENECA), nor in the multivariable-adjusted model (0.005, [95%CI -0.006,0.016]), P-trend=0.20 in 
NHS, -0.002 (95%CI -0.016,0.013), P-trend=0.98 in RS and 0.002 (95%CI -0.047,0.052), P-trend=0.52 
in SENECA (table 3)). Pooled analyses showed no association between highest HDI scores and 
cognitive decline (pooled multivariable-adjusted mean difference = 0.002 (95%CI: -0.006,0.011), 
I2=0%), (figure 1). Adding mediators to the model (type 2 diabetes mellitus, myocardial infarction, 
hypertension and hypercholesterolemia) did not affect the estimates (adjusted mean differences in 
rates between extreme quintiles 0.006 (95%CI -0.005,0.017), P-trend=0.15 in NHS, -0.002 (95%CI -
0.017,0.012), P-trend=0.98 in RS, and -0.001 (95%CI -0.049,0.048), P-trend=0.56 in SENECA, 
respectively). Subgroup analyses by sex, baseline cognitive function, age, and BMI did not show 
differences by strata or statistical interaction. Among those with a history of cardiovascular risk 
factors there was less cognitive decline with the highest HDI score in SENECA (P-trend=0.03, P-
interaction=0.03, table 4). Furthermore, in sensitivity analyses to address practice effects, in the 
Rotterdam Study and NHS where >2 repeated measures were available, we used models where the 
average of the first two cognitive assessments was considered as the new baseline from which 
cognitive change was evaluated; results did not differ from the main analyses (data not shown). 
 
Relation between the HDI score and cognitive status 
The HDI score was not associated with cognitive status in NHS, RS and SENECA in the basic adjusted 
model (P-trend=0.28 in NHS, 0.19 in RS, and 0.34 in SENECA), nor in the multivariable-adjusted 
model (P-trend=0.87 in NHS, 0.27 in RS, and 0.25 in SENECA), table 5. 
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Table 2. Baseline characteristics of participants in the Nurses’ Health Study (n=17,160), Rotterdam Study 
(n=3,660) and SENECA study (n=1,017) by extreme cohort- and sex-specific quintiles of HDI scorea 
 NHS RS SENECA 
 Quintile 1 Quintile 5 Quintile 1 Quintile 5 Quintile 1 Quintile 5 
 35.7  
(32.6-37.7) 
n=3,422 
52.7  
(51.4-54.4) 
n=3,431 
36.4 
(33.8-38.2) 
n=731 
53.2 
(51.9-55.2) 
n=731 
38.1 
(35.4-40.2) 
n=202 
57.1 
(55.3-59.23) 
n=203 
Age 74.1 (2.3) 74.4 (2.4) 66.3 (7.4) 65.6 (6.3) 77.8 (2.8) 78.0 (2.8) 
Men (%) N/A N/A 40.8 40.8 49.0 48.8 
Educational level (%)       
Low 78 77 34 29 53 49 
Middle 16 16 57 60 30 33 
High 6 6 8 11 10 10 
BMI (%)       
≤21, kg/m2   19  22 8 11 9  12 
22-24, kg/m2  24  27  28 34  22 20 
25-29, kg/m2  33  34  50  44  43  44 
≥30, kg/m2 20 14  15  12  20  14 
Physical activityb 13.8 (18.7) 18.3 (22.1)  83% 89% 8% 9% 
Employment (%)       
Employed 5 4 79 78 75 78 
Homemaker 7 7 11 9 17 12 
Other/retired  88 89 10 13 9 10 
Smoking (%)       
Never 44 48 30 36 55 60 
Former  44 46 39 46 30 30 
Current  12 6 31 18 15 10 
History of disease (%)       
Myocardial infarction 6 5 9 11 24 32 
Hypertension 56 55 36 37 32 37 
Hypercholesterolemia 60 67 2 3 11 6 
Diabetes 11 9 9 6 16 13 
Depression 10 9 9 9 19 19 
Dietary variables       
Energy intake, kcal 1518 (572) 1806 (497) 2007 (609) 2053 (414) 1897 (618) 2071 (607) 
Alcohol, g 5.3 (10.4) 4.6 (8.6) 12.1 (15.8) 7.46 (10.6) 12.6 (18.1) 10.7 (8.9) 
HDI components        
Saturated fatty 
acids 
11.7 (3.2) 8.1 (1.7) 16.9 (3.1) 13.1 (2.5) 16.6 (4.4) 12.2 (3.6) 
Polyunsaturated 
fatty acids 
5.5 (2.3) 6.3 (1.4) 6.5 (3.6) 7.7 (1.7) 6.3 (4.1) 6.4 (2.2) 
 
 
Mono- and 
disaccharides 
26.2 (7.8) 26.2 (6.1) 21.5 (6.1) 23.2 (6.0) 20.8 (7.3) 17.9 (6.3) 
Protein 18.5 (3.5) 15.0 (1.9) 18.6 (3.3) 16.2 (2.4) 16.9 (3.9) 13.9 (1.7) 
Cholesterol, g 221 (121) 166 (68) 285 (105) 204 (55) 351 (144) 239 (78.5) 
Fruit and 
vegetables, g 
286 (172) 505 (205) 395 (193) 500 (149) 465 (246) 604 (255) 
Dietary fiber, g 4.1 (1.9) 6.8 (2.3) 14.6 (4.7) 20.1 (4.4) 17.0 (6.9) 23.9 (7.5) 
MMSE/TICS 33.8 (2.7) 33.8 (2.7) 27.9 (1.5) 28.1 (1.6) 26.9 (2.7) 26.3 (2.7) 
Abbreviations: HDI, Healthy Diet Indicator; NHS, Nurses’ Health Study; RS, Rotterdam Study; MET-hours=metabolic 
equivalent-hours, PUFAs, polyunsaturated fatty acids. 
a Values are mean (SD) or percentage (%) 
b Physical activity in NHS represented in MET-hours, in RS and SENECA as % vigorous physical activity.  
HDI scores [median (IQR)] are provided in brackets for each quintile.  
Dietary variables represent mean intakes per day expressed in energy percentages, unless otherwise noted. 
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Results 
 
General characteristics 
Median HDI scores were 44.6 (range 13.3-62.5) in NHS, 45.5 (range 14.4-62.9) in RS, and 47.9 (range 
20.6-69.9) in SENECA. At the first cognitive assessment, mean age of participants was 74.2 (2.3) 
years in NHS, 65.7 (7.3) in RS, and 78.0 (2.8) in SENECA. Across all cohorts, participants with a higher 
HDI score were more likely to be physically active, higher educated, never smokers, normal weight, 
to have higher energy intakes, and a history of myocardial infarction and to be less likely to have a 
history of diabetes (table 2).  
 
Relation between HDI score and cognitive decline 
A higher HDI score was not associated with cognitive decline in the basic adjusted model (adjusted 
mean differences in rates between extreme quintiles = 0.005 (95%CI -0.005,0.016), P-trend=0.17 in 
NHS, 0.001 (95%CI -0.014,0.015), P-trend=0.69 in RS and 0.008 (95%CI -0.041,0.052), P-trend=0.49 in 
SENECA), nor in the multivariable-adjusted model (0.005, [95%CI -0.006,0.016]), P-trend=0.20 in 
NHS, -0.002 (95%CI -0.016,0.013), P-trend=0.98 in RS and 0.002 (95%CI -0.047,0.052), P-trend=0.52 
in SENECA (table 3)). Pooled analyses showed no association between highest HDI scores and 
cognitive decline (pooled multivariable-adjusted mean difference = 0.002 (95%CI: -0.006,0.011), 
I2=0%), (figure 1). Adding mediators to the model (type 2 diabetes mellitus, myocardial infarction, 
hypertension and hypercholesterolemia) did not affect the estimates (adjusted mean differences in 
rates between extreme quintiles 0.006 (95%CI -0.005,0.017), P-trend=0.15 in NHS, -0.002 (95%CI -
0.017,0.012), P-trend=0.98 in RS, and -0.001 (95%CI -0.049,0.048), P-trend=0.56 in SENECA, 
respectively). Subgroup analyses by sex, baseline cognitive function, age, and BMI did not show 
differences by strata or statistical interaction. Among those with a history of cardiovascular risk 
factors there was less cognitive decline with the highest HDI score in SENECA (P-trend=0.03, P-
interaction=0.03, table 4). Furthermore, in sensitivity analyses to address practice effects, in the 
Rotterdam Study and NHS where >2 repeated measures were available, we used models where the 
average of the first two cognitive assessments was considered as the new baseline from which 
cognitive change was evaluated; results did not differ from the main analyses (data not shown). 
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model (P-trend=0.28 in NHS, 0.19 in RS, and 0.34 in SENECA), nor in the multivariable-adjusted 
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Table 3. Multivariable-adjusted mean differences in annual rates of cognitive change by cohort- and  
sex-specific quintiles of baseline HDI scorea 
 Model 1b Model 2c 
NHS (n = 17,160)   
Quintile 1 Ref  Ref  
Quintile 2 -0.004 (-0.014, 0.006) -0.004 (-0.014, 0.007) 
Quintile 3   0.013 ( 0.003, 0.023)   0.012 ( 0.002, 0.023) 
Quintile 4  0.002 (-0.008, 0.012)  0.002 (-0.009, 0.012) 
Quintile 5  0.005 (-0.005, 0.016) 0.005 (-0.006, 0.016) 
p-trend 0.17 0.20 
   
RS (n = 3,660)   
Quintile 1 Ref Ref 
Quintile 2 0.000 (-0.014, 0.015) 0.000 (-0.015, 0.014) 
Quintile 3 0.012 (-0.003, 0.026) 0.010 (-0.004, 0.025) 
Quintile 4 0.004 (-0.011, 0.018) 0.002 (-0.013, 0.016) 
Quintile 5 0.001 (-0.014, 0.015) -0.002 (-0.016, 0.013) 
p-trend 0.69 0.98 
   
SENECA (n = 1,017)   
Quintile 1 Ref Ref 
Quintile 2 -0.015 (-0.063, 0.034) -0.029 (-0.079, 0.019) 
Quintile 3 0.022 (-0.028, 0.071) 0.017 (-0.033, 0.066) 
Quintile 4 0.006 (-0.043, 0.055) 0.000 (-0.049, 0.049) 
Quintile 5 0.008 (-0.041, 0.057) 0.002 (-0.047, 0.052) 
p-trend 0.49 0.52 
Abbreviations: HDI, Healthy Diet Indicator; NHS, Nurses’ Health Study; RS, Rotterdam Study; Ref, reference 
a Values are mean differences (95% confidence interval).  
b Adjusted for age, gender, education  
c Additionally adjusted for employment status, BMI, smoking status, energy intake, alcohol intake, physical activity, 
and depression 
 
 
 
Table 4. Multivariable-adjusted mean differences in annual rates of cognitive change by cohort- and sex-
specific quintiles of baseline HDI score by cardiovascular risk factor history in SENECAa,b 
 No cardiovascular risk factor Cardiovascular risk factor 
SENECA  n = 495 n = 522 
Quintile 1  Ref  Ref 
Quintile 2  -0.077 (-0.149, -0.005) 0.022 (-0.045, 0.087) 
Quintile 3  -0.053 (-0.128, 0.021) 0.076 (0.010, 0.142) 
Quintile 4  -0.061 (-0.132, 0.010) 0.076 (0.009, 0.143) 
Quintile 5 -0.048 (-0.122, 0.027) 0.056 (-0.009, 0.121) 
p-trend 0.23 0.03 
p-interaction  0.03 
Abbreviations: HDI, Healthy Diet Indicator; Ref, reference. Cardiovascular risk factor or disease included high blood 
pressure, hypercholesterolemia or myocardial infarction. 
a Values are mean differences (95% confidence interval).  
b Adjusted for age, education, study centre, employment status, BMI, smoking status, energy intake, alcohol intake, 
physical activity and depression. 
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Figure 1. Cohort- and sex-specific and pooled mean differences in the annual rate of cognitive change in 
relation to highest vs. lowest quintile of adherence to the WHO guidelines and cognitive decline. 
Adjusted for age, gender (TS and SENECA), education, employment status, BMI, smoking status, calorie intake, alcohol 
intake, physical activity, and depression in the Consortium on Health and Ageing: Network of Cohorts in Europe and the 
United States (CHANCES), 1988–2011. Cohorts are ordered according to cohort size, beginning with the largest cohort. I2 is 
expressed as the percentage of total variability caused by heterogeneity. All data were obtained from CHANCES 
(www.chancesfp7.eu). Bars indicate 95% confidence intervals (CIs). NHS, Nurses’ Health Study; RS, Rotterdam Study; 
SENECA, Survey in Europe on Nutrition and the Elderly, a Concerted Action. 
 
 
 
Table 5. Multivariable-adjusted mean differences in average cognitive status by cohort- and  
sex-specific quintiles of baseline HDI scorea 
 Model 1b Model 2c 
NHS (n = 16,807)   
Quintile 1 Ref Ref 
Quintile 2 0.00 (-0.04, 0.05) -0.02 (-0.06, 0.03) 
Quintile 3 0.04 (-0.01, 0.08)  0.01 (-0.03, 0.06) 
Quintile 4 0.00 (-0.04, 0.05) -0.02 (-0.07, 0.02) 
Quintile 5 0.03 (-0.02, 0.07)  0.00 (-0.04, 0.04) 
p-trend 0.28 0.87 
   
RS (n = 3,660)   
Quintile 1 Ref Ref 
Quintile 2 0.02 (-0.08, 0.12) 0.01 (-0.09, 0.11) 
Quintile 3 0.06 (-0.04, 0.16) 0.04 (-0.06, 0.14) 
Quintile 4 0.06 (-0.04, 0.15) 0.04 (-0.06, 0.14) 
Quintile 5 0.06 (-0.04, 0.15) 0.06 (-0.04, 0.15) 
p-trend 0.19 0.27 
   
SENECA (n = 1,017)   
Quintile 1 Ref Ref 
Quintile 2 0.00 (-0.19, 0.19) -0.02 (-0.21, 0.18) 
Quintile 3  0.25 ( 0.06, 0.45)  0.25 ( 0.05, 0.44) 
Quintile 4 0.01 (-0.19, 0.20) -0.01 (-0.20, 0.19) 
Quintile 5 -0.12 (-0.31, 0.08) -0.14 (-0.34, 0.06) 
p-trend 0.34 0.25 
Abbreviations: HDI, Healthy Diet Indicator; NHS, Nurses’ Health Study; RS, Rotterdam Study 
a Variables are mean differences (95% confidence interval).  
b Adjusted for age, gender, education, study centre (SENECA only) 
c Additionally adjusted for employment status, BMI, smoking status, energy intake, alcohol intake, physical activity, 
and depression 
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Discussion 
In the present consortium study, including 21,837 older men and women from Europe and the US, 
we found that a healthier diet adhering to the most recent WHO guidelines was not associated with 
a slower rate of cognitive decline, nor with cognitive status at older ages, which is in contrast to the 
findings between other dietary patterns [30-32] and cognition. 
 
As the HDI is developed to prevent chronic diseases, we hypothesized that it could also impact 
cognitive function. Previously, two cross-sectional studies assessed the association between a higher 
HDI score and cognitive impairment and reported a lower prevalence of cognitive impairment in 
1,049 Italian older men (odds ratio 0.75 (95%CI 0.58-0.97) [13]) and in a group of 1,651 Italian older 
men and women (odds ratio 0.85 (95%CI 0.77-0.93) [12]). Our study, using a much larger population, 
a prospective design, and using the updated HDI guidelines, did not confirm previous findings. 
 
The lack of significant associations could be a result of low variability in cognitive function as 
measured by the MMSE and TICS due to the ceiling effects of these tests. Future studies on cognitive 
functioning should preferably include tests that are able to measure areas of cognition most affected 
by common dementing illnesses, such as memory, attention, language and visuospatial abilities [33]. 
However, in our cohorts, we have observed associations between major risk factors and cognitive 
change based on TICS [34-38]. Two previous studies examining the initial HDI guidelines used the 
MMSE [13] and an extended and validated version of the MMSE, namely the 0-70 point 
neuropsychological test (NPT) [12], to assess cognitive function. Although these tests are 
comparable to the tests that we used, the outcome was differently defined. We studied cognitive 
function and cognitive decline, whereas the previous studies evaluated cognitive impairment based 
on predefined cut-offs. This latter approach does not allow a distinction between initial level and 
change [33]. Furthermore, as our cohorts included relatively healthy, well-educated participants 
compared to the other populations [12, 13], it is possible that our participants reported healthy diets 
at baseline with an overall good cognitive functioning, limiting the ability to detect an association 
between the HDI and cognitive decline. Nonetheless, we had extremely high ability to identify even 
modest associations given our very large sample size. At last, previous studies used the initial HDI 
including pulses and nuts, which were not part of the updated HDI. While we didn’t include nuts and 
pulses from the original HDI, the nutrients that would be neuroprotective from these foods, such as 
MUFAs, PUFAs, protein and fiber, would have been captured by the updated HDI, making it less 
likely that the omission of these two foods would explain the null findings. 
 
Another point to consider is that due to the limited amount of dietary information across the three 
cohort studies we included seven out of ten HDI components. However, we aimed to increase 
variability within the HDI score by using the recently developed continuous calculation system based 
on seven dietary components (range 0-70 points) as proposed by Jankovic et.al. [22]. It has been 
shown that using seven components rather than ten HDI components (where instead of 
polyunsaturated fat in the 7 component HDI model, n-3 PUFAs, n-6 PUFAs are used in addition to 
trans fatty acids and sodium) resulted in less heterogeneity when studying the HDI in multiple cohort 
studies [22]. To test the effect of using seven HDI components only compared to using ten HDI 
components, we studied ten HDI components in NHS and found similar null findings, indicating this 
probably does not explain our null-findings.  
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Other dietary patterns that have been shown to be related to cognitive function and decline in 
European and American observational studies in older adults include the Mediterranean diet [17, 39-
46], the Dietary Approaches to Stop Hypertension (DASH) diet [42, 44, 47] and the Healthy Eating 
Index (HEI) [45, 48]. Dietary intervention studies with the Mediterranean diet [30, 31] and the DASH 
diet [32] confirmed these findings. These food based scores include high intakes of vegetables, fruits, 
legumes, whole grains, nuts, fish, monounsaturated fatty acids (MUFAs), polyunsaturated fatty acids 
(PUFAs), moderate amounts of low-fat dairy products and alcohol and low amounts of red and 
processed meats, and the MUFA-to-saturated fats ratio.  
More recently, dietary components linked to neuroprotection and cognitive function have been 
summarized into one dietary pattern score, namely the Mediterranean-DASH Intervention for 
Neurodegenerative Delay (MIND) diet [49]. The MIND diet is a hybrid of the Mediterranean-DASH 
diets and includes high intakes of green leafy vegetables, other vegetables, nuts, berries, beans, 
whole grains, fish, poultry, olive oil, and wine and low amounts of red meats, butter and stick 
margarine, cheese, pastries and sweets, and fried/fast food. This diet has been related to slower 
cognitive ageing in a single study of 960 older adults (mean age 81.4 years) of the Memory and Aging 
Project [49]. As the HDI does not include the majority of these components [8], nor specific 
components shown to be associated with cognitive function, such as green leafy vegetables [36, 50] 
and berries [34] it could be that the HDI was well-designed to reduce risk of chronic diseases in 
general, but not cognitive function. On the contrary, the inclusion of very specific food items limits 
the possibility to jointly study effect estimates of multiple studies and to target multiple diseases at 
once by means of one dietary pattern, as does the HDI.  
In stratified analyses, we observed less cognitive function decline with higher HDI scores in 
participants reporting a history of cardiovascular risk factors in SENECA. As the HDI has been 
developed to prevent chronic diseases, including hypertension, and as hypertension has been 
associated with a worse cognitive function [9-11], it was hypothesized that this high risk group for 
cognitive decline would benefit from a healthy diet as the HDI. Biologically, the blood pressure 
lowering effect of the HDI reduces thickening of the vessel wall, leading to less vascular narrowing, 
resulting in less thickening of the media and atheromatous plaques within larger cerebral arteries. 
This could result in a lower risk of rupture of these plaques which could cause complete occlusion of 
arteries and infarction of surrounding tissues [51].  
The availability of harmonized dietary intake variables is a major strength of the present study. 
Furthermore, the use of harmonized outcome variables and covariates reduces heterogeneity. 
Additionally, four HDI components are expressed as energy percentage, increasing the comparability 
of diet between different cohorts using different dietary assessment methods. Another advantage is 
the relatively long follow-up time of cognitive function with multiple repeated measures (NHS and 
SENECA 6 years, RS 10 years), which could have been sufficient to measure changes in cognitive 
function, as other studies were able to measure changes in cognitive function after 4 to 5 years of 
follow-up [39, 52]. Another strength is that we were able to study changes in cognitive function over 
time, allowing us to use all available data of all cohorts using a comparable measure across cohorts. 
Finally, studying dietary intake prior to the cognitive assessments including many years of follow-up 
minimized possible reverse causation. 
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Discussion 
In the present consortium study, including 21,837 older men and women from Europe and the US, 
we found that a healthier diet adhering to the most recent WHO guidelines was not associated with 
a slower rate of cognitive decline, nor with cognitive status at older ages, which is in contrast to the 
findings between other dietary patterns [30-32] and cognition. 
 
As the HDI is developed to prevent chronic diseases, we hypothesized that it could also impact 
cognitive function. Previously, two cross-sectional studies assessed the association between a higher 
HDI score and cognitive impairment and reported a lower prevalence of cognitive impairment in 
1,049 Italian older men (odds ratio 0.75 (95%CI 0.58-0.97) [13]) and in a group of 1,651 Italian older 
men and women (odds ratio 0.85 (95%CI 0.77-0.93) [12]). Our study, using a much larger population, 
a prospective design, and using the updated HDI guidelines, did not confirm previous findings. 
 
The lack of significant associations could be a result of low variability in cognitive function as 
measured by the MMSE and TICS due to the ceiling effects of these tests. Future studies on cognitive 
functioning should preferably include tests that are able to measure areas of cognition most affected 
by common dementing illnesses, such as memory, attention, language and visuospatial abilities [33]. 
However, in our cohorts, we have observed associations between major risk factors and cognitive 
change based on TICS [34-38]. Two previous studies examining the initial HDI guidelines used the 
MMSE [13] and an extended and validated version of the MMSE, namely the 0-70 point 
neuropsychological test (NPT) [12], to assess cognitive function. Although these tests are 
comparable to the tests that we used, the outcome was differently defined. We studied cognitive 
function and cognitive decline, whereas the previous studies evaluated cognitive impairment based 
on predefined cut-offs. This latter approach does not allow a distinction between initial level and 
change [33]. Furthermore, as our cohorts included relatively healthy, well-educated participants 
compared to the other populations [12, 13], it is possible that our participants reported healthy diets 
at baseline with an overall good cognitive functioning, limiting the ability to detect an association 
between the HDI and cognitive decline. Nonetheless, we had extremely high ability to identify even 
modest associations given our very large sample size. At last, previous studies used the initial HDI 
including pulses and nuts, which were not part of the updated HDI. While we didn’t include nuts and 
pulses from the original HDI, the nutrients that would be neuroprotective from these foods, such as 
MUFAs, PUFAs, protein and fiber, would have been captured by the updated HDI, making it less 
likely that the omission of these two foods would explain the null findings. 
 
Another point to consider is that due to the limited amount of dietary information across the three 
cohort studies we included seven out of ten HDI components. However, we aimed to increase 
variability within the HDI score by using the recently developed continuous calculation system based 
on seven dietary components (range 0-70 points) as proposed by Jankovic et.al. [22]. It has been 
shown that using seven components rather than ten HDI components (where instead of 
polyunsaturated fat in the 7 component HDI model, n-3 PUFAs, n-6 PUFAs are used in addition to 
trans fatty acids and sodium) resulted in less heterogeneity when studying the HDI in multiple cohort 
studies [22]. To test the effect of using seven HDI components only compared to using ten HDI 
components, we studied ten HDI components in NHS and found similar null findings, indicating this 
probably does not explain our null-findings.  
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Other dietary patterns that have been shown to be related to cognitive function and decline in 
European and American observational studies in older adults include the Mediterranean diet [17, 39-
46], the Dietary Approaches to Stop Hypertension (DASH) diet [42, 44, 47] and the Healthy Eating 
Index (HEI) [45, 48]. Dietary intervention studies with the Mediterranean diet [30, 31] and the DASH 
diet [32] confirmed these findings. These food based scores include high intakes of vegetables, fruits, 
legumes, whole grains, nuts, fish, monounsaturated fatty acids (MUFAs), polyunsaturated fatty acids 
(PUFAs), moderate amounts of low-fat dairy products and alcohol and low amounts of red and 
processed meats, and the MUFA-to-saturated fats ratio.  
More recently, dietary components linked to neuroprotection and cognitive function have been 
summarized into one dietary pattern score, namely the Mediterranean-DASH Intervention for 
Neurodegenerative Delay (MIND) diet [49]. The MIND diet is a hybrid of the Mediterranean-DASH 
diets and includes high intakes of green leafy vegetables, other vegetables, nuts, berries, beans, 
whole grains, fish, poultry, olive oil, and wine and low amounts of red meats, butter and stick 
margarine, cheese, pastries and sweets, and fried/fast food. This diet has been related to slower 
cognitive ageing in a single study of 960 older adults (mean age 81.4 years) of the Memory and Aging 
Project [49]. As the HDI does not include the majority of these components [8], nor specific 
components shown to be associated with cognitive function, such as green leafy vegetables [36, 50] 
and berries [34] it could be that the HDI was well-designed to reduce risk of chronic diseases in 
general, but not cognitive function. On the contrary, the inclusion of very specific food items limits 
the possibility to jointly study effect estimates of multiple studies and to target multiple diseases at 
once by means of one dietary pattern, as does the HDI.  
In stratified analyses, we observed less cognitive function decline with higher HDI scores in 
participants reporting a history of cardiovascular risk factors in SENECA. As the HDI has been 
developed to prevent chronic diseases, including hypertension, and as hypertension has been 
associated with a worse cognitive function [9-11], it was hypothesized that this high risk group for 
cognitive decline would benefit from a healthy diet as the HDI. Biologically, the blood pressure 
lowering effect of the HDI reduces thickening of the vessel wall, leading to less vascular narrowing, 
resulting in less thickening of the media and atheromatous plaques within larger cerebral arteries. 
This could result in a lower risk of rupture of these plaques which could cause complete occlusion of 
arteries and infarction of surrounding tissues [51].  
The availability of harmonized dietary intake variables is a major strength of the present study. 
Furthermore, the use of harmonized outcome variables and covariates reduces heterogeneity. 
Additionally, four HDI components are expressed as energy percentage, increasing the comparability 
of diet between different cohorts using different dietary assessment methods. Another advantage is 
the relatively long follow-up time of cognitive function with multiple repeated measures (NHS and 
SENECA 6 years, RS 10 years), which could have been sufficient to measure changes in cognitive 
function, as other studies were able to measure changes in cognitive function after 4 to 5 years of 
follow-up [39, 52]. Another strength is that we were able to study changes in cognitive function over 
time, allowing us to use all available data of all cohorts using a comparable measure across cohorts. 
Finally, studying dietary intake prior to the cognitive assessments including many years of follow-up 
minimized possible reverse causation. 
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It may be considered a limitation that we used one dietary intake assessment, assuming stable diets 
over time. Additional analyses confirmed that dietary intakes were similar over multiple time points 
in NHS and SENECA (data not shown). Furthermore, FFQ’s rely on participants’ estimates of food 
intake which can lead to misclassification of dietary pattern adherence. This is a common limitation 
of studies of diet and our results from SENECA using a dietary history method did not result in 
different conclusions. Lastly, although we have tried to differentiate between a healthy lifestyle and 
a healthy diet by extensively adjusting for risk factors for cognitive decline, residual confounding 
remains possible due to unmeasured or imprecisely measured covariates.  
 
We demonstrated that greater adherence to the WHO dietary guidelines for a healthy diet was not 
associated with reduced rates of cognitive decline in European and American older adults. 
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Abstract 
Objectives: To examine the association between long-term adherence to the Dietary Approaches to 
Stop Hypertension (DASH) diet with cognitive function and decline in older American women. 
Setting: The Nurses’ Health Study (NHS), a cohort of registered nurses residing in 11 U.S. states. 
Participants: A total of 16,144 women from NHS, aged ≥70 years, who underwent cognitive testing a 
total of 4 times by telephone from 1995-2001 (baseline), with multiple dietary assessments between 
1984 and the first cognitive exam. DASH adherence for each individual was based on scoring of 
intakes of nine nutrient or food components. 
Measurements: Long-term DASH adherence was calculated as the average DASH adherence score 
from up to five repeated measures of diet. Primary outcomes were cognitive function calculated as 
the average scores of the four repeated measures, as well as cognitive change of the Telephone 
Interview for Cognitive Status (TICS) score and composite scores of global cognition and verbal 
memory. 
Results: Greater adherence to long-term DASH score was associated with better average cognitive 
function, irrespective of apolipoprotein E (APOE) ε4 allele status (multivariable-adjusted differences 
in mean z-scores between extreme DASH quintiles = 0.04 (95% CI 0.01-0.07), p-trend=0.009 for 
global cognition; 0.04 (95%CI 0.01-0.07), p-trend=0.002 for verbal memory, and 0.16 (95%CI 0.03–
0.29), p-trend=0.03 for TICS, p-interaction >0.24). These differences were equivalent to being one 
year younger in age. Adherence to the DASH score was not associated with change in cognitive 
function over six years. 
Conclusion: Our findings in the largest cohort on dietary patterns and cognitive function to date 
indicate that long-term adherence to the DASH diet is important to maintain cognitive function at 
older ages. 
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Introduction 
With the aging population, it is important to find modifiable risk factors to prevent cognitive decline 
and reduce the number of people with dementia [1]. One hypothesized factor is nutrition, and 
specifically dietary patterns in which combinations of nutrients and foods are studied simultaneously 
[2].  
A frequently studied dietary pattern is the Mediterranean Diet, which has been associated with a 
lower rate of cognitive decline [3]. Another dietary pattern of interest is the Dietary Approaches to 
Stop Hypertension (DASH) diet. The DASH diet specifies higher intakes of fruits, vegetables, low-fat 
dairy products, whole grains, poultry, fish, and nuts and low intakes of fats, red meat, sweets and 
sugar-containing beverages [4]. This diet has been shown to lower blood pressure in pre-
hypertensive and hypertensive adults [5]. It has been hypothesized that the DASH diet could impact 
cognitive function, as high blood pressure is associated with higher risk mild cognitive impairment 
[6], vascular dementia [7], and neurocognitive deficits [8]. A few observational studies have 
evaluated the DASH diet in relation to cognitive function and reported that the DASH diet was 
associated with a better cognitive function in elderly men and women (n=3,831) in the United States 
(U.S.) over an 11-year period [9], and with less cognitive decline among elderly American men and 
women (n=826) after 4.1 years of follow-up [10]. A dietary intervention study (n=124) demonstrated 
that four months on the DASH diet improved psychomotor speed in hypertensive American adults 
[11].  
We examined the association of long-term DASH diet adherence to cognitive function and 6-year 
cognitive decline among 16,144 women. 
 
 
Materials and methods 
 
Study population 
The Nurses’ Health Study (NHS) began in 1976, with 121,700 female, registered nurses, aged 30-55 
years, residing in 11 U.S. states. Participants completed a mailed questionnaire about their health 
and lifestyle. Follow-up questionnaires are sent every two years; follow-up of the cohort remains 
~90% to date. In 1984, participants completed a 116-item semi-quantitative food frequency 
questionnaire (FFQ) [12] and similar FFQs were sent in 1986 and every four years thereafter. During 
1995–2001, women who were ≥70 years old and free of stroke were invited to participate in their 
first telephone-based study of cognitive function. For the first interview, 93% of eligible women 
participated (n=19,415). Follow-up assessments were performed three times at two-year intervals 
until 2008, with a high participation rate (>90% among those remaining alive at each follow-up 
point). The study was approved by the Institutional Review Board of Brigham and Women’s Hospital 
(Boston, MA).  
In the present study, we excluded those who had not completed at least one of the two initial FFQs 
in 1984 or 1986 (n=2,892), without at least one complete cognition battery at follow-up (n=334), had 
no data for physical activity (n=36), or no information on energy intake (n=9), resulting in a total 
population for analysis of 16,144 participants. 
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Dietary assessment and DASH diet score 
For each item of the FFQ, responses ranged from ‘never or <1 time/month’ to ‘≥6 times/day’; a 
standardized portion size was specified for each food item to estimate quantities consumed daily. 
Food intake estimations were converted into nutrient intakes by multiplying the frequency of 
consumption of each food by its nutrient content by using the U.S. Department of Agriculture 
database.  
In this study, we used the 1984, 1986, 1990, 1994 and 1998 FFQs to estimate daily energy intake and 
to construct, at each of these time points, an alternate DASH 9-point score [13]. This score enhances 
the original DASH score by Appel et al. [4]. and is based on 8 criteria: high intake of fruits, 
vegetables, nuts and legumes, whole grains, low-fat dairy products, and low intake of sodium, red 
and processed meats and sweetened beverages [13]. As the DASH diet also aims for lower amounts 
of saturated fat and cholesterol with higher levels of unsaturated fatty acids, the component 
monounsaturated fatty acids (MUFA) plus polyunsaturated fatty acids (PUFA) has been added to the 
original score, resulting in a total of 9 components. For each of the components, we classified 
women into quintiles according to their intake ranking. Component scores were the women’s 
quintile ranking; one point was given for the lowest quintile of intake and five points for the highest 
intake. The scoring was reversed for components to limit (sodium, red and processed meat and 
sweetened beverages). Long-term dietary habits are likely most relevant because cognitive decline 
develops over many years [14]. Therefore, long-term DASH score was computed as the mean of up 
to five DASH scores from all dietary assessments from 1984 (or 1986, if 1984 FFQ was missing) to the 
questionnaire immediately preceding the first cognitive exam. Total long-term DASH scores were 
divided into quintiles based on the study population distribution. 
 
Cognitive assessment 
Cognitive testing was performed by trained interviewers using validated telephone interviews. The 
cognitive battery included: 1) the Telephone Interview for Cognitive Status (TICS) [15]; 2) immediate; 
and 3) delayed recalls of the East Boston Memory test (EBMT) [16]; 4) delayed recall of the TICS 10-
word list; 5) category fluency; and 6) digit span-backward. In the initial cognitive interview, we 
administered only the TICS and gradually added the five other tests. Thus, the sample size slightly 
differs across tests, but the participation rate remained identical for all tests.  
The TICS [15] (range 0–41 points) is a telephone adaptation of the Mini-Mental State Examination 
[17], which assesses global cognitive performance. The immediate and delayed recalls of the 
EBMT[16] (range 0–12 points) assess verbal (episodic) memory. The delayed recall of the TICS 10-
word list (range 0–10 points) also assesses verbal memory. A category fluency test assesses language 
and executive function [18] by scoring performance on naming as many animals as possible in one 
minute. Finally, the digit-span backward test (range 0–12 points), in which participants repeat 
backwards and increasingly long series of digits, assesses working memory and attention.  
The primary outcomes were the TICS and composite scores of global cognition and verbal memory. A 
global cognition score was computed as the mean of Z-scores of all six cognitive tests in the cognitive 
battery. A verbal memory score was calculated as the mean of Z-scores of the four tests assessing 
verbal memory (i.e., immediate and delayed recalls of both the EBMT and the TICS 10-word list). We 
calculated Z-scores at each time point using the distribution of scores at the first cognitive 
assessment. 
 
 
81 
Other variables 
Socio-demographic, lifestyle and health-related information were obtained from the questionnaires. 
Using cumulative and updated information from 1976, covariates were determined at the time of 
the first cognitive interview, except physical activity and energy intake, for which values were 
averaged across multiple assessments over time, similar to diet. Physical activity was assessed in 
1986, 1988 and 1992, and every 2 years thereafter by estimating mean energy expended per week 
(in metabolic equivalent-hours, mets). In a randomly selected subsample of 5,822 participants, data 
on apolipoprotein E (APOE) ε4 polymorphisms was available from cheek cell specimens (n=3,469) 
and genome wide association studies (n=2,353). 
 
Statistical analyses 
Relation between long-term DASH adherence, cognitive function and decline. 
Statistical analyses utilized two complementary approaches. As primary analyses, we averaged the 
four repeated measures of cognitive function to create an outcome representing average cognitive 
function at older ages and modelled the association of long-term DASH score with average cognitive 
status using linear regression models. Averaging repeated measures of cognition was relevant to our 
data, as it attenuates variability in each single cognitive assessment, which may be helpful when 
cognition is measured over a relatively short follow-up period in largely healthy, educated 
participants [19]. In another approach, we modelled trajectories of the four repeated cognitive 
scores using linear mixed models [20]. The linear mixed models included an intercept that 
represented the level of cognitive score at baseline and a slope that represented the annual change 
in scores over time as well as a random intercept and random slope to account for inter-individual 
variability. We examined linear trends across quintiles using a continuous variable in which 
participants in a given category were assigned the median value of the long-term DASH score. 
Adjustments were made for possible confounding factors age and education (registered nurse, 
bachelor, master or doctorate) (crude, model 1), and subsequently for long-term energy intake 
(quintiles) and physical activity (MET-hours/week, quintiles), body mass index (BMI, kg/m2, ≤21, 22-
24, 25-29, ≥30), smoking status (never, former, current), alcohol intake (<1, 1-15, ≥15 g), history of 
depression (yes/no), multivitamin use (yes/no), and cardiovascular risk factors / disease (history of 
diabetes (yes/no), hypertension (yes/no), hypercholesterolemia (yes/no), and myocardial infarction 
(yes/no)) (Model 2). Estimates did not change after adjusting for ApoE ε4 within the subsample, 
therefore, ApoE ε4 was not included in the multivariable adjusted model. Because for BMI and 
multivitamin use, data was missing for >4% of the sample (4.4 and 7.1%, respectively); a specific 
missing category was created for these two variables. For other covariates, participants with missing 
data were <1% and were assigned to the reference group. Effect modification was tested adding an 
interaction term for DASH quintiles with age (median), high blood pressure (yes/no), and presence of 
the ApoE ε4 allele (yes/no, within the ApoE ε4 subsample).  
 
Relative contribution of DASH-components and cognitive function. 
To examine the relative importance of individual DASH components, we recalculated separate long-
term DASH scores excluding one DASH component at a time while including this specific component 
as covariate in the model to adjust for this specific component (as quintiles of intake). 
All statistical analyses were carried out using SAS software version 9.2 (SAS Institute Inc., Cary, NC, 
USA). A two-sided p-value of <0.05 was considered significant. 
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Results 
 
General characteristics 
At first cognitive assessment, the mean age of participants was 74.3±2.3 years, and the mean TICS 
score was 33.8±2.7 points (maximum=41). The median long-term DASH score was 28.0 points (range 
12-41) with a large variation in intake of the individual DASH components across all quintiles. 
Women with higher long-term DASH adherence had lower BMI, greater physical activity, higher 
education (table 1), and better scores for global cognition, verbal memory and TICS (table 2). They 
were less likely to report a history of myocardial infarction and to be current smokers. They were 
more likely to use a multivitamin supplement and slightly more likely to have a history of 
hypercholesterolemia. 
 
 
Table 1. Baseline characteristics of the participants in the Nurses’ Health Study by quintiles of long-term 
adherence to the DASH score (n=16,144) 
 Quintile 1 
23.0 
(12.0-24.7) 
n =3,176 
Quintile 2 
25.8 
(24.8-26.8) 
n =3,107 
Quintile 3 
28.0 
(27.0-28.8) 
n =3,325 
Quintile 4 
29.8 
(29.0-30.8) 
n =3,184 
Quintile 5 
32.3 
(31.0-41.0) 
n =3,345 
Age  74.0 ± 2.3 74.2 ± 2.3 74.3 ± 2.3 74.4 ± 2.3 74.5 ± 2.3 
BMI       
≤21, kg/m2 666 (21.0) 586 (18.9) 597 (18.0) 617 (19.4) 724 (21.6) 
22-24, kg/m2 752 (23.7) 755 (24.3) 893 (26.9) 805 (25.3) 921 (27.5) 
25-29, kg/m2 1,056 (33.2) 1,082 (34.8) 1,107 (33.3) 1,098 (34.5) 1,028 (30.7) 
≥30, kg/m2 566 (17.8) 543 (17.5) 585 (17.6) 536 (16.8) 514 (15.4) 
Long-term physical activity  12.4 ± 12.7 14.9 ± 13.9 17.4 ± 16.0 18.9 ± 15.5 22.3 ± 19.0 
Educational level      
Registered nurse 2,672 (84.1) 2,494 (80.3) 2,621 (78.8) 2,385 (74.9) 2,332 (69.7) 
Bachelor  373 (11.7) 448 (14.4) 503 (15.1) 577 (18.1) 732 (21.9) 
Master or doctorate 131 (4.1) 165 (5.3) 201 (6.0) 222 (7.0) 281 (8.4) 
Smoking      
Never 1,366 (43.0) 1,385 (44.6) 1,547 (46.5) 1,533 (48.1) 1,685 (50.4) 
Former  1,350 (42.5) 1,434 (46.2) 1,573 (47.3) 1,471 (46.2) 1,538 (46.0) 
Current  460 (14.5) 288 (9.3) 205 (6.2) 180 (5.7) 122 (3.6) 
Disease history      
Myocardial infarction 215 (6.8) 203 (6.5) 191 (5.7) 186 (5.8) 179 (5.4) 
Hypertension 1,770 (55.7) 1,706 (54.9) 1,855 (55.8) 1,777 (55.8) 1,828 (54.6) 
Hypercholesterolemia 1,997 (62.9) 2,033 (65.4) 2,179 (65.5) 2,130 (66.9) 2,210 (66.1) 
Diabetes 315 (9.9) 326 (10.5) 335 (10.1) 316 (9.9) 329 (9.8) 
Depression 290 (9.1) 313 (10.1) 309 (9.3) 315 (9.9) 297 (8.9) 
Multivitamin use 1,603 (50.5) 1,761 (56.7) 2,027 (61.0) 1,985 (62.3) 2,235 (66.8) 
Long-term dietary variables (servings per day unless otherwise noted) 
Daily energy intake, kcal 1,640 ± 432 1,635 ± 436 1,698 ± 433 1,746 ± 420 1,800 ± 401 
Alcohol, g/day 7.2 ± 11.5 5.9 ± 9.1 5.4 ± 8.2 5.0 ± 7.5 4.5 ± 6.9 
DASH components       
Fruit 1.8 ± 1.0 2.3 ± 1.0 2.6 ± 1.0 3.0 ± 1.2 3.4 ± 1.2 
Vegetables 2.4 ± 1.0 3.0 ± 1.2 3.5 ± 1.3 4.0 ± 1.5 4.8 ± 1.7 
Nuts and legumes 0.5 ± 0.3 0.6 ± 0.4 0.7 ± 0.4 0.8 ± 0.4 1.0 ± 0.5 
Sodium, mg 2,093 ± 660 2,064 ± 659 2,132 ± 661 2,158 ± 648 2,168 ± 631 
Red and processed meat 0.9 ± 0.4 0.8 ± 0.4 0.7 ± 0.4 0.6 ± 0.4 0.5 ± 0.3 
Whole grains 0.8 ± 0.6 1.1 ± 0.7 1.4 ± 0.8 1.7 ± 0.9 2.1 ± 1.0 
Sweetened beverages 0.4 ± 0.5 0.3 ± 0.3 0.2 ± 0.3 0.1 ± 0.2 0.1 ± 0.2 
Low-fat dairy 0.5 ± 0.6 0.8 ± 0.7 1.0 ± 0.7 1.2 ± 0.8 1.5 ± 0.8 
MUFA+PUFA, mg 32.3 ± 5.0 31.6 ± 4.9 31.0 ± 5.0 30.2 ± 5.1 29.4 ± 5.5 
DASH score 22.4 ± 1.9 25.8 ± 0.6 27.9 ± 0.6 29.8 ± 0.6 32.7 ± 1.5 
Values are means ± SD or number (%)  
All dietary variables are in servings per day, unless otherwise indicated 
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Table 2. Baseline cognitive function and average cognitive function of the participants in the Nurses’ Health 
Study by quintiles of long-term adherence to the DASH score (n=16,144) 
 Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 
Animal naming score 16.6 ± 4.7 16.9 ± 4.6 17.0 ± 4.6 17.2 ± 4.6 17.2 ± 4.8 
Digit backward test  6.6 ± 2.3 6.7 ± 2.4 6.7 ± 2.4 6.8 ± 2.4 6.8 ± 2.5 
East Boston memory test      
Immediate recall 9.4 ± 1.7 9.5 ± 1.7 9.4 ± 1.7 9.4 ± 1.9 9.4 ± 1.7 
Delayed recall  9.0 ± 2.0 9.0 ± 2.0 8.9 ± 2.0 8.9 ± 1.9 8.9 ± 2.1 
TICS word list      
Immediate recall 4.5 ± 1.6 4.6 ± 1.7 4.6 ± 1.7 4.7 ± 1.7 4.7 ± 1.8 
Delayed recall 2.2 ± 1.9 2.3 ± 1.9 2.3 ± 2.0 2.4 ± 1.9 2.4 ± 2.1 
TICS score, total 33.6 ± 2.7 33.8 ± 2.6 33.8 ± 2.7 33.8 ± 2.8 33.9 ± 2.8 
Composite scores      
Global cognition -0.04 ± 0.60 -0.00 ± 0.59 -0.01 ± 0.61 0.01 ± 0.61 0.02 ± 0.62 
Verbal memory -0.04 ± 0.68 -0.01 ± 0.68 -0.01 ± 0.69 -0.00 ± 0.69 0.01 ± 0.71 
      
Average cognitive function     
Global cognition -0.08 ± 0.59 -0.05 ± 0.60 -0.05 ± 0.60 -0.03 ± 0.62 -0.02 ± 0.64 
Verbal memory -0.03 ± 0.63 -0.01 ± 0.66 -0.02 ± 0.70 0.01 ± 0.67 0.02 ± 0.69 
TICS 33.5 ± 2.6 33.6 ± 2.5 33.6 ± 2.6 33.6 ± 2.7 33.7 ± 2.6 
Values are means  ±  SD 
 
 
Average cognitive function 
Greater adherence to the long-term DASH score was linearly related to better average cognitive 
function, comprising the mean of the four repeated measures of cognitive function, in both the 
crude and the multivariable-adjusted model (mean differences in global cognition, verbal memory 
and TICS scores between the top and bottom quintiles of the DASH score in the fully adjusted model 
were 0.04, p-trend=0.009, 0.04, p-trend=0.002 and 0.16, p-trend=0.03 in model 2, table 3).  
There was no interaction between long-term DASH score and age (p-interaction=0.67, 0.80, 0.36 for 
global cognition, verbal memory and TICS, respectively), high blood pressure (p-interaction=0.85, 
0.66, 0.53 for global cognition, verbal memory and TICS, respectively), or ApoE ε4 status (p-
interaction=0.35, 0.32, 0.24 for global cognition, verbal memory and TICS, respectively). The 
association between long-term DASH score and average cognitive function was not mediated by high 
blood pressure as the effect estimates remained exactly the same when taking out high blood 
pressure from the multivariable-adjusted model (data not shown). 
 
Cognitive decline over time 
After 4.1 years, long-term DASH score was not associated with change over the four repeated 
measures of global cognition, verbal memory, and TICS, in neither the crude, nor in the 
multivariable-adjusted model (p-trend=0.51, 0.68, and 0.98, for global cognition, verbal memory and 
TICS, respectively in model 2) (table 4).  
 
DASH-components and average cognitive function.  
Taking out the vegetables or the nuts plus legumes component of the total long-term DASH score 
attenuated the associations between long-term DASH score and average cognitive function (p-trends 
across the DASH score categories of excluding the vegetables component were 0.27, 0.96, 0.09, and 
0.18, 0.19, and 0.04 while excluding the nuts plus legumes component, for global cognition, verbal 
memory and TICS, respectively). 
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Results 
 
General characteristics 
At first cognitive assessment, the mean age of participants was 74.3±2.3 years, and the mean TICS 
score was 33.8±2.7 points (maximum=41). The median long-term DASH score was 28.0 points (range 
12-41) with a large variation in intake of the individual DASH components across all quintiles. 
Women with higher long-term DASH adherence had lower BMI, greater physical activity, higher 
education (table 1), and better scores for global cognition, verbal memory and TICS (table 2). They 
were less likely to report a history of myocardial infarction and to be current smokers. They were 
more likely to use a multivitamin supplement and slightly more likely to have a history of 
hypercholesterolemia. 
 
 
Table 1. Baseline characteristics of the participants in the Nurses’ Health Study by quintiles of long-term 
adherence to the DASH score (n=16,144) 
 Quintile 1 
23.0 
(12.0-24.7) 
n =3,176 
Quintile 2 
25.8 
(24.8-26.8) 
n =3,107 
Quintile 3 
28.0 
(27.0-28.8) 
n =3,325 
Quintile 4 
29.8 
(29.0-30.8) 
n =3,184 
Quintile 5 
32.3 
(31.0-41.0) 
n =3,345 
Age  74.0 ± 2.3 74.2 ± 2.3 74.3 ± 2.3 74.4 ± 2.3 74.5 ± 2.3 
BMI       
≤21, kg/m2 666 (21.0) 586 (18.9) 597 (18.0) 617 (19.4) 724 (21.6) 
22-24, kg/m2 752 (23.7) 755 (24.3) 893 (26.9) 805 (25.3) 921 (27.5) 
25-29, kg/m2 1,056 (33.2) 1,082 (34.8) 1,107 (33.3) 1,098 (34.5) 1,028 (30.7) 
≥30, kg/m2 566 (17.8) 543 (17.5) 585 (17.6) 536 (16.8) 514 (15.4) 
Long-term physical activity  12.4 ± 12.7 14.9 ± 13.9 17.4 ± 16.0 18.9 ± 15.5 22.3 ± 19.0 
Educational level      
Registered nurse 2,672 (84.1) 2,494 (80.3) 2,621 (78.8) 2,385 (74.9) 2,332 (69.7) 
Bachelor  373 (11.7) 448 (14.4) 503 (15.1) 577 (18.1) 732 (21.9) 
Master or doctorate 131 (4.1) 165 (5.3) 201 (6.0) 222 (7.0) 281 (8.4) 
Smoking      
Never 1,366 (43.0) 1,385 (44.6) 1,547 (46.5) 1,533 (48.1) 1,685 (50.4) 
Former  1,350 (42.5) 1,434 (46.2) 1,573 (47.3) 1,471 (46.2) 1,538 (46.0) 
Current  460 (14.5) 288 (9.3) 205 (6.2) 180 (5.7) 122 (3.6) 
Disease history      
Myocardial infarction 215 (6.8) 203 (6.5) 191 (5.7) 186 (5.8) 179 (5.4) 
Hypertension 1,770 (55.7) 1,706 (54.9) 1,855 (55.8) 1,777 (55.8) 1,828 (54.6) 
Hypercholesterolemia 1,997 (62.9) 2,033 (65.4) 2,179 (65.5) 2,130 (66.9) 2,210 (66.1) 
Diabetes 315 (9.9) 326 (10.5) 335 (10.1) 316 (9.9) 329 (9.8) 
Depression 290 (9.1) 313 (10.1) 309 (9.3) 315 (9.9) 297 (8.9) 
Multivitamin use 1,603 (50.5) 1,761 (56.7) 2,027 (61.0) 1,985 (62.3) 2,235 (66.8) 
Long-term dietary variables (servings per day unless otherwise noted) 
Daily energy intake, kcal 1,640 ± 432 1,635 ± 436 1,698 ± 433 1,746 ± 420 1,800 ± 401 
Alcohol, g/day 7.2 ± 11.5 5.9 ± 9.1 5.4 ± 8.2 5.0 ± 7.5 4.5 ± 6.9 
DASH components       
Fruit 1.8 ± 1.0 2.3 ± 1.0 2.6 ± 1.0 3.0 ± 1.2 3.4 ± 1.2 
Vegetables 2.4 ± 1.0 3.0 ± 1.2 3.5 ± 1.3 4.0 ± 1.5 4.8 ± 1.7 
Nuts and legumes 0.5 ± 0.3 0.6 ± 0.4 0.7 ± 0.4 0.8 ± 0.4 1.0 ± 0.5 
Sodium, mg 2,093 ± 660 2,064 ± 659 2,132 ± 661 2,158 ± 648 2,168 ± 631 
Red and processed meat 0.9 ± 0.4 0.8 ± 0.4 0.7 ± 0.4 0.6 ± 0.4 0.5 ± 0.3 
Whole grains 0.8 ± 0.6 1.1 ± 0.7 1.4 ± 0.8 1.7 ± 0.9 2.1 ± 1.0 
Sweetened beverages 0.4 ± 0.5 0.3 ± 0.3 0.2 ± 0.3 0.1 ± 0.2 0.1 ± 0.2 
Low-fat dairy 0.5 ± 0.6 0.8 ± 0.7 1.0 ± 0.7 1.2 ± 0.8 1.5 ± 0.8 
MUFA+PUFA, mg 32.3 ± 5.0 31.6 ± 4.9 31.0 ± 5.0 30.2 ± 5.1 29.4 ± 5.5 
DASH score 22.4 ± 1.9 25.8 ± 0.6 27.9 ± 0.6 29.8 ± 0.6 32.7 ± 1.5 
Values are means ± SD or number (%)  
All dietary variables are in servings per day, unless otherwise indicated 
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Table 2. Baseline cognitive function and average cognitive function of the participants in the Nurses’ Health 
Study by quintiles of long-term adherence to the DASH score (n=16,144) 
 Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 
Animal naming score 16.6 ± 4.7 16.9 ± 4.6 17.0 ± 4.6 17.2 ± 4.6 17.2 ± 4.8 
Digit backward test  6.6 ± 2.3 6.7 ± 2.4 6.7 ± 2.4 6.8 ± 2.4 6.8 ± 2.5 
East Boston memory test      
Immediate recall 9.4 ± 1.7 9.5 ± 1.7 9.4 ± 1.7 9.4 ± 1.9 9.4 ± 1.7 
Delayed recall  9.0 ± 2.0 9.0 ± 2.0 8.9 ± 2.0 8.9 ± 1.9 8.9 ± 2.1 
TICS word list      
Immediate recall 4.5 ± 1.6 4.6 ± 1.7 4.6 ± 1.7 4.7 ± 1.7 4.7 ± 1.8 
Delayed recall 2.2 ± 1.9 2.3 ± 1.9 2.3 ± 2.0 2.4 ± 1.9 2.4 ± 2.1 
TICS score, total 33.6 ± 2.7 33.8 ± 2.6 33.8 ± 2.7 33.8 ± 2.8 33.9 ± 2.8 
Composite scores      
Global cognition -0.04 ± 0.60 -0.00 ± 0.59 -0.01 ± 0.61 0.01 ± 0.61 0.02 ± 0.62 
Verbal memory -0.04 ± 0.68 -0.01 ± 0.68 -0.01 ± 0.69 -0.00 ± 0.69 0.01 ± 0.71 
      
Average cognitive function     
Global cognition -0.08 ± 0.59 -0.05 ± 0.60 -0.05 ± 0.60 -0.03 ± 0.62 -0.02 ± 0.64 
Verbal memory -0.03 ± 0.63 -0.01 ± 0.66 -0.02 ± 0.70 0.01 ± 0.67 0.02 ± 0.69 
TICS 33.5 ± 2.6 33.6 ± 2.5 33.6 ± 2.6 33.6 ± 2.7 33.7 ± 2.6 
Values are means  ±  SD 
 
 
Average cognitive function 
Greater adherence to the long-term DASH score was linearly related to better average cognitive 
function, comprising the mean of the four repeated measures of cognitive function, in both the 
crude and the multivariable-adjusted model (mean differences in global cognition, verbal memory 
and TICS scores between the top and bottom quintiles of the DASH score in the fully adjusted model 
were 0.04, p-trend=0.009, 0.04, p-trend=0.002 and 0.16, p-trend=0.03 in model 2, table 3).  
There was no interaction between long-term DASH score and age (p-interaction=0.67, 0.80, 0.36 for 
global cognition, verbal memory and TICS, respectively), high blood pressure (p-interaction=0.85, 
0.66, 0.53 for global cognition, verbal memory and TICS, respectively), or ApoE ε4 status (p-
interaction=0.35, 0.32, 0.24 for global cognition, verbal memory and TICS, respectively). The 
association between long-term DASH score and average cognitive function was not mediated by high 
blood pressure as the effect estimates remained exactly the same when taking out high blood 
pressure from the multivariable-adjusted model (data not shown). 
 
Cognitive decline over time 
After 4.1 years, long-term DASH score was not associated with change over the four repeated 
measures of global cognition, verbal memory, and TICS, in neither the crude, nor in the 
multivariable-adjusted model (p-trend=0.51, 0.68, and 0.98, for global cognition, verbal memory and 
TICS, respectively in model 2) (table 4).  
 
DASH-components and average cognitive function.  
Taking out the vegetables or the nuts plus legumes component of the total long-term DASH score 
attenuated the associations between long-term DASH score and average cognitive function (p-trends 
across the DASH score categories of excluding the vegetables component were 0.27, 0.96, 0.09, and 
0.18, 0.19, and 0.04 while excluding the nuts plus legumes component, for global cognition, verbal 
memory and TICS, respectively). 
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Table 3. Multivariable-adjusted mean differences in average cognitive function over the follow-up period by 
quintiles of long-term DASH score in 16,144 older womena 
 Model 1b p Model 2c p 
Global cognitive score   
Quintile 1 Ref  Ref  
Quintile 2 0.03 (0.00,0.06) 0.07 0.02 (-0.01,0.05) 0.20 
Quintile 3 0.03 (0.00,0.06) 0.03 0.01 (-0.02,0.04) 0.40 
Quintile 4 0.06 (0.03,0.09) <0.01 0.03 (0.00,0.06) 0.02 
Quintile 5 0.06 (0.03,0.09) <0.01 0.04 (0.01,0.07) 0.01 
p-trend <0.001  0.009  
     
Verbal memory score     
Quintile 1 Ref  Ref  
Quintile 2 0.02 (-0.01,0.06) 0.14 0.02 (-0.01,0.05) 0.29 
Quintile 3 0.02 (-0.01,0.05) 0.19 0.00 (-0.03,0.04) 0.82 
Quintile 4 0.05 (0.02,0.08) <0.01 0.03 (0.00,0.07) 0.05 
Quintile 5 0.06 (0.03,0.09) <0.01 0.04 (0.01,0.07) 0.01 
p-trend <0.001  0.002  
     
TICS score     
Quintile 1 Ref  Ref  
Quintile 2 0.13 (0.01,0.26) 0.04 0.10 (-0.03,0.22) 0.12 
Quintile 3 0.16 (0.03,0.28) 0.01 0.08 (-0.05,0.20) 0.24 
Quintile 4 0.18 (0.05,0.30) <0.01 0.09 (-0.04,0.22) 0.17 
Quintile 5 0.27 (0.14,0.39) <0.01 0.16 (0.03,0.29) 0.02 
p-trend <0.001  0.03  
a Values are mean (95% Confidence Interval).  
b Adjusted for age and education 
c Adjusted for age, education, physical activity, calorie intake, alcohol intake, smoking status, depression, multivitamin use, BMI, and 
history of, high blood pressure, hypercholesterolemia, myocardial infarction, and diabetes mellitus.  
 
 
Table 4. Multivariable-adjusted mean differences in slopes of cognitive change by quintiles of long-term DASH 
score in 16,144 older womena 
 Model 1b p Model 2c p 
Global cognitive score    
Quintile 1 Ref  Ref  
Quintile 2 0.000 (-0.008,0.008) 0.96 -0.002 (-0.010,0.006) 0.64 
Quintile 3 0.001 (-0.007,0.008) 0.87 -0.002 (-0.010,0.006) 0.29 
Quintile 4 -0.001 (-0.009,0.006) 0.74 -0.004 (-0.012,0.004) 0.62 
Quintile 5 0.002 (-0.006,0.010) 0.64 -0.002 (-0.010,0.006) 0.68 
p-trend 0.77  0.51  
     
Verbal memory score    
Quintile 1 Ref  Ref  
Quintile 2 -0.003 (-0.013,0.006) 0.52 -0.005 (-0.014,0.005) 0.31 
Quintile 3 -0.002 (-0.011,0.007) 0.66 -0.004 (-0.014,0.005) 0.36 
Quintile 4 -0.002 (-0.011,0.007) 0.68 -0.005 (-0.014,0.005) 0.35 
Quintile 5 0.001 (-0.008,0.010) 0.83 -0.003 (-0.012,0.007) 0.61 
p-trend 0.77  0.68  
     
TICS score     
Quintile 1 Ref  Ref  
Quintile 2 -0.006 (-0.038,0.027) 0.73 -0.011 (-0.043,0.022) 0.52 
Quintile 3 -0.002 (-0.034,0.029) 0.89 -0.009 (-0.041,0.023) 0.57 
Quintile 4 -0.001 (-0.033,0.031) 0.89 -0.007 (-0.039,0.026) 0.69 
Quintile 5 0.006 (-0.025,0.038) 0.69 -0.001 (-0.034,0.032) 0.94 
p-trend 0.89  0.98  
a Values are mean (95% Confidence Interval).  
b Adjusted for age and education 
c Adjusted for age, education, physical activity, calorie intake, alcohol intake, smoking status, multivitamin use, BMI, and history of 
depression, high blood pressure, hypercholesterolemia, myocardial infarction, and diabetes mellitus. 
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Discussion 
In this large longitudinal study, long-term adherence to the DASH diet was associated with a higher 
average global cognitive function, verbal memory and TICS score at older ages. To put these results 
into perspective, the effect estimates we found for long-term DASH adherence were cognitively 
equivalent to ~1 year of aging. No associations were observed between long-term DASH adherence 
and cognitive change after 4.1 years. 
We found that long-term greater adherence to the DASH diet was associated with better average 
TICS score, global cognitive function and verbal memory, which is a strong predictor of Alzheimer’s 
Disease (AD) [21]. Previous longitudinal studies showed that greater adherence to a DASH diet was 
associated with better global cognitive function in the Cache County Study (3MS score quintile 5 
versus quintile 1 = 0.97, p-trend<0.001)[9] and with a slower rate of cognitive decline in the Memory 
and Aging Project (0.007, p-trend=0.003 per unit increase in DASH score) [10]. The only trial on the 
effect of the DASH diet on cognition did not study global cognition, verbal memory or TICS, but 
showed better psychomotor speed after 4 months on the DASH diet, compared to control group 
(Cohen’s D = 0.440, p = 0.036) [11].  
Other dietary patterns emphasizing foods and nutrients similar to those in our DASH score (e.g., 
fruits, vegetables, whole grains), have been associated with less cognitive decline, such as the 
extensively investigated (alternate) Mediterranean diet [9, 22-25], the alternate Healthy Eating Index 
2005 and 2010 [25], and the Healthy Diet Indicator [26]. In previous studies investigating the effect 
of single components, interactions between the remaining diet score components have been 
ignored. We studied the relative contribution of individual components to the DASH score to the 
association with average cognitive function. Using this approach, excluding vegetables and nuts plus 
legumes attenuated the association, indicating that these two components are the most important 
contributors to the overall DASH score in relation to average cognitive function. Other studies have 
demonstrated that nuts [19, 27] and nuts plus legumes [9] are associated with better average 
cognitive status, ignoring the relative contribution of these components. Future research should 
further explore the relative instead of the absolute contribution of components in the context of diet 
pattern scores.  
Biologically, the DASH diet could be linked with cognitive function by influencing blood pressure, 
thereby lowering vascular dementia risk and corresponding cognitive decline. The DASH diet 
lowered blood pressure in an 8-week randomized controlled trial (RCT) in middle-aged normotensive 
American men and women [4] and in a 6-month multi-centre RCT in middle-aged pre-hypertensive 
or hypertensive American men and women [28]. Given this blood pressure-lowering effect, and the 
fact that blood pressure is an important risk factor for cognitive decline and late-life dementia [29], 
there is a clear basis for hypothesizing that the DASH diet may be inversely associated with cognitive 
outcomes.  
Genetically, carrying one or more copies of the ApoE-ε4 allele is associated with an increased AD risk 
and cognitive function decline [30-33]. This supports the importance of finding strategies to prevent 
cognitive decline especially among ApoE-ε4 carriers. However, we did not observe an interaction 
between the DASH diet and ApoE-ε4 status. Other studies investigating the interaction between 
dietary patterns and cognitive function have shown inconsistent findings, with studies reporting 
better cognitive function among non-carriers [34, 35], others showing relations in carriers [36], and 
studies finding no interaction [35, 37, 38]. Overall, no consistent conclusion on the role of the ApoE4 
ε4 allele with diet and cognitive function can be drawn and this requires further research.  
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Table 3. Multivariable-adjusted mean differences in average cognitive function over the follow-up period by 
quintiles of long-term DASH score in 16,144 older womena 
 Model 1b p Model 2c p 
Global cognitive score   
Quintile 1 Ref  Ref  
Quintile 2 0.03 (0.00,0.06) 0.07 0.02 (-0.01,0.05) 0.20 
Quintile 3 0.03 (0.00,0.06) 0.03 0.01 (-0.02,0.04) 0.40 
Quintile 4 0.06 (0.03,0.09) <0.01 0.03 (0.00,0.06) 0.02 
Quintile 5 0.06 (0.03,0.09) <0.01 0.04 (0.01,0.07) 0.01 
p-trend <0.001  0.009  
     
Verbal memory score     
Quintile 1 Ref  Ref  
Quintile 2 0.02 (-0.01,0.06) 0.14 0.02 (-0.01,0.05) 0.29 
Quintile 3 0.02 (-0.01,0.05) 0.19 0.00 (-0.03,0.04) 0.82 
Quintile 4 0.05 (0.02,0.08) <0.01 0.03 (0.00,0.07) 0.05 
Quintile 5 0.06 (0.03,0.09) <0.01 0.04 (0.01,0.07) 0.01 
p-trend <0.001  0.002  
     
TICS score     
Quintile 1 Ref  Ref  
Quintile 2 0.13 (0.01,0.26) 0.04 0.10 (-0.03,0.22) 0.12 
Quintile 3 0.16 (0.03,0.28) 0.01 0.08 (-0.05,0.20) 0.24 
Quintile 4 0.18 (0.05,0.30) <0.01 0.09 (-0.04,0.22) 0.17 
Quintile 5 0.27 (0.14,0.39) <0.01 0.16 (0.03,0.29) 0.02 
p-trend <0.001  0.03  
a Values are mean (95% Confidence Interval).  
b Adjusted for age and education 
c Adjusted for age, education, physical activity, calorie intake, alcohol intake, smoking status, depression, multivitamin use, BMI, and 
history of, high blood pressure, hypercholesterolemia, myocardial infarction, and diabetes mellitus.  
 
 
Table 4. Multivariable-adjusted mean differences in slopes of cognitive change by quintiles of long-term DASH 
score in 16,144 older womena 
 Model 1b p Model 2c p 
Global cognitive score    
Quintile 1 Ref  Ref  
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Quintile 3 0.001 (-0.007,0.008) 0.87 -0.002 (-0.010,0.006) 0.29 
Quintile 4 -0.001 (-0.009,0.006) 0.74 -0.004 (-0.012,0.004) 0.62 
Quintile 5 0.002 (-0.006,0.010) 0.64 -0.002 (-0.010,0.006) 0.68 
p-trend 0.77  0.51  
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Quintile 1 Ref  Ref  
Quintile 2 -0.003 (-0.013,0.006) 0.52 -0.005 (-0.014,0.005) 0.31 
Quintile 3 -0.002 (-0.011,0.007) 0.66 -0.004 (-0.014,0.005) 0.36 
Quintile 4 -0.002 (-0.011,0.007) 0.68 -0.005 (-0.014,0.005) 0.35 
Quintile 5 0.001 (-0.008,0.010) 0.83 -0.003 (-0.012,0.007) 0.61 
p-trend 0.77  0.68  
     
TICS score     
Quintile 1 Ref  Ref  
Quintile 2 -0.006 (-0.038,0.027) 0.73 -0.011 (-0.043,0.022) 0.52 
Quintile 3 -0.002 (-0.034,0.029) 0.89 -0.009 (-0.041,0.023) 0.57 
Quintile 4 -0.001 (-0.033,0.031) 0.89 -0.007 (-0.039,0.026) 0.69 
Quintile 5 0.006 (-0.025,0.038) 0.69 -0.001 (-0.034,0.032) 0.94 
p-trend 0.89  0.98  
a Values are mean (95% Confidence Interval).  
b Adjusted for age and education 
c Adjusted for age, education, physical activity, calorie intake, alcohol intake, smoking status, multivitamin use, BMI, and history of 
depression, high blood pressure, hypercholesterolemia, myocardial infarction, and diabetes mellitus. 
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Discussion 
In this large longitudinal study, long-term adherence to the DASH diet was associated with a higher 
average global cognitive function, verbal memory and TICS score at older ages. To put these results 
into perspective, the effect estimates we found for long-term DASH adherence were cognitively 
equivalent to ~1 year of aging. No associations were observed between long-term DASH adherence 
and cognitive change after 4.1 years. 
We found that long-term greater adherence to the DASH diet was associated with better average 
TICS score, global cognitive function and verbal memory, which is a strong predictor of Alzheimer’s 
Disease (AD) [21]. Previous longitudinal studies showed that greater adherence to a DASH diet was 
associated with better global cognitive function in the Cache County Study (3MS score quintile 5 
versus quintile 1 = 0.97, p-trend<0.001)[9] and with a slower rate of cognitive decline in the Memory 
and Aging Project (0.007, p-trend=0.003 per unit increase in DASH score) [10]. The only trial on the 
effect of the DASH diet on cognition did not study global cognition, verbal memory or TICS, but 
showed better psychomotor speed after 4 months on the DASH diet, compared to control group 
(Cohen’s D = 0.440, p = 0.036) [11].  
Other dietary patterns emphasizing foods and nutrients similar to those in our DASH score (e.g., 
fruits, vegetables, whole grains), have been associated with less cognitive decline, such as the 
extensively investigated (alternate) Mediterranean diet [9, 22-25], the alternate Healthy Eating Index 
2005 and 2010 [25], and the Healthy Diet Indicator [26]. In previous studies investigating the effect 
of single components, interactions between the remaining diet score components have been 
ignored. We studied the relative contribution of individual components to the DASH score to the 
association with average cognitive function. Using this approach, excluding vegetables and nuts plus 
legumes attenuated the association, indicating that these two components are the most important 
contributors to the overall DASH score in relation to average cognitive function. Other studies have 
demonstrated that nuts [19, 27] and nuts plus legumes [9] are associated with better average 
cognitive status, ignoring the relative contribution of these components. Future research should 
further explore the relative instead of the absolute contribution of components in the context of diet 
pattern scores.  
Biologically, the DASH diet could be linked with cognitive function by influencing blood pressure, 
thereby lowering vascular dementia risk and corresponding cognitive decline. The DASH diet 
lowered blood pressure in an 8-week randomized controlled trial (RCT) in middle-aged normotensive 
American men and women [4] and in a 6-month multi-centre RCT in middle-aged pre-hypertensive 
or hypertensive American men and women [28]. Given this blood pressure-lowering effect, and the 
fact that blood pressure is an important risk factor for cognitive decline and late-life dementia [29], 
there is a clear basis for hypothesizing that the DASH diet may be inversely associated with cognitive 
outcomes.  
Genetically, carrying one or more copies of the ApoE-ε4 allele is associated with an increased AD risk 
and cognitive function decline [30-33]. This supports the importance of finding strategies to prevent 
cognitive decline especially among ApoE-ε4 carriers. However, we did not observe an interaction 
between the DASH diet and ApoE-ε4 status. Other studies investigating the interaction between 
dietary patterns and cognitive function have shown inconsistent findings, with studies reporting 
better cognitive function among non-carriers [34, 35], others showing relations in carriers [36], and 
studies finding no interaction [35, 37, 38]. Overall, no consistent conclusion on the role of the ApoE4 
ε4 allele with diet and cognitive function can be drawn and this requires further research.  
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We did not find an association between the long-term DASH diet and cognitive change over time. 
Possibly our participants had higher education than participants in the Cache County Study [9] and 
Memory and Aging Project [10], with relatively slower cognitive decline over time. This could have 
resulted in a more narrow distribution of average cognitive function and cognitive change, reducing 
the magnitude of association in our study. Participants in our study were followed for a relatively 
short period, compared to the Cache County Study (11 years) [9]. Additionally, participants in the 
DASH-trial were obese, younger, and had above-normal blood pressure, compared to our relatively 
healthy older population [11]. At last, our modest association may be due to lower long-term 
adherence to the DASH diet compared to participants of the DASH-trial who received controlled 
feeding for exact DASH diet compliance, resulting in a vegetable intake of 5.7 [5] compared to 4.8 
servings/day in the highest long-term DASH score quintile in our study.  
 
Several potential limitations of our study should be discussed. First, the FFQ was not designed to 
provide precise measurements of some dietary components, such as sodium. However, it is a 
hallmark of the DASH-Sodium trial; thus, using the quintile approach would be least prone to 
misclassification. Using the actual cut-off approach for number of servings weakened our results, 
likely owing to greater misclassification. Hence, we chose to award points for adhering to what the 
DASH diet emphasizes rather than precise compliance to the DASH recommendations in number of 
servings. Although these population-specific cut-offs limits generalizability to other populations, this 
approach addresses the focus of the DASH diet and allows for adequate variation in adherence to 
examine any association with cognitive function. Second, as this was an observational study, residual 
confounding might influence analyses of average cognition due to factors that persist over time (e.g., 
education) and affect the cognitive level a person achieves more than a person’s cognitive trajectory 
in later life. However, we carefully adjusted for many potentially confounding variables. These 
adjustments did not meaningfully change our results for average cognition, suggesting that residual 
confounding would be unlikely to completely explain our findings. Third, cognitive function was 
assessed with use of telephone assessment, possibly causing some misclassification of cognitive 
function. A validation study, however, has shown that telephone-based cognitive batteries perform 
well compared with in-person interviews (ρ=0.81 comparing the two models) [39]. At last, as 
participants of this cohort are cognitively relatively healthy, middle-aged nurses, we expect a limited 
generalizability of our results to American women, and men. 
 
The long follow-up allowed us to assess long-term associations between the DASH score and 
cognitive function. By averaging repeated measures of diet to obtain a better assessment of long-
term overall diet we accounted for within-person change in intake and reduced measurement error, 
as previously documented by our group [40]. Measurement error in cognitive function assessments 
has also been limited by averaging all repeated measures into a more robust measure of average 
cognitive function at older ages. The prospective nature reduces the probability of recall bias and 
selection bias. In addition, a high follow-up rate reduced potential loss of follow-up bias. 
Nevertheless, our results need to be replicated in other populations. 
 
Conclusion 
Our findings in the largest cohort on dietary patterns and cognitive function to date indicate that 
long-term adherence to the DASH diet is important to maintain global cognitive function, verbal 
memory and TICS scores at older ages. Future studies should focus on participants at risk of poorer 
cognitive function, to elucidate the role of healthy diets on cognitive decline over time.  
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Abstract 
Objectives: There is increasing attention for dietary patterns as a potential strategy to prevent 
cognitive decline. We examined the association between adherence to a recently developed 
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet with cognitive function 
and cognitive decline, taking into account the interaction between the apolipoprotein E ε4 genotype 
and the MIND diet. 
Design: Population-based prospective cohort study. Participants: A total of 16,058 older women aged 
70 and over from the Nurses’ Health Study. 
Measurements: Dietary intake was assessed five times between 1984 and 1998 with a 116-item Food 
Frequency Questionnaire. The MIND score includes ten brain-healthy foods and five unhealthy foods. 
Cognition was assessed four times by telephone from 1995 to 2001 with the Telephone Interview for 
Cognitive Status (TICS) and by calculating composite scores of verbal memory and global cognition. 
Linear regression modelling and linear mixed modelling were used to examine the associations of 
adherence to the MIND diet with average cognitive function and cognitive change over six years, 
respectively.  
Results: Greater long-term adherence to the MIND diet was associated with a better verbal memory 
score (multivariable-adjusted mean differences between extreme MIND quintiles=0.04 (95%CI 0.01-
0.07), p-trend=0.006), but not with cognitive decline over 6 years in global cognition, verbal memory 
or TICS. 
Conclusion: Long-term adherence to the MIND diet was moderately associated with better verbal 
memory in later life. Future studies should address this association within populations at greater risk 
of cognitive decline. 
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Introduction 
The proportion of the world’s population over 60 years is expected to double from 11% in 2010 to 
22% by 2050 [1]. With population ageing, there will be an increase in the prevalence of age-related 
diseases and disabilities, such as dementia [2]. As, to date, there is no effective treatment for 
dementia [3], it is important to identify disease-modifying risk factors to prevent cognitive decline. 
One of these factors could be nutrition. Especially studying dietary patterns as a potential strategy to 
prevent cognitive decline has increasingly received attention in recent years. The Mediterranean diet 
(MeDi) is a frequently studied dietary pattern which has been shown to be associated with a slower 
rate of cognitive decline [4]. A less studied dietary pattern in relation to cognition is the Dietary 
Approaches to Stop Hypertension (DASH) diet. So far, three observational studies and one 
intervention study have demonstrated that higher adherence to the DASH diet was associated with 
less cognitive decline [5-8]. However, the MeDi and DASH diets do not include specific dietary 
components that optimize brain health.  
Recently, a hybrid of these two dietary patterns has been developed by Morris et al. [9], 
namely the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet. Similar to 
the MeDi and DASH diets, the MIND diet emphasizes natural plant-based foods and limited intakes of 
animal and high saturated fat foods. Uniquely, it also specifies the consumption of berries and green 
leafy vegetables [9], which have been demonstrated to have antioxidant and anti-inflammatory 
properties and inhibit β-amyloid deposition and neurotoxic death [10]. Greater adherence to the 
MIND diet was associated with slower rates of cognitive decline in the only study conducted to date 
[10].  
Besides lifestyle factors, the apolipoprotein E ε4 (ApoE ε4) allele has been shown to be a major 
genetic risk factor for more rapid cognitive decline and earlier onset of Alzheimer’s Disease (AD) [11, 
12]. The few human studies that have investigated an interaction between dietary patterns and 
cognitive function showed inconsistent findings [13-17]. Overall, the contribution of the ApoE ε4 
allele in the association between dietary patterns and cognitive function is unclear.  
We evaluated the association between long-term adherence to the MIND diet with cognitive 
function and cognitive decline during 6 years in 16,058 women from the Nurses’ Health Study. 
Additionally, we examined the interaction between the ApoE ε4 genotype and the MIND diet in 
relation to cognitive function. 
 
 
Methods  
 
Study population 
The Nurses’ Health Study (NHS) began in 1976, with 121,700 female registered nurses aged 30-55 
years and resided in 11 U.S. states. Participants completed a mailed questionnaire about their health 
and lifestyle. Follow-up questionnaires are sent every two years. To date, follow-up of the cohort 
remains ~90%. In 1984, participants completed a 116-item semi-quantitative food frequency 
questionnaire (FFQ) and similar FFQs were sent in 1986 and every 4 years thereafter [18]. During 
1995–2001, women who were ≥70 years old and free of stroke were invited to participate in the first 
telephone-based study of cognitive function. A total of 19,415 eligible women completed the first 
interview (93%). Follow-up assessments were performed three times at two-year intervals until 
2008, with a participation rate of >90% among those who remained alive and could be contacted at 
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each follow-up point. The study was approved by the Institutional Review Board of Brigham and 
Women’s Hospital (Boston, MA) and all participants consented.  
In the present study, we excluded those who had not completed at least one of the two 
initial FFQs in 1984 and 1986 (n=2,990), without at least one complete cognition battery at follow-up 
(n=331), or had no data for physical activity (n=36), resulting in a total population for analysis of 
16,058 participants. 
 
Dietary assessment and MIND diet score 
For each item of the FFQ, possible responses ranged from ‘never or <1 time/month’ to ‘≥6 
times/day’, and specific standardized portion sizes. Food intake estimations were converted into 
nutrient intakes by multiplying the frequency of consumption of each food by its nutrient content by 
using the U.S. Department of Agriculture database and other sources of updated supplementary 
information.  
In this study, we used the 1984, 1986, 1990, 1994 and 1998 FFQs to estimate daily energy 
intake and to construct a MIND diet score at each of these time points using the methodology 
described by Morris et al. [9]. The MIND score is based on 10 brain-healthy foods groups: namely, 
higher intake of green leafy vegetables (spinach, lettuce, kale), other vegetables, berries (blueberries, 
strawberries), nuts, whole grains, fish, beans, poultry, limited intake of wine (red and white wine), 
and use of olive oil as primary source of fat; and 5 unhealthy foods: namely, lower intakes of butter 
and margarine, cheese, red meat and products, fast fried foods, and pastries and sweets [9] (table 1). 
For healthy components, we assigned 0, 0.5 or 1 point for higher intakes, and for unhealthy 
components the scoring was reversed (total score 0 to 15 points). As long-term dietary habits are 
likely most relevant because cognitive decline develops over many years [19], long-term MIND score 
was computed as the mean of up to five MIND scores from all dietary assessments from 1984 (or 
1986, if 1984 FFQ was missing) to the questionnaire immediately preceding the first cognitive 
interview. Total MIND scores were divided into quintiles based on the study population distribution. 
 
Table 1. Components and scoring of the MIND diet within the Nurses’ Health Study 
    Score 
MIND component 0 0.5 1 
Green leafy vegetables ≤2 servings/week >2 to <6/week ≥6 servings/week 
Other vegetables <5 servings/week 5 to <7/week ≥1 serving/day 
Berries <1 serving/week 1-2/week ≥2 servings/week 
Nuts <1/month 1/month to <5/week ≥5 servings/week 
Olive Oil Not primary oil  Primary oil used 
Butter, margarine >2 table spoon/day 1-2 table spoon/day <1 table spoon/day 
Cheese ≥7 servings/week ≥1-<7/week <1 serving/week 
Whole grains <1 serving/day ≥1-<3/day ≥3 servings/day 
Fish (not fried) Rarely 1-3/month ≥1 meals/week 
Beans <1 meal/week 1-3/week >3 meals/week 
Poultry (not fried) <1 meal/week ≥1-<2/week ≥2 meals/week 
Red meat and products >6 meals/week ≥4-≤6/week <4 meals/week 
Fast fried foods ≥4 times/week 1-<4/week <1 time/week 
Pastries and sweets ≥7 servings/week ≥5-<7/week <5 servings/week 
Wine >1 glass/day or never 1/month to 6/week 1 glass/day 
Total score 0 7.5 15 
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Cognitive assessment 
Cognitive testing was performed by trained interviewers using validated telephone interviews. The 
cognitive battery included: 1) the Telephone Interview for Cognitive Status (TICS) [20]; 2) immediate; 
and 3) delayed recalls of the East Boston Memory test (EBMT) [21]; 4) delayed recall of the TICS 10-
word list; 5) category fluency; and 6) digit span-backward test. The sample size slightly differs across 
tests as in the initial stage of the first cognitive interview only the TICS was administered and 
gradually five other tests were added. The participation rate remained identical for all tests.  
The TICS [20] (0–41 points) is a telephone adaptation of the Mini-Mental State Examination 
[22] and assesses overall cognitive performance. The EBMT [21] (0–12 points) and delayed recall of 
the TICS 10-word list (0–10 points) assesses verbal (episodic) memory. The category fluency test 
assesses language and executive function [23]; performance is based on naming as many animals as 
possible in one minute. Finally, the digit-span backward test (0–12 points) assesses working memory 
and attention, where participants repeat backwards an increasingly long series of digits.  
The primary outcomes were the TICS and composite scores of global cognition and verbal 
memory. A global cognitive score was computed as the mean of z-scores of all six cognitive tests. A 
verbal memory score was calculated as the mean of z-scores of four tests assessing verbal memory 
(i.e., immediate and delayed recalls of both the EBMT and the TICS 10-word list). We calculated          
z-scores at each follow-up using means and standard deviations of scores at the first cognitive 
assessment. 
 
Other variables 
Socio-demographic, lifestyle and health-related information were obtained from questionnaires. 
Using cumulative and updated information from 1976, covariates were determined at the time of the 
first cognitive exam. For physical activity and energy intake values were averaged across multiple 
assessments over time, similar to diet. Physical activity was assessed in 1986, 1988 and 1992, and 
every 2 years thereafter by estimating mean energy expended per week (in metabolic equivalent-
hours, Met-hrs). In a randomly selected subsample (n=5,822), data on ApoE polymorphisms was 
available from cheek cell specimens (n=3,469) and genome wide association studies (n=2,353). 
 
Statistical analyses 
Long-term MIND adherence, cognitive function and decline 
Statistical analyses consisted of two complementary approaches. As primary analyses, we averaged 
the four repeated measures of cognitive function to create an outcome representing overall 
cognitive status at older ages. Averaging repeated measures of cognition was relevant to our data, as 
it attenuates variability in each single cognitive assessment, which may be helpful when cognition is 
measured over a relatively short follow-up period in largely healthy, educated participants, as 
described in previous studies [24, 25]. The association of long-term MIND score with cognitive status 
was modelled using linear regression models.  
As secondary approach, we modelled trajectories of the four repeated cognitive scores using 
linear mixed models [26]. The linear mixed models included an intercept representing the level of 
cognitive score at baseline and a slope representing the annual change in scores over time, as well as 
a random intercept and random slope to account for inter-individual variability.  
Adjustments were made for confounding factors age and education (registered nurse, 
bachelor, master or doctorate) (Model 1), and additionally for long-term energy intake (quintiles) and 
physical activity (Met-hrs/week, quintiles), body mass index (BMI, ≤21, 22-24, 25-29, ≥30 kg/m2), 
6Chapter 6     |     The MIND diet, cognitive function and decline 
94 
each follow-up point. The study was approved by the Institutional Review Board of Brigham and 
Women’s Hospital (Boston, MA) and all participants consented.  
In the present study, we excluded those who had not completed at least one of the two 
initial FFQs in 1984 and 1986 (n=2,990), without at least one complete cognition battery at follow-up 
(n=331), or had no data for physical activity (n=36), resulting in a total population for analysis of 
16,058 participants. 
 
Dietary assessment and MIND diet score 
For each item of the FFQ, possible responses ranged from ‘never or <1 time/month’ to ‘≥6 
times/day’, and specific standardized portion sizes. Food intake estimations were converted into 
nutrient intakes by multiplying the frequency of consumption of each food by its nutrient content by 
using the U.S. Department of Agriculture database and other sources of updated supplementary 
information.  
In this study, we used the 1984, 1986, 1990, 1994 and 1998 FFQs to estimate daily energy 
intake and to construct a MIND diet score at each of these time points using the methodology 
described by Morris et al. [9]. The MIND score is based on 10 brain-healthy foods groups: namely, 
higher intake of green leafy vegetables (spinach, lettuce, kale), other vegetables, berries (blueberries, 
strawberries), nuts, whole grains, fish, beans, poultry, limited intake of wine (red and white wine), 
and use of olive oil as primary source of fat; and 5 unhealthy foods: namely, lower intakes of butter 
and margarine, cheese, red meat and products, fast fried foods, and pastries and sweets [9] (table 1). 
For healthy components, we assigned 0, 0.5 or 1 point for higher intakes, and for unhealthy 
components the scoring was reversed (total score 0 to 15 points). As long-term dietary habits are 
likely most relevant because cognitive decline develops over many years [19], long-term MIND score 
was computed as the mean of up to five MIND scores from all dietary assessments from 1984 (or 
1986, if 1984 FFQ was missing) to the questionnaire immediately preceding the first cognitive 
interview. Total MIND scores were divided into quintiles based on the study population distribution. 
 
Table 1. Components and scoring of the MIND diet within the Nurses’ Health Study 
    Score 
MIND component 0 0.5 1 
Green leafy vegetables ≤2 servings/week >2 to <6/week ≥6 servings/week 
Other vegetables <5 servings/week 5 to <7/week ≥1 serving/day 
Berries <1 serving/week 1-2/week ≥2 servings/week 
Nuts <1/month 1/month to <5/week ≥5 servings/week 
Olive Oil Not primary oil  Primary oil used 
Butter, margarine >2 table spoon/day 1-2 table spoon/day <1 table spoon/day 
Cheese ≥7 servings/week ≥1-<7/week <1 serving/week 
Whole grains <1 serving/day ≥1-<3/day ≥3 servings/day 
Fish (not fried) Rarely 1-3/month ≥1 meals/week 
Beans <1 meal/week 1-3/week >3 meals/week 
Poultry (not fried) <1 meal/week ≥1-<2/week ≥2 meals/week 
Red meat and products >6 meals/week ≥4-≤6/week <4 meals/week 
Fast fried foods ≥4 times/week 1-<4/week <1 time/week 
Pastries and sweets ≥7 servings/week ≥5-<7/week <5 servings/week 
Wine >1 glass/day or never 1/month to 6/week 1 glass/day 
Total score 0 7.5 15 
 
 
 
 
 
95 
Cognitive assessment 
Cognitive testing was performed by trained interviewers using validated telephone interviews. The 
cognitive battery included: 1) the Telephone Interview for Cognitive Status (TICS) [20]; 2) immediate; 
and 3) delayed recalls of the East Boston Memory test (EBMT) [21]; 4) delayed recall of the TICS 10-
word list; 5) category fluency; and 6) digit span-backward test. The sample size slightly differs across 
tests as in the initial stage of the first cognitive interview only the TICS was administered and 
gradually five other tests were added. The participation rate remained identical for all tests.  
The TICS [20] (0–41 points) is a telephone adaptation of the Mini-Mental State Examination 
[22] and assesses overall cognitive performance. The EBMT [21] (0–12 points) and delayed recall of 
the TICS 10-word list (0–10 points) assesses verbal (episodic) memory. The category fluency test 
assesses language and executive function [23]; performance is based on naming as many animals as 
possible in one minute. Finally, the digit-span backward test (0–12 points) assesses working memory 
and attention, where participants repeat backwards an increasingly long series of digits.  
The primary outcomes were the TICS and composite scores of global cognition and verbal 
memory. A global cognitive score was computed as the mean of z-scores of all six cognitive tests. A 
verbal memory score was calculated as the mean of z-scores of four tests assessing verbal memory 
(i.e., immediate and delayed recalls of both the EBMT and the TICS 10-word list). We calculated          
z-scores at each follow-up using means and standard deviations of scores at the first cognitive 
assessment. 
 
Other variables 
Socio-demographic, lifestyle and health-related information were obtained from questionnaires. 
Using cumulative and updated information from 1976, covariates were determined at the time of the 
first cognitive exam. For physical activity and energy intake values were averaged across multiple 
assessments over time, similar to diet. Physical activity was assessed in 1986, 1988 and 1992, and 
every 2 years thereafter by estimating mean energy expended per week (in metabolic equivalent-
hours, Met-hrs). In a randomly selected subsample (n=5,822), data on ApoE polymorphisms was 
available from cheek cell specimens (n=3,469) and genome wide association studies (n=2,353). 
 
Statistical analyses 
Long-term MIND adherence, cognitive function and decline 
Statistical analyses consisted of two complementary approaches. As primary analyses, we averaged 
the four repeated measures of cognitive function to create an outcome representing overall 
cognitive status at older ages. Averaging repeated measures of cognition was relevant to our data, as 
it attenuates variability in each single cognitive assessment, which may be helpful when cognition is 
measured over a relatively short follow-up period in largely healthy, educated participants, as 
described in previous studies [24, 25]. The association of long-term MIND score with cognitive status 
was modelled using linear regression models.  
As secondary approach, we modelled trajectories of the four repeated cognitive scores using 
linear mixed models [26]. The linear mixed models included an intercept representing the level of 
cognitive score at baseline and a slope representing the annual change in scores over time, as well as 
a random intercept and random slope to account for inter-individual variability.  
Adjustments were made for confounding factors age and education (registered nurse, 
bachelor, master or doctorate) (Model 1), and additionally for long-term energy intake (quintiles) and 
physical activity (Met-hrs/week, quintiles), body mass index (BMI, ≤21, 22-24, 25-29, ≥30 kg/m2), 
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smoking status (never, former, current), alcohol intake (<1, 1-15, ≥15 g/d), history of depression 
(yes/no), multivitamin use (yes/no), and cardiovascular risk factors (history of diabetes, 
hypertension, hypercholesterolemia, and/or myocardial infarction (yes/no) (Model 2). Because for 
BMI and multivitamin use data was missing for >4% of the sample (4.4 and 7.1%, respectively); a 
missing category was created. For other covariates, participants with missing data were <1% of the 
sample and were assigned to the reference group. Effect modification was tested by adding an 
interaction term for MIND score quintiles with age (median split), BMI (<25/≥25 kg/m2), high blood 
pressure (yes/no), hypercholesterolemia (yes/no), myocardial infarction (yes/no). In a subset of 
5,822 participants, a variable indicating the product of the number of ApoE ε4 alleles (0,1,2) was 
used to test for effect modification by ApoE ε4 genotype. 
 
MIND-components and cognitive function 
To examine the relative importance of the individual MIND components, we recalculated separate 
MIND scores by excluding one MIND component at a time while including this component as 
covariate (in quintiles of intake).  
 
All statistical analyses were carried out using SAS software version 9.2 (SAS Institute Inc., Cary, NC, 
USA). A two-sided p-value of <0.05 was considered significant. We examined linear trends across 
quintiles of the MIND score using a continuous variable in which participants in a given category 
were assigned the median value. 
 
 
Results 
 
General characteristics  
At the first cognitive assessment, the mean age of participants was 74.3 ± 2.3 years (mean ± SD), and 
the mean TICS score was 33.8 ± 2.7 points. The median MIND score was 6.4 points (range 2.6–11.0) 
with a large variation in intake of individual MIND components across quintiles of the average MIND 
score of 4.4 dietary assessments over 12.9 years (table 2). Women with greater long-term MIND 
adherence were more likely to have a lower BMI, to be more physically active, to be higher educated, 
to use a multivitamin supplement, to report a history of hypercholesterolemia and were less likely to 
be current smokers and to report a history of depression. 
 
Average cognitive function  
Greater long-term adherence to the MIND score was linearly related to significantly higher verbal 
memory scores, comprising the mean of the 4 repeated measures of cognitive function, in both the 
age and education adjusted model and the multivariable-adjusted model (p-trend <0.0001 for model 
1, 0.006 for model 2), but not with a better global cognition or TICS score (table 3). The mean 
difference in mean verbal memory between the top and bottom quintiles of the MIND score in the 
fully adjusted model was 0.04 standard units.  
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Table 2. Baseline characteristics of the participants in the Nurses’ Health Study by quintiles of long-term 
adherence to the MIND score (n=16,058)a 
 Quintile 1 
4.9 (2.6-5.4) 
n = 3,339 
Quintile 2 
5.8 (5.5-6.1) 
n = 3,259 
Quintile 3 
6.4 (6.1-6.7) 
n = 2,962 
Quintile 4 
7.0 (6.7-7.3) 
n = 3,261 
Quintile 5 
7.9 (7.4-11.0) 
n = 3,237 
Age at first cognitive exam 74.3 ± 2.3 74.2 ± 2.3 74.3 ± 2.3 74.3 ± 2.4 74.3 ± 2.3 
BMI at first cognitive exam      
≤21, kg/m2 709 (21.2) 612 (18.8) 561 (18.9) 602 (18.5) 686 (21.2) 
22-24, kg/m2 780 (23.4) 771 (23.7) 829 (28.0) 866 (26.6) 860 (26.6) 
25-29, kg/m2 1,138 (34.1) 1,090 (33.4) 955 (32.2) 1,127 (34.6) 1,041 (32.2) 
≥30, kg/m2 592 (17.7) 647 (19.9) 488 (16.5) 526 (16.1) 476 (14.7) 
Long-term physical activity 12.5 ± 12.6 15.0 ± 13.8 17.2 ± 14.7 18.7 ± 15.9 23.1 ± 1 9.8 
Educational level      
Registered nurse 2,785 (83.4) 2,589 (79.4) 2,325 (78.5) 2,445 (75.0) 2,304 (71.2) 
Bachelor  403 (12.1) 505 (15.5) 459 (15.5) 588 (18.0) 657 (20.3) 
Master or doctorate 151 (4.5) 165 (5.1) 178 (6.0) 228 (7.0) 276 (8.5) 
Smoking      
Never 1,582 (47.4) 1,554 (47.7) 1,360 (45.9) 1,512 (46.4) 1,466 (45.3) 
Former  1,376 (41.2) 1,408 (43.2) 1,377 (46.5) 1,552 (47.6) 1,627 (50.3) 
Current  381 (11.4) 297 (9.1) 225 (7.6) 197 (6.0) 144 (4.4) 
History of:      
Myocardial infarction 214 (6.4) 197 (6.0) 180 (6.1) 196 (6.0) 182 (5.6) 
Hypertension 1,860 (55.7) 1,810 (55.5) 1,634 (55.2) 1,829 (56.1) 1,757 (54.3) 
Hypercholesterolemia 2,107 (63.1) 2,122 (65.1) 1,942 (65.6) 2,179 (66.8) 2,152 (66.5) 
Diabetes 331 (9.9) 336 (10.3) 329 (11.1) 326 (10.0) 289 (8.9) 
Depression 346 (10.4) 315 (9.7) 273 (9.2) 305 (9.4) 271 (8.4) 
Multivitamin use 1,736 (54.5) 1,888 (58.8) 1,925 (58.7) 1,983 (61.6) 2,026 (64.1) 
Long-term dietary variables (servings per day unless otherwise noted) 
Energy intake, kcal/day 1,646 ± 440 1,686 ± 428 1,694 ± 421 1,712 ± 409 1,783 ± 420 
Alcohol, g/day 4.6 ± 8.8 5.2 ± 8.9 5.8 ± 9.0 6.1 ± 8.8 6.3 ± 8.4 
MIND components       
Green leafy vegetablesb 3.4 ± 5.2 5.0 ± 6.7 6.5 ± 8.6 7.4 ± 8.6 9.6 ± 10.1 
Other vegetables 2.0 ± 1.8 2.6 ± 2.3 3.1 ± 2.9 3.4 ± 2.9 4.2 ± 3.7 
Berriesb 0.8 ± 2.7 1.3 ± 3.5 1.6 ± 4.1 1.8 ± 4.0 2.4 ± 4.7 
Nutsb 1.5 ± 2.6 2.1 ± 3.9 2.6 ± 4.7 2.6 ± 4.8 3.4 ± 6.1 
Primarily vegetable oil 0.2 ± 0.3 0.3 ± 0.4 0.3 ± 0.4 0.4 ± 0.5 0.6 ± 0.5 
Butter, margarine 1.4 ± 1.0 1.2 ± 0.9 1.1 ± 0.9 1.0 ± 0.8 0.8 ± 0.8 
Cheeseb 5.9 ± 7.9 5.4 ± 7.2 5.5 ± 7.6 5.3 ± 7.3 5.2 ± 7.6 
Whole grains 1.0 ± 1.2 1.4 ± 1.6 1.7 ± 2.1 1.8 ± 2.1 2.4 ± 2.6 
Fish (not fried)b 1.1 ± 2.8 1.8 ± 3.8 2.3 ± 4.8 2.6 ± 5.0 3.3 ± 5.2 
Beansb 0.6 ± 2.2 1.2 ± 3.4 1.5 ± 4.1 1.8 ± 4.6 2.3 ± 5.4 
Poultry (not fried)b 2.3 ± 3.8 3.0 ± 4.7 3.5 ± 4.8 3.7 ± 4.8 4.3 ± 5.2 
Red meat and productsb 6.7 ± 6.0 6.3 ± 6.9 6.1 ± 7.6 5.8 ± 8.8 5.4 ± 9.6 
Fast fried foodsb 8.0 ± 1.6 8.0 ± 1.7 8.2 ± 1.7 8.3 ± 1.7 8.3 ± 1.9 
Pastries and sweetsb 15.1 ± 15.0 14.3 ± 17.8 14.2 ± 21.5 13.0 ± 22.2 13.0 ± 27.4 
Wine 0.1 ± 0.4 0.2 ± 0.6 0.3 ± 0.6 0.3 ± 0.6 0.3 ± 0.7 
Abbreviation: MIND= Mediterranean-DASH Intervention for Neurodegenerative Delay 
a Values are means ± SD or number (%) 
b Servings per week 
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smoking status (never, former, current), alcohol intake (<1, 1-15, ≥15 g/d), history of depression 
(yes/no), multivitamin use (yes/no), and cardiovascular risk factors (history of diabetes, 
hypertension, hypercholesterolemia, and/or myocardial infarction (yes/no) (Model 2). Because for 
BMI and multivitamin use data was missing for >4% of the sample (4.4 and 7.1%, respectively); a 
missing category was created. For other covariates, participants with missing data were <1% of the 
sample and were assigned to the reference group. Effect modification was tested by adding an 
interaction term for MIND score quintiles with age (median split), BMI (<25/≥25 kg/m2), high blood 
pressure (yes/no), hypercholesterolemia (yes/no), myocardial infarction (yes/no). In a subset of 
5,822 participants, a variable indicating the product of the number of ApoE ε4 alleles (0,1,2) was 
used to test for effect modification by ApoE ε4 genotype. 
 
MIND-components and cognitive function 
To examine the relative importance of the individual MIND components, we recalculated separate 
MIND scores by excluding one MIND component at a time while including this component as 
covariate (in quintiles of intake).  
 
All statistical analyses were carried out using SAS software version 9.2 (SAS Institute Inc., Cary, NC, 
USA). A two-sided p-value of <0.05 was considered significant. We examined linear trends across 
quintiles of the MIND score using a continuous variable in which participants in a given category 
were assigned the median value. 
 
 
Results 
 
General characteristics  
At the first cognitive assessment, the mean age of participants was 74.3 ± 2.3 years (mean ± SD), and 
the mean TICS score was 33.8 ± 2.7 points. The median MIND score was 6.4 points (range 2.6–11.0) 
with a large variation in intake of individual MIND components across quintiles of the average MIND 
score of 4.4 dietary assessments over 12.9 years (table 2). Women with greater long-term MIND 
adherence were more likely to have a lower BMI, to be more physically active, to be higher educated, 
to use a multivitamin supplement, to report a history of hypercholesterolemia and were less likely to 
be current smokers and to report a history of depression. 
 
Average cognitive function  
Greater long-term adherence to the MIND score was linearly related to significantly higher verbal 
memory scores, comprising the mean of the 4 repeated measures of cognitive function, in both the 
age and education adjusted model and the multivariable-adjusted model (p-trend <0.0001 for model 
1, 0.006 for model 2), but not with a better global cognition or TICS score (table 3). The mean 
difference in mean verbal memory between the top and bottom quintiles of the MIND score in the 
fully adjusted model was 0.04 standard units.  
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5.8 (5.5-6.1) 
n = 3,259 
Quintile 3 
6.4 (6.1-6.7) 
n = 2,962 
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7.9 (7.4-11.0) 
n = 3,237 
Age at first cognitive exam 74.3 ± 2.3 74.2 ± 2.3 74.3 ± 2.3 74.3 ± 2.4 74.3 ± 2.3 
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≤21, kg/m2 709 (21.2) 612 (18.8) 561 (18.9) 602 (18.5) 686 (21.2) 
22-24, kg/m2 780 (23.4) 771 (23.7) 829 (28.0) 866 (26.6) 860 (26.6) 
25-29, kg/m2 1,138 (34.1) 1,090 (33.4) 955 (32.2) 1,127 (34.6) 1,041 (32.2) 
≥30, kg/m2 592 (17.7) 647 (19.9) 488 (16.5) 526 (16.1) 476 (14.7) 
Long-term physical activity 12.5 ± 12.6 15.0 ± 13.8 17.2 ± 14.7 18.7 ± 15.9 23.1 ± 1 9.8 
Educational level      
Registered nurse 2,785 (83.4) 2,589 (79.4) 2,325 (78.5) 2,445 (75.0) 2,304 (71.2) 
Bachelor  403 (12.1) 505 (15.5) 459 (15.5) 588 (18.0) 657 (20.3) 
Master or doctorate 151 (4.5) 165 (5.1) 178 (6.0) 228 (7.0) 276 (8.5) 
Smoking      
Never 1,582 (47.4) 1,554 (47.7) 1,360 (45.9) 1,512 (46.4) 1,466 (45.3) 
Former  1,376 (41.2) 1,408 (43.2) 1,377 (46.5) 1,552 (47.6) 1,627 (50.3) 
Current  381 (11.4) 297 (9.1) 225 (7.6) 197 (6.0) 144 (4.4) 
History of:      
Myocardial infarction 214 (6.4) 197 (6.0) 180 (6.1) 196 (6.0) 182 (5.6) 
Hypertension 1,860 (55.7) 1,810 (55.5) 1,634 (55.2) 1,829 (56.1) 1,757 (54.3) 
Hypercholesterolemia 2,107 (63.1) 2,122 (65.1) 1,942 (65.6) 2,179 (66.8) 2,152 (66.5) 
Diabetes 331 (9.9) 336 (10.3) 329 (11.1) 326 (10.0) 289 (8.9) 
Depression 346 (10.4) 315 (9.7) 273 (9.2) 305 (9.4) 271 (8.4) 
Multivitamin use 1,736 (54.5) 1,888 (58.8) 1,925 (58.7) 1,983 (61.6) 2,026 (64.1) 
Long-term dietary variables (servings per day unless otherwise noted) 
Energy intake, kcal/day 1,646 ± 440 1,686 ± 428 1,694 ± 421 1,712 ± 409 1,783 ± 420 
Alcohol, g/day 4.6 ± 8.8 5.2 ± 8.9 5.8 ± 9.0 6.1 ± 8.8 6.3 ± 8.4 
MIND components       
Green leafy vegetablesb 3.4 ± 5.2 5.0 ± 6.7 6.5 ± 8.6 7.4 ± 8.6 9.6 ± 10.1 
Other vegetables 2.0 ± 1.8 2.6 ± 2.3 3.1 ± 2.9 3.4 ± 2.9 4.2 ± 3.7 
Berriesb 0.8 ± 2.7 1.3 ± 3.5 1.6 ± 4.1 1.8 ± 4.0 2.4 ± 4.7 
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Butter, margarine 1.4 ± 1.0 1.2 ± 0.9 1.1 ± 0.9 1.0 ± 0.8 0.8 ± 0.8 
Cheeseb 5.9 ± 7.9 5.4 ± 7.2 5.5 ± 7.6 5.3 ± 7.3 5.2 ± 7.6 
Whole grains 1.0 ± 1.2 1.4 ± 1.6 1.7 ± 2.1 1.8 ± 2.1 2.4 ± 2.6 
Fish (not fried)b 1.1 ± 2.8 1.8 ± 3.8 2.3 ± 4.8 2.6 ± 5.0 3.3 ± 5.2 
Beansb 0.6 ± 2.2 1.2 ± 3.4 1.5 ± 4.1 1.8 ± 4.6 2.3 ± 5.4 
Poultry (not fried)b 2.3 ± 3.8 3.0 ± 4.7 3.5 ± 4.8 3.7 ± 4.8 4.3 ± 5.2 
Red meat and productsb 6.7 ± 6.0 6.3 ± 6.9 6.1 ± 7.6 5.8 ± 8.8 5.4 ± 9.6 
Fast fried foodsb 8.0 ± 1.6 8.0 ± 1.7 8.2 ± 1.7 8.3 ± 1.7 8.3 ± 1.9 
Pastries and sweetsb 15.1 ± 15.0 14.3 ± 17.8 14.2 ± 21.5 13.0 ± 22.2 13.0 ± 27.4 
Wine 0.1 ± 0.4 0.2 ± 0.6 0.3 ± 0.6 0.3 ± 0.6 0.3 ± 0.7 
Abbreviation: MIND= Mediterranean-DASH Intervention for Neurodegenerative Delay 
a Values are means ± SD or number (%) 
b Servings per week 
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Table 3. Multivariable-adjusted mean differencesa in cognition averaged over the follow-up period across 
quintiles of the MIND score in 16,058 older women participating in the Nurses’ Health Study 
 Model 1b Model 2c 
Global cognitive score   
Quintile 1 Ref Ref 
Quintile 2 0.02 (-0.01,0.05) 0.00 (-0.02,0.03) 
Quintile 3 0.02 (-0.01,0.05) 0.00 (-0.03,0.03) 
Quintile 4 0.02 (-0.01,0.05) 0.00 (-0.03,0.03) 
Quintile 5 0.03 (0.00,0.06) 0.00 (-0.03,0.03) 
p-trend 0.03 0.88 
   
Verbal memory score   
Quintile 1 Ref Ref 
Quintile 2 0.02 (-0.01,0.06) 0.01 (-0.02,0.05) 
Quintile 3 0.03 (0.00,0.07) 0.02 (-0.01,0.05) 
Quintile 4 0.04 (0.01,0.08) 0.02 (-0.01,0.06) 
Quintile 5 0.06 (0.03,0.09) 0.04 (0.01,0.07) 
p-trend <0.0001 0.02 
   
TICS score   
Quintile 1 Ref Ref 
Quintile 2 -0.01 (-0.13,0.11) -0.05 (-0.18,0.07) 
Quintile 3 0.06 (-0.07,0.19) 0.00 (-0.13,0.12) 
Quintile 4 0.07 (-0.05,0.19) -0.02 (-0.14,0.11) 
Quintile 5 0.02 (-0.10,0.14) -0.09 (-0.21,0.04) 
p-trend 0.44 0.31 
Abbreviations: MIND= Mediterranean-DASH Intervention for Neurodegenerative Delay; TICS= Telephone interview of 
cognitive status 
a Values are mean difference in score (95% confidence interval) 
b Model 1: adjusted for age and education 
c Model 2: additionally adjusted physical activity, calorie intake, alcohol intake, smoking status, multivitamin use, BMI, 
depression, and history of high blood pressure, hypercholesterolemia, myocardial infarction, and diabetes mellitus 
 
 
The associations did not change when additionally adjusting for family history of dementia and socio- 
economic variables such as income, job, and marital status (data not shown). There was no 
interaction between adherence to the MIND diet and age, BMI, high blood pressure or ApoE ε4 
status for global cognition, verbal memory or TICS (p-interaction age: 0.45, 0.70, 0.82, BMI: 0.63, 
0.61, 0.69, high blood pressure: 0.90, 0.70, 0.85, ApoE ε4 status: 0.38, 0.40, 0.27 for global cognition, 
verbal memory and TICS, respectively). The association between the MIND diet and cognitive 
function was not mediated by high blood pressure as the effect estimates remained exactly the same 
when taking out high blood pressure from the multivariable adjusted model (data not shown). 
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Cognitive decline over time 
Long-term adherence to the MIND score was not significantly associated with change over time in 
the global cognitive score, verbal memory score, or the TICS score, in either the age and education 
adjusted models, or in the multivariable-adjusted model (p-trend 0.95, 0.98, and 0.73 for global 
cognition, verbal memory and TICS, respectively) (table 4).  
 
Table 4. Multivariable-adjusted mean differencesa in slopes of cognitive change by quintiles of long-term 
MIND-score in 16,058 older women 
 Model 1b Model 2c 
Global cognitive score   
Quintile 1 Ref Ref 
Quintile 2 0.002 (-0.005,0.010) 0.001 (-0.007,0.009) 
Quintile 3 -0.002 (-0.010,0.006) -0.004 (-0.011,0.004) 
Quintile 4 0.000 (-0.009,0.008) -0.002 (-0.010,0.006) 
Quintile 5 0.004 (-0.003,0.012) 0.001 (-0.007,0.009) 
p-trend 0.44 0.95 
   
Verbal memory score   
Quintile 1 Ref Ref 
Quintile 2 0.002 (-0.007,0.011) 0.000 (-0.009,0.009) 
Quintile 3 -0.005 (-0.015,0.004) -0.007 (-0.017,0.002) 
Quintile 4 -0.001 (-0.010,0.008) -0.003 (-0.013,0.006) 
Quintile 5 0.005 (-0.004,0.015) 0.002 (-0.008,0.011) 
p-trend 0.44 0.98 
   
TICS score   
Quintile 1 Ref Ref 
Quintile 2 0.017 (-0.015,0.048) 0.014 (-0.018,0.045) 
Quintile 3 0.007 (-0.025,0.039) 0.003 (-0.030,0.035) 
Quintile 4 -0.007 (-0.039,0.024) -0.011 (-0.043,0.020) 
Quintile 5 0.011 (-0.021,0.042) 0.004 (-0.028,0.036) 
p-trend 0.95 0.73 
Abbreviations: MIND= Mediterranean-DASH Intervention for Neurodegenerative Delay; TICS= Telephone interview of 
cognitive status 
a Values are mean difference in score (95% confidence interval) 
b Model 1: adjusted for age and education 
c Model 2: additionally adjusted for physical activity, calorie intake, alcohol intake, smoking status, multivitamin use, BMI, 
depression and history of high blood pressure, hypercholesterolemia, myocardial infarction, and diabetes mellitus. 
 
 
MIND-components and cognitive function 
Excluding the component ‘Butter and margarine’ and ‘Pastries and sweets’ attenuated the 
association between the MIND score and average verbal memory (adjusted mean differences 
between extreme quintiles of intake were 0.02 (95%CI -0.02,0.05) for ‘Butter and margarine’ and 
0.03 (95%CI -0.01,0.06) for ‘Pastries and sweets, p-trends across categories of intake = 0.14 for both 
components), demonstrating that these components were the most important contributors to the 
association, as part of the MIND diet. 
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Table 3. Multivariable-adjusted mean differencesa in cognition averaged over the follow-up period across 
quintiles of the MIND score in 16,058 older women participating in the Nurses’ Health Study 
 Model 1b Model 2c 
Global cognitive score   
Quintile 1 Ref Ref 
Quintile 2 0.02 (-0.01,0.05) 0.00 (-0.02,0.03) 
Quintile 3 0.02 (-0.01,0.05) 0.00 (-0.03,0.03) 
Quintile 4 0.02 (-0.01,0.05) 0.00 (-0.03,0.03) 
Quintile 5 0.03 (0.00,0.06) 0.00 (-0.03,0.03) 
p-trend 0.03 0.88 
   
Verbal memory score   
Quintile 1 Ref Ref 
Quintile 2 0.02 (-0.01,0.06) 0.01 (-0.02,0.05) 
Quintile 3 0.03 (0.00,0.07) 0.02 (-0.01,0.05) 
Quintile 4 0.04 (0.01,0.08) 0.02 (-0.01,0.06) 
Quintile 5 0.06 (0.03,0.09) 0.04 (0.01,0.07) 
p-trend <0.0001 0.02 
   
TICS score   
Quintile 1 Ref Ref 
Quintile 2 -0.01 (-0.13,0.11) -0.05 (-0.18,0.07) 
Quintile 3 0.06 (-0.07,0.19) 0.00 (-0.13,0.12) 
Quintile 4 0.07 (-0.05,0.19) -0.02 (-0.14,0.11) 
Quintile 5 0.02 (-0.10,0.14) -0.09 (-0.21,0.04) 
p-trend 0.44 0.31 
Abbreviations: MIND= Mediterranean-DASH Intervention for Neurodegenerative Delay; TICS= Telephone interview of 
cognitive status 
a Values are mean difference in score (95% confidence interval) 
b Model 1: adjusted for age and education 
c Model 2: additionally adjusted physical activity, calorie intake, alcohol intake, smoking status, multivitamin use, BMI, 
depression, and history of high blood pressure, hypercholesterolemia, myocardial infarction, and diabetes mellitus 
 
 
The associations did not change when additionally adjusting for family history of dementia and socio- 
economic variables such as income, job, and marital status (data not shown). There was no 
interaction between adherence to the MIND diet and age, BMI, high blood pressure or ApoE ε4 
status for global cognition, verbal memory or TICS (p-interaction age: 0.45, 0.70, 0.82, BMI: 0.63, 
0.61, 0.69, high blood pressure: 0.90, 0.70, 0.85, ApoE ε4 status: 0.38, 0.40, 0.27 for global cognition, 
verbal memory and TICS, respectively). The association between the MIND diet and cognitive 
function was not mediated by high blood pressure as the effect estimates remained exactly the same 
when taking out high blood pressure from the multivariable adjusted model (data not shown). 
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Cognitive decline over time 
Long-term adherence to the MIND score was not significantly associated with change over time in 
the global cognitive score, verbal memory score, or the TICS score, in either the age and education 
adjusted models, or in the multivariable-adjusted model (p-trend 0.95, 0.98, and 0.73 for global 
cognition, verbal memory and TICS, respectively) (table 4).  
 
Table 4. Multivariable-adjusted mean differencesa in slopes of cognitive change by quintiles of long-term 
MIND-score in 16,058 older women 
 Model 1b Model 2c 
Global cognitive score   
Quintile 1 Ref Ref 
Quintile 2 0.002 (-0.005,0.010) 0.001 (-0.007,0.009) 
Quintile 3 -0.002 (-0.010,0.006) -0.004 (-0.011,0.004) 
Quintile 4 0.000 (-0.009,0.008) -0.002 (-0.010,0.006) 
Quintile 5 0.004 (-0.003,0.012) 0.001 (-0.007,0.009) 
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Quintile 3 -0.005 (-0.015,0.004) -0.007 (-0.017,0.002) 
Quintile 4 -0.001 (-0.010,0.008) -0.003 (-0.013,0.006) 
Quintile 5 0.005 (-0.004,0.015) 0.002 (-0.008,0.011) 
p-trend 0.44 0.98 
   
TICS score   
Quintile 1 Ref Ref 
Quintile 2 0.017 (-0.015,0.048) 0.014 (-0.018,0.045) 
Quintile 3 0.007 (-0.025,0.039) 0.003 (-0.030,0.035) 
Quintile 4 -0.007 (-0.039,0.024) -0.011 (-0.043,0.020) 
Quintile 5 0.011 (-0.021,0.042) 0.004 (-0.028,0.036) 
p-trend 0.95 0.73 
Abbreviations: MIND= Mediterranean-DASH Intervention for Neurodegenerative Delay; TICS= Telephone interview of 
cognitive status 
a Values are mean difference in score (95% confidence interval) 
b Model 1: adjusted for age and education 
c Model 2: additionally adjusted for physical activity, calorie intake, alcohol intake, smoking status, multivitamin use, BMI, 
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MIND-components and cognitive function 
Excluding the component ‘Butter and margarine’ and ‘Pastries and sweets’ attenuated the 
association between the MIND score and average verbal memory (adjusted mean differences 
between extreme quintiles of intake were 0.02 (95%CI -0.02,0.05) for ‘Butter and margarine’ and 
0.03 (95%CI -0.01,0.06) for ‘Pastries and sweets, p-trends across categories of intake = 0.14 for both 
components), demonstrating that these components were the most important contributors to the 
association, as part of the MIND diet. 
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Discussion 
In this large observational study in 16,058 older women, we observed that greater long-term 
adherence to the MIND diet was associated with a better verbal memory score, irrespective of ApoE 
ε4 status. We did not find evidence of an association between MIND diet adherence with global 
cognition or the TICS score, nor with cognitive change over time in any of the domains.  
 
To put our results into perspective, we observed that each increase of one year of age of participants 
in this study population was associated with a mean difference of -0.05 standard units for verbal 
memory score. To provide a more clinical interpretation of the findings, this means that the effect 
estimate we found for MIND adherence was cognitively equivalent to being approximately one year 
younger.  
 
The Memory and Aging Project (MAP), an open prospective cohort study in 960 older persons, 
demonstrated that the MIND diet was associated with slower decline in the global cognitive score 
and also in each of the five cognitive domains studied. The difference in rate of decline for highest 
adherence to the MIND diet compared to the lowest adherence was equivalent to that seen in 
women who were 7.5 years apart in age [10]. To date, there have been no other studies on the MIND 
diet and cognitive function. A possible explanation for the difference in the strength of associations 
as reported in the MAP study and the present study could be related to different population 
characteristics of the two cohorts. Compared to NHS participants, MAP study participants were on 
average ten years older than NHS participants, had a lower education level, mainly lived in 
retirement houses, were more likely to have ever smoked and more likely to have reported high 
blood pressure, diabetes and myocardial infarction. This would suggest that MAP participants were 
at higher risk of poor cognitive function and faster cognitive decline compared to NHS participants, 
resulting in a stronger association between the MIND diet and cognitive decline over time. Another 
explanation may relate to a difference in the cohort design, specifically the number and timing of 
dietary and cognitive assessments. First, the MAP study used 19 cognitive tests ten times over a 
period of nine years to compute a global measure of cognitive function and five cognitive domains, 
whereas the NHS used six cognitive tests four times during six years to construct a global measure of 
cognitive function and three cognitive domains. It could be that the MAP study was better able to 
detect differences in cognitive change with the more extensive cognitive assessment battery over a 
longer period of follow-up. Second, in the NHS study, we used all dietary assessments prior to the 
first cognitive assessment to create a measure of long-term dietary intake capturing changes in 
dietary intake over time, whereas the MAP study used the first dietary assessment to study cognitive 
change from that point forward. Hence, it could be that MAP study participants with good cognitive 
function at baseline may have reported healthier dietary intakes, which could have led to less decline 
in cognitive function at follow-up. On the other hand, those with poor cognitive function at baseline 
probably reported worse dietary intakes, resulting in a stronger association between the MIND diet 
and cognitive decline. These two issues could also explain why we were not able to find any 
association with cognitive change over time. 
 
We additionally examined the relative contribution of individual components when excluding one 
component from the MIND score at a time, while including it as a covariate into the regression 
models. Using this approach, we observed that butter plus margarine and pastries plus sweets were 
the main components as part of the total MIND diet driving the association between the MIND diet 
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and verbal memory within the NHS population. So far, no other studies have taken into account the 
relative contribution of these components to cognitive function. Future research should further 
explore the relative contribution of components of dietary patterns to better understand underlying 
mechanisms.  
 
There are several biological mechanisms by which the MIND diet could impact cognitive function. 
First, by keeping the intake low for items such as butter and margarine or pastries and sweets, the 
consumption of saturated fats and trans-fatty acids would be kept low, resulting in a better fat 
composition of the diet that can improve the blood-brain barrier function and decrease Aβ 
aggregation [27]. Second, in an Alzheimer’s disease mouse model, higher intakes of long-chain n-3 
fatty acids from fish has been shown to reduce Aβ formation and oxidative damage and increase 
synaptic proteins and dendritic spine density [28, 29]. Finally, the components of berries and green 
leafy vegetables provide high amounts of vitamin E, flavonoids, folate and carotenoids, which, in 
rodents, have been shown to have antioxidant and anti-inflammatory properties [30, 31] and to 
inhibit Aβ deposition [30, 32-35]. Thus, there is a solid biological basis that the MIND diet could 
impact brain health. 
 
Genetically, carrying one or more copies of the ApoE ε4 is associated with an increased risk of 
Alzheimer’s disease (AD) and cognitive function decline [11, 36]. Observational studies have 
demonstrated the largest cognitive decline among homozygous and an intermediate cognitive 
decline in heterozygous ApoE ε4 carriers after three years [37] and a more rapid decline in all 
cognitive domains in those carrying at least one ApoE ε4 allele [12]. This evidence supports the 
importance of finding strategies to prevent cognitive decline especially among ApoE ε4 carriers. 
However, we were not able to demonstrate an interaction between the MIND diet and ApoE ε4 
status. Additionally, adding the ApoE ε4 genotype to our fully adjusted model did not result in 
different or stronger associations. Other studies investigating an interaction between different 
dietary patterns and cognitive function have shown inconsistent findings, with studies reporting 
better cognitive function among non-carriers [13, 14], one study reporting an association among 
carriers [15], and three studies presenting no interaction [14, 16, 17]. Overall, no consistent 
conclusion on the role of the ApoE4 ε4 allele between diet and cognitive function can be drawn and 
this requires further research. 
 
This study has several limitations to consider. First, the FFQ did not specifically ask if olive oil was the 
primary source of fat, as this is not commonly consumed in this US population. As a best estimate, 
we chose to study the use of primarily vegetable oil instead of butter or margarine. Second, cognitive 
function was assessed by telephone assessment, possibly leading to some misclassification of 
cognitive function. A validation study, however, has shown that telephone-based cognitive battery 
performed well compared with detailed, in-person interviews (ρ = 0.81 comparing the two modes of 
assessment) [38]. Third, participants were relatively healthy and highly educated, limiting the 
generalizability of the results to other populations. It could be that a healthy diet is not so beneficial 
in the NHS population, whereas it may be more beneficial in the general population with more risk 
factors for poorer health and a lower educational level. Finally, we cannot exclude the possibility of 
residual confounding by unmeasured variables within this cohort, although we have adjusted for 
many potential confounders.  
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The relatively long follow-up allowed us to assess long-term associations between the MIND score 
and cognitive function. By averaging repeated measures of diet to obtain an assessment of long-term 
overall diet, we accounted for within-person change in intake and reduced measurement error (as 
previously documented by our group [39]). The same approach has been taken to limit measurement 
error in cognitive function assessments, by averaging all repeated measures into a more robust 
measure of cognitive function at older ages. The prospective nature of this analysis reduces the 
probability of recall bias and selection bias. In addition, a high follow-up rate reduced potential bias 
due to loss of follow-up. Nevertheless, our results need to be replicated in other populations at risk 
of poorer health to clarify the relevance of this association within populations at risk of cognitive 
decline.  
 
To summarize, long-term adherence to the MIND diet, with high intakes of berries, green leafy 
vegetables and low intakes of pastries and sweets, was associated with a better verbal memory in 
later life, but not with global cognitive function, TICS score or cognitive decline.  
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Abstract  
Background: The proportion of European elderly is expected to increase to 22% in 2050. Specific 
individual dietary components may reduce disease risk and improve quality of life in elderly. Combining 
dietary components may modulate many processes involved in ageing and so it is likely that a whole diet 
approach might have greater impact on age-related decline than individual components. This 
intervention studies the effects of a whole diet on health and quality of life in European elderly. 
Methods: The NU-AGE study is a randomized one year intervention in 1250 apparently healthy, 
independently living European subjects aged 65 to 80 years. Subjects are randomised into either the diet 
group or the control group. Participants in the diet group received dietary advice aimed at meeting the 
nutritional requirement of the ageing population. Special attention was paid to nutrients that may be 
inadequate or limiting in diets of elderly.  
Discussion: The NU-AGE study is the first dietary intervention investigating the effect of a whole diet and 
providing targeted nutritional recommendations for optimal health and quality of life in apparently 
healthy European elderly. Results of this intervention will provide evidence on the effect of a whole diet 
on the prevention of age related decline. 
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Introduction 
The number of people aged 65 years and older is continuously increasing. By the year 2050 the 
proportion of elderly in Europe will be approximately 22% [1]. This demographic shift will most probably 
increase age-related diseases and disabilities; therefore it is of critical importance to find strategies that 
decrease morbidity by slowing down the ageing process and thereby increasing the number of European 
elderly in good health. 
The ageing process is currently defined as a dynamic process involving the continual adaptation 
of the body to life-long exposure to internal and external stressors, conceptualised as the ‘remodelling 
theory of ageing’[2]. It is a complex process involving interactions between environmental, stochastic 
and genetic-epigenetic variables. One of the basic molecular mechanisms of ageing is the development 
of a chronic, low-grade inflammatory status, also referred to as ‘inflammageing’ [3-5]. Inflammageing 
plays a role in the onset of age-related chronic diseases, such as atherosclerosis and type 2 diabetes 
mellitus, and geriatric conditions, such as sarcopenia, frailty and disability [3-5]. Of all variables involved 
in inflammageing, diet and lifestyle appear to be the most modifiable. Dietary patterns of the elderly can 
be inappropriate [6-11] and intake of vitamin D, folate, iron, vitamin B12 and calcium [12] are often 
below what is recommended.  
Results from randomized controlled trials, meta-analyses and reviews have shown that certain 
foods and nutrients can reduce the risk of disease and improve the quality of life of the elderly. 
Monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), olive oil or oily fish have been 
shown to have beneficial effects on blood pressure, inflammatory processes and inflammatory bowel 
diseases, cognitive function, mood and depression [13-15]. Whole grains and some cereals positively 
influenced diabetes, BMI, cardiovascular disease and blood lipids [16-20]. To reduce the development of 
sarcopenia, meat and protein have shown to be important [21]. Other components frequently studied, 
such as fruits, vegetables, vitamin C, vitamin D, vitamin B12 and folate, improved nutritional status and 
markers of inflammation, beneficially affected type 2 diabetes mellitus [22-24], risk of falls [25], and 
were shown to improve bone health and reduce fractures [26-29].   
 Manipulating dietary patterns can be a more powerful approach than single nutrients or foods 
because these may have synergistic or antagonistic effects when consumed in combination [30, 31]. 
Many studies have shown that altering dietary patterns is more effective than effects of single dietary 
components on reducing disease risk [32-37]. A frequently studied dietary pattern is the Mediterranean 
diet. Observational and intervention studies have shown that the Mediterranean diet increases survival 
among older people [35, 37] and in patients with a history of myocardial infarction [33], reduces 
incidence of cardiovascular events in patients at risk [38], improves anthropometric and metabolic 
parameters in subjects aged 51-59 years [36], influences cardiovascular risk factors [34] and lowers risk 
of cognitive function decline in older individuals [32].  
 Besides the impact on survival [33], anthropometric and metabolic parameters [36], 
cardiovascular risk factors [34] and cognitive function [32], a whole diet approach might also have 
impact on the ageing process and inflammatory parameters [39]. However, apart from one study 
showing that components of the Mediterranean-type food pattern influence serum inflammatory 
markers [40] there appear to be no studies on the effects of a whole diet on the ageing process in an 
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elderly population. Therefore NU-AGE focuses on nutrition as a major modulator of inflammageing and 
other age-related functional outcomes. 
The NU-AGE dietary intervention will investigate whether a newly designed, personally tailored, 
whole diet, designed to meet the nutritional needs of people over 65 years of age can counteract or 
slow down the decline of function at the level of different organs and systems which occurs with age. 
This approach will allow an evaluation of the whole-organism response using a systems biology 
approach. It will consider several tissues and systems as a functional network instead of assessing the 
single tissue and organ responses separately. 
 
 
Materials and methods 
 
Study design   
The NU-AGE project involves a consortium of 30 partners from 17 European countries. A detailed 
description of this project has been described in the paper of Santoro et al. in this special issue. The NU-
AGE dietary intervention comprises a one-year, randomized, parallel trial with two arms – control and 
intervention - carried out in five European study centres (Clermont Ferrand in France, Bologna in Italy, 
Wageningen in the Netherlands, Warsaw in Poland and Norwich in the United Kingdom). Each centre 
aimed to recruit 250 subjects to end up with a combined total of 1250 subjects. Inclusion and exclusion 
criteria of eligible participants can be found in table 1.  
 
Table 1. Inclusion and exclusion criteria for participants of the NU-AGE dietary intervention study 
Inclusion criteria Exclusion criteria 
Men and women Overt disease such as cancer or dementia 
Aged 65 to 79 years History of severe heart disease 
Free of disease compromising 2–year survival  Unstable organ failure 
Free and independent living Organ failure necessitating a special diet 
Competent to make own decisions Diabetes Mellitus Type I 
 Diabetes Mellitus Type 2 with insulin therapy 
 Chronic use of corticosteroid medication 
 Recent use of antibiotics 
 Change in habitual medication use 
 Malnutrition 
 Presence of frailty 
 
All participants signed informed consent prior to their inclusion in the study. Recruitment started in April 
2012 and will continue until October 2013. We used screening questionnaires to verify that none of the 
exclusion criteria were present. In case of recent use of corticosteroids or antibiotics or change in use of 
habitual medication we postponed inclusion for 1, 2 or 3 months, respectively. Presence of frailty was 
assessed with a test described by Fried et al. [41] combining measures of height, weight, BMI, hand grip 
strength, gait speed, depression and physical activity. Participants were randomly allocated to the 
intervention or control group to a 1:1 ratio after stratification by gender, age (65-72 or 73-79 years), 
frailty status (pre-frail or non-frail) and BMI (<25 or ≥25 kg/m2). Randomization was performed by 
entering the described variables of a subject into a program that automatically randomly allocates and 
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generates a unique ID-code. Participants were informed about their intervention group after the 
randomisation. Only technicians performing the laboratory analyses were blinded to the group 
assignment. All eligible participants were invited for baseline measurements at the research centre for a 
blood withdrawal, urine and faeces collection, anthropometric measurements, completion of a general 
questionnaire, DEXA-scan, physical performance and cognitive function tests. All measures were taken 
by trained research assistants. Trained dieticians/research nutritionists assessed dietary intake. After 4 
and 8 months all participants were contacted by telephone to complete a follow-up questionnaire. After 
one year intervention all measurements were repeated (table 2). The NU-AGE study is registered with 
clinicialtrials.gov since December 21st 2012, NCT01754012. The study protocol is approved by the South-
East 6 Person Protection Committee (France), Independent Ethics Committee of the S. Orsola-Malpighi 
Hospital Bologna (Italy), the Wageningen University Medical Ethics Committee (Netherlands), the 
National Research Ethics Committee - East of England (UK) and the Bioethics Committee of the Polish 
National Food and Nutrition Institute (Poland).  
 
Table 2. Measurements over time (months) 
Measurements Timeline (months) 
 0 4 8 12 
Blood  X   X 
Urine  X   X 
Faeces X   X 
Anthropometric measurements X    X 
DEXA-scan X   X 
Physical activity  X    X 
Physical performance X    X  
General questionnaire X    X  
Follow-up questionnaire   X  X  X 
Dietary intake  X   Xa   Xa X  
a Dietary intake at 4 month and month 8 is assessed only in participants in the diet group 
 
Dietary intake assessment  
Average usual food and nutrient intake of all participants at baseline and after one year follow-up was 
estimated from 7-day food records. These take into account the dietary pattern, infrequently consumed 
foods that can be important sources of specific nutrients, and portion sizes [42-44]. Within two weeks 
after baseline measurements records were collected by means of a paper-based self-administered pre-
formatted food diary. This diary includes 8 meal occasions (before breakfast, breakfast, morning snacks, 
lunch, afternoon snacks, evening meal, evening snacks, night snacks) referring to the current day. 
Portion sizes of frequently consumed foods were estimated with real-life models. Other portion sizes 
were estimated in household measures, based on pictures or measured in gram or millilitres. 
Participants received oral and written instructions about the level of detail required to describe foods 
and amounts consumed, including the name of food, preparation methods, recipes for mixed foods and 
portion sizes [45]. Whenever possible, a trained dietician/research nutritionist visited the participants at 
their homes (in the Netherlands and the UK) to review the records and to check frequently used 
household measures; otherwise this meeting took place at the research unit (in France, Italy and 
Poland). If participants did not prepare the meals themselves, the one in charge of meal preparation was 
consulted. Dieticians/research nutritionists were familiar with basic rules of communication and 
7Chapter 7     |     Design NU-AGE dietary intervention study 
110 
elderly population. Therefore NU-AGE focuses on nutrition as a major modulator of inflammageing and 
other age-related functional outcomes. 
The NU-AGE dietary intervention will investigate whether a newly designed, personally tailored, 
whole diet, designed to meet the nutritional needs of people over 65 years of age can counteract or 
slow down the decline of function at the level of different organs and systems which occurs with age. 
This approach will allow an evaluation of the whole-organism response using a systems biology 
approach. It will consider several tissues and systems as a functional network instead of assessing the 
single tissue and organ responses separately. 
 
 
Materials and methods 
 
Study design   
The NU-AGE project involves a consortium of 30 partners from 17 European countries. A detailed 
description of this project has been described in the paper of Santoro et al. in this special issue. The NU-
AGE dietary intervention comprises a one-year, randomized, parallel trial with two arms – control and 
intervention - carried out in five European study centres (Clermont Ferrand in France, Bologna in Italy, 
Wageningen in the Netherlands, Warsaw in Poland and Norwich in the United Kingdom). Each centre 
aimed to recruit 250 subjects to end up with a combined total of 1250 subjects. Inclusion and exclusion 
criteria of eligible participants can be found in table 1.  
 
Table 1. Inclusion and exclusion criteria for participants of the NU-AGE dietary intervention study 
Inclusion criteria Exclusion criteria 
Men and women Overt disease such as cancer or dementia 
Aged 65 to 79 years History of severe heart disease 
Free of disease compromising 2–year survival  Unstable organ failure 
Free and independent living Organ failure necessitating a special diet 
Competent to make own decisions Diabetes Mellitus Type I 
 Diabetes Mellitus Type 2 with insulin therapy 
 Chronic use of corticosteroid medication 
 Recent use of antibiotics 
 Change in habitual medication use 
 Malnutrition 
 Presence of frailty 
 
All participants signed informed consent prior to their inclusion in the study. Recruitment started in April 
2012 and will continue until October 2013. We used screening questionnaires to verify that none of the 
exclusion criteria were present. In case of recent use of corticosteroids or antibiotics or change in use of 
habitual medication we postponed inclusion for 1, 2 or 3 months, respectively. Presence of frailty was 
assessed with a test described by Fried et al. [41] combining measures of height, weight, BMI, hand grip 
strength, gait speed, depression and physical activity. Participants were randomly allocated to the 
intervention or control group to a 1:1 ratio after stratification by gender, age (65-72 or 73-79 years), 
frailty status (pre-frail or non-frail) and BMI (<25 or ≥25 kg/m2). Randomization was performed by 
entering the described variables of a subject into a program that automatically randomly allocates and 
111 
generates a unique ID-code. Participants were informed about their intervention group after the 
randomisation. Only technicians performing the laboratory analyses were blinded to the group 
assignment. All eligible participants were invited for baseline measurements at the research centre for a 
blood withdrawal, urine and faeces collection, anthropometric measurements, completion of a general 
questionnaire, DEXA-scan, physical performance and cognitive function tests. All measures were taken 
by trained research assistants. Trained dieticians/research nutritionists assessed dietary intake. After 4 
and 8 months all participants were contacted by telephone to complete a follow-up questionnaire. After 
one year intervention all measurements were repeated (table 2). The NU-AGE study is registered with 
clinicialtrials.gov since December 21st 2012, NCT01754012. The study protocol is approved by the South-
East 6 Person Protection Committee (France), Independent Ethics Committee of the S. Orsola-Malpighi 
Hospital Bologna (Italy), the Wageningen University Medical Ethics Committee (Netherlands), the 
National Research Ethics Committee - East of England (UK) and the Bioethics Committee of the Polish 
National Food and Nutrition Institute (Poland).  
 
Table 2. Measurements over time (months) 
Measurements Timeline (months) 
 0 4 8 12 
Blood  X   X 
Urine  X   X 
Faeces X   X 
Anthropometric measurements X    X 
DEXA-scan X   X 
Physical activity  X    X 
Physical performance X    X  
General questionnaire X    X  
Follow-up questionnaire   X  X  X 
Dietary intake  X   Xa   Xa X  
a Dietary intake at 4 month and month 8 is assessed only in participants in the diet group 
 
Dietary intake assessment  
Average usual food and nutrient intake of all participants at baseline and after one year follow-up was 
estimated from 7-day food records. These take into account the dietary pattern, infrequently consumed 
foods that can be important sources of specific nutrients, and portion sizes [42-44]. Within two weeks 
after baseline measurements records were collected by means of a paper-based self-administered pre-
formatted food diary. This diary includes 8 meal occasions (before breakfast, breakfast, morning snacks, 
lunch, afternoon snacks, evening meal, evening snacks, night snacks) referring to the current day. 
Portion sizes of frequently consumed foods were estimated with real-life models. Other portion sizes 
were estimated in household measures, based on pictures or measured in gram or millilitres. 
Participants received oral and written instructions about the level of detail required to describe foods 
and amounts consumed, including the name of food, preparation methods, recipes for mixed foods and 
portion sizes [45]. Whenever possible, a trained dietician/research nutritionist visited the participants at 
their homes (in the Netherlands and the UK) to review the records and to check frequently used 
household measures; otherwise this meeting took place at the research unit (in France, Italy and 
Poland). If participants did not prepare the meals themselves, the one in charge of meal preparation was 
consulted. Dieticians/research nutritionists were familiar with basic rules of communication and 
Chapter 7     |     Design NU-AGE dietary intervention study 
112 
interviewing, composition of local menus and standard recipes and encoding or entering of data. The 
consumed foods were coded according to standardized coding procedures and translated into nutrients 
by use of local food composition tables (NEVO 2011 in The Netherlands, WISP in The UK, INRAN and IEO 
in Italy, NFNI in Poland and CIQUAL French food composition table in France).  
 
Dietary intervention 
All participants had an interview with a trained dietician/research nutritionist to complete the 7-day 
food records. At the end of the interview participants randomised into the control group received only a 
leaflet with general national dietary guidelines that are freely available in France, Italy, the Netherlands, 
Poland and the United Kingdom [46-50]. Participants randomised to the diet group received individually 
tailored dietary advice aiming to meet on average the nutritional requirements for the elderly. The 
advice was based on FBDG’s and recommended daily allowances (RDA’s) from the countries of the 5 
participating study centres [46, 48, 51-56], on the modified MyPyramid for Older Adults [57, 58], 
European Commission [59] and Institute of Medicine [60] to ensure no risk of inadequate or excessive 
intakes in the diet group. Adequacy components of the NU-AGE diet included consumption of 4-6 
servings of whole grain products per day (25g of bread or 50g breakfast cereal/serving); 2 servings of 
fresh fruits per day (including fresh fruit juices, dried fruits and frozen fruits); 3 servings of vegetables 
per day (100g of salad or cooked vegetables/serving and 2 servings of legumes per week (100g/serving); 
up to 500g low-fat calcium-enriched dairy per day (of which 30g of low-fat cheese); 2 servings of fish or 
seafood per week (125g/serving, at least one serving of fatty fish); 4 servings of lean meat or poultry per 
week (125g/serving); 2 or more servings nuts per week (20g/serving); 3 servings of potatoes 
(50g/serving), or 1 serving of whole-grain rice, or 1 serving pasta per day (80g/serving) of which at least 
2 times per week whole grain rice or pasta; 2-4 eggs per week; total oils and fat consumption of 50g per 
day (of which at least 20g olive oil and a maximum of 30g margarine rich in MUFA and PUFA); alcohol 
consumption of maximum 2 glasses per day for men and 1 glass per day for women; 1500 ml of fluids. 
Components of the NU-AGE diet that were restricted included salt where intake was reduced to 5g per 
day (eliminate or limit adding salt and ready-made meals) and sweets and sweet drinks (e.g., sweet 
pastries, cookies, carbonated and/or sugared beverages).  
The dietary advice was based on individual education using the Motivational Interview 
technique taking into account the Stages of changes theory model and goal setting [61]. To improve 
compliance to the NU-AGE diet this individually-tailored dietary advice, either given face-to-face or by 
telephone, was administered nine times during one year and supported by mail or e-mail (table 3). A 
trained dietician/research nutritionist adapted the dietary advice to personal situations and dietary 
preferences, habits and beliefs.  
 
Table 3. Frequency of dietary advice 
 Timeline (months) 
 0 1 2 3 4 5 6 7 8 9 10 11 12 
Control DA    T    T    DA 
Intervention DA T/E E T/E FR/V T/E E T/E FR/V  T/E E T/E DA 
DA = Dietary Assessment (7-day food records), including leaflet containing general healthy eating guidelines for the control 
group and motivational interview fostering the NU-AGE diet for the diet group. E = e-mail with recipes, daily menus; T = 
Telephone contact for motivational interview; FR/V = 3-day food records prior to study centre Visit to verify compliance by the 
dietician/research nutritionist and for motivational interview. 
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To standardise the dietary counselling each dietician/research nutritionist followed the same process 
(table 4). The dietary counselling covered a total of fifteen dietary goals, including the vitamin D 
supplement. During the first meeting (month 0) the dietician/research nutritionist and participant 
agreed on 5 dietary goals to work on. After one month, the participant could choose 5 other dietary 
goals to work on until month 3. At month 3, the dietician/research nutritionist called the participant to 
evaluate the first 10 goals and to implement the last set of 5 dietary goals. To measure compliance 
participants were asked to keep 3-day food records (3d-FR’s) before month 4. Based on the 3d-FR, 
months 5, 6 and 7 were used to optimise compliance to the NU-AGE diet. Compliance was measured 
again in month 8 with 3d-FR’s. Months 9, 10 and 11 were used to motivate the participant to continue 
the NU-AGE diet. In between, additional information was sent out on topics that were considered 
important to achieve the NU-AGE FBDG’s (e.g. fish consumption, food labelling, fruit and vegetable 
consumption, variation in foods, protein intake). Finally, at month 12 habitual intake and compliance 
was measured by means of 7-day food records. 
Meeting NU-AGE’s FBDG’s by means of a normal diet can be a challenge in terms of financial 
resources and food availability. Therefore, participants in the diet group received commercially available 
foods meeting the criteria of the NU-AGE dietary guidelines. Most products - cheese, wholegrain pasta, 
olive oil and margarine - were provided for free and to all study centres to obtain diets as similar as 
possible across all five study centres. Italy additionally provided vegetable soup to their participants. If a 
product could not be included in the diet, a similar product was chosen in consultation with the 
dietician/research nutritionist. Each participant in the diet group received their first allocation of 
products – sufficient for the first four months – at the first meeting with the dietician/research 
nutritionist. During the research unit visit after 4 and 8 months the participants received a new 
allocation of products. 
It is well-known that achieving an adequate vitamin D intake from diet alone is merely 
impossible [53, 62] because vitamin D is only present in a limited number of foods and the vitamin 
requirement for elderly is set at a high level. To ensure the NU-AGE diet reached the recommended 
vitamin D intake of 15-20 μg, participants in the diet group received a vitamin D supplement of 10 μg 
produced by MCO Health, the Netherlands. Each participant in the diet group received a bottle 
containing vitamin D supplements for 4 months during the first meeting with the dietician/research 
nutritionist. After 4 and 8 months during the research unit visits another bottle of vitamin D was 
provided to the participants in the diet group. The compliance was evaluated by counting the remaining 
vitamin D capsules, which were returned simultaneously with the 3d-FR at month 4 and 8. 
Compliance in all participants was enhanced through newsletters, contact via e-mail and with 
regular telephone calls - bimonthly for participants in the diet group and once per 4 months for 
participants in the control group.  
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Table 4. Structure and main topics per contact moment  
Month Occasion Topic 
0 Home visit or 
Research Unit 
visit 
Assess dietary intake (7–day estimated food records) 
Agree on first set of five dietary goals (vitamin D supplement should at least be 
included) 
Hand out information of the first set of 5 dietary goals and hand out vitamin D 
supplement plus products  
1 Telephone Evaluate first set of five dietary goals and agree on second set of five dietary goals for 
the next month 
 E-mail/post Send out tips and/or recipes for second set of five dietary goals  
2 E-mail/post Send out additional information of the first two sets of five dietary goals and about 
fish consumption 
3 Telephone Evaluate second set of five dietary goals and agree on third set of five dietary goals 
Explain keeping the 3d-FR and make an appointment for the Research Unit visit in 
month 4 
 E-mail/post Send out information regarding the third set of dietary goals and the 3d-FR plus 
explanation 
4 Research Unit 
visit 
Receive bottle with remaining vitamin D tablets and go through the 3d-FR.  
Evaluate compliance to the dietary goals and agree on goals that need extra attention. 
Hand out the vitamin D supplement and foods for the next 4 months plus info about 
goals that were not met yet. 
Hand out additional information regarding food labelling, recipes, variation 
5 Telephone Evaluate goals that needed more attention and determine which goals need extra 
information/attention 
 E-mail/post Send out appropriate info sheet belonging to goals that need extra attention/ were 
not obtained. 
6 E-mail/post Send out additional information regarding fruit and vegetable consumption 
7 Telephone Evaluate goals that needed more attention and determine which goals need extra 
information/attention 
Explain keeping the 3d-FR and make an appointment for the Research Unit visit in 
month 8 
 E-mail/post Send out additional information regarding goals that were not met yet and the 3d-FR 
plus explanation 
8 Research Unit 
visit 
Receive bottle with remaining vitamin D tablets and go through the 3d-FR.  
Evaluate compliance to the dietary goals and agree on goals that need extra attention. 
Hand out the vitamin D supplement and foods for the next 4 months plus info about 
goals that were not met yet. 
9 Telephone Evaluate goals that needed more attention and determine which goals need extra 
attention during the last months 
 E-mail/post Send out appropriate info sheet belonging to goals that need extra attention/ were 
not obtained. 
10 E-mail/post Send out additional information regarding protein intake 
11 Telephone Evaluate goals that were not met yet and agree on goals that need extra attention in 
the last month 
Explain keeping the 7d-FR and make appointment for the Research Unit visit in month 
12 
 E-mail/post Send out the 7d-FR plus explanation  
12 Home visit or 
Research Unit 
visit 
Assess dietary intake (7-day Estimated Food Record) 
Topics in bold are additional information regarded as important for compliance to NU-AGE FBDG’s 
 
115 
Standardisation and training 
In order to perform all measurements in the same standardized way across the five study centres, all 
questionnaires, procedures and tests were practiced and discussed during a training session prior to the 
start of the intervention. These training sessions took place in December 2011 in Warsaw and in January 
2012 in Wageningen. From each study centre at least one research assistant was required to attend this 
training. Based on these training sessions standard operating procedures were developed and 
standardized across all research centres.   
 
Outcome measures 
Several health outcomes were measured to investigate whether adhering to the NU-AGE diet impacts 
on age-related diseases and functional decline, and thereby contribute to improved health and quality 
of life in the ageing population in Europe.  
The primary outcome measure of the intervention is inflammatory status measured as plasma 
levels of C-reactive protein (hsCRP). Secondary measures of inflammatory status include plasma levels of 
IL-1Beta, IL-12, INF gamma, IL-6, sIL-6R, IL-1RA, TNFalpha, IL-17, IL-8, IL-10 and TGF-beta1.  
Additionally, a limited number of basic parameters for describing the function of several 
domains, e.g. metabolism, bone, heart, muscle, intestine, cognition, mood, anthropometry were 
measured before and after dietary intervention. These parameters include measures of insulin 
sensitivity, liver function status, hormonal function status, bone health, cardiovascular health, cognitive 
status, mental health, quality of life, physical functioning, digestive health, anthropometry and measures 
of nutritional status. Also genetic analysis will be performed on DNA to characterize volunteers for 
polymorphisms involved in nutrition, ageing and inflammageing, in order to explain the individual 
variability of the effect of dietary intervention. Further details on the outcome measurements can be 
found in the paper of Santoro et al. in this special issue.  
 
 
Discussion 
To the best of our knowledge, the NU-AGE study is the first dietary intervention study investigating the 
effect of a whole diet targeted on the nutritional requirements of the elderly with respect to optimal 
health and quality of life in an apparently healthy elderly European population. Currently, dietary advice 
specifically adapted to the elderly population is not standard included in public health care practices in 
Europe. Therefore this intervention is an excellent opportunity to investigate the effect of a whole diet 
approach on the prevention of ageing related decline in a European ageing population across cultural 
differences. Positive findings from this study might prevent age-related decline and so facilitate longer 
healthy lives in the elderly. Implementation of structured dietary advice in health care of the elderly 
might therefore contribute to a reduction in health-care related costs.   
 Adequate dietary intakes of individual macro- and micronutrients and food groups have been 
shown to positively influence several organ systems and diseases, [13, 15, 16, 18, 19, 21, 26, 63] but 
until now, there are not many studies investigating the effect of a whole dietary intervention on 
inflammageing and overall age-related decline at the cellular, organ and whole body level. There have 
been studies showing positive effects of certain dietary patterns, such as the Mediterranean diet, on 
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cardiovascular health [64-66], metabolic syndrome [67, 68], survival [37] and mortality [35]. However, 
none of these studies investigated health in such a broad way as the NU-AGE study. Therefore the broad 
range of outcomes measured in the NU-AGE study is unique, and will clarify the potential synergistic 
effects of many different food constituents, and the interaction between the different organ systems.   
We expected the effect of a whole dietary intervention to be most effective and efficient in 
generally healthy elderly. We therefore only included elderly people without major medical conditions 
and with a maximum frailty score of one [41]. As a consequence, findings from this study in generally 
healthy subjects cannot be generalized to the total elderly population which includes less healthy and 
more fragile elderly. Another reason that results cannot be generalised is the fact that potential 
participants were informed in advance that there was a chance that they would have to change their 
dietary intake depending on the randomisation. This could have contributed to the inclusion of health-
conscious individuals who have an above average interest in diet and health.  
 Participants in the diet group were given frequent dietary advice, foods and a vitamin 
supplement aiming to meet the nutritional requirements of the elderly. Because it is practically not 
possible to provide participants in the control group with placebo advice and placebo foods they were 
only given a leaflet with general dietary guidelines instead. As a consequence the diet group does not 
only differ in dietary intake and advice but also in received attention compared to the control group. 
This could result in a better rating of health in this group, rather than an improvement in their diet. In 
order to reduce this bias to some extent participants in both control and diet group were assessed every 
4 months and fulfilled a follow-up questionnaire to check for health status, unexpected events and 
treatment changes.      
The major strength of this study is its whole diet approach specifically adapted to target the 
nutritional requirements for the elderly with a strong Mediterranean Diet influence. This allows us to 
study the synergy of multiple nutrients and adequacy of single nutrients. Although nutritional 
requirements for elderly people in all five participating countries have been merged into NU-AGE dietary 
guidelines flexibility was allowed for country specific food based dietary habits.  
Other strengths include the use of Motivational Interviewing in the dietary counselling. 
Motivational Interviewing focuses on exploring and resolving ambivalence and centres on motivational 
processes within the individual that facilitate change [61]. Quarterly administration of a motivational 
interview has been shown to improve adherence to a Mediterranean-type diet [66]. By administering 
this interview nine times during one year we strived for an optimal compliance with the dietary advice.  
The provision of foods and a vitamin supplement were also used to improve compliance. It has 
been shown that free provision of foods is effective in improving dietary habits [66, 69, 70]. Both the 
counselling and free provision of foods most likely will result to the best possible strategy to promote 
dietary change in participants in the diet group.  
The one year duration of the dietary intervention is long enough for participants in the diet 
group to change their dietary habits over time, and avoids any seasonal-dependent changes in outcome 
measures. A nutrition education trial of 15 weeks and a primary prevention trial of 12 months have both 
been shown to be effective in improving dietary intakes [36, 66]. Within six months and one year 
respectively, it would also be possible to measure changes in health outcomes such as a reduction in 
systolic blood pressure [71] and change in reduction of bone mineral density [72]. Within even five 
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weeks of consuming a Mediterranean Diet it has shown to be possible to reduce inflammatory status 
(CRP) with 26.1% in men with metabolic syndrome [73]. 
The use of 7-day food records instead of a dietary history or 24-hour recall is another strength of 
this study. Keeping 7-day food records does not rely on the memory of the elderly participants thus 
minimising the possible recall bias [45]. Also keeping 7-day food records helps participants to become 
aware of what they eat and represents a useful tool to encourage participants in the diet group to 
change dietary habits. 
The NU-AGE dietary intervention study is the biggest randomized trial ever conducted on the 
effect of a whole diet targeting the nutritional requirements of elderly and counteracting 
inflammageing, age related decline and contributing to increase the healthy lifespan in the elderly 
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aware of what they eat and represents a useful tool to encourage participants in the diet group to 
change dietary habits. 
The NU-AGE dietary intervention study is the biggest randomized trial ever conducted on the 
effect of a whole diet targeting the nutritional requirements of elderly and counteracting 
inflammageing, age related decline and contributing to increase the healthy lifespan in the elderly 
 
 
Acknowledgments 
This project is supported by the European Union’s Seventh Framework Program under grant agreement 
no. 266486 (‘NU-AGE: New dietary strategies addressing the specific needs of the elderly population for 
healthy ageing in Europe’). The Authors thank all principal investigators and collaborators. We especially 
thank all of the participants for their valuable cooperation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7     |     Design NU-AGE dietary intervention study 
118 
References 
1. United Nations. Population Division. Department of Economics and Social Affairs. World Population Ageing:  1950-2050. 
2002. 
2. Franceschi C, Valensin S, Bonafè M, Paolisso G, Yashin AI, Monti D, et al. The network and the remodeling theories of aging: 
Historical background and new perspectives. Experimental Gerontology. 2000;35(6-7):879-96. 
3. Cevenini E, Monti D, Franceschi C. Inflamm-ageing. Curr Opin Clin Nutr Metab Care. 2013;16(1):14-20. 
4. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging: An Evolutionary Perspective on 
Immunosenescence. Annals of the New York Academy of Sciences. 2000;908(1):244-54. 
5. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic 
perspective on aging and longevity emerged from studies in humans. Mechanisms of ageing and development. 
2007;128(1):92-105. 
6. Carriere I, Delcourt C, Lacroux A, Gerber M. Nutrient intake in an elderly population in southern France (POLANUT): 
deficiency in some vitamins, minerals and omega-3 PUFA. Int J Vitam Nutr Res. 2007;77(1):57-65. 
7. Elmadfa I, Freisling H. Nutritional status in Europe: methods and results. Nutr Rev. 2009;67 Suppl 1:S130-4. 
8. Rodriguez Sangrador M, Beltran de Miguel B, Quintanilla Murillas L, Cuadrado Vives C, Moreiras Tuny O. [The contribution 
of diet and sun exposure to the nutritional status of vitamin D in elderly Spanish women: the five countries study 
(OPTIFORD Project)]. Nutr Hosp. 2008;23(6):567-76. 
9. Tokarz A, Stawarska A, Kolczewska M. [Nutritional habits and supplementation of elderly people with cardiovascular 
diseases from Warsaw]. Rocz Panstw Zakl Hig. 2008;59(4):467-72. 
10. van Dam RM, Snijder MB, Dekker JM, Stehouwer CD, Bouter LM, Heine RJ, et al. Potentially modifiable determinants of 
vitamin D status in an older population in the Netherlands: the Hoorn Study. Am J Clin Nutr. 2007;85(3):755-61. 
11. Vinas BR, Barba LR, Ngo J, Gurinovic M, Novakovic R, Cavelaars A, et al. Projected prevalence of inadequate nutrient intakes 
in Europe. Annals of nutrition & metabolism. 2011;59(2-4):84-95. 
12. Cavelaars AE, Doets EL, Dhonukshe-Rutten RA, Hermoso M, Fairweather-Tait SJ, Koletzko B, et al. Prioritizing micronutrients 
for the purpose of reviewing their requirements: a protocol developed by EURRECA. Eur J Clin Nutr. 2010;64 Suppl 2:S19-30. 
13. Alonso A, Ruiz-Gutierrez V, Martinez-Gonzalez MA. Monounsaturated fatty acids, olive oil and blood pressure: 
epidemiological, clinical and experimental evidence. Public Health Nutr. 2006;9(2):251-7. 
14. Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Molecular Nutrition and 
Food Research. 2008;52(8):885-97. 
15. Kraguljac NV, Montori VM, Pavuluri M, Chai HS, Wilson BS, Unal SS. Efficacy of omega-3 fatty acids in mood disorders - a 
systematic review and metaanalysis. Psychopharmacology bulletin. 2009;42(3):39-54. 
16. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2 diabetes: 
a prospective cohort study and systematic review. PLoS Med. 2007;4(8):e261. 
17. Donini LM, Savina C, Cannella C. Nutrition in the elderly: role of fiber. Arch Gerontol Geriatr. 2009;49 Suppl 1:61-9. 
18. Gaesser GA. Carbohydrate quantity and quality in relation to body mass index. J Am Diet Assoc. 2007;107(10):1768-80. 
19. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab 
Cardiovasc Dis. 2008;18(4):283-90. 
20. Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X. Meta-analysis of the effects of flaxseed interventions on blood lipids. 
Am J Clin Nutr. 2009;90(2):288-97. 
21. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr 
Metab Care. 2009;12(1):86-90. 
22. Bermejo LM, Aparicio A, Andres P, Lopez-Sobaler AM, Ortega RM. The influence of fruit and vegetable intake on the 
nutritional status and plasma homocysteine levels of institutionalised elderly people. Public Health Nutr. 2007;10(3):266-72. 
23. Hamer M, Chida Y. Intake of fruit, vegetables, and antioxidants and risk of type 2 diabetes: systematic review and meta-
analysis. J Hypertens. 2007;25(12):2361-9. 
24. Wannamethee SG, Lowe GD, Rumley A, Bruckdorfer KR, Whincup PH. Associations of vitamin C status, fruit and vegetable 
intakes, and markers of inflammation and hemostasis. Am J Clin Nutr. 2006;83(3):567-74; quiz 726-7. 
25. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental 
and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. 
26. Andres E, Serraj K, Mecili M, Ciobanu E, Vogel T, Weitten T. [Update of oral vitamin B12]. Ann Endocrinol (Paris). 
2009;70(6):455-61. 
27. Hin H, Clarke R, Sherliker P, Atoyebi W, Emmens K, Birks J, et al. Clinical relevance of low serum vitamin B12 concentrations 
in older people: the Banbury B12 study. Age Ageing. 2006;35(4):416-22. 
28. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a 
randomized controlled trial. JAMA. 2005;293(9):1082-8. 
29. Vaes BL, Lute C, Blom HJ, Bravenboer N, de Vries TJ, Everts V, et al. Vitamin B(12) deficiency stimulates osteoclastogenesis 
via increased homocysteine and methylmalonic acid. Calcif Tissue Int. 2009;84(5):413-22. 
119 
30. Jacobs DR, Jr., Steffen LM. Nutrients, foods, and dietary patterns as exposures in research: a framework for food synergy. 
Am J Clin Nutr. 2003;78(3 Suppl):508S-13S. 
31. Jacques PF, Tucker KL. Are dietary patterns useful for understanding the role of diet in chronic disease? Am J Clin Nutr. 
2001;73(1):1-2. 
32. Alles B, Samieri C, Feart C, Jutand MA, Laurin D, Barberger-Gateau P. Dietary patterns: a novel approach to examine the link 
between nutrition and cognitive function in older individuals. Nutr Res Rev. 2012:207-22. 
33. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in 
secondary prevention of coronary heart disease. Lancet. 1994;343(8911):1454-9. 
34. Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI, et al. Effects of a Mediterranean-
style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145(1):1-11. 
35. McNaughton SA, Bates CJ, Mishra GD. Diet quality is associated with all-cause mortality in adults aged 65 years and older. J 
Nutr. 2012;142(2):320-5. 
36. Panunzio MF, Caporizzi R, Antoniciello A, Cela EP, Ferguson LR, D'Ambrosio P. Randomized, controlled nutrition education 
trial promotes a Mediterranean diet and improves anthropometric, dietary, and metabolic parameters in adults. Ann Ig. 
2011;23(1):13-25. 
37. Trichopoulou A, Orfanos P, Norat T, Bueno-de-Mesquita B, Ocke MC, Peeters PH, et al. Modified Mediterranean diet and 
survival: EPIC-elderly prospective cohort study. BMJ. 2005;330(7498):991. 
38. Estruch R, Ros E, Salas-Salvado J, Covas MI, Pharm D, Corella D, et al. Primary Prevention of Cardiovascular Disease with a 
Mediterranean Diet. N Engl J Med. 2013;368:1279-90. 
39. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured? 
40. Salas-Salvado J, Garcia-Arellano A, Estruch R, Marquez-Sandoval F, Corella D, Fiol M, et al. Components of the 
Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. 
Eur J Clin Nutr. 2008;62(5):651-9. 
41. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J 
Gerontol A Biol Sci Med Sci. 2001;56(3):M146-56. 
42. Day N, McKeown N, Wong M, Welch A, Bingham S. Epidemiological assessment of diet: a comparison of a 7-day diary with a 
food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol. 2001;30(2):309-17. 
43. Prentice RL, Mossavar-Rahmani Y, Huang Y, Van Horn L, Beresford SA, Caan B, et al. Evaluation and comparison of food 
records, recalls, and frequencies for energy and protein assessment by using recovery biomarkers. Am J Epidemiol. 
2011;174(5):591-603. 
44. Bingham SA, Gill C, Welch A, Day K, Cassidy A, Khaw KT, et al. Comparison of dietary assessment methods in nutritional 
epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr. 
1994;72(4):619-43. 
45. Coulston AM, Boushey CJ. Nutrition in the prevention and treatment of disease. 2nd ed. Coulston AM, editor. Burlingotn, 
USA: Elsevier Academie Press; 2008 2008. 
46. Department of Health. Report on Health & Social Subjects 41 Dietary reference values for food energy and nutrients for the 
United Kingdom. London: 1991. 
47. Health council of the Netherlands. Guidelines for a healthy diet 2006. The Hague: 2006. 
48. Jarosz M, Bulhak-Jachymczyk B. Normy zywienia czlowieka. Podstawy prewencji otylosci i chorob niezakaznych / Nutrition 
recommendations. Basis for the prevention of obesity and non-communicable dieseases. Warsaw: Wydawnictwo Lekarskie 
PZWL / National Food and Nutrition Institute 2008. 
49. Ministère du Travail dlEedlS. French National Nutrition and Health Program 2011-2015 2011. Available from: 
http://www.sante.gouv.fr/IMG/pdf/French_National_Nutrition_and_Health_Program_2011-2015.pdf. 
50. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione 
2003 [cited 2012 03-08-2011]. Italian Dietary Guidelines]. Available from: http://www.inran.it/. 
51. AFSSA, CNERNA-CNRS. Apports Nutritionnels conseillés pour la population française. 3 ed. Martin A, editor. Paris: Tec et 
Doc Lavoisier; 2001. 608 p. 
52. Food and Nutrition Council. Nederlandse normen 1989 / Dutch dietary reference values 1989. The Hague: 1992. 
53. Health council of the Netherlands. Dietary reference intakes: calcium, vitamin D, thiamin, riboflavin, niacin, pantothenic 
acid, and biotin. The Hague: 2000. 
54. Health council of the Netherlands. Dietary Reference Intakes: energy, proteins, fats and digestible carbohydrates. . The 
Hague 2001  
55. Health council of the Netherlands. Dietary Reference Intakes: vitamin B6, folic acid, and vitamin B12. The Hague: 2003. 
56. Health council of the Netherlands. Guideline for dietary fiber intake. The Hague: 2006. 
57. Peregrin T. Getting to Know the Modified MyPyramid for Older Adults. Journal of the American Dietetic Association. 
2008;108(6):937-8. 
58. Shelnutt KP, Bobroff LB, Diehl DC. MyPyramid for Older Adults. Journal of Nutrition Education and Behavior.41(4):300-2. 
7Chapter 7     |     Design NU-AGE dietary intervention study 
118 
References 
1. United Nations. Population Division. Department of Economics and Social Affairs. World Population Ageing:  1950-2050. 
2002. 
2. Franceschi C, Valensin S, Bonafè M, Paolisso G, Yashin AI, Monti D, et al. The network and the remodeling theories of aging: 
Historical background and new perspectives. Experimental Gerontology. 2000;35(6-7):879-96. 
3. Cevenini E, Monti D, Franceschi C. Inflamm-ageing. Curr Opin Clin Nutr Metab Care. 2013;16(1):14-20. 
4. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging: An Evolutionary Perspective on 
Immunosenescence. Annals of the New York Academy of Sciences. 2000;908(1):244-54. 
5. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic 
perspective on aging and longevity emerged from studies in humans. Mechanisms of ageing and development. 
2007;128(1):92-105. 
6. Carriere I, Delcourt C, Lacroux A, Gerber M. Nutrient intake in an elderly population in southern France (POLANUT): 
deficiency in some vitamins, minerals and omega-3 PUFA. Int J Vitam Nutr Res. 2007;77(1):57-65. 
7. Elmadfa I, Freisling H. Nutritional status in Europe: methods and results. Nutr Rev. 2009;67 Suppl 1:S130-4. 
8. Rodriguez Sangrador M, Beltran de Miguel B, Quintanilla Murillas L, Cuadrado Vives C, Moreiras Tuny O. [The contribution 
of diet and sun exposure to the nutritional status of vitamin D in elderly Spanish women: the five countries study 
(OPTIFORD Project)]. Nutr Hosp. 2008;23(6):567-76. 
9. Tokarz A, Stawarska A, Kolczewska M. [Nutritional habits and supplementation of elderly people with cardiovascular 
diseases from Warsaw]. Rocz Panstw Zakl Hig. 2008;59(4):467-72. 
10. van Dam RM, Snijder MB, Dekker JM, Stehouwer CD, Bouter LM, Heine RJ, et al. Potentially modifiable determinants of 
vitamin D status in an older population in the Netherlands: the Hoorn Study. Am J Clin Nutr. 2007;85(3):755-61. 
11. Vinas BR, Barba LR, Ngo J, Gurinovic M, Novakovic R, Cavelaars A, et al. Projected prevalence of inadequate nutrient intakes 
in Europe. Annals of nutrition & metabolism. 2011;59(2-4):84-95. 
12. Cavelaars AE, Doets EL, Dhonukshe-Rutten RA, Hermoso M, Fairweather-Tait SJ, Koletzko B, et al. Prioritizing micronutrients 
for the purpose of reviewing their requirements: a protocol developed by EURRECA. Eur J Clin Nutr. 2010;64 Suppl 2:S19-30. 
13. Alonso A, Ruiz-Gutierrez V, Martinez-Gonzalez MA. Monounsaturated fatty acids, olive oil and blood pressure: 
epidemiological, clinical and experimental evidence. Public Health Nutr. 2006;9(2):251-7. 
14. Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Molecular Nutrition and 
Food Research. 2008;52(8):885-97. 
15. Kraguljac NV, Montori VM, Pavuluri M, Chai HS, Wilson BS, Unal SS. Efficacy of omega-3 fatty acids in mood disorders - a 
systematic review and metaanalysis. Psychopharmacology bulletin. 2009;42(3):39-54. 
16. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2 diabetes: 
a prospective cohort study and systematic review. PLoS Med. 2007;4(8):e261. 
17. Donini LM, Savina C, Cannella C. Nutrition in the elderly: role of fiber. Arch Gerontol Geriatr. 2009;49 Suppl 1:61-9. 
18. Gaesser GA. Carbohydrate quantity and quality in relation to body mass index. J Am Diet Assoc. 2007;107(10):1768-80. 
19. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab 
Cardiovasc Dis. 2008;18(4):283-90. 
20. Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X. Meta-analysis of the effects of flaxseed interventions on blood lipids. 
Am J Clin Nutr. 2009;90(2):288-97. 
21. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr 
Metab Care. 2009;12(1):86-90. 
22. Bermejo LM, Aparicio A, Andres P, Lopez-Sobaler AM, Ortega RM. The influence of fruit and vegetable intake on the 
nutritional status and plasma homocysteine levels of institutionalised elderly people. Public Health Nutr. 2007;10(3):266-72. 
23. Hamer M, Chida Y. Intake of fruit, vegetables, and antioxidants and risk of type 2 diabetes: systematic review and meta-
analysis. J Hypertens. 2007;25(12):2361-9. 
24. Wannamethee SG, Lowe GD, Rumley A, Bruckdorfer KR, Whincup PH. Associations of vitamin C status, fruit and vegetable 
intakes, and markers of inflammation and hemostasis. Am J Clin Nutr. 2006;83(3):567-74; quiz 726-7. 
25. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental 
and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. 
26. Andres E, Serraj K, Mecili M, Ciobanu E, Vogel T, Weitten T. [Update of oral vitamin B12]. Ann Endocrinol (Paris). 
2009;70(6):455-61. 
27. Hin H, Clarke R, Sherliker P, Atoyebi W, Emmens K, Birks J, et al. Clinical relevance of low serum vitamin B12 concentrations 
in older people: the Banbury B12 study. Age Ageing. 2006;35(4):416-22. 
28. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a 
randomized controlled trial. JAMA. 2005;293(9):1082-8. 
29. Vaes BL, Lute C, Blom HJ, Bravenboer N, de Vries TJ, Everts V, et al. Vitamin B(12) deficiency stimulates osteoclastogenesis 
via increased homocysteine and methylmalonic acid. Calcif Tissue Int. 2009;84(5):413-22. 
119 
30. Jacobs DR, Jr., Steffen LM. Nutrients, foods, and dietary patterns as exposures in research: a framework for food synergy. 
Am J Clin Nutr. 2003;78(3 Suppl):508S-13S. 
31. Jacques PF, Tucker KL. Are dietary patterns useful for understanding the role of diet in chronic disease? Am J Clin Nutr. 
2001;73(1):1-2. 
32. Alles B, Samieri C, Feart C, Jutand MA, Laurin D, Barberger-Gateau P. Dietary patterns: a novel approach to examine the link 
between nutrition and cognitive function in older individuals. Nutr Res Rev. 2012:207-22. 
33. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in 
secondary prevention of coronary heart disease. Lancet. 1994;343(8911):1454-9. 
34. Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI, et al. Effects of a Mediterranean-
style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145(1):1-11. 
35. McNaughton SA, Bates CJ, Mishra GD. Diet quality is associated with all-cause mortality in adults aged 65 years and older. J 
Nutr. 2012;142(2):320-5. 
36. Panunzio MF, Caporizzi R, Antoniciello A, Cela EP, Ferguson LR, D'Ambrosio P. Randomized, controlled nutrition education 
trial promotes a Mediterranean diet and improves anthropometric, dietary, and metabolic parameters in adults. Ann Ig. 
2011;23(1):13-25. 
37. Trichopoulou A, Orfanos P, Norat T, Bueno-de-Mesquita B, Ocke MC, Peeters PH, et al. Modified Mediterranean diet and 
survival: EPIC-elderly prospective cohort study. BMJ. 2005;330(7498):991. 
38. Estruch R, Ros E, Salas-Salvado J, Covas MI, Pharm D, Corella D, et al. Primary Prevention of Cardiovascular Disease with a 
Mediterranean Diet. N Engl J Med. 2013;368:1279-90. 
39. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured? 
40. Salas-Salvado J, Garcia-Arellano A, Estruch R, Marquez-Sandoval F, Corella D, Fiol M, et al. Components of the 
Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. 
Eur J Clin Nutr. 2008;62(5):651-9. 
41. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J 
Gerontol A Biol Sci Med Sci. 2001;56(3):M146-56. 
42. Day N, McKeown N, Wong M, Welch A, Bingham S. Epidemiological assessment of diet: a comparison of a 7-day diary with a 
food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol. 2001;30(2):309-17. 
43. Prentice RL, Mossavar-Rahmani Y, Huang Y, Van Horn L, Beresford SA, Caan B, et al. Evaluation and comparison of food 
records, recalls, and frequencies for energy and protein assessment by using recovery biomarkers. Am J Epidemiol. 
2011;174(5):591-603. 
44. Bingham SA, Gill C, Welch A, Day K, Cassidy A, Khaw KT, et al. Comparison of dietary assessment methods in nutritional 
epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr. 
1994;72(4):619-43. 
45. Coulston AM, Boushey CJ. Nutrition in the prevention and treatment of disease. 2nd ed. Coulston AM, editor. Burlingotn, 
USA: Elsevier Academie Press; 2008 2008. 
46. Department of Health. Report on Health & Social Subjects 41 Dietary reference values for food energy and nutrients for the 
United Kingdom. London: 1991. 
47. Health council of the Netherlands. Guidelines for a healthy diet 2006. The Hague: 2006. 
48. Jarosz M, Bulhak-Jachymczyk B. Normy zywienia czlowieka. Podstawy prewencji otylosci i chorob niezakaznych / Nutrition 
recommendations. Basis for the prevention of obesity and non-communicable dieseases. Warsaw: Wydawnictwo Lekarskie 
PZWL / National Food and Nutrition Institute 2008. 
49. Ministère du Travail dlEedlS. French National Nutrition and Health Program 2011-2015 2011. Available from: 
http://www.sante.gouv.fr/IMG/pdf/French_National_Nutrition_and_Health_Program_2011-2015.pdf. 
50. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione 
2003 [cited 2012 03-08-2011]. Italian Dietary Guidelines]. Available from: http://www.inran.it/. 
51. AFSSA, CNERNA-CNRS. Apports Nutritionnels conseillés pour la population française. 3 ed. Martin A, editor. Paris: Tec et 
Doc Lavoisier; 2001. 608 p. 
52. Food and Nutrition Council. Nederlandse normen 1989 / Dutch dietary reference values 1989. The Hague: 1992. 
53. Health council of the Netherlands. Dietary reference intakes: calcium, vitamin D, thiamin, riboflavin, niacin, pantothenic 
acid, and biotin. The Hague: 2000. 
54. Health council of the Netherlands. Dietary Reference Intakes: energy, proteins, fats and digestible carbohydrates. . The 
Hague 2001  
55. Health council of the Netherlands. Dietary Reference Intakes: vitamin B6, folic acid, and vitamin B12. The Hague: 2003. 
56. Health council of the Netherlands. Guideline for dietary fiber intake. The Hague: 2006. 
57. Peregrin T. Getting to Know the Modified MyPyramid for Older Adults. Journal of the American Dietetic Association. 
2008;108(6):937-8. 
58. Shelnutt KP, Bobroff LB, Diehl DC. MyPyramid for Older Adults. Journal of Nutrition Education and Behavior.41(4):300-2. 
Chapter 7     |     Design NU-AGE dietary intervention study 
120 
59. Commission of the European Communities. Nutrient and energy intakes for the European Community. Luxembourg: 
European Food Safety Authority (EFSA), Scientific Committee for Food, 1993. 
60. Medicine Io. Dietary Reference Intakes. The essential guide to nutrient requirements. Otten J, Pitzi Hellwig, J. Meyers L, 
editors. Washington: The National Academies Press; 2006. 
61. Miller WR, Rollnick S. Motivational interviewing : preparing people for change. New York [etc.]: The Guilford Press; 2002. 
62. Health council of the Netherlands. Towards an adequate intake of vitamin D. The Hague: 2008. 
63. Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, Orav JE, Li R, Spiegelman D, et al. Dietary calcium and serum 25-
hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res. 2009;24(5):935-42. 
64. Richard C, Couture P, Desroches S, Charest A, Lamarche B. Effect of the Mediterranean diet with and without weight loss on 
cardiovascular risk factors in men with the metabolic syndrome. Nutrition, Metabolism and Cardiovascular Diseases. 
2011;21(9):628-35. 
65. Vincent-Baudry S, Defoort C, Gerber M, Bernard MC, Verger P, Helal O, et al. The Medi-RIVAGE study: reduction of 
cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. Am J Clin 
Nutr. 2005;82(5):964-71. 
66. Zazpe I, Sanchez-Tainta A, Estruch R, Lamuela-Raventos RM, Schroder H, Salas-Salvado J, et al. A large randomized 
individual and group intervention conducted by registered dietitians increased adherence to Mediterranean-type diets: the 
PREDIMED study. J Am Diet Assoc. 2008;108(7):1134-44; discussion 45. 
67. Babio N, Bullo M, Basora J, Martinez-Gonzalez MA, Fernandez-Ballart J, Marquez-Sandoval F, et al. Adherence to the 
Mediterranean diet and risk of metabolic syndrome and its components. Nutr Metab Cardiovasc Dis. 2009;19(8):563-70. 
68. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on 
metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol. 
2011;57(11):1299-313. 
69. Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ros E, Covas MI, Fiol M, et al. Cohort profile: design and methods of the 
PREDIMED study. Int J Epidemiol. 2012;41(2):377-85. 
70. Troyer JL, Racine EF, Ngugi GW, McAuley WJ. The effect of home-delivered Dietary Approach to Stop Hypertension (DASH) 
meals on the diets of older adults with cardiovascular disease. Am J Clin Nutr. 2010;91(5):1204-12. 
71. Svetkey LP, Erlinger TP, Vollmer WM, Feldstein A, Cooper LS, Appel LJ, et al. Effect of lifestyle modifications on blood 
pressure by race, sex, hypertension status, and age. J Hum Hypertens. 2005;19(1):21-31. 
72. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men 
and women 65 years of age or older. N Engl J Med. 1997;337(10):670-6. 
73. Richard C, Couture P, Desroches S, Lamarche B. Effect of the mediterranean diet with and without weight loss on markers of 
inflammation in men with metabolic syndrome. Obesity (Silver Spring, Md). 2013;21(1):51-7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
121 
7Chapter 7     |     Design NU-AGE dietary intervention study 
120 
59. Commission of the European Communities. Nutrient and energy intakes for the European Community. Luxembourg: 
European Food Safety Authority (EFSA), Scientific Committee for Food, 1993. 
60. Medicine Io. Dietary Reference Intakes. The essential guide to nutrient requirements. Otten J, Pitzi Hellwig, J. Meyers L, 
editors. Washington: The National Academies Press; 2006. 
61. Miller WR, Rollnick S. Motivational interviewing : preparing people for change. New York [etc.]: The Guilford Press; 2002. 
62. Health council of the Netherlands. Towards an adequate intake of vitamin D. The Hague: 2008. 
63. Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, Orav JE, Li R, Spiegelman D, et al. Dietary calcium and serum 25-
hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res. 2009;24(5):935-42. 
64. Richard C, Couture P, Desroches S, Charest A, Lamarche B. Effect of the Mediterranean diet with and without weight loss on 
cardiovascular risk factors in men with the metabolic syndrome. Nutrition, Metabolism and Cardiovascular Diseases. 
2011;21(9):628-35. 
65. Vincent-Baudry S, Defoort C, Gerber M, Bernard MC, Verger P, Helal O, et al. The Medi-RIVAGE study: reduction of 
cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. Am J Clin 
Nutr. 2005;82(5):964-71. 
66. Zazpe I, Sanchez-Tainta A, Estruch R, Lamuela-Raventos RM, Schroder H, Salas-Salvado J, et al. A large randomized 
individual and group intervention conducted by registered dietitians increased adherence to Mediterranean-type diets: the 
PREDIMED study. J Am Diet Assoc. 2008;108(7):1134-44; discussion 45. 
67. Babio N, Bullo M, Basora J, Martinez-Gonzalez MA, Fernandez-Ballart J, Marquez-Sandoval F, et al. Adherence to the 
Mediterranean diet and risk of metabolic syndrome and its components. Nutr Metab Cardiovasc Dis. 2009;19(8):563-70. 
68. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on 
metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol. 
2011;57(11):1299-313. 
69. Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ros E, Covas MI, Fiol M, et al. Cohort profile: design and methods of the 
PREDIMED study. Int J Epidemiol. 2012;41(2):377-85. 
70. Troyer JL, Racine EF, Ngugi GW, McAuley WJ. The effect of home-delivered Dietary Approach to Stop Hypertension (DASH) 
meals on the diets of older adults with cardiovascular disease. Am J Clin Nutr. 2010;91(5):1204-12. 
71. Svetkey LP, Erlinger TP, Vollmer WM, Feldstein A, Cooper LS, Appel LJ, et al. Effect of lifestyle modifications on blood 
pressure by race, sex, hypertension status, and age. J Hum Hypertens. 2005;19(1):21-31. 
72. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men 
and women 65 years of age or older. N Engl J Med. 1997;337(10):670-6. 
73. Richard C, Couture P, Desroches S, Lamarche B. Effect of the mediterranean diet with and without weight loss on markers of 
inflammation in men with metabolic syndrome. Obesity (Silver Spring, Md). 2013;21(1):51-7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
121 

Chapter 8
Changes in dietary intake and 
adherence to the NU-AGE diet 
after a one-year dietary intervention 
among European older adults
Agnes A.M. Berendsen, Edith J.M. Feskens, Ondine van de Rest, 
Aurelia Santoro, Rita Ostan, Barbara Pietruszka, 
Anna Brzozowska, Agnieszka Stelmaszczyk-Kusz, Amy Jennings, 
Rachel Gillings, Aedin Cassidy, Aurélie Caille, Elodie Caumon, 
Corinne Malpuech-Brugere, Claudio Franceschi, Lisette
C.P.G.M. de Groot
Submitted Frontiers in Physiology, section 
Integrative Physiology
Chapter 8     |     Changes in dietary intake after a one-year intervention in Dutch older adults 
124 
Abstract 
With the ageing population, it is important to find modifiable strategies that slow down the ageing 
process and its consequences. One proposed strategy to postpone the development of age-related 
chronic diseases is improving nutrition. We evaluated if Mediterranean-like diet could be effective to 
shift dietary intake of older adults towards a more healthful diet. Apparently healthy older adults 
aged 65-80 years, living in Italy, the UK, the Netherlands, Poland, and France were randomly assigned 
to an intervention group or control group. The intervention group followed one year of dietary 
intervention on a Mediterranean-like diet uniquely designed to target dietary recommendations for 
the ageing population (NU-AGE diet). The NU-AGE diet specified the consumption of 15 food groups 
and relative portions plus the use of a vitamin D supplement. During one year, participants in the 
intervention group received counselling and individually tailored dietary advice, food products (e.g., 
whole grain pasta, extra-virgin olive oil, margarine high in monounsaturated and polyunsaturated 
fatty acids, low fat cheese) and a vitamin D supplement. Participants in the control group only 
received a leaflet with general national dietary guidelines. At baseline and after one-year follow-up 
dietary intake was assessed by means of 7-day food records. In total, 1,296 participants were 
randomized and 1,141 participants completed the intervention (571 intervention, 570 control). After 
one-year follow-up, the intervention group improved mean intake of 13 out of 16 dietary 
recommendations of the NU-AGE diet (p<0.05) with the greatest magnitude of improvement 
observed for the consumption of wholegrains, (79%), legumes (70%) and nuts (49%) with a significant 
increase of the total NU-AGE index, compared to the control group (mean change in NU-AGE index 
21.3±15.9, p<0.01). In conclusion, the NU-AGE dietary intervention, based on dietary 
recommendations for older adults may be a feasible strategy to improve dietary intake in an ageing 
European population. 
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Introduction 
With the ageing population [1], it is important to find modifiable strategies that slow down the 
ageing process and its consequences in order to increase the number of years in good health in 
European elderly.  
The ageing process can be described as a chronic low-grade inflammatory process, which is 
referred to as inflammageing. Inflammageing impacts many organ systems and domains and plays a 
role in the onset of age-related chronic diseases [2-4]. One proposed strategy to postpone the 
development of age-related chronic diseases is improving nutrition. Evidence shows, that especially 
monounsaturated fatty acids, polyunsaturated fatty acids [5, 6], protein [7], vitamin D [8], vitamin 
B12 [9], folate [10], and anti-oxidants [11] can impact age-related health outcomes.  
At the same time, it is known that with increasing age, elderly people are at higher risk of low 
nutrient intakes [12]. At the food group level, diets of elderly are lacking in multiple food groups, 
such as fruit, vegetables, and fish [13]. On the other hand diets of elderly are exceeding the 
requirements for saturated fatty acids [13]. Manipulating dietary patterns can be a more powerful 
approach than changing single nutrients or foods, because these may have synergistic or antagonistic 
effects when consumed in combination [14, 15]. Many studies have shown that altering dietary 
patterns is more effective than altering single nutrients on reducing disease risk [16-21]. 
To bridge the gap between current dietary intakes and a healthful pattern in an ageing 
population, the NU-AGE study was started. The NU-AGE study aimed to improve health of the ageing 
population by means of a dietary intervention specifically targeting the dietary recommendations of 
older adults [22]. 
The aim of the current study was to evaluate if the NU-AGE dietary intervention is effective 
to shift the dietary intake of apparently healthy elderly subjects more towards the NU-AGE guidelines 
for a healthful diet. Additionally, we evaluated if adherence to the NU-AGE guidelines is comparable 
at five European sites involved within the NU-AGE study.  
 
 
Materials and methods 
 
Study design 
This study was performed using baseline and follow-up data of the NU-AGE dietary intervention 
study. The NU-AGE study is a one-year, randomized, parallel trial to investigate whether a newly 
designed, personally tailored diet, designed to target dietary recommendations of people over 65 
years of age can counteract or slow down the decline of function at the level of different organs and 
systems. The study was carried out in five European study centres (Bologna in Italy, Norwich in the 
UK, Wageningen in the Netherlands, Warsaw in Poland, and Clermont-Ferrand in France). 
Recruitment started in in April 2012 and finished in January 2014 including 1,296 apparently healthy 
European men and women aged 65-80 years. The rationale and design of this intervention study are 
described in detail elsewhere [22, 23]. In short, participants completed questionnaires about their 
health and lifestyle and a 7-day food record to obtain information about their dietary intake. Tests 
were conducted to measure a wide range of health outcomes. All questionnaires and measurements 
were repeated after one year. The study protocol was approved by local medical ethics committees 
at all study sites and the NU-AGE study is registered with clinicialtrials.gov since December 21st 2012, 
NCT01754012. 
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In the present study, we excluded those who had not completed both 7-day food records at baseline 
and follow-up (n=145), those with missing data on vitamin D supplement use (n=3), incomplete diet 
data (n=4) and those with an energy intake below 500 kcal (n=0) or exceeding 3500 kcal (n=3)[32], 
resulting in a total population for analysis of 1,141 participants (figure 1) of which 241 participants 
were from Italy, 252 from the UK, 241 from the Netherlands, 220 from Poland, and 187 from France.  
 
 
 
 
Figure 1. Flow chart of recruitment process NU-AGE participants 
 
 
Dietary intervention 
Participants randomized into the intervention group received monthly counselling from a trained 
dietician/research nutritionist and individually tailored dietary advice aiming to meet the NU-AGE 
Food Based Dietary Guidelines (FBDG’s) (table 1). To achieve changes in dietary intake by means of 
intrinsic motivation the dietary advice was based on the Motivational Interview technique [24] and 
the Stages of Changes model [25]. Dietary advice was provided nine times during one year, either 
face-to-face or by telephone [22] using standardized procedures. To sustain compliance to the NU-
AGE FBDG’s, participants in all five study centres received commercially available foods meeting the 
NU-AGE dietary guidelines, namely low-fat and low-salt cheese, wholegrain pasta, olive oil and 
margarine rich in monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA). Italy 
additionally provided vegetable soup to their participants. Additionally, participants received a 
vitamin D supplement, because it is not possible to achieve an adequate vitamin D intake from diet 
alone [26, 27]. Participants in the control group received a leaflet with national dietary guidelines 
that are generally available in Italy [28], the United Kingdom, the Netherlands [29], Poland [30] and 
France [31].  
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Table 1. Components and scoring of the NU-AGE diet index 
   Scoring 
Component Servings Minimum 
score (0) 
Range (1-10) Maximum 
score (10) 
Upper range 
(10-1) 
Wholemeal bread,  
wholegrain pasta 
and rice 
4-6 servings/day  
(140-210g/day) 
Rice/pasta 2x80 g/week 
(23g/day) 
max 1-163g 163-233 g 233-max 
Fruitsa 2 servings/day  
(240 gram) 
0g 0-240g ≥240  
Vegetables 300 gram/day 0g 0-300g ≥300g  
Legumes 200 gram/week 
(29g/day) 
0g 0-200g ≥200g  
Low-fat dairy 500 ml /day 0g 0-500g ≥500g  
Low-fat cheese 30 gram/day 0g 0-30g ≥30g  
Fish 2 times 125g/week 
(36g/day) 
0g 0-36g ≥36g  
Low-fat meat and 
poultry 
4 times 125g/week 
(71g/day) 
Max 0-71g 71-125 125-max 
Nutsb 2 times 20g/week 
(6g/day) 
0g 0-6g >6g  
Eggs 2-4/week  
(14-26g/day) 
0g 0-14g >14g  
Olive oil 20 gram/day 0ml 0-20ml ≥20ml  
Alcohol 2 for men 
1 for women 
>10g women 
>20g men 
 ≤10 women 
≤20 men 
 
Fluid 1.5 litre/day <1000ml 1000-
1500ml 
>1500ml  
Salt 5 grams/day  
(1200 mg sodium) 
≥85th 0-1500 mg 1500-2000mg 2000-85th 
Sweets Limited use ≥85th  0 0-85th 
Vitamin D Use supplement No  Yes  
a Fruit: maximum 1 glass of fresh fruit juices (120 ml) can be counted as one portion of fruit. 
b Nuts: includes salted and unsalted nuts 
 
 
Dietary assessment  
Dietary intake was estimated by means of 7-day food records completed by the participants. During a 
one hour interview with dieticians the food record was checked to obtain more detailed information 
about types of foods, preparation methods and recipes and to estimate portion sizes by using real-
life models and pictures. Consumed foods were coded according to standardized coding procedures 
and translated into nutrients by use of local food composition tables (NEVO 2011 in The Netherlands 
[33], WISP in The UK, INRAN and IEO in Italy, NFNI in Poland and CIQUAL French food composition 
table in France). Data on supplement use are obtained by means of a self-reported supplement 
questionnaire and checked by a trained dietician/research nutritionist. 
 
Other variables 
Data on smoking status (current, former), educational level (years), employment (defined as 1) 
employed, 2) retired, or 3) other, and medical history (prevalence of hypertension [yes/no], heart 
disease [yes/no], diabetes mellitus type II [yes/no], hypercholesterolemia [yes/no], neurological 
diseases [yes/no], osteoporosis [yes/no]) were obtained by means of questionnaires. Frailty status 
(non-frail/pre-frail) was assessed using the frailty criteria from Fried et al. [34]. Height was measured 
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with a stadiometer to the nearest 0.1 cm. Weight was measured to the nearest 0.1 kg with a 
calibrated scale while wearing light clothes. Body Mass Index (BMI) was calculated as weight/height2. 
All measures were taken by trained research assistants. 
 
NU-AGE index 
Food based dietary guidelines for the elderly population 
The NU-AGE index is meant to reflect adherence to guidance based on nutrient reference values and 
food based dietary guidelines for elderly from Italy [28], the UK [35], the Netherlands [26, 36-39], 
Poland [30], and France [40], on the modified MyPyramid for Older Adults [41, 42], and nutrient 
requirements from the European Community [43], and from the Institute of Medicine [44]. These 
recommendations were jointly integrated into NU-AGE food based dietary guidelines in order to 
inform participants on a food level on what they should consume (table 1). The NU-AGE index 
comprises recommendations of minimum amounts to consume for fruits, vegetables, legumes, low-
fat dairy, low-fat cheese, fish, low-fat meat and poultry, nuts, olive oil, fluids, and vitamin D (from a 
supplement). Two recommendations give a definition of minimum and maximum intake frequencies 
for whole grains and eggs and three recommendations refer to components to limit (alcohol, salt and 
sweets).  
 
Definition of food groups 
Specific NU-AGE food groups were created based on the underlying principles of the NU-AGE diet 
(e.g. low-fat, low-sodium, high MUFA and PUFA, high fibre), using country-specific food grouping 
systems as starting point (e.g. INRAN from Italy, WISP from the UK, NEVO from the Netherlands, 
DIETA-5 from Poland, and SUVIMAX from France). To reach consensus on the NU-AGE food groups, 
expert meetings with trained dieticians/research nutritionists from all five study centres were held. 
All individually consumed foods were grouped into NU-AGE food groups in each country, resulting in 
comparable food groups across countries.  
 
Choice of cut-offs and scoring 
A continuous scoring system was created to assign participants a score according to their level of 
adherence to each of the 16 NU-AGE components. This continuous scoring system allows us to better 
observe changes in dietary intake compared to a dichotomous scoring system [45]. Cut-off values for 
each NU-AGE component were based on the NU-AGE food based dietary guidelines. For the 
adequacy components (whole grains, fruits, vegetables, legumes, low-fat dairy, low-fat cheese, fish, 
low-fat meat and poultry, nuts, olive oil, fluids) a score ranging from 0 to 10 could be obtained for 
greater intakes of a specific food component. For moderation components (alcohol, sodium and 
sweets) participants with lower intakes received 10 points, ranging to 0 points for participants with 
greater intakes. For several components an maximum level of intake was established based on the 
country-specific population’s intake distribution (i.e., 85th pct. for sodium and sweets, 100th pct. for 
whole grains and low-fat meat). In total, the NU-AGE index ranged from 0 to 160 points, ranking 
participants according to their compliance to the NU-AGE diet. Components and their cut-off values 
are shown in table 1.  
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Statistical analyses 
Population characteristics are reported as mean and standard deviation (SD), or percentages 
(number). To compare nutrient intake changes from baseline to follow-up and differences in changes 
between intervention groups, a t-test was used, and the chi-squared test was used for vitamin D 
supplement use. The magnitude of differences in change in dietary intake was calculated as the 
percentage in change from baseline intake in the diet group. Two categories of adherence to the NU-
AGE guidelines at follow-up were established; the first if the intake fell below the NU-AGE guideline 
and the second if the intake was equal or greater than the guideline.  
All statistical analyses were carried out using SAS software version 9.2 (SAS Institute Inc., Cary, NC, 
USA). A two-sided p-value of <0.05 was considered significant.  
 
 
Results 
The mean age of NU-AGE participants was 71.0±4.0 years, with a BMI of 26.7±3.9, and 45% were 
men (table 2). History of hypertension was most frequently reported in both control and intervention 
group (39% and 42% respectively) and 18% of the control group were pre-frail compared to 24% in 
the intervention group. 
 
Table 2. Baseline characteristics of the NU-AGE participants by intervention group (n=1,141) 
 Control 
(n=570) 
Intervention 
(n=571) 
Men 262 (46.0) 248 (43.3) 
Age, years 71.1±3.9 70.7±4.0 
Current occupationa   
Employed 19 (3.4) 24 (4.2) 
Retired 540 (94.7) 541 (94.7) 
Other  11 (2.1) 6 (1.1) 
Education, years 12.6±3.6 12.7±3.6 
BMI, kg/m2 26.7±3.7  26.7±4.1  
Physical activity, pase score 135.1±57.4 132.5±54.9 
Multivitamin use, yes 67 (11.8) 86 (15.1) 
Nutrient intake   
Energy, Kcal 1899±448 1854±432 
Carbohydrates, en% 46.9±7.9 47.3±7.2 
Protein, en% 16.3 ± 2.4 16.5±2.8 
Fat, en% 34.3±5.4 34.1±5.5 
Current smokers 21 (7.9) 26 (9.7) 
Pre-frail 101 (17.8) 137 (24.0) 
Prevalence of diseases   
Hypertension 222 (39.0) 242 (42.4) 
Heart disease 97 ( 17.0) 94 ( 16.5) 
Diabetes Mellitus type II 26 ( 4.6) 29 ( 5.1) 
Hypercholesterolemia  142 (24.9) 154 (27.0) 
Neurological disease 12 ( 2.1) 17 (3.0) 
Osteoporosis 59 (10.4) 70 (12.3) 
Values are mean SD or number (percentage), en% = energy percent  
a Current occupation was defined as 1) employed (including part-time, 2) full-time and self-employed),  
3) retired (including fully retired and semi-retired), or 4) other (including disability pension and other) 
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with a stadiometer to the nearest 0.1 cm. Weight was measured to the nearest 0.1 kg with a 
calibrated scale while wearing light clothes. Body Mass Index (BMI) was calculated as weight/height2. 
All measures were taken by trained research assistants. 
 
NU-AGE index 
Food based dietary guidelines for the elderly population 
The NU-AGE index is meant to reflect adherence to guidance based on nutrient reference values and 
food based dietary guidelines for elderly from Italy [28], the UK [35], the Netherlands [26, 36-39], 
Poland [30], and France [40], on the modified MyPyramid for Older Adults [41, 42], and nutrient 
requirements from the European Community [43], and from the Institute of Medicine [44]. These 
recommendations were jointly integrated into NU-AGE food based dietary guidelines in order to 
inform participants on a food level on what they should consume (table 1). The NU-AGE index 
comprises recommendations of minimum amounts to consume for fruits, vegetables, legumes, low-
fat dairy, low-fat cheese, fish, low-fat meat and poultry, nuts, olive oil, fluids, and vitamin D (from a 
supplement). Two recommendations give a definition of minimum and maximum intake frequencies 
for whole grains and eggs and three recommendations refer to components to limit (alcohol, salt and 
sweets).  
 
Definition of food groups 
Specific NU-AGE food groups were created based on the underlying principles of the NU-AGE diet 
(e.g. low-fat, low-sodium, high MUFA and PUFA, high fibre), using country-specific food grouping 
systems as starting point (e.g. INRAN from Italy, WISP from the UK, NEVO from the Netherlands, 
DIETA-5 from Poland, and SUVIMAX from France). To reach consensus on the NU-AGE food groups, 
expert meetings with trained dieticians/research nutritionists from all five study centres were held. 
All individually consumed foods were grouped into NU-AGE food groups in each country, resulting in 
comparable food groups across countries.  
 
Choice of cut-offs and scoring 
A continuous scoring system was created to assign participants a score according to their level of 
adherence to each of the 16 NU-AGE components. This continuous scoring system allows us to better 
observe changes in dietary intake compared to a dichotomous scoring system [45]. Cut-off values for 
each NU-AGE component were based on the NU-AGE food based dietary guidelines. For the 
adequacy components (whole grains, fruits, vegetables, legumes, low-fat dairy, low-fat cheese, fish, 
low-fat meat and poultry, nuts, olive oil, fluids) a score ranging from 0 to 10 could be obtained for 
greater intakes of a specific food component. For moderation components (alcohol, sodium and 
sweets) participants with lower intakes received 10 points, ranging to 0 points for participants with 
greater intakes. For several components an maximum level of intake was established based on the 
country-specific population’s intake distribution (i.e., 85th pct. for sodium and sweets, 100th pct. for 
whole grains and low-fat meat). In total, the NU-AGE index ranged from 0 to 160 points, ranking 
participants according to their compliance to the NU-AGE diet. Components and their cut-off values 
are shown in table 1.  
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Statistical analyses 
Population characteristics are reported as mean and standard deviation (SD), or percentages 
(number). To compare nutrient intake changes from baseline to follow-up and differences in changes 
between intervention groups, a t-test was used, and the chi-squared test was used for vitamin D 
supplement use. The magnitude of differences in change in dietary intake was calculated as the 
percentage in change from baseline intake in the diet group. Two categories of adherence to the NU-
AGE guidelines at follow-up were established; the first if the intake fell below the NU-AGE guideline 
and the second if the intake was equal or greater than the guideline.  
All statistical analyses were carried out using SAS software version 9.2 (SAS Institute Inc., Cary, NC, 
USA). A two-sided p-value of <0.05 was considered significant.  
 
 
Results 
The mean age of NU-AGE participants was 71.0±4.0 years, with a BMI of 26.7±3.9, and 45% were 
men (table 2). History of hypertension was most frequently reported in both control and intervention 
group (39% and 42% respectively) and 18% of the control group were pre-frail compared to 24% in 
the intervention group. 
 
Table 2. Baseline characteristics of the NU-AGE participants by intervention group (n=1,141) 
 Control 
(n=570) 
Intervention 
(n=571) 
Men 262 (46.0) 248 (43.3) 
Age, years 71.1±3.9 70.7±4.0 
Current occupationa   
Employed 19 (3.4) 24 (4.2) 
Retired 540 (94.7) 541 (94.7) 
Other  11 (2.1) 6 (1.1) 
Education, years 12.6±3.6 12.7±3.6 
BMI, kg/m2 26.7±3.7  26.7±4.1  
Physical activity, pase score 135.1±57.4 132.5±54.9 
Multivitamin use, yes 67 (11.8) 86 (15.1) 
Nutrient intake   
Energy, Kcal 1899±448 1854±432 
Carbohydrates, en% 46.9±7.9 47.3±7.2 
Protein, en% 16.3 ± 2.4 16.5±2.8 
Fat, en% 34.3±5.4 34.1±5.5 
Current smokers 21 (7.9) 26 (9.7) 
Pre-frail 101 (17.8) 137 (24.0) 
Prevalence of diseases   
Hypertension 222 (39.0) 242 (42.4) 
Heart disease 97 ( 17.0) 94 ( 16.5) 
Diabetes Mellitus type II 26 ( 4.6) 29 ( 5.1) 
Hypercholesterolemia  142 (24.9) 154 (27.0) 
Neurological disease 12 ( 2.1) 17 (3.0) 
Osteoporosis 59 (10.4) 70 (12.3) 
Values are mean SD or number (percentage), en% = energy percent  
a Current occupation was defined as 1) employed (including part-time, 2) full-time and self-employed),  
3) retired (including fully retired and semi-retired), or 4) other (including disability pension and other) 
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Changes in dietary intake by intervention group 
Baseline mean dietary intake did not differ between the two treatment groups (e.g., NU-AGE index 
was 82.6±16.5 in both the control and intervention group (range 36-132), except for low-fat dairy 
(155±155g versus 173±163g, respectively, table 3).  
A significant increase in the NU-AGE diet score was found in the intervention group compared to the 
control group (mean change 21.3g (±15.9), p<0.01, (table 3). Dietary intake of thirteen out of sixteen 
NU-AGE guidelines improved in the intervention group compared to the control group (p <0.05), 
except for low-fat meat and poultry (p=0.53), eggs (p=0.16) and sodium (p=0.34). Major differences 
in changes expressed as percentages of dietary intake in the intervention group compared to the 
control group were observed for whole grains (79%), legumes (70%), nuts (49%), low-fat cheese 
(46%), fish (42%), low-fat dairy (30%), and olive oil (29%) (figure 2). 
 
Adherence to the NU-AGE guidelines by intervention group 
After one year intervention, the number of NU-AGE guidelines to which participants in the 
intervention group completely adhered to was 6.2±1.9 (range 1-12) compared to 4.5±1.7 out of 16 
guidelines in the control group. The highest percentage adherence in both control and intervention 
group was obtained for fluid (90% and 94%, respectively), followed by alcohol (77% and 81%, 
respectively) and eggs (54% and 67%, respectively) (figure 3). The largest differences in percentage 
adherence to the guidelines between the intervention and control group was observed for vitamin D 
(69%), fish (18%) and nuts (16%). For low-fat meat and poultry the intervention group had a lower 
adherence at follow-up compared to the control group, possible demonstrating an overall reduction 
in meat intake.  
 
Changes in dietary intake by country 
At baseline, the mean NU-AGE index of participants was 84.6±15.3 in Italy, 80.8±14.0 in the UK, 
74.5±15.6 in the Netherlands, 85.4±15.9 in Poland and 89.8±14.4 in France (data not shown). Within 
each country, baseline dietary intake for the control and intervention group were similar (table 4), 
whereas between countries baseline dietary intakes were different (e.g. wholegrains 30.8±42.9g in 
Italy vs. 74.2±61.1g in Poland, vegetables 165±83.9g in the Netherlands vs. 282±170g in Poland, low-
fat dairy 74.0±93.1g in Poland vs. 264±162g in the UK, olive oil 16.8±8.5g in Italy vs. 2.4±3.5g in the 
Netherlands). Overall, the NU-AGE diet score significantly improved in intervention diet group 
compared to the control group in all countries (p<0.01). Of all study centres, French participants in 
the intervention group changed 12 out of 16 NU-AGE guidelines, followed by the Netherlands (11 out 
of 16), Italy and Poland (8 out of 16), and the UK (6 out of 16).  
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Changes in dietary intake by intervention group 
Baseline mean dietary intake did not differ between the two treatment groups (e.g., NU-AGE index 
was 82.6±16.5 in both the control and intervention group (range 36-132), except for low-fat dairy 
(155±155g versus 173±163g, respectively, table 3).  
A significant increase in the NU-AGE diet score was found in the intervention group compared to the 
control group (mean change 21.3g (±15.9), p<0.01, (table 3). Dietary intake of thirteen out of sixteen 
NU-AGE guidelines improved in the intervention group compared to the control group (p <0.05), 
except for low-fat meat and poultry (p=0.53), eggs (p=0.16) and sodium (p=0.34). Major differences 
in changes expressed as percentages of dietary intake in the intervention group compared to the 
control group were observed for whole grains (79%), legumes (70%), nuts (49%), low-fat cheese 
(46%), fish (42%), low-fat dairy (30%), and olive oil (29%) (figure 2). 
 
Adherence to the NU-AGE guidelines by intervention group 
After one year intervention, the number of NU-AGE guidelines to which participants in the 
intervention group completely adhered to was 6.2±1.9 (range 1-12) compared to 4.5±1.7 out of 16 
guidelines in the control group. The highest percentage adherence in both control and intervention 
group was obtained for fluid (90% and 94%, respectively), followed by alcohol (77% and 81%, 
respectively) and eggs (54% and 67%, respectively) (figure 3). The largest differences in percentage 
adherence to the guidelines between the intervention and control group was observed for vitamin D 
(69%), fish (18%) and nuts (16%). For low-fat meat and poultry the intervention group had a lower 
adherence at follow-up compared to the control group, possible demonstrating an overall reduction 
in meat intake.  
 
Changes in dietary intake by country 
At baseline, the mean NU-AGE index of participants was 84.6±15.3 in Italy, 80.8±14.0 in the UK, 
74.5±15.6 in the Netherlands, 85.4±15.9 in Poland and 89.8±14.4 in France (data not shown). Within 
each country, baseline dietary intake for the control and intervention group were similar (table 4), 
whereas between countries baseline dietary intakes were different (e.g. wholegrains 30.8±42.9g in 
Italy vs. 74.2±61.1g in Poland, vegetables 165±83.9g in the Netherlands vs. 282±170g in Poland, low-
fat dairy 74.0±93.1g in Poland vs. 264±162g in the UK, olive oil 16.8±8.5g in Italy vs. 2.4±3.5g in the 
Netherlands). Overall, the NU-AGE diet score significantly improved in intervention diet group 
compared to the control group in all countries (p<0.01). Of all study centres, French participants in 
the intervention group changed 12 out of 16 NU-AGE guidelines, followed by the Netherlands (11 out 
of 16), Italy and Poland (8 out of 16), and the UK (6 out of 16).  
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Figure 2. Percentage of differences in change from baseline to follow-up in the intervention 
group compared to the control group 
Figure 3. Percentage of participants in the control and intervention group meeting the 
NU-AGE guidelines 
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Figure 2. Percentage of differences in change from baseline to follow-up in the intervention 
group compared to the control group 
Figure 3. Percentage of participants in the control and intervention group meeting the 
NU-AGE guidelines 
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Discussion  
The NU-AGE study is a one-year randomized dietary intervention with a healthful diet targeting the 
dietary recommendations of the ageing population versus a control diet to reduce inflammageing, 
optimise health and quality of life in European older adults. In the current study we demonstrated 
that following a one-year dietary intervention, comprising dietary counselling, provision of free foods 
and a vitamin D supplement, the dietary intake of an elderly European population shifts more 
towards the NU-AGE guidelines for a healthful diet.  
Changes in in dietary intake in elderly populations has been reported in previous studies. For 
example, a dietary intervention study of a personalized nutrition program consisting of home visits, 
phone calls and newsletters observed that after 6 months of intervention in participants aged 70 
years and above, their fruit, vegetables and dairy intake improved [46]. A one-year trial 
demonstrated favourable changes in dietary intakes for olive oil, nuts, vegetables, legumes, fruits, 
meat and pastries, cakes and sweets in persons aged 55 to 80 years of age [47].  
However, none of these studies investigated a dietary pattern that was specifically 
developed to target the dietary recommendations for the ageing population. To date, dietary 
recommendations for the elderly population to improve healthy ageing at a global level are lacking. 
Our study, investigating a diet that was specifically designed at targeting the dietary 
recommendations of elderly people could fill this knowledge gap. Besides incorporating the dietary 
recommendations, also nutrients related to various ageing related health outcomes and nutrients 
involved in inflammageing have been taken into account when designing the NU-AGE diet, including 
monounsaturated fatty acids, polyunsaturated fatty acids, olive oil or oily fish (inflammatory 
processes [5] and inflammatory bowel diseases [48]), protein (sarcopenia [7]), vitamin D (falling [8]), 
vitamin B12 (cognitive impairment [9]), vitamin C and fruit (CRP [11]), and whole grains (type 2 
diabetes [49], cardiovascular disease [50], BMI [51], and blood lipids [52]). Thus, a solid basis of 
evidence was used to develop the NU-AGE diet for healthier ageing. 
The NU-AGE diet seems to be feasible to implement in the increasingly ageing population. As 
demonstrated in the present study, following one year of intervention, participants in the 
intervention group had a 21 point higher NU-AGE diet score compared to the control group. 
Compared to a trial studying the Mediterranean diet in which 2 points (out of a 14) change has been 
achieved resulting in a reduction of cardiovascular risk factors, e.g., decreased blood pressure, blood 
glucose levels, and cholesterol-HDL cholesterol ratio and increased HDL cholesterol levels [18], the 
effects of the changes in dietary intake within the NU-AGE dietary intervention seem promising to 
improve health at a European level.  
An important strength of the dietary intervention is the approach to change the entire 
dietary pattern, rather than single foods or nutrients. Changing an entire dietary pattern has been 
shown to be the preferred method as it is easier to change a dietary pattern rather than focussing on 
specific nutrients [53]. Moreover, we were able to achieve changes in dietary intake by making use of 
dietary counselling, the provision of free foods and a vitamin D supplement only. It has been 
demonstrated by a review that the provision of free foods is effective to improve adherence [54]. 
The use of Motivational Interviewing [24] in the dietary counselling could be the key of success in this 
intervention. A systematic review and meta-analysis has demonstrated that interventions 
incorporating behaviour change techniques are effective ingredients of interventions to change 
dietary intakes [55]. The provision of free foods and a vitamin D supplement were also used to 
improve compliance. It has been shown that free provision of foods is effective in improving dietary 
habits [56, 57]. Thus, with relatively less effort, without making use of a controlled feeding trial, the 
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NU-AGE intervention seemed to be successful in making older adults change their dietary habits - 
even after only one year of follow-up. Additionally, the construction of the NU-AGE diet index is 
another strength of this study, as this enables us to rank participants according to their adherence to 
the NU-AGE diet. This approach will allow us to study the effects of the changes in dietary intake on 
health outcomes using an intention to treat analysis (efficacy), but also by using a per protocol 
analysis (efficiency). Furthermore, to make sure that all outcome measurements were conducted in 
the same standardized way across the five study centres, all questionnaires, procedures and tests 
were practiced and discussed during training sessions prior to the start of the intervention period. At 
last, the use of standardized and harmonized food based dietary guidelines across five study centres 
in Europe enabled us to provide a comparable dietary advice and to implement the same dietary 
principles at a large scale.  
Our study has limitations. Firstly, the use of country specific food composition databases and 
nutrient calculation systems could have resulted in differences in intake between the countries 
caused by a different food composition database rather than a real-life difference in intake. We have 
improved the comparability in calculations by organizing training sessions in which all research 
dieticians of each research centre participated. Secondly, we had losses to follow-up - primarily pre-
frail participants in the control group - likely because participants did not receive food incentives and 
their frailty status could have limited their ability to comply to the intervention. Finally, participants 
were apparently healthy, well-educated, which limits the generalizability of our findings to the 
general elderly population.  
 
Our results show that the NU-AGE diet, based on dietary recommendations of older adults, is feasible 
to achieve favourable changes in dietary intake in an elderly population. Evidence on the effects from 
this diet on health outcomes will contribute to the development of European-wide dietary guidelines 
for healthier ageing across Europe. 
 
 
Acknowledgments 
This project is supported by the European Union’s Seventh Framework Program under grant 
agreement no. 266486 (‘NU-AGE: new dietary strategies addressing the specific needs of the elderly 
population for healthy ageing in Europe’). Participants, staff and investigators of NU-AGE are 
gratefully acknowledged. FrieslandCampina, Unilever, Lesieur, COOP, MCO Health are acknowledged 
for the provision of low-fat low-salt cheese, margarine, olive oil, whole grain pasta and vitamin D 
supplement, respectively.  
 
 
 
 
 
 
 
 
 
8Chapter 8     |     Changes in dietary intake after a one-year intervention in Dutch older adults 
134 
Discussion  
The NU-AGE study is a one-year randomized dietary intervention with a healthful diet targeting the 
dietary recommendations of the ageing population versus a control diet to reduce inflammageing, 
optimise health and quality of life in European older adults. In the current study we demonstrated 
that following a one-year dietary intervention, comprising dietary counselling, provision of free foods 
and a vitamin D supplement, the dietary intake of an elderly European population shifts more 
towards the NU-AGE guidelines for a healthful diet.  
Changes in in dietary intake in elderly populations has been reported in previous studies. For 
example, a dietary intervention study of a personalized nutrition program consisting of home visits, 
phone calls and newsletters observed that after 6 months of intervention in participants aged 70 
years and above, their fruit, vegetables and dairy intake improved [46]. A one-year trial 
demonstrated favourable changes in dietary intakes for olive oil, nuts, vegetables, legumes, fruits, 
meat and pastries, cakes and sweets in persons aged 55 to 80 years of age [47].  
However, none of these studies investigated a dietary pattern that was specifically 
developed to target the dietary recommendations for the ageing population. To date, dietary 
recommendations for the elderly population to improve healthy ageing at a global level are lacking. 
Our study, investigating a diet that was specifically designed at targeting the dietary 
recommendations of elderly people could fill this knowledge gap. Besides incorporating the dietary 
recommendations, also nutrients related to various ageing related health outcomes and nutrients 
involved in inflammageing have been taken into account when designing the NU-AGE diet, including 
monounsaturated fatty acids, polyunsaturated fatty acids, olive oil or oily fish (inflammatory 
processes [5] and inflammatory bowel diseases [48]), protein (sarcopenia [7]), vitamin D (falling [8]), 
vitamin B12 (cognitive impairment [9]), vitamin C and fruit (CRP [11]), and whole grains (type 2 
diabetes [49], cardiovascular disease [50], BMI [51], and blood lipids [52]). Thus, a solid basis of 
evidence was used to develop the NU-AGE diet for healthier ageing. 
The NU-AGE diet seems to be feasible to implement in the increasingly ageing population. As 
demonstrated in the present study, following one year of intervention, participants in the 
intervention group had a 21 point higher NU-AGE diet score compared to the control group. 
Compared to a trial studying the Mediterranean diet in which 2 points (out of a 14) change has been 
achieved resulting in a reduction of cardiovascular risk factors, e.g., decreased blood pressure, blood 
glucose levels, and cholesterol-HDL cholesterol ratio and increased HDL cholesterol levels [18], the 
effects of the changes in dietary intake within the NU-AGE dietary intervention seem promising to 
improve health at a European level.  
An important strength of the dietary intervention is the approach to change the entire 
dietary pattern, rather than single foods or nutrients. Changing an entire dietary pattern has been 
shown to be the preferred method as it is easier to change a dietary pattern rather than focussing on 
specific nutrients [53]. Moreover, we were able to achieve changes in dietary intake by making use of 
dietary counselling, the provision of free foods and a vitamin D supplement only. It has been 
demonstrated by a review that the provision of free foods is effective to improve adherence [54]. 
The use of Motivational Interviewing [24] in the dietary counselling could be the key of success in this 
intervention. A systematic review and meta-analysis has demonstrated that interventions 
incorporating behaviour change techniques are effective ingredients of interventions to change 
dietary intakes [55]. The provision of free foods and a vitamin D supplement were also used to 
improve compliance. It has been shown that free provision of foods is effective in improving dietary 
habits [56, 57]. Thus, with relatively less effort, without making use of a controlled feeding trial, the 
 
135 
NU-AGE intervention seemed to be successful in making older adults change their dietary habits - 
even after only one year of follow-up. Additionally, the construction of the NU-AGE diet index is 
another strength of this study, as this enables us to rank participants according to their adherence to 
the NU-AGE diet. This approach will allow us to study the effects of the changes in dietary intake on 
health outcomes using an intention to treat analysis (efficacy), but also by using a per protocol 
analysis (efficiency). Furthermore, to make sure that all outcome measurements were conducted in 
the same standardized way across the five study centres, all questionnaires, procedures and tests 
were practiced and discussed during training sessions prior to the start of the intervention period. At 
last, the use of standardized and harmonized food based dietary guidelines across five study centres 
in Europe enabled us to provide a comparable dietary advice and to implement the same dietary 
principles at a large scale.  
Our study has limitations. Firstly, the use of country specific food composition databases and 
nutrient calculation systems could have resulted in differences in intake between the countries 
caused by a different food composition database rather than a real-life difference in intake. We have 
improved the comparability in calculations by organizing training sessions in which all research 
dieticians of each research centre participated. Secondly, we had losses to follow-up - primarily pre-
frail participants in the control group - likely because participants did not receive food incentives and 
their frailty status could have limited their ability to comply to the intervention. Finally, participants 
were apparently healthy, well-educated, which limits the generalizability of our findings to the 
general elderly population.  
 
Our results show that the NU-AGE diet, based on dietary recommendations of older adults, is feasible 
to achieve favourable changes in dietary intake in an elderly population. Evidence on the effects from 
this diet on health outcomes will contribute to the development of European-wide dietary guidelines 
for healthier ageing across Europe. 
 
 
Acknowledgments 
This project is supported by the European Union’s Seventh Framework Program under grant 
agreement no. 266486 (‘NU-AGE: new dietary strategies addressing the specific needs of the elderly 
population for healthy ageing in Europe’). Participants, staff and investigators of NU-AGE are 
gratefully acknowledged. FrieslandCampina, Unilever, Lesieur, COOP, MCO Health are acknowledged 
for the provision of low-fat low-salt cheese, margarine, olive oil, whole grain pasta and vitamin D 
supplement, respectively.  
 
 
 
 
 
 
 
 
 
Chapter 8     |     Changes in dietary intake after a one-year intervention in Dutch older adults 
136 
References 
1. Eurostat. EUROPOP2010 - Convergence scenario, national level - Assumptions [Internet]. 2011 [updated 06-03-2012; 
cited 2013 25-09-2013]. Population projections]. Available from: 
http://epp.eurostat.ec.europa.eu/portal/page/portal/population/data/database. 
2. Cevenini E, Monti D, Franceschi C. Inflamm-ageing. Curr Opin Clin Nutr Metab Care. 2013;16(1):14-20. 
3. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging: An Evolutionary Perspective 
on Immunosenescence. Annals of the New York Academy of Sciences. 2000;908(1):244-54. 
4. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic 
perspective on aging and longevity emerged from studies in humans. Mechanisms of ageing and development. 
2007;128(1):92-105. 
5. Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LC, Geleijnse JM, et al. Fish-oil supplementation 
induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr. 2009;90(2):415-
24. 
6. Kraguljac NV, Montori VM, Pavuluri M, Chai HS, Wilson BS, Unal SS. Efficacy of omega-3 fatty acids in mood disorders - a 
systematic review and metaanalysis. Psychopharmacology bulletin. 2009;42(3):39-54. 
7. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin 
Nutr Metab Care. 2009;12(1):86-90. 
8. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with 
supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. 
9. Hin H, Clarke R, Sherliker P, Atoyebi W, Emmens K, Birks J, et al. Clinical relevance of low serum vitamin B12 
concentrations in older people: the Banbury B12 study. Age Ageing. 2006;35(4):416-22. 
10. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with 
stroke: a randomized controlled trial. JAMA. 2005;293(9):1082-8. 
11. Wannamethee SG, Lowe GD, Rumley A, Bruckdorfer KR, Whincup PH. Associations of vitamin C status, fruit and 
vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr. 2006;83(3):567-74; quiz 726-7. 
12. Vinas BR, Barba LR, Ngo J, Gurinovic M, Novakovic R, Cavelaars A, et al. Projected prevalence of inadequate nutrient 
intakes in Europe. Annals of nutrition & metabolism. 2011;59(2-4):84-95. 
13. Ocke MC B-RE, de Boer EJ, Wilson-van den Hooven C, Etemad-Ghameslou Z, Drijvers JJMM, van Rossum CTM. Diet of 
community-dwelling older adults: Dutch National Food Consumption Survey Older adults 2010-2012. RIVM, 2013  
Contract No.: 050413001. 
14. Jacobs DR, Jr., Steffen LM. Nutrients, foods, and dietary patterns as exposures in research: a framework for food 
synergy. Am J Clin Nutr. 2003;78(3 Suppl):508S-13S. 
15. Jacques PF, Tucker KL. Are dietary patterns useful for understanding the role of diet in chronic disease? Am J Clin Nutr. 
2001;73(1):1-2. 
16. Alles B, Samieri C, Feart C, Jutand MA, Laurin D, Barberger-Gateau P. Dietary patterns: a novel approach to examine the 
link between nutrition and cognitive function in older individuals. Nutr Res Rev. 2012:207-22. 
17. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in 
secondary prevention of coronary heart disease. Lancet. 1994;343(8911):1454-9. 
18. Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI, et al. Effects of a 
Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145(1):1-11. 
19. McNaughton SA, Bates CJ, Mishra GD. Diet quality is associated with all-cause mortality in adults aged 65 years and 
older. J Nutr. 2012;142(2):320-5. 
20. Panunzio MF, Caporizzi R, Antoniciello A, Cela EP, Ferguson LR, D'Ambrosio P. Randomized, controlled nutrition 
education trial promotes a Mediterranean diet and improves anthropometric, dietary, and metabolic parameters in 
adults. Ann Ig. 2011;23(1):13-25. 
21. Trichopoulou A, Orfanos P, Norat T, Bueno-de-Mesquita B, Ocke MC, Peeters PH, et al. Modified Mediterranean diet 
and survival: EPIC-elderly prospective cohort study. BMJ. 2005;330(7498):991. 
22. Berendsen A, Santoro A, Pini E, Cevenini E, Ostan R, Pietruszka B, et al. Reprint of: A parallel randomized trial on the 
effect of a healthful diet on inflammageing and its consequences in European elderly people: design of the NU-AGE 
dietary intervention study. Mechanisms of ageing and development. 2014;136-137:14-21. 
23. Santoro A, Pini E, Scurti M, Palmas G, Berendsen A, Brzozowska A, et al. Combating inflammaging through a 
Mediterranean whole diet approach: The NU-AGE project's conceptual framework and design. Mechanisms of ageing 
and development. 2014;136-137:3-13. 
24. Miller WR, Rollnick S. Motivational interviewing : preparing people for change. New York [etc.]: The Guilford Press; 
2002. 
25. Prochaska JO, DiClemente CC. Transtheoretical therapy: Toward a more integrative model of change. . Psychotherapy: 
Theory, Research & Practice. 1982;19(3):276-88. 
26. Health council of the Netherlands. Dietary reference intakes: calcium, vitamin D, thiamin, riboflavin, niacin, pantothenic 
acid, and biotin. The Hague: 2000. 
27. Health council of the Netherlands. Towards an adequate intake of vitamin D. The Hague: 2008. 
28. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione 
2003 [cited 2012 03-08-2011]. Italian Dietary Guidelines]. Available from: http://www.inran.it/. 
137 
29. Health council of the Netherlands. Guidelines for a healthy diet 2006. The Hague: 2006.
30. Jarosz M, Bulhak-Jachymczyk B. Normy zywienia czlowieka. Podstawy prewencji otylosci i chorob niezakaznych / 
Nutrition recommendations. Basis for the prevention of obesity and non-communicable dieseases. Warsaw:
Wydawnictwo Lekarskie PZWL / National Food and Nutrition Institute 2008.
31. Ministère du Travail dlEedlS. French National Nutrition and Health Program 2011-2015 2011. Available from:
http://www.sante.gouv.fr/IMG/pdf/French_National_Nutrition_and_Health_Program_2011-2015.pdf. 
32. Rhee JJ, Sampson L, Cho E, Hughes MD, Hu FB, Willett WC. Comparison of methods to account for implausible reporting 
of energy intake in epidemiologic studies. Am J Epidemiol. 2015;181(4):225-33. 
33. RIVM/Voedingscentrum. NEVO-tabel; Nederlands Voedingsstoffenbestand 2011. Den Haag2011. 
34. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a
phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-56. 
35. Department of Health. Report on Health & Social Subjects 41 Dietary reference values for food energy and nutrients for
the United Kingdom. London: 1991. 
36. Food and Nutrition Council. Nederlandse normen 1989 / Dutch dietary reference values 1989. The Hague: 1992.
37. Health council of the Netherlands. Dietary Reference Intakes: energy, proteins, fats and digestible carbohydrates. The 
Hague 2001
38. Health council of the Netherlands. Dietary Reference Intakes: vitamin B6, folic acid, and vitamin B12. The Hague: 2003.
39. Health council of the Netherlands. Guideline for dietary fiber intake. The Hague: 2006.
40. AFSSA, CNERNA-CNRS. Apports Nutritionnels conseillés pour la population française. 3 ed. Martin A, editor. Paris: Tec et
Doc Lavoisier; 2001. 608 p. 
41. Peregrin T. Getting to Know the Modified MyPyramid for Older Adults. Journal of the American Dietetic Association. 
2008;108(6):937-8. 
42. Shelnutt KP, Bobroff LB, Diehl DC. MyPyramid for Older Adults. Journal of Nutrition Education and Behavior.41(4):300-2. 
43. Commission of the European Communities. Nutrient and energy intakes for the European Community. Luxembourg:
European Food Safety Authority (EFSA), Scientific Committee for Food, 1993.
44. Institute of Medicine. Dietary Reference Intakes. The essential guide to nutrient requirements. Otten J, Pitzi Hellwig, J. 
Meyers L, editors. Washington: The National Academies Press; 2006.
45. van Lee L, Geelen A, van Huysduynen EJ, de Vries JH, van't Veer P, Feskens EJ. The Dutch Healthy Diet index (DHD-
index): an instrument to measure adherence to the Dutch Guidelines for a Healthy Diet. Nutrition journal. 2012;11:49.
46. Bernstein A, Nelson ME, Tucker KL, Layne J, Johnson E, Nuernberger A, et al. A home-based nutrition intervention to
increase consumption of fruits, vegetables, and calcium-rich foods in community dwelling elders. J Am Diet Assoc. 
2002;102(10):1421-7. 
47. Zazpe I, Sanchez-Tainta A, Estruch R, Lamuela-Raventos RM, Schroder H, Salas-Salvado J, et al. A large randomized
individual and group intervention conducted by registered dietitians increased adherence to Mediterranean-type diets:
the PREDIMED study. J Am Diet Assoc. 2008;108(7):1134-44. 
48. Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Molecular Nutrition
and Food Research. 2008;52(8):885-97. 
49. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2
diabetes: a prospective cohort study and systematic review. PLoS Med. 2007;4(8):e261.
50. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab
Cardiovasc Dis. 2008;18(4):283-90. 
51. Gaesser GA. Carbohydrate quantity and quality in relation to body mass index. J Am Diet Assoc. 2007;107(10):1768-80. 
52. Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X. Meta-analysis of the effects of flaxseed interventions on blood
lipids. Am J Clin Nutr. 2009;90(2):288-97. 
53. Maillot M, Issa C, Vieux F, Lairon D, Darmon N. The shortest way to reach nutritional goals is to adopt Mediterranean
food choices: evidence from computer-generated personalized diets. Am J Clin Nutr. 2011;94(4):1127-37. 
54. Wibisono C, Probst Y, Neale E, Tapsell L. Impact of food supplementation on weight loss in randomised-controlled
dietary intervention trials: a systematic review and meta-analysis. Br J Nutr. 2016;115(8):1406-14. 
55. Lara J, Evans EH, O'Brien N, Moynihan PJ, Meyer TD, Adamson AJ, et al. Association of behaviour change techniques
with effectiveness of dietary interventions among adults of retirement age: a systematic review and meta-analysis of
randomised controlled trials. BMC Med. 2014;12(177). 
56. Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ros E, Covas MI, Fiol M, et al. Cohort profile: design and methods of
the PREDIMED study. Int J Epidemiol. 2010;41(2):377-85. 
57. Troyer JL, Racine EF, Ngugi GW, McAuley WJ. The effect of home-delivered Dietary Approach to Stop Hypertension
(DASH) meals on the diets of older adults with cardiovascular disease. Am J Clin Nutr. 2010;91(5):1204-12. 
8Chapter 8     |     Changes in dietary intake after a one-year intervention in Dutch older adults 
136 
References 
1. Eurostat. EUROPOP2010 - Convergence scenario, national level - Assumptions [Internet]. 2011 [updated 06-03-2012; 
cited 2013 25-09-2013]. Population projections]. Available from: 
http://epp.eurostat.ec.europa.eu/portal/page/portal/population/data/database. 
2. Cevenini E, Monti D, Franceschi C. Inflamm-ageing. Curr Opin Clin Nutr Metab Care. 2013;16(1):14-20. 
3. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging: An Evolutionary Perspective 
on Immunosenescence. Annals of the New York Academy of Sciences. 2000;908(1):244-54. 
4. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic 
perspective on aging and longevity emerged from studies in humans. Mechanisms of ageing and development. 
2007;128(1):92-105. 
5. Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LC, Geleijnse JM, et al. Fish-oil supplementation 
induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am J Clin Nutr. 2009;90(2):415-
24. 
6. Kraguljac NV, Montori VM, Pavuluri M, Chai HS, Wilson BS, Unal SS. Efficacy of omega-3 fatty acids in mood disorders - a 
systematic review and metaanalysis. Psychopharmacology bulletin. 2009;42(3):39-54. 
7. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin 
Nutr Metab Care. 2009;12(1):86-90. 
8. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with 
supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. 
9. Hin H, Clarke R, Sherliker P, Atoyebi W, Emmens K, Birks J, et al. Clinical relevance of low serum vitamin B12 
concentrations in older people: the Banbury B12 study. Age Ageing. 2006;35(4):416-22. 
10. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with 
stroke: a randomized controlled trial. JAMA. 2005;293(9):1082-8. 
11. Wannamethee SG, Lowe GD, Rumley A, Bruckdorfer KR, Whincup PH. Associations of vitamin C status, fruit and 
vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr. 2006;83(3):567-74; quiz 726-7. 
12. Vinas BR, Barba LR, Ngo J, Gurinovic M, Novakovic R, Cavelaars A, et al. Projected prevalence of inadequate nutrient 
intakes in Europe. Annals of nutrition & metabolism. 2011;59(2-4):84-95. 
13. Ocke MC B-RE, de Boer EJ, Wilson-van den Hooven C, Etemad-Ghameslou Z, Drijvers JJMM, van Rossum CTM. Diet of 
community-dwelling older adults: Dutch National Food Consumption Survey Older adults 2010-2012. RIVM, 2013  
Contract No.: 050413001. 
14. Jacobs DR, Jr., Steffen LM. Nutrients, foods, and dietary patterns as exposures in research: a framework for food 
synergy. Am J Clin Nutr. 2003;78(3 Suppl):508S-13S. 
15. Jacques PF, Tucker KL. Are dietary patterns useful for understanding the role of diet in chronic disease? Am J Clin Nutr. 
2001;73(1):1-2. 
16. Alles B, Samieri C, Feart C, Jutand MA, Laurin D, Barberger-Gateau P. Dietary patterns: a novel approach to examine the 
link between nutrition and cognitive function in older individuals. Nutr Res Rev. 2012:207-22. 
17. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in 
secondary prevention of coronary heart disease. Lancet. 1994;343(8911):1454-9. 
18. Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI, et al. Effects of a 
Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145(1):1-11. 
19. McNaughton SA, Bates CJ, Mishra GD. Diet quality is associated with all-cause mortality in adults aged 65 years and 
older. J Nutr. 2012;142(2):320-5. 
20. Panunzio MF, Caporizzi R, Antoniciello A, Cela EP, Ferguson LR, D'Ambrosio P. Randomized, controlled nutrition 
education trial promotes a Mediterranean diet and improves anthropometric, dietary, and metabolic parameters in 
adults. Ann Ig. 2011;23(1):13-25. 
21. Trichopoulou A, Orfanos P, Norat T, Bueno-de-Mesquita B, Ocke MC, Peeters PH, et al. Modified Mediterranean diet 
and survival: EPIC-elderly prospective cohort study. BMJ. 2005;330(7498):991. 
22. Berendsen A, Santoro A, Pini E, Cevenini E, Ostan R, Pietruszka B, et al. Reprint of: A parallel randomized trial on the 
effect of a healthful diet on inflammageing and its consequences in European elderly people: design of the NU-AGE 
dietary intervention study. Mechanisms of ageing and development. 2014;136-137:14-21. 
23. Santoro A, Pini E, Scurti M, Palmas G, Berendsen A, Brzozowska A, et al. Combating inflammaging through a 
Mediterranean whole diet approach: The NU-AGE project's conceptual framework and design. Mechanisms of ageing 
and development. 2014;136-137:3-13. 
24. Miller WR, Rollnick S. Motivational interviewing : preparing people for change. New York [etc.]: The Guilford Press; 
2002. 
25. Prochaska JO, DiClemente CC. Transtheoretical therapy: Toward a more integrative model of change. . Psychotherapy: 
Theory, Research & Practice. 1982;19(3):276-88. 
26. Health council of the Netherlands. Dietary reference intakes: calcium, vitamin D, thiamin, riboflavin, niacin, pantothenic 
acid, and biotin. The Hague: 2000. 
27. Health council of the Netherlands. Towards an adequate intake of vitamin D. The Hague: 2008. 
28. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione 
2003 [cited 2012 03-08-2011]. Italian Dietary Guidelines]. Available from: http://www.inran.it/. 
137 
29. Health council of the Netherlands. Guidelines for a healthy diet 2006. The Hague: 2006.
30. Jarosz M, Bulhak-Jachymczyk B. Normy zywienia czlowieka. Podstawy prewencji otylosci i chorob niezakaznych / 
Nutrition recommendations. Basis for the prevention of obesity and non-communicable dieseases. Warsaw:
Wydawnictwo Lekarskie PZWL / National Food and Nutrition Institute 2008.
31. Ministère du Travail dlEedlS. French National Nutrition and Health Program 2011-2015 2011. Available from:
http://www.sante.gouv.fr/IMG/pdf/French_National_Nutrition_and_Health_Program_2011-2015.pdf. 
32. Rhee JJ, Sampson L, Cho E, Hughes MD, Hu FB, Willett WC. Comparison of methods to account for implausible reporting 
of energy intake in epidemiologic studies. Am J Epidemiol. 2015;181(4):225-33. 
33. RIVM/Voedingscentrum. NEVO-tabel; Nederlands Voedingsstoffenbestand 2011. Den Haag2011. 
34. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a
phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-56. 
35. Department of Health. Report on Health & Social Subjects 41 Dietary reference values for food energy and nutrients for
the United Kingdom. London: 1991. 
36. Food and Nutrition Council. Nederlandse normen 1989 / Dutch dietary reference values 1989. The Hague: 1992.
37. Health council of the Netherlands. Dietary Reference Intakes: energy, proteins, fats and digestible carbohydrates. The 
Hague 2001
38. Health council of the Netherlands. Dietary Reference Intakes: vitamin B6, folic acid, and vitamin B12. The Hague: 2003.
39. Health council of the Netherlands. Guideline for dietary fiber intake. The Hague: 2006.
40. AFSSA, CNERNA-CNRS. Apports Nutritionnels conseillés pour la population française. 3 ed. Martin A, editor. Paris: Tec et
Doc Lavoisier; 2001. 608 p. 
41. Peregrin T. Getting to Know the Modified MyPyramid for Older Adults. Journal of the American Dietetic Association. 
2008;108(6):937-8. 
42. Shelnutt KP, Bobroff LB, Diehl DC. MyPyramid for Older Adults. Journal of Nutrition Education and Behavior.41(4):300-2. 
43. Commission of the European Communities. Nutrient and energy intakes for the European Community. Luxembourg:
European Food Safety Authority (EFSA), Scientific Committee for Food, 1993.
44. Institute of Medicine. Dietary Reference Intakes. The essential guide to nutrient requirements. Otten J, Pitzi Hellwig, J. 
Meyers L, editors. Washington: The National Academies Press; 2006.
45. van Lee L, Geelen A, van Huysduynen EJ, de Vries JH, van't Veer P, Feskens EJ. The Dutch Healthy Diet index (DHD-
index): an instrument to measure adherence to the Dutch Guidelines for a Healthy Diet. Nutrition journal. 2012;11:49.
46. Bernstein A, Nelson ME, Tucker KL, Layne J, Johnson E, Nuernberger A, et al. A home-based nutrition intervention to
increase consumption of fruits, vegetables, and calcium-rich foods in community dwelling elders. J Am Diet Assoc. 
2002;102(10):1421-7. 
47. Zazpe I, Sanchez-Tainta A, Estruch R, Lamuela-Raventos RM, Schroder H, Salas-Salvado J, et al. A large randomized
individual and group intervention conducted by registered dietitians increased adherence to Mediterranean-type diets:
the PREDIMED study. J Am Diet Assoc. 2008;108(7):1134-44. 
48. Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Molecular Nutrition
and Food Research. 2008;52(8):885-97. 
49. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2
diabetes: a prospective cohort study and systematic review. PLoS Med. 2007;4(8):e261.
50. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab
Cardiovasc Dis. 2008;18(4):283-90. 
51. Gaesser GA. Carbohydrate quantity and quality in relation to body mass index. J Am Diet Assoc. 2007;107(10):1768-80. 
52. Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X. Meta-analysis of the effects of flaxseed interventions on blood
lipids. Am J Clin Nutr. 2009;90(2):288-97. 
53. Maillot M, Issa C, Vieux F, Lairon D, Darmon N. The shortest way to reach nutritional goals is to adopt Mediterranean
food choices: evidence from computer-generated personalized diets. Am J Clin Nutr. 2011;94(4):1127-37. 
54. Wibisono C, Probst Y, Neale E, Tapsell L. Impact of food supplementation on weight loss in randomised-controlled
dietary intervention trials: a systematic review and meta-analysis. Br J Nutr. 2016;115(8):1406-14. 
55. Lara J, Evans EH, O'Brien N, Moynihan PJ, Meyer TD, Adamson AJ, et al. Association of behaviour change techniques
with effectiveness of dietary interventions among adults of retirement age: a systematic review and meta-analysis of
randomised controlled trials. BMC Med. 2014;12(177). 
56. Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ros E, Covas MI, Fiol M, et al. Cohort profile: design and methods of
the PREDIMED study. Int J Epidemiol. 2010;41(2):377-85. 
57. Troyer JL, Racine EF, Ngugi GW, McAuley WJ. The effect of home-delivered Dietary Approach to Stop Hypertension
(DASH) meals on the diets of older adults with cardiovascular disease. Am J Clin Nutr. 2010;91(5):1204-12. 

Chapter 9
Effect of the NU-AGE dietary 
intervention on cognitive
decline in Dutch older adults
Agnes A.M. Berendsen, Ondine van de Rest, 
Edith J.M. Feskens, Lisette C.P.G.M de Groot
Chapter 9     |     Effect of the NU-AGE dietary intervention on cognitive decline 
140 
Abstract 
The Mediterranean diet may affect cognitive functioning in older adults, but results are inconsistent. 
The present study aimed to examine the effect of the NU-AGE diet - a Mediterranean-like dietary 
pattern for older adults - on cognitive functioning. Between April 2012 and March 2013, a total of 
252 independently living non-frail and pre-frail participants from the Netherlands (mean age 
71.0±4.0 years) were enrolled into the NU-AGE parallel, randomized dietary intervention study. 
Participants were randomly assigned to the NU-AGE diet group (n=123) or to the control diet group 
(n=129). The primary outcome was one-year change in global cognition and in four cognitive 
domains as measured through a comprehensive neuropsychological test battery. Data were 
analysed using mixed-effects linear regression models for the effect of the NU-AGE intervention on 
cognitive change over time.  Comparing the intervention with the control group, there was no effect 
of the intervention on cognitive functioning. Estimated mean change in global cognition z-score at 1 
year was 0.33 (95%CI 0.21,0.45) in the intervention group and 0.42 (95%CI 0.29,0.54) in the control 
group, with a mean difference of -0.10 (-0.45,0.25, p group × time = 0.56). Additionally, the 
intervention was not related to change over time for any of the cognitive domains. The results of this 
study suggest that a one year intervention with the NU-AGE diet did not improve cognitive 
functioning in Dutch older adults aged 65 years and older. 
141 
Introduction 
Life expectancy continues to rise due to technical and medical developments, which results in a shift 
towards an ageing population. The proportion of adults aged over 60 years will be more than 20% of 
the world population by 2050 [1]. This increase in older adults will result in a higher prevalence of 
age-related diseases and disabilities, such as the occurrence of dementia [2]. In 2015, 46.8 million 
people were living with dementia and it is estimated that this number will increase to 74.7 million in 
2030 and 131.5 million in 2050 [3].Therefore, the delay of onset of dementia or cognitive 
impairment is a major public health priority [4].  
It has been estimated that a third of all Alzheimer’s disease (AD) cases might be attributable to 
modifiable risk factors, including hypertension, obesity and diabetes [5]. Nutritional components 
might play a role in the prevention of cognitive decline by impacting these modifiable risk factors. A 
combination of nutrients might have even stronger beneficial effects on cognitive health, due to 
interactive or cumulative effects. Therefore, the interest in the relationship between dietary 
patterns and cognitive health has increased.  
One of the dietary patterns which is of great interest is the Mediterranean diet, 
characterized by a high consumption of plant based foods including vegetables and fruits and low 
consumption of red meat and sugary or high-fat food products [6]. Two meta-analyses on 
longitudinal studies reported that a higher adherence to the Mediterranean diet is associated with a 
reduced risk of Mild Cognitive Impairment (MCI) and AD [7, 8]. One randomized trial reported that a 
Mediterranean diet supplemented with nuts or olive oil was associated with improved cognitive 
function among older Spanish participants [9]. However, data from additional randomized controlled 
trials are lacking. 
Additionally, to date, there is no study investigating the effect of a diet that is based on 
dietary recommendations for the ageing population. The NU-AGE dietary intervention study 
investigates the effect of a Mediterranean-like dietary pattern specifically adjusted to the dietary 
recommendations of elderly people on health outcomes. The present study aimed to study the 
effect of the NU-AGE intervention on cognitive change over one year in Dutch adults aged 65-80. 
Materials and methods 
Study design and participants 
The NU-AGE study is a randomized one-year dietary intervention study conducted in five European 
countries: Italy, the United Kingdom (UK), the Netherlands, France, and Poland [10, 11]. For the 
present analyses we used data from the Dutch cohort. The design of the study has been extensively 
described elsewhere [10]. In short, between April 2012 and March 2013 a total of 252 apparently 
healthy non-frail and pre-frail older adults aged 65-80 years were recruited in the surroundings of 
Wageningen, the Netherlands. At baseline and after one year follow-up participants completed 
questionnaires, and a cognitive assessment and physical examination were conducted. Dietary 
intake was assessed by means of a 7-day food record at baseline and follow-up. All foods consumed 
during the day, including their portion sizes, were reported. Written informed consent was obtained 
from all participants. The study protocol was approved by the Medical Ethics Committee of 
Wageningen University and the NU-AGE study is registered at clinicialtrials.gov since December 21st 
2012, NCT01754012. 
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trials are lacking. 
Additionally, to date, there is no study investigating the effect of a diet that is based on 
dietary recommendations for the ageing population. The NU-AGE dietary intervention study 
investigates the effect of a Mediterranean-like dietary pattern specifically adjusted to the dietary 
recommendations of elderly people on health outcomes. The present study aimed to study the 
effect of the NU-AGE intervention on cognitive change over one year in Dutch adults aged 65-80. 
Materials and methods 
Study design and participants 
The NU-AGE study is a randomized one-year dietary intervention study conducted in five European 
countries: Italy, the United Kingdom (UK), the Netherlands, France, and Poland [10, 11]. For the 
present analyses we used data from the Dutch cohort. The design of the study has been extensively 
described elsewhere [10]. In short, between April 2012 and March 2013 a total of 252 apparently 
healthy non-frail and pre-frail older adults aged 65-80 years were recruited in the surroundings of 
Wageningen, the Netherlands. At baseline and after one year follow-up participants completed 
questionnaires, and a cognitive assessment and physical examination were conducted. Dietary 
intake was assessed by means of a 7-day food record at baseline and follow-up. All foods consumed 
during the day, including their portion sizes, were reported. Written informed consent was obtained 
from all participants. The study protocol was approved by the Medical Ethics Committee of 
Wageningen University and the NU-AGE study is registered at clinicialtrials.gov since December 21st 
2012, NCT01754012. 
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Dietary intervention  
Participants were randomized to either the intervention or control group. The intervention group 
received individual dietary counselling including motivational interviewing nine times during one 
year to improve adherence to the NU-AGE diet. The NU-AGE diet is based on nutrient reference 
values and food based dietary guidelines for elderly from Italy [12], the UK [13], the Netherlands [14-
18], Poland [19], and France [20], on the modified MyPyramid for Older Adults [21, 22], and nutrient 
requirements from the European Community [23], and the Institute of Medicine [24]. Specific 
products – e.g. low-salt low-fat cheese, whole grain pasta, margarine, olive oil and a vitamin D 
supplement (10 μg) – were provided for free to the intervention group to facilitate adherence to the 
diet. The control group received a leaflet with general nutritional guidelines. 
 
Cognitive functioning  
Cognitive functioning was measured at baseline and follow-up by trained research assistants 
following standardized procedures. The comprehensive neuropsychological test battery included the 
Consortium to Establish a Registry for Alzheimer Disease (CERAD) [25] test battery (Verbal Fluency 
Category [26], Boston Naming Test [27], Constructional Praxis [28], Word List Memory [25], Word 
List Delayed Recall [25], and Word List Recognition [25]), plus five additional tests; 1) Babcock Story 
Recall [29], 2) Trail Making Test A (TMT-A) [30], 3) Trail Making Test B (TMT-B) [30], 4) Number 
Cancellation [31], and 5) Pattern Comparison [32].   
 
Covariates 
Information on age, sex, educational level (years), smoking status (non-smoker vs. current smoker), 
medical history (hypertension, hypercholesterolemia, diabetes mellitus type 2 with no insulin 
therapy, myocardial infarction, and heart disease) was collected using questionnaires. A history of 
either myocardial infarction or heart disease was evaluated as having a history of cardiovascular 
disease (CVD). Body weight, height, subjective cognitive complaints (range 0-10), Mini-Mental State 
Examination (MMSE, range 0-30) [33], and frailty status (non-frail or pre-frail [34], were examined by 
trained research assistants following standardized procedures. Physical activity was measured using 
a validated version of the Physical Activity Scale for Elderly [35]. Energy intake was derived from the 
means of the 7-day food records. Depressive symptoms were categorized as having two or more 
points on the Geriatric Depression Scale [36], to differentiate subjects with no and a few depressive 
symptoms. 
 
Statistical analyses 
Data are expressed as mean±SD for continuous variables, or as number (percentage) for categorical 
variables. Baseline characteristics were compared between treatment groups using analysis of 
variances (ANOVA) for continuous and Pearson χ2 or Fisher’s exact test for categorical variables.  
Z-scores for each cognitive test at each time point were standardized to the baseline mean and 
standard deviation. Higher Z-scores represent a higher cognitive test outcome. Z-scores for TMT-A 
and TMT-B were reversed, as for these tests higher test outcomes represented lower cognitive 
functioning. An interference measure for TMT-A was calculated (TMT-B/TMT-A), to control for the 
effect of motor speed on performance [37]. CERAD Z-score was calculated based on the sum of 
individual tests. Z-scores for cognitive tests were clustered into compound scores for four cognitive 
domains, namely 1) episodic memory, 2) executive functioning, 3) information processing speed and 
4) visuospatial ability:  
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Episodic memory = ZWordList Immediate + ZWordList Delayed Recall + ZWordList Recognition + ZBabcock Story Recall immediate + 
ZBabcock Story Recall  delayed) /  5 
Executive functioning = ZVerbalFluencyCategory + -ZTrailMakingTest B/A / 2 
Information processing speed = -ZTrailMakingTestA + ZNumberCancellation + ZPatternComparison / 3 
Visuospatial ability = ZConstructionalPraxis + ZContructionalPraxis recall / 2 
Tests included in the four cognitive domains are specified in table 1. 
 
Table 1. Cognitive domains and included tests in the NU-AGE study 
Domain  Test Description  Scoring 
Episodic memory   
 Word list memory Recall of 10 presented words in 3 sessions  0-30  
 Word list delayed recall  Delayed recall of the 10 presented words 
in the Word list memory test  
0-10  
 Word list recognition  Recognition of the 10 presented words in 
the Word list memory test in a list of 20 
words  
0-20  
 Babcock story immediate recall  Recall of a brief story  0-21  
 Babcock story delayed recall  Delayed recall of the brief story in 
Babcock story recall  
0-21  
Executive functioning   
 Verbal fluency category  Mention as many words of a category in 
60 seconds  
0 - ∞  
 Trail Making Test B / A  B: Draw lines sequentially, connecting 13 
numbers and letters in order 1 A 2 B etc., 
as fast as possible  
A: Draw lines sequentially connecting 25 
encircled numbers, as fast as possible  
Outcome ratio of TMT B and TMT A  
0-300 
seconds  
Information processing speed   
 Trail Making Test A  A: Draw lines sequentially connecting 25 
encircled numbers, as fast as possible  
0-300 
seconds  
 Number cancellation  Cross out all number ‘4’ from a list of 
numbers, as fast as possible  
0-30  
 Pattern comparison  Same/different decisions about pairs of 
patterns needs to be made, as fast as 
possible in 2 sessions  
0-60  
Visuospatial ability   
 Constructional praxis  Drawing of presented figures  0-11  
 Constructional praxis recall  Recall of drawn figures on blank paper  0-14  
 
 
Mixed-effects linear regression models were used to study the effect of the NU-AGE intervention on 
cognitive change over time as a function of intervention, time and intervention × time interaction. 
This analysis was based on an intention-to-treat approach in which all randomized participants were 
included in the analysis. Sensitivity analyses were performed by excluding all participants with 
missing values for cognitive outcomes and stratified analyses by sex and age (median) were 
performed. Stratified analyses were relevant because beneficial effects of Mediterranean-like 
dietary patterns were reported in women [9], and in subjects with a higher age [16], while no effects 
were reported in men [19] and in subjects with a lower age [18]. Two-sided p-values <0.05 were 
considered significant for all tests. All statistical analyses were performed using SAS version 9.3. 
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Results 
Between April 2012 and March 2013, 350 individuals were screened and 252 were randomly 
assigned to the intervention group (n=123) or control group (n=129), figure 1. A total of 244 (97%) 
participants completed the follow-up assessments. The intervention was completed in March 2014. 
The analyses included 250 participants (99% of enrolled participants). Dropout rates were similar in 
the intervention (4 [3%] participants) and control (4 [3%] participants) groups. Main reasons for 
drop-out were difficulties adhering to the intervention (n=1), health related (n=3), and difficulties in 
arranging participation (n=3). One participant in the control group died during the study. 
 
 
 
 
Figure 1. Flow chart of Dutch NU-AGE participants 
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The mean age of the population was 71.0 (±4.1) years and MMSE score was 27.7±1.8. Compared to 
the control group those in the intervention group were more likely to be women (57% vs. 54%), 
were higher educated (12.8 vs. 11.8% years), had a lower BMI (25.4±3.7 vs. 26.5±3.5 kg/m2) and had 
a higher prevalence of depressive symptoms (26.2% vs. 19.5%; table 2). 
 
Table 2. Baseline characteristics of Dutch participants in the NU-AGE study 
 Intervention group (n=122) Control group (n=128) 
Demographic characteristics   
Age at baseline, years 70.9 ± 4.2 71.0 ± 3.9 
Women 70 (57.0) 69 (54.0) 
Education, years 12.8 ± 3.7 11.8 ± 3.6 
Vascular factors   
Systolic blood pressure, mmHg 130.0 ± 19.1 136.3 ± 18.0 
Diastolic blood pressure, mmHg 69.4 ± 9.5 71.0 ± 10.3 
Body mass index, kg/m2a 25.4 ± 3.7 26.5 ± 3.5 
Lifestyle factors   
Physical activity, met 137.1 ± 51.7 137.9 ± 55.5 
Pre-frail 26 (21.3) 28 (21.9) 
Current smokers 6 (4.9) 2 (1.6) 
Energy intake, kcal 1902 ± 369 1911 ± 432 
Self-reported medical disorders   
Hypertension 38 (31.1) 44 (34.4) 
Hypercholesterolemia 28 (23) 34 (26.6) 
Diabetes Mellitus, type II 3 (2.5) 6 (4.8) 
Cardiovacular disease 17 (14.0) 15 (11.7) 
Depressive symptoms 32 (26.2) 25 (19.5) 
Cognition   
MMSE (0-30) 27.8 ± 1.8 27.6 ± 1.8 
SCC (0-10) 2.9 ± 1.8 2.9 ± 1.9 
Data are mean ± SD, or n (%) 
MMSE = Mini-Mental State Examination; SCC = Subjective Cognitive Complaints 
a p-value <0.05 
 
Estimated mean change in CERAD total z-score at one year was 0.33 (95%CI 0.21; 0.45) in the 
intervention group and 0.42 (95%CI 0.29; 0.54) in the control group. The mean difference between 
groups (group × time interaction) in change of cognitive function per year was -0.10 (95%CI -0.45; 
0.25), p=0.56; table 3. There was no significant intervention effect over time for the cognitive 
domains episodic memory (p=0.56), executive function (p=0.58), information processing speed 
(p=0.75), and visuospatial ability (p=0.30). 
The results remained unchanged when adjusting for potential confounding variables and while 
excluding subjects with missing data in cognitive outcomes (n=5). No interaction was observed for 
sex, age or energy intake (data not shown).  
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Discussion 
We investigated the effect of the one-year NU-AGE dietary intervention on cognitive functioning in 
252 non-frail and pre-frail Dutch older adults. Compared to the control diet, the NU-AGE 
intervention did not improve global cognition or the cognitive domains episodic memory, executive 
function, information processing speed, and visuospatial ability. To the best of our knowledge, this is 
the first dietary intervention study investigating the effect of a diet specifically targeting dietary 
recommendations for the elderly population on cognitive functioning in non-frail and pre-frail older 
adults aged 65-80 years of age.  
 
Other dietary patterns that have been investigated in relation to cognitive functioning include the 
Mediterranean diet and the DASH diet. The effect of a Mediterranean diet has been investigated in a 
dietary intervention study with three arms (Mediterranean diet supplemented with mixed nuts (30 
g/d), or extra virgin olive oil (1 L/week), or control) in 447 cognitively healthy volunteers. Compared 
to the control group, the Mediterranean diet plus olive oil group had a better RAVLT test score 
(p=0.049) and memory composite score (p=0.04), and participants in the Mediterranean diet plus 
nuts group had a better frontal cognition composite score and global cognition score [9]. The less 
frequently studied DASH diet has been shown to result in a better psychomotor speed after four 
months intervention in 124 participants with elevated blood pressure randomized to the DASH diet 
compared to a control group [38].  
The most recent developed dietary pattern specifically capturing dietary components shown 
to be neuroprotective is the ‘Mediterranean-dietary approach to stop hypertension diet Intervention 
for Neurodegenerative Delay’ (MIND) diet. The MIND diet was prospectively associated with slower 
decline in global cognitive score; participants with highest adherence to the MIND diet were 
cognitively 7.5 years younger in age compared to those with the lowest adherence after 4.7 years of 
follow-up [39].  
However, dietary intervention studies on the effect of a dietary pattern specifically targeting 
nutritional recommendations and dietary habits of the ageing population on cognitive functioning 
are scarce. Very recently, a two-year multi-domain intervention including diet, exercise, cognitive 
training and vascular risk monitoring, or a control group (general health advice) was conducted [40]. 
The intervention group received dietary advice based on the Finnish Nutrition Recommendations in 
three individual sessions and seven to nine group sessions. In addition they received a physical 
exercise program, cognitive training and metabolic and vascular risk factors were managed. After 
two years of intervention, mean change in neuropsychological test battery (NTB) z-score was 
0.20±0.51 in the intervention group and 0.16±0.51 in the control group with a between group 
difference in change per year of 0.022 (95% CI 0.002-0.042, p = 0.030). It was concluded that this 
multi-domain approach could improve or maintain cognitive function in at-risk elderly people [41]. 
Thus, a multi-domain approach could be more effective in achieving beneficial changes in cognitive 
functioning than targeting dietary recommendations only as in the current intervention study. 
 
To investigate the effect of the NU-AGE intervention on cognitive functioning, we included an 
extensive cognitive test battery of 14 sensitive neuropsychological tests covering the domains most 
affected by aging, which is a major strength of the current study. As recommended by previous 
research [42], we have clustered data of the individual neuropsychological tests by standardizing 
values to z-scores in order to construct more robust cognitive domain scores. All tests were 
conducted by trained research assistants in a valid and standardized way following a strict protocol.  
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Discussion 
We investigated the effect of the one-year NU-AGE dietary intervention on cognitive functioning in 
252 non-frail and pre-frail Dutch older adults. Compared to the control diet, the NU-AGE 
intervention did not improve global cognition or the cognitive domains episodic memory, executive 
function, information processing speed, and visuospatial ability. To the best of our knowledge, this is 
the first dietary intervention study investigating the effect of a diet specifically targeting dietary 
recommendations for the elderly population on cognitive functioning in non-frail and pre-frail older 
adults aged 65-80 years of age.  
 
Other dietary patterns that have been investigated in relation to cognitive functioning include the 
Mediterranean diet and the DASH diet. The effect of a Mediterranean diet has been investigated in a 
dietary intervention study with three arms (Mediterranean diet supplemented with mixed nuts (30 
g/d), or extra virgin olive oil (1 L/week), or control) in 447 cognitively healthy volunteers. Compared 
to the control group, the Mediterranean diet plus olive oil group had a better RAVLT test score 
(p=0.049) and memory composite score (p=0.04), and participants in the Mediterranean diet plus 
nuts group had a better frontal cognition composite score and global cognition score [9]. The less 
frequently studied DASH diet has been shown to result in a better psychomotor speed after four 
months intervention in 124 participants with elevated blood pressure randomized to the DASH diet 
compared to a control group [38].  
The most recent developed dietary pattern specifically capturing dietary components shown 
to be neuroprotective is the ‘Mediterranean-dietary approach to stop hypertension diet Intervention 
for Neurodegenerative Delay’ (MIND) diet. The MIND diet was prospectively associated with slower 
decline in global cognitive score; participants with highest adherence to the MIND diet were 
cognitively 7.5 years younger in age compared to those with the lowest adherence after 4.7 years of 
follow-up [39].  
However, dietary intervention studies on the effect of a dietary pattern specifically targeting 
nutritional recommendations and dietary habits of the ageing population on cognitive functioning 
are scarce. Very recently, a two-year multi-domain intervention including diet, exercise, cognitive 
training and vascular risk monitoring, or a control group (general health advice) was conducted [40]. 
The intervention group received dietary advice based on the Finnish Nutrition Recommendations in 
three individual sessions and seven to nine group sessions. In addition they received a physical 
exercise program, cognitive training and metabolic and vascular risk factors were managed. After 
two years of intervention, mean change in neuropsychological test battery (NTB) z-score was 
0.20±0.51 in the intervention group and 0.16±0.51 in the control group with a between group 
difference in change per year of 0.022 (95% CI 0.002-0.042, p = 0.030). It was concluded that this 
multi-domain approach could improve or maintain cognitive function in at-risk elderly people [41]. 
Thus, a multi-domain approach could be more effective in achieving beneficial changes in cognitive 
functioning than targeting dietary recommendations only as in the current intervention study. 
 
To investigate the effect of the NU-AGE intervention on cognitive functioning, we included an 
extensive cognitive test battery of 14 sensitive neuropsychological tests covering the domains most 
affected by aging, which is a major strength of the current study. As recommended by previous 
research [42], we have clustered data of the individual neuropsychological tests by standardizing 
values to z-scores in order to construct more robust cognitive domain scores. All tests were 
conducted by trained research assistants in a valid and standardized way following a strict protocol.  
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Moreover, randomization was used to obtain two equally balanced intervention groups. 
However, despite the randomization participants in the intervention group were more likely to be 
women (i.e. 57% vs. 54%) and had a lower BMI compared to the control group (i.e. 25.4±3.7 vs. 
26.5±3.5 kg/m2). Though, we have performed multivariate adjusted linear mixed model regression 
analyses including these and other factors and the results did not change. Importantly, with respect 
to the exposure and outcome variables participants in both groups were comparable at baseline.  
Furthermore, we were able to conduct stratified analyses to explore if the intervention 
would be effective in the oldest participants. This was relevant as studies in older populations (e.g., 
mean age 81.5 years) demonstrated a relation of the DASH and MIND diet with cognitive decline [8, 
43]. Our stratified analyses by age, however, did not result in differences between age groups (data 
not shown).  
At last, adherence to the NU-AGE guidelines did substantially improve over time in the 
intervention group compared to the control group and it was concluded that the NU-AGE dietary 
intervention was feasible to make elderly people change their dietary intakes more towards their 
nutritional needs (Berendsen 2017, in preparation, Chapter 8 in this thesis).  
 
Our relatively short follow-up time is a limitation of our study and could be an explanation for our 
null-findings. It has been recommended to conduct trials with a duration of at least 18 months to 
study effects on cognitive functioning [44]. However, it was expected that the follow-up period 
would be sufficient to impact cognitive functioning in our population including a proportion of older 
adults at greater risk of cognitive function decline (i.e. the pre-frail). Another explanation for our null 
finding of the NU-AGE diet could be the lack of power, as the sample size was not calculated to 
detect an effect on cognitive functioning. The required sample size has been calculated to be at least 
600 participants per intervention group to detect a 50% difference change in the Neuropsychological 
Test Battery score between two intervention groups over two years [45]. The effect of the NU-AGE 
diet on cognitive functioning will be further investigated in the total NU-AGE sample including over 
1,250 participants.  
 
Summarizing, this study did not find an effect of the NU-AGE intervention on cognitive change over 
time. Longer-term randomized controlled trials with a sufficient sample size and multiple repeated 
measures of cognitive function are needed to study the effect of a dietary pattern specifically 
targeting dietary recommendations, but also incorporating components that have been shown to 
impact brain health of older adults at risk of cognitive impairment.  
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Moreover, randomization was used to obtain two equally balanced intervention groups. 
However, despite the randomization participants in the intervention group were more likely to be 
women (i.e. 57% vs. 54%) and had a lower BMI compared to the control group (i.e. 25.4±3.7 vs. 
26.5±3.5 kg/m2). Though, we have performed multivariate adjusted linear mixed model regression 
analyses including these and other factors and the results did not change. Importantly, with respect 
to the exposure and outcome variables participants in both groups were comparable at baseline.  
Furthermore, we were able to conduct stratified analyses to explore if the intervention 
would be effective in the oldest participants. This was relevant as studies in older populations (e.g., 
mean age 81.5 years) demonstrated a relation of the DASH and MIND diet with cognitive decline [8, 
43]. Our stratified analyses by age, however, did not result in differences between age groups (data 
not shown).  
At last, adherence to the NU-AGE guidelines did substantially improve over time in the 
intervention group compared to the control group and it was concluded that the NU-AGE dietary 
intervention was feasible to make elderly people change their dietary intakes more towards their 
nutritional needs (Berendsen 2017, in preparation, Chapter 8 in this thesis).  
 
Our relatively short follow-up time is a limitation of our study and could be an explanation for our 
null-findings. It has been recommended to conduct trials with a duration of at least 18 months to 
study effects on cognitive functioning [44]. However, it was expected that the follow-up period 
would be sufficient to impact cognitive functioning in our population including a proportion of older 
adults at greater risk of cognitive function decline (i.e. the pre-frail). Another explanation for our null 
finding of the NU-AGE diet could be the lack of power, as the sample size was not calculated to 
detect an effect on cognitive functioning. The required sample size has been calculated to be at least 
600 participants per intervention group to detect a 50% difference change in the Neuropsychological 
Test Battery score between two intervention groups over two years [45]. The effect of the NU-AGE 
diet on cognitive functioning will be further investigated in the total NU-AGE sample including over 
1,250 participants.  
 
Summarizing, this study did not find an effect of the NU-AGE intervention on cognitive change over 
time. Longer-term randomized controlled trials with a sufficient sample size and multiple repeated 
measures of cognitive function are needed to study the effect of a dietary pattern specifically 
targeting dietary recommendations, but also incorporating components that have been shown to 
impact brain health of older adults at risk of cognitive impairment.  
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Aim and main findings
The main aim of this thesis was to study the association of healthful dietary patterns with cognitive 
functioning. In addition, nutrient intake inadequacies were assessed and the potential to change 
dietary intake in older adults aged 65 years and older was studied. This was done using data of a 
cross-sectional study, by conducting a literature review, by analysing data of several prospective 
studies, and by conducting a dietary intervention study. 
The findings of these studies are summarized in table 1. A high percentage of inadequate intake was 
observed for the nutrients vitamin D, selenium, and vitamin B6 in Dutch adults aged 65 years and 
older (chapter 2). Of all dietary patterns studied in our systematic literature review we found most 
evidence for the Mediterranean dietary pattern to be associated with less cognitive decline, 
dementia or Alzheimer’s Disease (AD) risk in older adults, demonstrated by many observational 
studies and the first intervention study conducted to date (chapter 3). Whilst the Healthy Diet 
Indicator (HDI) was not associated with cognitive decline or functioning at older ages in European 
and American populations (chapter 4), greater adherence to the Dietary Approach to Stop 
Hypertension (DASH) was associated with better cognitive functioning (chapter 5), and the 
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet with a better verbal 
memory score at older ages (chapter 6). Although the NU-AGE (NUtrients and AGEing) diet was 
specially designed at targeting the dietary recommendations for the ageing population (chapter 7) 
and considering the dietary habits of elderly people (chapter 8), it did not result in a better cognitive 
functioning after one year intervention in a Dutch population aged 65 years and older (chapter 9).  
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Table 1. Summary of main findings  
Exposure Study  Design and study population Results  Chapter 
Nutrients  NU-AGE Cross-sectional study; 252 Dutch 
men and women ≥65 years 
High prevalence of inadequate dietary 
intakes for vitamin D (99%), selenium 
(41%) and vitamin B6 (54%). 
2 
     
Dietary 
patterns 
Review Cross-sectional, prospective, 
interventions, reviews, meta-
analyses  
Better adherence to a Mediterranean 
diet is likely to be associated with less 
cognitive decline, dementia, or AD.  
3 
     
Healthy 
Diet 
Indicator 
(HDI) 
NHS, RS, 
SENECA 
Meta-analysis of three cohort 
studies; 17,160 women ≥70 
years, 3,660 men and women 
≥55 years, 1,017 men and 
women ≥70 years 
A higher HDI score is not related to 
reduced rates of cognitive decline in 
European and American older adults 
4 
     
DASH NHS Prospective cohort study; 16,144 
women ≥70 years 
Long-term adherence to the DASH diet 
is important to maintain cognitive 
functioning (global cognition, verbal 
memory and TICS) at older ages 
5 
     
MIND NHS Prospective cohort study; 16,058 
women ≥70 years 
Long-term adherence to the MIND diet 
is moderately associated with better 
verbal memory in later life 
6 
     
Healthful 
diet  
  
NU-AGE 
  
Design of a one-year randomized 
dietary intervention study in 
1,250 European adults aged 65-
80 years 
Results of this intervention will provide 
evidence on the effect of a healthful 
diet on the prevention of age related 
decline 
7 
     
  One-year randomized dietary 
intervention study; 1,250 
European adults aged 65-80 
years 
The NU-AGE diet, specifically targeting 
nutritional recommendations for older 
adults, is feasible to achieve 
favourable changes in dietary intake in 
an ageing European population 
8 
     
  One-year randomized dietary 
intervention study; sub-
population of 252 Dutch adults 
aged 65-80 years 
After one year, the NU-AGE diet did 
not improve cognitive functioning in 
Dutch older adults aged 65 years and 
older 
9 
Abbreviations: AD, Alzheimer’s Disease; DASH, Dietary Approach to Stop Hypertension; HDI, Healthy Diet Indicator; MIND, 
Mediterranean-DASH Intervention for Neurodegenerative Delay; NHS, Nurses’ Health Study; NU-AGE, NUtrients and 
AGEing; RS, Rotterdam Study; TICS, Telephone Interview for Cognitive Status  
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From single nutrients to combinations of nutrients  
Chapter 2 describes nutrient intake inadequacies for vitamin D, vitamin B6 and selenium in a 
population of Dutch adults aged 65-80 years. Additionally, to simultaneously study the intake of 
several nutrients and to rank foods based on their nutrient density, we explored the possibility of 
applying the Nutrient Rich Food (NRF) 9.3 score [1]. The NRF9.3 score includes nine nutrients to 
encourage and three nutrients to limit, based on current regulatory frameworks and dietary 
guidance in the US [2]. The NRF9.3 was of interest as it was demonstrated in an observational study 
that adults aged 55 years and older with a higher NRF9.3 score had a lower risk of all-cause mortality 
[3]. As such, we were interested to know if this score could be used in a population of older adults 
aged 65 years and older to cluster nutrients of concern within foods and to study nutrient intake 
inadequacy in relation to cognitive outcomes. We confirmed that this score was able to rank foods 
based on their nutrient density, however, these foods did not necessarily contain high amounts of 
nutrients that were inadequate in this Dutch population of older adults. Thus, the score at its present 
form had limited applicability to study combinations of nutrients in older adults in this thesis. 
 
 
Dietary patterns and cognitive functioning 
In chapters 3 to 9, methodological considerations specific for the respective chapters have been 
addressed. The following paragraphs will discuss how the main findings of this thesis fit with the 
existing literature and overarching methodological considerations are receiving due attention. First, a 
reflection is given on issues related to dietary patterns and cognitive functioning, followed by a 
discussion about the study population. Finally, suggestions for further research and public health 
implications will be presented together with a final conclusion. 
 
 
Dietary patterns; assessment, construction and evaluation 
In this thesis we focussed on dietary patterns derived using so called a priori diet scores based on 
existing knowledge of healthful dietary components, namely the Mediterranean diet (chapter 3), the 
HDI (chapter 4), the DASH diet (chapter 5), the MIND diet (chapter 6), and the NU-AGE diet (chapter 
7-9). When evaluating associations between dietary patterns and health outcomes, one should take 
into account the dietary assessment method used, the origin of the included foods and components, 
the cut-offs and scoring system used, and the applied weighting factors. We will discuss each of these 
factors in the paragraphs below. Table 2 provides an overview of all these aspects of the studied 
dietary patterns in this thesis. 
 
Assessment of dietary intake 
Dietary patterns are based on dietary intake data assessed by means of several dietary assessment 
methods. Food frequency questionnaires (FFQ) have most frequently been used to assess dietary 
intake to derive the Mediterranean diet (chapter 3), the HDI (Rotterdam Study, Nurses’ Health Study, 
chapter 4), the DASH diet (chapter 5), and the MIND diet (chapter 6), table 2. A dietary history 
method and a 7-day food record were used to assess dietary intake to construct the HDI in SENECA 
(chapter 4) and the NU-AGE index, respectively (chapters 7-9). 
 
 
157 
Table 2. Overview of dietary assessment methods, selection of dietary components, cut-off values 
and scoring systems used to define dietary patterns in this thesis 
Dietary 
pattern 
Dietary 
assessment 
Basis of included components Basis of cut-off values Scoring 
Mediterranean Mostly FFQ Healthful dietary pattern in the 
Mediterranean region 
Population’s intake 
distribution 
Quintiles,  
0-3,4-6,7-9 
     
HDI  FFQ (NHS, RS), 
dietary history 
(SENECA) 
Recommendations to prevent 
chronic diseases 
Pre-defined & 
Population‘s intake 
distribution 
Continuous 
     
DASH  FFQ Recommendations to lower 
blood pressure 
Population’s intake 
distribution 
Quintiles  
     
MIND  FFQ Literature/human/animal 
studies on neuroprotection 
Pre-defined 0, 0.5, 1 
     
NU-AGE  7-day food 
record 
European dietary guidelines for 
the ageing population, 
inflammation 
Pre-defined & 
Population’s intake 
distribution 
Continuous 
Abbreviations: DASH, Dietary Approach to Stop Hypertension; FFQ, Food Frequency Questionnaire; HDI, Healthy Diet 
Indicator; MIND, Mediterranean-DASH Intervention for Neurodegenerative Delay; NHS, Nurses’ Health Study; NU-AGE, 
NUtrients and Ageing; RS, Rotterdam Study 
 
 
All these dietary assessment methods rely on self-report and may be influenced by socially desirable 
answers, the participant’s ability to recall dietary intake (except for the 7-day food record), and to 
estimate portion sizes correctly, possibly resulting in random and systematic errors [4]. Random 
errors lead to a correct – but less precise – estimate of the mean dietary pattern score if the sample 
size is large enough. Systematic under- or overreporting of dietary intake results in a biased mean 
dietary pattern score which is of concern when comparing the intake of the population to dietary 
guidelines. However, as systematic errors do not influence the ranking of participants, they do not 
attenuate diet-disease associations as assessed in this thesis. Differential under- or overreporting on 
the other hand may influence the ranking of participants [5]. For example, obese people tend to 
underreport energy intake and overreport fruit intake more than normal weight people do, and sex 
seems to differentially result in an over- or underestimation of energy intake [6, 7], resulting in a 
biased mean dietary pattern score. At the same time, obesity is a risk factor for cognitive decline [8] 
and thus this misclassification could lead to a biased association between dietary patterns and 
cognitive functioning. Using correction factors (e.g., calculated from summary questions on for 
example fruit consumption to correct fruit consumption obtained from the sum of questions on 
individual fruit items) does not necessarily improve estimates of dietary intake, yet [9]. By adding 
BMI and sex to the multivariable adjusted models, this bias was taken into account to some extent. 
 
Dietary intake data are prone to errors, which will be reflected in dietary patterns. This is important to 
consider when evaluating study results, especially from observational studies when comparing dietary 
intakes to dietary guidelines. 
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Dietary patterns and cognitive functioning 
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Dietary patterns; assessment, construction and evaluation 
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into account the dietary assessment method used, the origin of the included foods and components, 
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Assessment of dietary intake 
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intake to derive the Mediterranean diet (chapter 3), the HDI (Rotterdam Study, Nurses’ Health Study, 
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Table 2. Overview of dietary assessment methods, selection of dietary components, cut-off values 
and scoring systems used to define dietary patterns in this thesis 
Dietary 
pattern 
Dietary 
assessment 
Basis of included components Basis of cut-off values Scoring 
Mediterranean Mostly FFQ Healthful dietary pattern in the 
Mediterranean region 
Population’s intake 
distribution 
Quintiles,  
0-3,4-6,7-9 
     
HDI  FFQ (NHS, RS), 
dietary history 
(SENECA) 
Recommendations to prevent 
chronic diseases 
Pre-defined & 
Population‘s intake 
distribution 
Continuous 
     
DASH  FFQ Recommendations to lower 
blood pressure 
Population’s intake 
distribution 
Quintiles  
     
MIND  FFQ Literature/human/animal 
studies on neuroprotection 
Pre-defined 0, 0.5, 1 
     
NU-AGE  7-day food 
record 
European dietary guidelines for 
the ageing population, 
inflammation 
Pre-defined & 
Population’s intake 
distribution 
Continuous 
Abbreviations: DASH, Dietary Approach to Stop Hypertension; FFQ, Food Frequency Questionnaire; HDI, Healthy Diet 
Indicator; MIND, Mediterranean-DASH Intervention for Neurodegenerative Delay; NHS, Nurses’ Health Study; NU-AGE, 
NUtrients and Ageing; RS, Rotterdam Study 
 
 
All these dietary assessment methods rely on self-report and may be influenced by socially desirable 
answers, the participant’s ability to recall dietary intake (except for the 7-day food record), and to 
estimate portion sizes correctly, possibly resulting in random and systematic errors [4]. Random 
errors lead to a correct – but less precise – estimate of the mean dietary pattern score if the sample 
size is large enough. Systematic under- or overreporting of dietary intake results in a biased mean 
dietary pattern score which is of concern when comparing the intake of the population to dietary 
guidelines. However, as systematic errors do not influence the ranking of participants, they do not 
attenuate diet-disease associations as assessed in this thesis. Differential under- or overreporting on 
the other hand may influence the ranking of participants [5]. For example, obese people tend to 
underreport energy intake and overreport fruit intake more than normal weight people do, and sex 
seems to differentially result in an over- or underestimation of energy intake [6, 7], resulting in a 
biased mean dietary pattern score. At the same time, obesity is a risk factor for cognitive decline [8] 
and thus this misclassification could lead to a biased association between dietary patterns and 
cognitive functioning. Using correction factors (e.g., calculated from summary questions on for 
example fruit consumption to correct fruit consumption obtained from the sum of questions on 
individual fruit items) does not necessarily improve estimates of dietary intake, yet [9]. By adding 
BMI and sex to the multivariable adjusted models, this bias was taken into account to some extent. 
 
Dietary intake data are prone to errors, which will be reflected in dietary patterns. This is important to 
consider when evaluating study results, especially from observational studies when comparing dietary 
intakes to dietary guidelines. 
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Constructing dietary patterns relevant for cognitive functioning 
There are different ways to construct dietary patterns and many decisions have to be taken in doing 
so, such as which components to include, which cut-offs to use and how to score the components.  
 
Selecting dietary components  
When comparing the components of the dietary patterns studied in this thesis (see table 1, chapter 
1) it should be noted that there are different dietary components included, but also some similar 
components, such as whole grains, fruits, vegetables, nuts and legumes. 
Of all dietary patterns studied, the MIND diet uniquely emphasizes dietary components and 
servings linked to neuroprotection and dementia prevention (table 2, [10]). As there was no evidence 
for an association between fruit consumption and cognitive decline [11-15] the MIND diet does not 
specify daily fruit servings - in contrast to the Mediterranean diet and the DASH diet. The MIND diet 
did include a component for berry consumption [10] as there was evidence for a positive association 
between intakes of blueberries and strawberries with slower cognitive decline [16], supported by a 
number of rodent models [17-20]. Additionally, green leafy vegetables were included in the MIND 
diet based on studies reporting less cognitive decline with a greater consumption of green leafy 
vegetables [12, 13]. 
Although the inclusion of such specific components can be considered a unique feature of 
the MIND diet, this feature introduces a limited applicability of this score in other studies, especially 
in studies using a FFQ. In a FFQ, individual foods (e.g., berries) are normally clustered into food 
groups (e.g., fruits) to reduce the total number of foods. This limits the possibility to obtain intake 
data of those specific foods. Adding these specific and relevant components to optimize brain health 
to FFQs should be considered in future studies investigating the association between diet and 
cognitive functioning.  
This problem has been overcome within the NU-AGE study by using food records with which 
it is possible to assess and revisit the intake of an almost infinite number of specific foods within each 
country, as opposed to a FFQ. Moreover, as the NU-AGE study is an international study, it was 
necessary to construct food groups that are comparable across the different countries. To achieve a 
comparable food group classification, we created standardized rules to assign individual foods to 
food groups in each of the five study centres. Additionally, the underlying concepts (e.g., a nutrient 
dense diet based on dietary recommendations for older adults, table 2) of the NU-AGE diet were 
taken into account when constructing food groups enabling us to distinguish for example low-fat or 
high-fat dairy and low-fibre or high-fibre products. This allowed us to study culturally different 
dietary intakes with similar food groups using an internationally comparable dietary index. 
Another advantage of the NU-AGE diet is that it has a wider scope by implementing different 
cultures from five European countries, as opposed to the Mediterranean diet that is based on a 
healthful dietary pattern observed in the Mediterranean. Despite the demonstrated health benefits 
of the Mediterranean diet (e.g., cardiovascular prevention [21, 22], cancer [23], and mortality [22]), 
strong intrinsic Western socio-cultural values, traditions and norms may hamper the feasibility of 
adhering to the Mediterranean diet in non-Mediterranean countries [24], such as to the high 
consumption of olive oil, fish and legumes.  
 
When designing a dietary pattern relevant for cognitive functioning, components should be selected 
that; 1) are related to neuroprotection, 2) can be assessed by means of commonly used dietary 
assessment methods, and 3) that are feasible to be consumed within the population of study. 
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Cut-off values, scoring systems and weighting of dietary components  
Cut-off values either represent the required levels of intake to receive the maximum number of 
points for adequacy components, or the amount of food at which zero points are given in case of 
maximum levels of intake (e.g., components to limit).  
When comparing the cut-off values used for the dietary patterns studied in this thesis it 
should be noted that two different approaches towards cut-off values have been used, namely pre-
defined cut-off values and cut-off values based on the intake distribution in a population (table 2). 
Pre-defined cut-off values are either based on literature or derived from healthy dietary patterns 
observed in a population (e.g., in the Mediterranean). If no biological references are available for 
maximum levels of intake, cut-off values based on the intake distribution in a population can be 
used. For example, to define maximum levels of intake for a component to limit, such as sodium, the 
85th percentile of the population’s intake distribution can be used.  
Both the HDI and the NU-AGE diet score include a combination of cut-off values. Pre-defined 
cut-off values were based on worldwide (WHO; HDI, chapter 4) or European (NU-AGE, chapters 7-9) 
dietary guidelines. The cut-off values for maximum levels of intake were derived from the 
populations’ intake distributions within a country to optimally fit the intake within the study 
populations and to obtain a maximum variation in scores.  
The MIND diet includes pre-defined cut-off values based on literature only. We were able to 
demonstrate an association between the MIND diet and verbal memory in the Nurses’ Health Study, 
but the effect sizes were smaller compared to results from the Memory and Aging Project (MAP) 
[25]. The use of predefined cut off values can be considered an advantage as they are comparable 
among different study populations. However, if these cut-off values do not match dietary intake of 
another study population, this could result in less variation in dietary exposure causing a weaker 
association, as observed in the Nurses’ Health Study (chapter 6). 
 
Dietary components within a dietary pattern can be scored using a dichotomous, continuous or 
proportional scoring system. A continuous (e.g., HDI, NU-AGE) or proportional scoring system (e.g., 
DASH; quintiles of intake), results in a larger variation in dietary component scores covering a wide 
range of adherence and a higher sensitivity and specificity achieving maximum diagnostic accuracy, 
compared to a dichotomous scoring system [26, 27]. However, proportional scoring of intakes above 
the maximum level of intake could result in less variation in the component scores. This could have 
caused a weakened association of the NU-AGE diet with cognitive functioning.  
On the contrary, the MIND diet uses a dichotomous-like scoring system assigning participants 
0, 0.5, or 1 point depending on the degree of adherence. A dichotomous-like scoring system is easier 
to apply in clinical practice and to translate the dietary goals to the general public. 
A general limitation of all used scoring systems is that they do not take into account that 
certain food groups might need different cut-offs as not all components show a linear relation with 
cognitive functioning. As such, the possibility that some associations of dietary components with 
cognitive functioning could be non-linear (e.g., J-shaped or U-shaped), has not been taken into 
account. 
 
In the dietary patterns studied, all dietary components received equal weights, assuming that each 
component is equally important for cognitive functioning. However, it is very likely that some 
components are more important. Therefore, some authors have suggested applying weighting 
factors when constructing dietary pattern scores, such as relative risks or odds ratios for specific food 
10
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groups and health outcomes [26, 28, 29]. However, taking this approach would result in different 
dietary patterns for each possible cognition outcome, limiting the general applicability and 
comparability of these dietary patterns. Although certain components within a dietary pattern are 
correlated (e.g., fruits, vegetables and dietary fibre [30]), we did not apply weighting factors in any of 
the dietary patterns studied. Because of this collinearity, these components indirectly weigh more 
heavily within the dietary pattern than other components. 
  
Dietary patterns including cut-off values based on the population’s intake distribution and a 
continuous scoring system allow capturing the full range of variation in diet scores relevant when 
studying diet disease associations. Dietary patterns using pre-defined cut-off values and a 
dichotomous scoring system are easier to apply and understand for the general public. 
 
 
Evaluating dietary patterns 
As the MIND diet and NU-AGE diet are newly developed dietary patterns their validity needs to be 
evaluated. There are various aspects to consider, namely 1) association with nutrient intake, 2) 
content validity, 3) construct validity, and 4) reliability [31].  
Firstly, the association with nutrient intakes among several degrees of adherence can be 
studied. For the NU-AGE and MIND diet we observed that nutrient intake increased with higher diet 
scores without increasing energy intake (e.g., for NU-AGE, mean energy intake was ~1,900 kcal 
across tertiles, PUFA intake was 10.9g, 11,3g and 12.9g, and fibre intake was 19.3g, 21.9g, and 25.8g). 
Secondly, content validity assesses if the dietary pattern captures all aspects of the specific 
dietary patterns. Both the MIND diet score and the NU-AGE diet score qualitatively capture the 
various components relevant for both diets. 
Thirdly, construct validity includes a check if the dietary pattern score provides the maximum 
range to discriminate participants according to their adherence. Another part of construct validity is 
the possibility to distinguish between groups with known differences in dietary quality, e.g., across 
levels of education. The range of the MIND diet score was 2.6-11 (out of 0-15) in our study (chapter 
6) and 36-132 (out of 0-160) for the NU-AGE diet score (chapter 8), indicating that both indexes are 
able to measure a wide range of adherence. For the MIND diet score the ability to distinguish 
between populations with known differences in dietary intake has been confirmed; participants with 
the lowest MIND scores had lower education, were more likely to be obese and to have diabetes, 
and reported fewer hours of physical activity and more depressive symptoms [10]. 
At last, reliability evaluates if a dietary pattern score performs the same at different time 
points and which dietary components have most influence on the overall dietary pattern score. We 
have calculated the relative contribution of the MIND diet components, demonstrating that some 
components had more influence on the total MIND diet score (e.g., ‘Butter and margarine’ and 
‘Pastries and sweets’). To evaluate the NU-AGE diet score, it could be studied in relation to markers 
of inflammation, as it was targeted to impact inflammation. Moreover, reliability of both the MIND 
diet score and the NU-AGE diet score should be tested using different dietary assessment methods.  
 
Although the newly developed MIND diet and NU-AGE diet are based on components relevant for 
(brain) health and include cut-off values and a scoring system relevant for studying diet disease 
associations, their validity needs to be confirmed. 
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Biomarkers to assess dietary pattern adherence 
Ideally, adherence to dietary patterns should be quantifiable; therefore, the use of biomarkers to 
assess dietary pattern intake should be considered. Biomarkers of dietary intake are less prone to 
misclassification bias in older adults with and without mild cognitive impairment (MCI) compared to 
conventional methods of dietary assessment, e.g., food frequency questionnaires [32]. One cross-
sectional study explored the use of nutrient status to construct nutrient biomarker patterns to 
examine the relation with psychometric and imaging indices of brain health (Magnetic Resonance 
Imaging; MRI) in dementia free women [33]. Two nutrient biomarker patterns (one high in plasma 
vitamins B (B1, B2, B6, folate, and B12), C, D, and E, and another high in plasma omega-3 fatty acids) 
were associated with more favourable cognitive and brain MRI measures. In contrast, a third pattern 
(high in trans-fat) was associated with less favourable cognitive functioning and less total cerebral 
brain volume. Despite this interesting finding, it remains questionable if dietary patterns can be 
captured by nutrient biomarker pattern analysis, as nutrient status only does not cover the large 
diversity of food within a dietary pattern. Additionally, currently only a limited number of validated 
biomarkers is available [34].  
 
When creating dietary patterns many decisions need to be taken based on the aim of the study and – 
preferably – the inclusion of biomarkers should be considered to improve and validate estimates of 
dietary pattern exposure. 
 
 
Cognitive functioning; assessment and challenges 
Cognitive functioning can be measured by means of a broad range of neuropsychological tests. These 
tests capture different cognitive processes that are important to maintain activities in daily life. 
Studies described in this thesis include commonly used and validated paper-pencil tests, but also 
telephone based methods to assess cognitive functioning. An overview of included tests is given in 
table 3, thereby indicating in which chapters they have been used. Roughly, these tests can be 
divided into screening tools as a global measure of cognitive function and tests that are able to 
assess specific cognitive domains. 
 
Screening tools for cognitive functioning 
In large prospective observational studies it is common to use the Mini Mental State Examination 
(MMSE) [35], or its telephone version; the Telephone Interview of Cognitive Status (TICS) [36], as a 
screening tool for cognitive functioning.  
The MMSE and the TICS were used in chapter 4 to study the association between the Healthy Diet 
Indicator (HDI) and cognitive functioning in three cohort studies. Although we used harmonized 
exposure and outcome variables we were not able to demonstrate an association between the HDI 
and reduced rates of cognitive decline in European and American adults aged 65 years and older. The 
MIND diet (chapter 5), the DASH diet (chapter 6) and the NU-AGE diet (chapter 9) were also not 
associated with the TICS or MMSE in this thesis. An important limitation of the MMSE and TICS is that 
they are both very global tests that have originally been developed to grade cognitive functioning of 
patients with relatively severe cognitive deficits [36]. 
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associated with the TICS or MMSE in this thesis. An important limitation of the MMSE and TICS is that 
they are both very global tests that have originally been developed to grade cognitive functioning of 
patients with relatively severe cognitive deficits [36]. 
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Thus, a possible explanation for the lack of an association of the HDI, DASH, MIND and NU-AGE diet 
with the MMSE and TICS is that these tests are not sensitive and specific enough to detect subtle 
cognitive differences in cognitive domains within generally healthy study participants. 
  
Commonly used screening tools for cognitive functioning are useful to characterize a study population 
for their level of cognitive functioning, however, these tests are not sensitive and specific enough to 
detect differences or decline in cognitive functioning in a relatively healthy study population. 
 
 
Specific cognitive domains  
The use of more specific cognitive tests as compared to the MMSE or TICS enables detection of 
smaller differences in specific cognitive domains, such as verbal memory, information processing 
speed, and executive functioning. For example, impaired verbal memory is part of the typical 
memory-dominant dementia syndrome in AD [48], and thus relevant to measure.  
In chapters 5, 6 and 9 we were able to use many neuropsychological tests to construct 
cognitive domains. Greater adherence to the DASH diet was associated with a better global cognitive 
function - a composite score based on six cognitive tests - and with better verbal memory at older 
ages in the Nurses’ Health Study (chapter 5). This was in line with the few observational studies 
reporting that the DASH diet was associated with less cognitive decline among elderly American men 
and women (n=826) after 4.1 years of follow-up using 19 cognitive tests combined into a global 
measure of cognition [49]. A dietary intervention study in hypertensive American adults (n=124) 
demonstrated that four months on the DASH diet improved psychomotor speed [50].  
Greater adherence to the MIND diet was moderately associated with a better verbal memory 
at older ages (chapter 6). In a prospective cohort study, the MIND diet was associated with slower 
decline in global cognitive function (a composite score of 19 cognitive tests) [25] and a lower risk of 
AD [10] over 4.7 and 4.5 years in 960 and 923 American men and women from the Memory and 
Aging Project (MAP) study. We were not able to confirm this association with global cognitive 
function in a sample of 16,058 American women living in the Boston area (chapter 6). A possible 
explanation could be the timing of dietary and cognitive assessment, as cognitive assessment 
(starting in 1997) preceded dietary assessment (2004-2013) in the MAP study, whereas dietary 
assessment preceded cognitive assessment in the NHS study, importantly limiting the effect of 
reversed causation.  
Although we used specific cognitive tests within the NU-AGE study as well, we were not able 
to demonstrate an effect of the NU-AGE diet on any of the cognitive domains in the Dutch NU-AGE 
cohort (chapter 9). This could be due to the relatively short period of follow-up, as it has been 
proposed that it takes at least 1.5 years to induce and detect changes in cognitive functioning [51]. 
Another important explanation for our null finding for the NU-AGE diet could be the lack of power, as 
the sample size was not calculated to detect an effect on cognitive functioning. The required sample 
size has been calculated to be at least 600 participants per intervention group to detect a 50% 
difference change in the Neuropsychological Test Battery score between two intervention groups 
over two years [52]. The effect of the NU-AGE diet on cognitive functioning will be further 
investigated in the total NU-AGE sample including ~1,250 participants. 
As outlined above, the use of specific cognitive tests allows to detect small differences within 
a study population and to study specific cognitive domains. However, the lack of harmonized 
construction of these domains limits the comparability of findings from different studies. This also 
10
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Thus, a possible explanation for the lack of an association of the HDI, DASH, MIND and NU-AGE diet 
with the MMSE and TICS is that these tests are not sensitive and specific enough to detect subtle 
cognitive differences in cognitive domains within generally healthy study participants. 
  
Commonly used screening tools for cognitive functioning are useful to characterize a study population 
for their level of cognitive functioning, however, these tests are not sensitive and specific enough to 
detect differences or decline in cognitive functioning in a relatively healthy study population. 
 
 
Specific cognitive domains  
The use of more specific cognitive tests as compared to the MMSE or TICS enables detection of 
smaller differences in specific cognitive domains, such as verbal memory, information processing 
speed, and executive functioning. For example, impaired verbal memory is part of the typical 
memory-dominant dementia syndrome in AD [48], and thus relevant to measure.  
In chapters 5, 6 and 9 we were able to use many neuropsychological tests to construct 
cognitive domains. Greater adherence to the DASH diet was associated with a better global cognitive 
function - a composite score based on six cognitive tests - and with better verbal memory at older 
ages in the Nurses’ Health Study (chapter 5). This was in line with the few observational studies 
reporting that the DASH diet was associated with less cognitive decline among elderly American men 
and women (n=826) after 4.1 years of follow-up using 19 cognitive tests combined into a global 
measure of cognition [49]. A dietary intervention study in hypertensive American adults (n=124) 
demonstrated that four months on the DASH diet improved psychomotor speed [50].  
Greater adherence to the MIND diet was moderately associated with a better verbal memory 
at older ages (chapter 6). In a prospective cohort study, the MIND diet was associated with slower 
decline in global cognitive function (a composite score of 19 cognitive tests) [25] and a lower risk of 
AD [10] over 4.7 and 4.5 years in 960 and 923 American men and women from the Memory and 
Aging Project (MAP) study. We were not able to confirm this association with global cognitive 
function in a sample of 16,058 American women living in the Boston area (chapter 6). A possible 
explanation could be the timing of dietary and cognitive assessment, as cognitive assessment 
(starting in 1997) preceded dietary assessment (2004-2013) in the MAP study, whereas dietary 
assessment preceded cognitive assessment in the NHS study, importantly limiting the effect of 
reversed causation.  
Although we used specific cognitive tests within the NU-AGE study as well, we were not able 
to demonstrate an effect of the NU-AGE diet on any of the cognitive domains in the Dutch NU-AGE 
cohort (chapter 9). This could be due to the relatively short period of follow-up, as it has been 
proposed that it takes at least 1.5 years to induce and detect changes in cognitive functioning [51]. 
Another important explanation for our null finding for the NU-AGE diet could be the lack of power, as 
the sample size was not calculated to detect an effect on cognitive functioning. The required sample 
size has been calculated to be at least 600 participants per intervention group to detect a 50% 
difference change in the Neuropsychological Test Battery score between two intervention groups 
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As outlined above, the use of specific cognitive tests allows to detect small differences within 
a study population and to study specific cognitive domains. However, the lack of harmonized 
construction of these domains limits the comparability of findings from different studies. This also 
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limited us to study the TICS and MMSE only, instead of including specific cognitive domains as well 
within the three cohorts used to study the relation of the HDI with cognitive functioning (chapter 4). 
Moreover, the use of many different cognitive tests between studies complicates drawing an overall 
conclusion based on multiple studies. For example, although four meta-analyses reported an inverse 
association of the Mediterranean diet with cognitive functioning based on pooled analysis of 
observational studies [53-56] we concluded in chapter 3 that better adherence to the Mediterranean 
diet is likely associated with less cognitive decline, dementia or AD. Our conclusion is more 
conservative in comparison to the meta-analyses as the results of the studies are mixed, studies 
reporting an association were mainly conducted in the US, many different measures of global 
cognition were used, and because evidence from intervention studies is limited. 
 
Standardised neuropsychological test batteries and harmonized rules to construct specific cognitive 
domains are needed, covering the domains on which effects of the respective intervention can be 
expected and that are sensitive to ageing. 
 
 
Biological markers to assess cognitive functioning 
Another possibility to study cognitive functioning would be to include biological markers as outcome 
measures (e.g., biomarkers and imaging techniques). Examples of brain imaging techniques are 
(fluorodeoxyglucose) positron emission tomography (f)(PET) (to detect tracers of fibrillary amyloid 
[57]) and MRI [58]. Cerebrospinal fluid (CSF) can be used to measure biomarkers of disease type and 
progression (e.g., levels of amyloid-β protein (Aβ1-42), total tau (tTau) or phosphorylated tau (pTau)181 
[59]. With these measures early stages of AD can be diagnosed. Few studies have prospectively 
investigated the association between dietary patterns and these more objective measures of brain 
health. One cross-sectional study demonstrated that adherence to the Mediterranean diet was 
associated with a lower white matter hyperintensity volume in 1,090 non-demented participants 
(mean age 72 years) [60], which is a marker of small vessel damage in the brain. A prospective study 
reported that lower adherence to the Mediterranean diet was associated with greater 3-year 
reduction in total brain volume [61]. Higher adherence to the Mediterranean diet was found to be 
cross-sectionally associated with larger cortical thickness in 672 cognitively normal participants) 
mean age 79.8) [62], which was not confirmed in a prospective study including 323 older aged 73 to 
76 years of age [61]. Less brain atrophy was observed in 674 participants without dementia (mean 
age 80.1)in a cross-sectional study – with an effect similar to 5 years of ageing [63]. A prospective 
study in 146 participants (mean age 73 years) reported that adherence to the Mediterranean diet 
was associated with preserved white matter microstructure, nine years after completion of a FFQ 
[64].  
 
Novel biomarkers and imaging techniques for early clinical stages of dementia need to be further 
developed, applied and consensus needs to be reached on which of these biological markers is best to 
use for specific purposes. 
 
 
 
 
165 
Populations to study 
To demonstrate a relation between diet and cognitive functioning, a study population should be 
selected that is either at risk of suboptimal dietary intake or status, or at risk of cognitive 
impairment, providing an optimal window of opportunity (figure 1).  
 
 
Figure 1. Window of opportunity within a hypothetical model of dynamic biomarkers and nutritional status 
across the dementia spectrum (adapted from Mi, Nutrition 2013) [65]  
 
 
Cognitive functioning 
The age at which cognitive decline becomes evident remains a subject of debate [66-68]. Although 
some authors demonstrated that there is no decline before the age of 60 years [69], it has been 
demonstrated that cognitive decline is already evident in middle age (age 45-49 years) [70]. Prior to 
the diagnosis of dementia, many years of underlying brain damage have been present [71, 72]. 
Moreover, it is relevant to consider risk factors of cognitive decline when selecting study participants, 
e.g., low educational level, obesity and Apolipoprotein E (APOE) genotype, to study cognitive decline 
or MCI occurrence. 
 
In intervention studies, when targeting populations with preclinical symptoms of cognitive decline, it 
might be of concern whether the brain damage is reversible. Given this information, there is a 
general consensus that nutritional intervention studies should aim at prevention rather than 
treatment of cognitive decline. Thus middle-aged people should be targeted before brain function is 
too comprised for substantial benefit, thereby focussing on the earliest stages of the disease [71, 73].  
Participants in the NU-AGE study (chapters 7-9) were aged 65 to 80 years, potentially 
allowing us to detect changes in cognitive functioning. Besides the follow-up time being relatively 
short and the fact that the NU-AGE study was not powered to detect an effect on cognitive 
functioning – as mentioned above – another explanation for our null-finding could be that the NU-
AGE participants were apparently healthy individuals at a relatively good cognitive function level 
limiting the possibility to detect a decline in cognitive functioning within the study period. Although 
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intervention studies are considered to be the standard for providing evidence, assessing long-term 
effects of nutritional factors with intervention studies is considered to be too expensive and difficult 
[71]. In this respect, prospective studies with long-term follow-up will provide useful information on 
the role of nutritional compounds on cognitive functioning [71].  
 
An important advantage of prospective studies is the possibility to follow participants for a long 
period of time. For example, a recent study demonstrated that cumulative burden of cardiovascular 
risk factors, such as high blood pressure, from childhood (3-18 years) was associated with worse 
midlife cognitive performance after 31 years of follow-up [74].  Another important advantage of 
prospective studies is the selection of cohorts with a specific exposure, such as APOE genotype, 
allowing the comparison of disease development.  
Participants within the Nurses’ Health Study (NHS) (chapters 4-6) comprised relatively 
healthy adults aged 70 years and older without a major decline in cognitive function over 4.1 years of 
follow-up. Studying populations that remain at optimal brain health do not provide enough variation 
in the outcome to detect an association between diet and cognitive functioning. To overcome the 
limited variation in cognitive functioning all measures were averaged to create a measure of 
cognitive status at older ages in chapter 5 and 6. Despite this method, we demonstrated a smaller 
effect size of the MIND diet with cognitive functioning in the NHS compared to the Memory and 
Aging Project study (MAP) (e.g., one year difference in cognitive age in NHS versus 7.5 years in MAP). 
Compared to NHS, MAP participants were on average ten years older than NHS participants, had a 
lower educational level, mainly lived in retirement houses, were more likely to have ever smoked and 
more likely to have reported high blood pressure, diabetes and myocardial infarction demonstrating 
that MAP participants were at higher risk of poor cognitive function and faster cognitive decline 
compared to NHS participants.  
Thus, ideally, a life course approach would be needed to study changes in cognitive 
functioning, already starting before the preclinical stages of dementia, e.g., by including a 
heterogeneous population aged 60 years and older followed for a period of up to 20 to 30 years.  
 
When designing intervention or prospective studies, participants at risk, or at a very early stage, of 
cognitive decline should be included and followed for a sufficient period – ranging from at least 1.5 
year in intervention studies to ideally 20 to 30 years for prospective studies. 
 
 
Nutrient intake and/or nutrient status 
Nutrient intake and/or status in elderly populations is relevant to consider, as with aging, energy 
needs decrease while nutrient requirements remain or increase, necessitating a more nutrient dense 
diet [75]. Inadequate nutrient intake may cause chronic metabolic disruption, including 
mitochondrial decay, resulting in acceleration of various degenerative diseases [76]. The prevalence 
of inadequate intakes is relatively high in both institutionalized (40-65%), and non-institutionalized 
older adults (5-10%) [75]. In Europe, over 20% of adults aged 65 years and older have inadequate 
intakes of vitamin D, folate, calcium, selenium and iodine [77]. Importantly, low nutrient status is 
highly prevalent in MCI and AD patients. Lower plasma levels of folate and vitamin A, vitamin B12, 
vitamin C, vitamin E [78], omega-3 fatty acids [79], and selenium [80] were reported in AD patients 
compared to cognitively healthy controls. In patients with MCI, nutrient status was low for folate 
[81], vitamin A, vitamin C, vitamin E, lutein, zeaxanthin, α-carotene [82, 83] and DHA [79]. Such 
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compromised nutritional status may result from alteration in nutrient intake, uptake, metabolism, 
and utilization [65]. Thus, low nutrient status is a consistent finding during disease progression [65] 
(figure 1). 
For intervention studies reporting a null association between a single nutrient and cognitive 
functioning, the lack of taking baseline nutrient status into account may be a possible explanation for 
their null findings. Studying apparently healthy individuals with optimal nutrient status has the 
disadvantage that there is not much room for improvement on the exposure side and thus no effects 
between nutrients and cognitive outcomes can be detected. Thus, participants who are likely to be 
sensitive and gain most benefit from the intervention should be included. In the NU-AGE study, 
plasma and serum values of nutrient have been measured, although not used as an inclusion 
criterion to specifically select participants at risk of suboptimal nutrient intake or status. As the NU-
AGE participants were relatively healthy, it is very well likely that we have included participants with 
adequate nutrient intake and status, thus resulting in less room for improvement with respect to 
changes in nutrient intake and status.   
 
Despite the relevance of nutrient intake and/or status in older adults, a major obstacle of long-term 
intervention studies is the lack of information about history of deficiencies, e.g., whether the 
deficiency is a chronic state or just a snapshot of temporary physiological state [71]. Conducting 
prospective studies with a long follow-up period including measures of nutrient intake and/or status 
could provide insights to this. Additionally, within a study population a large variety in dietary intake 
should be covered to study combinations of nutrients or dietary patterns in relation to cognitive 
functioning. Studying a study population with limited variation in dietary intake could hamper the 
detection of diet-disease associations. For example, we observed a weaker association of the MIND 
diet with cognitive functioning in the NHS compared to the MAP study, possibly caused by a limited 
variation in MIND diet score, e.g., total MIND score was 7.4 (range 2.5-12.5 in MAP [10] versus 6.4 
(2.6-11.0) in NHS (chapter 6). 
  
When selecting participants for intervention studies, low baseline nutrient intake and/or status 
should be considered as an inclusion criterion. For prospective studies, including a population with a 
wide range of dietary intake and status allows the detection of diet-cognition associations. 
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Further research 
The increase in life expectancy and its accompanying decline in cognitive functioning and increased 
risk of dementia call for research on dietary strategies that impact brain health, especially as 
effective medicines to prevent or cure dementia are lacking. Based on the current evidence and as 
outlined above, there is need for both well-designed intervention studies and prospective studies, 
which should include:  
- Dietary assessment methods that are able to assess intake of specific foods relevant for the 
dietary pattern of interest 
- Biomarkers of dietary patterns or cognitive functioning 
- Harmonized cognitive test batteries allowing the construction of specific cognitive domains 
- Imaging techniques (e.g., MRI or fMRI)  
- Sufficient follow-up time, e.g., at least 1.5 years for intervention studies, and ideally up to 20 to 
30 years in prospective studies 
- Participants either at risk of cognitive decline or with suboptimal nutrient intake and/or status 
for intervention studies, or a heterogeneous population for prospective studies.  
Additionally, to define guidelines for healthier cognitive ageing a holistic approach should be used 
considering multi-domain exposures. For example, the Finnish Geriatric Intervention Study to 
Prevent Cognitive Impairment and Disability (FINGER) study not only focussed on a healthy diet, but 
also included exercise, cognitive training and social activity, and management of metabolic and 
vascular risk factors [52] observed promising effects on cognitive functioning [84]. 
On the other hand, long-term prospective studies simultaneously studying multiple health outcomes 
should be used to better understand why some people develop age-related diseases while others 
age more healthily. An example is the Rhineland study, which envisages to include up to 30.000 
participants from Bonn in which both mental and physical health are uniquely being assessed over 
their lifespan - starting at age 30 [85]. 
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Conclusions and public health implications 
This thesis described results from a literature review, a cross-sectional study, observational studies 
and an intervention study on the relation between diet and cognitive functioning. The 
Mediterranean diet seems to be most consistently associated with less cognitive decline, dementia 
or AD (chapter 3). Although we did not find an association between the Healthy Diet Indicator or the 
NU-AGE diet with global cognitive function (chapter 4 & 9), we demonstrated that participants with 
the highest adherence to the DASH diet and MIND diet were cognitively one year younger compared 
to participants with the lowest adherence (chapter 5 & 6). Although previous studies showed that 
dietary intakes of elderly are rather stable [86, 87], chapter 8 importantly adds to this knowledge, by 
demonstrating that adults aged 65 years and older are able to change their dietary intakes. This is an 
encouraging finding, demonstrating that diet is a modifiable and feasible risk factor for cognitive 
decline prevention - even at older ages.  
 
This last chapter demonstrates that there are many aspects to consider when studying dietary 
patterns in relation to cognitive functioning. This thesis adds scientific evidence to ultimately define 
the optimal dietary pattern to preserve cognitive functioning, describing results from multiple study 
designs. Additionally, this thesis does provide important insights into methodological considerations 
and suggestions for further research. When grading the reported associations in previous studies and 
studies in this thesis [88], we can conclude that there is probable evidence for a role of the 
Mediterranean diet on cognitive functioning. For the DASH and MIND diet there is a possible link 
with cognitive functioning; for the HDI and the NU-AGE diet there is no sufficient evidence yet to 
conclude that there is a relation with cognitive functioning. 
 
We do call for communication strategies to the general public about the consumption of healthier 
dietary patterns to not only impact cardiovascular but also potentially impact brain health. We 
should not only invest in further studies, but also invest in communication to the general public, as 
many individuals will face progressive cognitive decline and the sooner they can act the more benefit 
they may have. A first step was the inclusion of dementia as one of the targeted diseases in the 
updated Dutch food based dietary guidelines [89], and subsequently the ‘Wheel of five’ (in Dutch: 
Richtlijnen Schijf van Vijf) [90] has been updated. However, evidence on dementia was included in 
only one of the guidelines. Therefore, a next step would be the inclusion of findings from further 
research to be used for nutrition education in the Netherlands. 
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With ageing of our population and the accompanying increase in the number of people living with 
dementia, it is important to find modifiable risk factors to postpone the onset of cognitive decline. 
Diet has been proposed such a modifiable risk factor. To date, numerous studies have been 
conducted demonstrating a possible role of specific nutrients and foods in cognitive functioning. 
However, as people do not consume single nutrients, the research field has shifted towards studying 
dietary patterns in which synergistic effects of single nutrients and/or foods can be studied. The 
main aim of this thesis was to study the association of healthful dietary patterns with cognitive 
functioning. In addition, nutrient intake inadequacies were assessed and the potential to change 
dietary intake in older adults aged 65 years and older was studied. 
Chapter 2 describes nutrient intake of 245 Dutch adults aged 65-80 years. We identified the 
contribution of nutrient dense foods, fortified foods and dietary supplements to the total intake of 
micronutrients. Nutrient density of foods was evaluated using the Nutrient Rich Food score 9.3. 
Nutrient intake inadequacies were observed for vitamin D, vitamin B6 and selenium. Conventional 
foods were the main source of vitamin D, vitamin B6 and selenium intake. Foods with the highest 
nutrient density contributed most to total vitamin B6 intake. In order to optimize nutrient intakes of 
elderly, combinations of natural food sources, fortified foods and dietary supplements should be 
considered. 
Chapter 3 provides a systematic review of the literature on human studies up to May 2014 that 
examined the role of dietary patterns in relation to cognitive decline or dementia. The results 
demonstrate that better adherence to a Mediterranean diet was associated with less cognitive 
decline, dementia or Alzheimer’s Disease (AD) in four out of six cross-sectional studies, six out of 12 
longitudinal studies, one trial and three meta-analyses. Other healthy dietary patterns, among which 
the Healthy Diet Indicator, have shown to be associated with reduced cognitive decline and/or a 
reduced risk of dementia in all six cross-sectional studies and six out of eight longitudinal studies. 
The conclusion of this literature review was that more conclusive evidence is needed to come to 
more targeted and detailed dietary guidelines to prevent or postpone cognitive decline. 
In chapter 4 the association between the Healthy Diet Indicator (HDI) and cognitive functioning in 
older adults from three different cohort studies was investigated. The cohorts included in total 
21,837 subjects from Europe (SENECA and the Rotterdam Study [RS]) and the Unites States (Nurses’ 
Health Study [NHS]). Cognitive functioning was measured using the Mini-Mental State Examination 
(MMSE) in SENECA and RS, and the Telephone Interview for Cognitive Status (TICS) in NHS. In all 
three cohorts, the HDI was not significantly associated with cognitive decline, nor with cognitive 
function. 
In chapter 5 the association of long-term adherence to the Dietary Approaches to Stop Hypertension 
(DASH) diet with cognitive function and decline in older American women was examined. A total of 
16,144 women from the Nurses’ Health Study, aged ≥70 years, who underwent cognitive testing a 
total of 4 times by telephone from 1995-2001 (baseline), with multiple dietary assessments between 
1984 and the first cognitive exam were studied. Greater adherence to long-term DASH score was 
significantly associated with better average global cognition, verbal memory and TICS score at older 
ages, but not with cognitive decline. 
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In chapter 6, the same cohort as in chapter 5 was studied to examine the association between long-
term adherence to a recently developed Mediterranean-DASH Intervention for Neurodegenerative 
Delay (MIND) diet with cognitive function and decline. Higher MIND diet scores were associated with 
better verbal memory at older ages, but not with cognitive decline over 6 years in global cognition, 
verbal memory or TICS.  
Chapter 7 provides an overview of the NU-AGE (NUtrients and AGEing) dietary intervention study. 
The NU-AGE study is a randomized one-year intervention in 1,250 apparently healthy, independently 
living European subjects aged 65 to 80 years. Subjects were randomised into either the intervention 
group or the control group. Participants in the intervention group received dietary advice aimed at 
meeting the dietary recommendations of the ageing population. At the start of this thesis, the NU-
AGE study was the first dietary intervention investigating the effect of a whole diet and providing 
targeted dietary recommendations for optimal health and quality of life in apparently healthy 
European elderly.  
In chapter 8, we evaluated if the NU-AGE intervention could be effective to shift the dietary intake 
of apparently healthy older adults aged 65-80 years living in Italy, the UK, the Netherlands, Poland, 
and France towards a more healthful diet. The NU-AGE index was created to assess adherence to the 
NU-AGE diet. At baseline and after one-year follow-up dietary intake was assessed by means of 7-
day food records. In total, 1,296 participants were randomized and 1,145 participants completed the 
intervention (571 in intervention group, 570 in control group). After one-year follow-up, the 
intervention group improved mean intake of 13 out of 16 dietary recommendations of the NU-AGE 
diet (p<0.05) with a significant increase of the total NU-AGE index, compared to the control group 
(mean change in NU-AGE index 21.3±15.9, p<0.01). The NU-AGE dietary intervention, based on 
dietary recommendations for older adults, may be a feasible strategy to improve dietary intake in an 
ageing European population. 
Chapter 9 shows the results of the NU-AGE parallel randomized dietary intervention study on 
cognitive functioning in the Dutch NU-AGE subpopulation, including 252 older adults aged 65-80 
years (123 intervention, 129 control). The primary outcome was one-year change in global cognition 
and in four cognitive domains as measured through a comprehensive neuropsychological test 
battery. Comparing the intervention with the control group, there was no effect of the intervention 
on cognitive functioning. 
In chapter 10 the main findings of this thesis were summarized and a reflection on methodological 
aspects was given. When grading the reported associations in previous studies and studies in this 
thesis, it was concluded that there is probable evidence for a role of the Mediterranean diet on 
cognitive functioning. For the DASH and MIND diet there is a possible link with cognitive functioning; 
for the HDI and the NU-AGE diet there is no sufficient evidence yet to conclude that there is a 
relation with cognitive functioning. Not only is there a need for well-designed intervention and 
prospective studies, we also call for communication strategies to the general public about the 
consumption of healthier diets to not only impact cardiovascular but also potentially impact brain 
health as many individuals will face progressive cognitive decline in the near future. 
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- Gezonde voeding, gezond ouder worden - 25 jaar voedingsonderzoek bij ouderen in 
Wageningen2, Wageningen, 2013 
- Ageing Research@NL2, NCHA, Den Haag, 2013 
- ILSI expert group meetings, ILSI, Brussels, Belgium, 20141, 20161 
- Nutrition for the ageing brain, ILSI, Milan, Italy, 2014 
- Mix & Match meeting, Alzheimer Nederland, Utrecht, 2015 
- International Academy Nutrition & Aging congress2, Barcelona, Spain, 2015 
- Voeding Nederland - Wetenschap en praktijk, Utrecht, 2015 
- Challenges in translational research to promote healthy ageing2, DUSRA/KNAW, Leiden, 2017 
 
General courses 
- Scientific Writing Workshop, VLAG, Wageningen, 2011  
- Wet- en regelgeving voor klinisch onderzoek, ZGV, Ede, 2011 
- Competence Assessment, WGS, Wageningen, 2012 
- VLAG PhD week (26th edition), Baarlo, 2012 
- Supervising MSc thesis, ESD/WUR, Wageningen, 2012 
- Project and Time Management, WGS, Wageningen, 2012 
- Stress Identification and management, VLAG, Wageningen, 2013 
- Philosophy and Ethics of Food Science and Technology, VLAG, Wageningen, 2013 
- Data management, VLAG, Wageningen, 2014 
- PhD Workshop carrousel, VLAG, Wageningen, 2014 
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- European Nutrition Leadership Program, Luxembourg, Luxembourg, 2016 
- Teaching an online course, ESD/WUR, Wageningen, 2017 
 
Optional courses and activities 
- Preparation PhD research proposal, Wageningen, 2011 
- PhD study tour3, Division of Human Nutrition, Melbourne/Sydney, Australia, 2013 
- Epi-research meetings, HNE, Wageningen, 2011-2015 
- Methodology Club, HNE, Wageningen, 2011-2015 
- Rothman lunches, HNE, Wageningen, 2013-2016 
 
1 Oral presentation given; 2 Poster presentation given, 3 Member of the organizing committee 
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